data_2mmx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mmx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 C--O 1.228 -0.057 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.1 102.77 6.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -92.1 121.08 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.008 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.549 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.55 164.86 25.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 106' ' ' THR . 6.0 Cg_exo -50.15 134.42 36.91 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.246 1.964 . . . . 0.0 111.612 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.546 ' HD1' ' CB ' ' A' ' 9' ' ' SER . 9.7 t-80 -67.0 -68.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.546 ' CB ' ' HD1' ' A' ' 8' ' ' HIS . 53.2 m -148.43 146.04 28.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -162.52 156.14 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.525 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -133.86 145.55 49.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.384 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -133.82 156.68 47.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.093 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -77.06 136.76 65.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.166 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.56 125.19 17.07 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.583 1.522 . . . . 0.0 111.093 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 -6.68 25.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -94.08 173.52 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.778 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.6 p -100.56 136.62 40.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.225 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.5 137.43 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -125.14 127.59 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' H ' HD22 ' A' ' 76' ' ' LEU . 21.7 mm -104.59 139.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.42 127.71 53.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.379 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 11.2 m -118.62 126.36 51.79 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.8 m -118.93 141.64 48.47 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.719 ' C ' ' H ' ' A' ' 26' ' ' SER . 33.1 mtp85 -94.74 141.11 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.185 170.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.5 t -58.2 0.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.544 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.719 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.25 -18.1 14.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.794 -173.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 75.47 21.87 76.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' OD1' ' A' ' 32' ' ' ASN . 10.5 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.32 -63.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.439 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.96 1.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 29' ' ' ILE . 54.7 m -104.97 -27.08 11.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.378 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.409 HD22 ' HD3' ' A' ' 24' ' ' ARG . 4.0 p-10 -122.2 163.58 19.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.152 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -81.92 142.88 32.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.67 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.02 148.26 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.558 HE21 ' C ' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -133.24 144.52 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.558 ' C ' HE21 ' A' ' 35' ' ' GLN . 97.9 m95 -110.43 135.03 51.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 110.878 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.538 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -128.29 149.11 50.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.03 140.55 52.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.415 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 6.6 tm0? -148.24 144.65 27.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.449 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.663 0.193 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 m -138.78 110.31 7.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.538 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -60.87 121.15 11.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.45 -27.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.408 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mt -145.11 146.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 8.5 t80 -130.96 159.08 38.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.251 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 3.7 tt0 49.3 24.31 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.653 0.74 . . . . 0.0 110.682 -175.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.2 p-10 44.5 19.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.61 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.67 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.0 -46.35 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.378 0.609 . . . . 0.0 109.811 171.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.67 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.55 124.79 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.033 -167.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 108.8 40.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.462 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.56 144.54 55.44 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.475 1.45 . . . . 0.0 111.662 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -67.26 -32.38 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.711 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.99 -58.65 13.44 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.45 137.87 48.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.544 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.2 Cg_exo -59.01 137.92 82.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.966 1.111 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 63' ' ' PHE . 12.0 p-10 -61.5 1.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.445 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 60' ' ' PRO . 9.1 ptm180 -49.79 -2.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.93 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.558 ' H ' ' C ' ' A' ' 61' ' ' ASP . 47.2 m-85 -104.45 143.65 32.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.31 122.55 34.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.893 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.07 125.29 8.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.497 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.3 p -157.57 161.88 38.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.194 0.521 . . . . 0.0 111.124 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.89 158.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.769 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.8 m-20 -102.65 145.96 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.8 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.91 -3.72 10.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.442 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.3 m -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.068 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 28.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.593 -177.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -98.77 -40.55 8.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -168.17 169.83 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.088 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.32 135.54 49.46 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 120.613 -1.304 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -128.48 115.6 18.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.137 -171.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -98.03 140.72 31.94 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 118.622 -2.549 . . . . 0.0 116.91 168.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.0 m -104.63 129.22 52.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 162.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.45 ' CG2' ' NH2' ' A' ' 62' ' ' ARG . 6.0 mt -109.65 105.94 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 120.179 -1.576 . . . . 0.0 110.193 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 t -88.86 153.13 21.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 61.34 4.06 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.21 137.92 34.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.163 0.506 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 84' ' ' GLU . 22.3 mttt -151.45 173.73 14.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.694 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -19.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.497 173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 82' ' ' LYS . 91.2 mt-10 -68.81 -41.0 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.392 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.543 ' CG ' HH22 ' A' ' 62' ' ' ARG . 16.7 t70 -72.68 -9.9 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.242 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 82.3 tt0 -56.4 120.97 8.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.812 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 161.88 176.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -88.73 152.86 21.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.668 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 17.6 m-85 -117.67 143.26 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.997 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.3 m-85 -144.58 142.51 30.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.727 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.1 p -134.96 140.86 46.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.829 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -121.16 148.55 44.07 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.76 -0.587 . . . . 0.0 110.482 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 p -135.15 153.37 52.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 110.68 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.98 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.2 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.694 0.283 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.99 -141.99 4.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.68 53.86 38.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.06 103.5 2.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 34.4 m -126.27 141.7 51.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 110.642 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -104.93 101.15 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.69 124.97 36.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.379 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 m -120.74 124.91 46.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.55 100.94 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.113 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.836 179.612 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.439 ' H ' ' HB2' ' A' ' 25' ' ' SER . 4.4 ptm . . . . . 0 C--O 1.231 0.105 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.38 104.49 9.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.44 ' H ' ' HG1' ' A' ' 5' ' ' THR . 12.0 p -80.17 129.68 34.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.321 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.568 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 3.0 mt-30 -145.34 166.68 16.8 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -63.84 133.32 38.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.475 1.45 . . . . 0.0 111.319 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.645 ' CG ' ' H ' ' A' ' 9' ' ' SER . 6.1 p80 -44.19 -60.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.645 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 35.2 p -164.08 160.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -162.95 147.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 p -130.71 132.2 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.849 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.92 158.23 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 m -80.93 140.03 50.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.57 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.38 116.13 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.751 1.634 . . . . 0.0 111.043 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.32 -0.6 18.82 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -107.56 -163.05 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.9 p -136.63 153.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.16 147.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.051 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 131.74 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.85 134.27 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.292 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.8 m -104.92 123.56 47.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.877 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.99 111.91 18.92 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.7 m -116.59 141.97 47.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.9 mtm180 -99.55 143.27 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.071 170.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -58.24 1.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 176.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.699 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -101.45 -14.05 17.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.784 -174.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.33 27.14 70.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.8 p -124.5 109.53 13.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 110.571 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.558 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -135.17 -64.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.995 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.522 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -66.59 -2.41 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.6 t -100.93 -29.18 12.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.57 -2.104 . . . . 0.0 111.339 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -121.09 148.53 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.0 112.84 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.372 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 22.0 t -102.3 146.3 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.58 HE21 ' CB ' ' A' ' 92' ' ' GLN . 7.1 tt0 -127.97 165.09 20.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 28.2 m95 -130.04 127.43 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.936 0.398 . . . . 0.0 110.914 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.504 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 2.1 m-85 -121.19 148.99 43.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.374 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -126.74 134.79 50.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -112.31 117.54 32.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.687 -179.567 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.49 1.278 0 N-CA-C 110.812 -0.495 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 126.82 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.436 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.504 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -74.94 120.96 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.099 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.17 -28.4 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.491 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -145.42 151.66 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.801 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 3.5 t80 -140.82 164.86 29.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' ASN . 2.7 tt0 44.84 21.9 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 110.887 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 43.09 18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.614 -177.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.79 -46.97 1.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 173.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.801 ' OE1' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.01 153.28 40.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.993 -164.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' O ' ' A' ' 60' ' ' PRO . 3.3 ttt85 -132.0 108.67 14.01 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 120.322 -1.486 . . . . 0.0 109.939 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -69.7 143.0 49.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.446 1.43 . . . . 0.0 111.449 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -73.99 -18.86 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.062 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.46 -38.33 96.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.08 149.95 37.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 122.291 -0.535 . . . . 0.0 109.626 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.4 Cg_endo -53.65 125.98 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.795 1.663 . . . . 0.0 111.342 -173.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.486 ' C ' HH21 ' A' ' 55' ' ' ARG . 97.8 m-20 -61.05 2.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.443 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' A' ' 60' ' ' PRO . 19.6 mtm105 -69.25 21.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -173.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' O ' ' CZ ' ' A' ' 55' ' ' ARG . 16.9 m-85 -131.32 143.6 50.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.151 0.432 . . . . 0.0 110.626 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 77' ' ' THR . 2.1 t -126.64 123.14 36.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.139 -0.457 . . . . 0.0 111.269 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.21 136.54 13.66 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.374 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.4 p -163.83 159.92 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.03 154.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.669 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 70' ' ' SER . 15.9 m-20 -102.98 154.21 19.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.948 176.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.4 p -69.7 7.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 68' ' ' ASP . 24.4 m -74.19 -43.11 58.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.596 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 70' ' ' SER . 12.7 p 79.5 30.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.657 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.05 -38.14 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.767 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -169.5 172.39 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.775 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.76 123.81 49.6 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 120.864 -1.147 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' SER . 13.7 m -114.02 112.8 23.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.519 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -96.92 140.48 31.4 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 119.3 -2.125 . . . . 0.0 116.019 169.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.481 ' O ' ' CB ' ' A' ' 64' ' ' SER . 5.6 m -112.64 126.23 55.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 164.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 78' ' ' ILE . 28.5 mm -86.29 114.25 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 120.21 -1.556 . . . . 0.0 110.919 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.9 t -103.76 131.71 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.85 52.92 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.96 133.82 10.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.252 0.548 . . . . 0.0 110.106 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 84' ' ' GLU . 3.0 ttmt -144.17 171.98 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.198 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -19.03 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.831 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 82' ' ' LYS . 5.6 mp0 -70.86 -39.38 72.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -69.76 -9.05 53.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.276 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 72.0 tt0 -60.37 122.91 15.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 157.38 -179.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 90' ' ' TYR . 9.8 t0 -87.62 149.89 24.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.9 m-85 -115.28 145.39 42.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 88' ' ' ASP . 67.7 m-85 -143.5 154.1 43.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.215 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.84 141.0 49.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.58 ' CB ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.48 120.74 31.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.615 0.643 . . . . 0.0 109.386 174.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.598 ' HG ' ' CD ' ' A' ' 24' ' ' ARG . 59.7 p -128.54 152.5 48.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.966 0.412 . . . . 0.0 110.649 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.73 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.746 0.308 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.82 -132.47 1.39 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 48.37 47.01 28.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.33 108.78 2.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 92.8 m -133.16 134.57 44.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.841 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.83 124.31 36.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -113.81 131.32 56.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.934 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.3 m -124.29 128.97 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 58.2 t -87.56 34.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.952 -179.791 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.431 ' H ' ' HB2' ' A' ' 25' ' ' SER . 30.1 mtm . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.32 103.24 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.48 113.93 11.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.588 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 14.0 tt0 -144.87 141.82 17.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 118.977 -0.535 . . . . 0.0 109.58 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -51.4 137.16 48.08 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 CA-C-N 120.563 1.237 . . . . 0.0 110.954 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 9' ' ' SER . 42.2 p-80 -58.85 -49.43 77.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.629 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' ' CD2' ' A' ' 8' ' ' HIS . 2.4 m -158.7 151.68 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.45 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 p -160.29 154.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -131.9 149.0 52.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.312 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -141.37 162.19 36.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.459 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -85.93 156.8 57.87 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.325 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.71 128.36 19.84 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.69 1.593 . . . . 0.0 112.283 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.77 -5.27 39.94 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -89.4 167.94 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.672 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p -102.75 125.41 49.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.782 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' ILE . 2.6 t -114.44 138.95 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 32.5 m -128.59 119.78 25.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.931 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.06 132.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -109.07 124.93 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.0 m -118.86 115.4 24.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.4 m -116.96 137.66 52.07 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 26' ' ' SER . 12.7 ttp85 -92.81 139.18 30.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.498 170.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 3' ' ' MET . 16.6 m -58.41 2.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.627 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.71 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.06 -18.13 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.89 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.68 22.98 76.32 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.58 ' C ' HD22 ' A' ' 32' ' ' ASN . 30.1 t -120.82 110.02 15.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.507 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.47 -63.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.799 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -63.35 0.35 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.0 p -103.87 -11.63 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.837 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.602 ' N ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -132.33 152.07 51.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 109.982 -177.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.98 127.96 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.092 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' HA ' HE21 ' A' ' 35' ' ' GLN . 20.5 t -119.81 146.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.228 0.537 . . . . 0.0 110.719 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.56 156.99 47.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.341 -177.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.538 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 98.0 m95 -113.93 136.69 52.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.445 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.435 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 10.2 m-85 -126.17 149.15 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.42 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -146.13 133.53 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.575 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.07 160.21 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.533 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.08 178.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.491 1.333 0 CA-C-O 120.587 0.161 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 p -132.72 143.31 49.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.435 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 5.5 m -71.7 120.89 17.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.455 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -102.84 -28.66 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.299 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 49' ' ' ILE . 5.9 mt -145.61 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.2 t80 -127.79 166.04 18.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.7 tt0 44.77 22.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.083 0.944 . . . . 0.0 110.6 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.2 p30 43.48 17.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.763 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.09 -47.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 170.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 1.1 pp0? -80.9 126.12 30.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.936 -166.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -121.22 119.29 29.67 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.276 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.26 141.37 97.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.8 1.321 . . . . 0.0 111.64 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -67.3 -5.35 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.54 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.99 59.03 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.24 148.5 35.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 122.587 -0.361 . . . . 0.0 110.845 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -59.35 139.41 89.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.813 1.675 . . . . 0.0 111.568 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -61.05 -0.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 63' ' ' PHE . 42.6 ptt85 -56.12 -31.87 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 0.0 111.313 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 60.3 m-85 -72.25 140.89 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.6 t -128.36 122.61 31.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.89 123.94 7.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.41 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -154.56 158.23 39.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.631 . . . . 0.0 111.29 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pp -143.46 157.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.635 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 70' ' ' SER . 4.6 m-20 -105.16 143.63 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.813 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -0.05 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.955 0.407 . . . . 0.0 110.327 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 68' ' ' ASP . 19.4 m -70.58 -40.77 73.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.02 29.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.397 -177.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -98.93 -39.7 8.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.579 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.5 p -167.78 169.55 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.889 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.36 130.29 55.21 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.544 -1.348 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' SER . 9.1 m -129.94 114.78 16.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.143 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -97.95 140.53 32.16 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 118.645 -2.534 . . . . 0.0 116.166 167.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 64' ' ' SER . 86.2 m -100.12 128.03 46.27 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 162.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.44 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 120.684 -1.26 . . . . 0.0 110.072 174.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.78 170.94 10.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.032 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.36 56.63 4.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.38 136.47 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.536 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' GLU . 14.0 mttp -145.66 -176.6 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.399 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -47.3 -18.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.509 171.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 82' ' ' LYS . 77.9 tt0 -69.97 -41.63 74.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.233 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.517 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 14.5 t70 -74.3 -3.65 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 73.6 tt0 -69.16 124.14 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.76 -175.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.817 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -88.55 135.38 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.239 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 85' ' ' ASP . 13.5 m-85 -114.27 139.95 49.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.028 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.4 m-85 -129.52 154.15 47.31 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.538 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -118.53 140.68 49.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -123.81 116.47 23.02 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 p -135.41 141.68 45.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.703 178.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.6 p90 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.486 0.184 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.24 -154.41 11.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.76 40.17 97.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.67 96.96 0.87 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 63.3 m -120.48 131.39 54.72 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.89 117.43 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 29.8 tp -100.32 125.22 46.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.74 109.64 17.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 61.6 t -84.37 44.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.615 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.236 178.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.432 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 3.8 ttt . . . . . 0 C--O 1.231 0.081 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.432 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.3 OUTLIER -129.41 103.15 6.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -83.38 119.71 24.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.875 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.5 tt0 -144.98 145.54 27.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.649 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -49.94 136.59 36.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.257 1.128 . . . . 0.0 111.209 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.537 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.69 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 5.1 m -156.41 160.18 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.683 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.84 146.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.912 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p -141.08 145.87 36.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.589 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -142.95 154.24 43.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -78.04 140.67 62.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.635 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.06 123.98 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.737 1.624 . . . . 0.0 111.021 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.79 22.41 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -97.88 -171.73 2.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.662 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p -119.89 142.42 48.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.47 142.41 44.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.079 0.466 . . . . 0.0 110.611 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -128.62 134.45 48.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.434 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.529 ' H ' HD21 ' A' ' 76' ' ' LEU . 5.4 mm -105.8 146.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.179 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -124.06 122.8 38.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.5 117.91 30.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 m -117.01 142.11 47.38 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.733 ' C ' ' H ' ' A' ' 26' ' ' SER . 50.9 mtt85 -98.59 140.53 32.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.315 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -58.54 3.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.733 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.33 -17.11 15.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.603 -174.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.48 -41.3 2.49 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -65.42 111.0 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.054 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.12 -59.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.505 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -60.66 1.09 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.709 ' H ' ' C ' ' A' ' 29' ' ' ILE . 7.8 t -107.92 -30.23 8.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.901 -1.5 . . . . 0.0 111.568 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -111.86 143.11 43.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.4 m-85 -73.95 134.31 43.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.888 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' CG2' ' NH2' ' A' ' 24' ' ' ARG . 1.5 t -121.0 145.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.354 0.597 . . . . 0.0 109.944 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.7 153.23 45.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.463 -176.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 29.3 m95 -129.99 132.34 46.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 110.519 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.53 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 32.3 m-85 -119.29 149.39 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.633 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.547 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -131.37 129.27 41.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -113.56 124.83 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.491 1.332 0 N-CA-C 111.458 -0.247 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.5 p -139.25 134.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.507 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.53 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 4.4 m -70.29 118.79 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.162 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.88 -21.82 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.338 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.4 mt -144.56 143.16 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 52' ' ' ASP . 76.8 t80 -133.12 167.22 20.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.314 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 53' ' ' ASN . 10.0 tp10 44.67 23.51 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.043 0.925 . . . . 0.0 110.241 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.2 t70 44.22 19.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.255 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' ND2' ' NE2' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -128.04 -45.18 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.783 168.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.629 ' NE2' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.31 143.89 17.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.36 -170.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -146.82 108.57 4.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 118.989 -0.529 . . . . 0.0 109.866 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.21 148.89 56.76 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.534 1.489 . . . . 0.0 111.95 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -74.13 -30.2 62.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.38 -47.12 63.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.51 145.31 31.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.1 Cg_endo -53.01 117.99 4.33 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.915 1.744 . . . . 0.0 111.293 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 63' ' ' PHE . 18.5 p-10 -60.78 0.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.644 HH12 ' N ' ' A' ' 85' ' ' ASP . 47.2 mtm105 -46.12 -11.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.996 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 3.4 m-85 -105.4 143.08 34.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.6 t -124.75 122.86 38.66 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.81 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.19 121.77 7.0 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.47 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.1 p -157.29 163.75 38.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.1 155.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.522 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -100.18 152.06 20.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.836 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.7 m -67.94 -8.56 38.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' SER . 58.0 m -61.34 -41.17 96.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER 79.6 27.29 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.347 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -98.55 -41.75 7.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.413 ' H ' HD13 ' A' ' 29' ' ' ILE . 62.7 p -164.43 174.85 10.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.67 47.78 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.614 -1.303 . . . . 0.0 110.011 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 66' ' ' SER . 69.1 m -116.77 116.67 27.93 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.839 -169.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.529 HD21 ' H ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -97.82 140.58 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 118.474 -2.642 . . . . 0.0 117.386 170.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 64' ' ' SER . 4.5 m -107.85 127.39 53.68 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 163.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -104.18 109.92 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 120.08 -1.638 . . . . 0.0 110.21 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.99 155.75 16.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.332 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.06 42.22 96.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.21 136.86 57.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -151.83 177.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.262 177.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.93 -21.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.521 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.8 mt-10 -70.22 -40.69 74.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.261 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.644 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.9 OUTLIER -70.82 -9.03 56.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.145 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 39.5 tt0 -64.18 125.22 23.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.183 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 163.1 -175.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.039 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.085 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.547 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 16.2 m-85 -115.25 146.82 41.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.459 . . . . 0.0 111.08 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.6 m-85 -144.79 149.01 34.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.077 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.7 140.18 34.86 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.432 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 mt-30 -133.16 149.02 52.09 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.62 ' CB ' ' HE ' ' A' ' 24' ' ' ARG . 15.1 m -135.19 126.76 28.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.389 . . . . 0.0 110.938 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 35' ' ' GLN . 12.3 p90 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.849 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.723 0.297 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.52 -145.0 4.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 12.78 83.98 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.15 99.33 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.446 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 16.4 m -142.42 141.76 32.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.005 0.431 . . . . 0.0 110.26 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -106.19 119.16 38.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 tp -104.04 122.61 45.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' LEU . 1.2 m -117.29 111.66 19.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 47.6 t -82.76 31.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.779 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' THR . 13.7 mt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.984 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 CA--C 1.522 -0.111 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.79 118.82 25.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -85.88 120.47 27.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.783 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.698 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.6 tt0 -145.48 141.94 17.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.45 160.76 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.247 1.298 . . . . 0.0 111.773 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.43 ' ND1' ' OG ' ' A' ' 9' ' ' SER . 3.3 t-80 -81.29 -56.56 3.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.43 ' OG ' ' ND1' ' A' ' 8' ' ' HIS . 59.6 p -156.31 150.55 25.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.48 149.62 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 p -120.26 137.62 54.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -117.01 155.38 29.29 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 m -82.99 131.99 52.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.978 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.4 116.77 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.665 1.577 . . . . 0.0 111.018 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.53 -1.97 20.25 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -101.93 -171.74 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.242 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 p -125.85 146.77 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.205 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.83 150.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.553 ' OG1' ' O ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -126.26 137.31 53.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.54 150.45 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -125.83 114.93 19.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.812 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.698 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 50.5 m -118.69 113.76 21.68 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.2 m -113.31 141.22 47.28 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.02 -1.05 . . . . 0.0 108.272 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.693 ' C ' ' H ' ' A' ' 26' ' ' SER . 40.5 mtp85 -89.53 137.24 32.5 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.32 -0.862 . . . . 0.0 110.377 170.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -60.97 2.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.48 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -102.75 -16.93 15.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.499 -175.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.03 22.84 70.44 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 m -125.89 111.06 14.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.496 0.189 . . . . 0.0 110.829 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.701 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.31 -61.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.14 -0.35 . . . . 0.0 111.584 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -61.0 1.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.701 ' H ' ' C ' ' A' ' 29' ' ' ILE . 94.0 p -109.77 -9.83 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.483 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 28' ' ' SER . 2.7 m120 -124.69 145.7 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.27 134.84 45.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.0 t -130.06 147.93 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.509 0.671 . . . . 0.0 111.164 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -137.88 153.39 49.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.108 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -117.58 120.75 39.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -121.48 149.31 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.229 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.34 137.21 47.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 135.48 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.76 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.983 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 N--CA 1.49 1.323 0 CA-C-O 120.704 0.21 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 m -120.63 121.72 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.139 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 m -62.13 120.59 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.793 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.14 -28.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.007 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -145.23 149.35 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 52' ' ' ASP . 62.7 t80 -134.3 160.85 36.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.033 172.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 6.6 tt0 47.19 24.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.326 0.584 . . . . 0.0 111.136 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.6 p30 44.42 19.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.602 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.734 HD21 HE22 ' A' ' 54' ' ' GLN . 0.4 OUTLIER -127.76 -46.19 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.432 0.634 . . . . 0.0 109.56 170.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.734 HE22 HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.65 135.52 40.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.599 -167.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 108.79 18.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -63.36 148.71 92.59 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.96 1.774 . . . . 0.0 111.771 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 t -64.15 -29.54 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.86 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.34 -49.57 71.69 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.03 129.63 33.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.559 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.5 Cg_endo -62.91 164.34 19.4 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.641 1.561 . . . . 0.0 111.901 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -59.54 1.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.081 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.631 ' NE ' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -39.59 -37.08 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 44.3 m-85 -89.53 143.75 26.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.5 t -136.93 122.97 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.221 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.12 125.93 7.09 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.562 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 68.8 p -159.43 161.35 35.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.069 0.462 . . . . 0.0 111.023 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -137.02 161.31 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.646 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 70' ' ' SER . 86.6 m-20 -102.39 154.9 18.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.717 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -68.87 10.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 68' ' ' ASP . 26.1 m -80.49 -42.94 21.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.88 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.0 28.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.444 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -99.69 -38.12 8.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.607 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.9 p -167.95 166.26 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.545 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.97 134.18 51.24 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.063 -1.023 . . . . 0.0 109.655 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 7.4 m -134.07 120.07 19.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.79 140.35 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.296 -1.503 . . . . 0.0 114.101 167.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 57.6 m -106.6 128.84 54.46 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 164.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -104.82 116.56 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 120.82 -1.175 . . . . 0.0 109.672 171.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 t -98.82 127.98 44.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.704 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 69.65 1.38 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.7 tt -85.4 127.84 34.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.383 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 84' ' ' GLU . 8.3 mtmt -137.05 -177.0 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.8 0.334 . . . . 0.0 110.636 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -19.36 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.316 171.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 82' ' ' LYS . 52.7 tp10 -67.2 -41.18 86.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.849 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 1.3 m-20 -68.99 -19.05 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.082 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 68.3 tt0 -51.16 120.83 5.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.669 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.87 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.317 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.76 143.7 26.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.18 139.64 50.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.158 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -137.8 142.49 40.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.764 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.463 ' SG ' ' HA3' ' A' ' 103' ' ' GLY . 5.7 p -121.84 140.46 52.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 40.1 mt-30 -124.25 128.75 49.63 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.214 -0.304 . . . . 0.0 110.478 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 155.61 50.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.682 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HH ' ' NE2' ' A' ' 35' ' ' GLN . 2.8 p90 . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.175 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.359 0.6 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.463 ' HA3' ' SG ' ' A' ' 91' ' ' CYS . . . -103.49 27.7 18.74 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.469 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.55 63.27 5.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.233 -0.985 . . . . 0.0 110.74 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.55 149.46 8.23 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.598 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.8 m -111.04 141.47 44.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -81.55 123.94 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.504 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 tp -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.565 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.5 m -123.73 121.46 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.406 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 111' ' ' LEU . 39.0 t -83.76 96.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 110' ' ' VAL . 7.0 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.725 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.4 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 13.0 ttp . . . . . 0 C--O 1.231 0.092 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.5 OUTLIER -119.4 103.02 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 130.89 35.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.493 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.758 HE22 ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -146.34 164.41 24.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.023 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.85 145.29 51.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.398 2.066 . . . . 0.0 110.869 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.25 -73.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.503 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 49.0 m -161.47 159.35 27.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.605 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.24 155.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.467 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -125.6 137.3 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.373 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.12 161.93 18.64 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -89.94 142.29 28.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.312 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.3 114.9 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.576 1.517 . . . . 0.0 111.452 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.43 -20.3 16.03 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.56 -169.42 1.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.5 p -129.61 153.89 47.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.42 152.23 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -124.27 134.05 53.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.948 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.2 mt -101.85 143.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.584 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -119.59 127.96 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.737 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -118.46 112.52 20.06 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.9 m -113.22 140.58 47.83 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.707 -1.246 . . . . 0.0 108.02 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.713 ' C ' ' H ' ' A' ' 26' ' ' SER . 20.2 mtp85 -94.1 139.35 31.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.011 170.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -59.13 1.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.542 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.713 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.94 -18.2 14.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.546 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 86.57 -19.16 29.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.409 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 1.1 t -87.12 116.78 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.978 -0.719 . . . . 0.0 110.543 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.42 -61.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -60.34 -0.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.8 t -97.23 -26.66 14.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.268 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 28' ' ' SER . 2.4 p30 -114.85 141.46 47.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.25 144.38 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.46 140.71 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.446 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 13.6 pt20 -121.44 152.54 38.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.363 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.18 142.31 46.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CE2' ' OG1' ' A' ' 47' ' ' THR . 26.8 m-85 -139.14 149.24 44.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.89 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.409 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -131.18 141.54 50.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.423 HE21 ' N ' ' A' ' 45' ' ' PRO . 1.4 tt0 -125.75 135.35 51.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.358 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.225 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.423 ' N ' HE21 ' A' ' 39' ' ' GLN . 5.9 Cg_exo . . . . . 0 N--CA 1.491 1.336 0 CA-C-O 120.421 0.092 . . . . 0.0 111.865 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 m -132.83 126.69 32.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.351 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.502 ' OG1' ' CE2' ' A' ' 37' ' ' TYR . 7.0 m -64.14 119.02 9.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.176 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 t -101.29 -29.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.048 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' CG1' HH11 ' A' ' 55' ' ' ARG . 14.9 mt -145.35 150.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.3 t80 -136.22 163.9 29.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.888 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp10 44.68 24.27 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.834 0.826 . . . . 0.0 110.682 -172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' TYR . 33.7 t0 43.97 20.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.015 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.754 HD21 HE22 ' A' ' 54' ' ' GLN . 0.9 OUTLIER -128.06 -46.13 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 169.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.754 HE22 HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.97 131.06 26.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.124 -168.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.751 ' NH2' ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -116.43 108.82 44.8 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 48' ' ' VAL . 5.7 Cg_exo -65.91 147.24 84.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.965 1.777 . . . . 0.0 111.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 p -70.81 -36.58 73.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.67 -43.12 86.31 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.0 m -98.1 127.74 35.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.4 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.7 Cg_exo -62.78 161.93 27.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.322 1.348 . . . . 0.0 111.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' C ' HH21 ' A' ' 55' ' ' ARG . 47.3 t0 -60.12 3.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.412 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -48.02 -27.59 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.633 -175.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.751 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 31.8 m-85 -92.07 136.55 33.08 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.215 -0.303 . . . . 0.0 110.663 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.4 t -125.12 123.85 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.933 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.67 131.74 10.65 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.128 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.7 p -161.63 172.43 16.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.304 0.574 . . . . 0.0 111.224 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -149.56 163.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.229 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.85 152.76 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.698 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 p -68.02 -8.32 36.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.42 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.3 m -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.886 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.03 27.73 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 -178.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -99.13 -37.07 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.224 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.5 p -165.96 166.76 17.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.406 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.01 130.04 55.47 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.084 -1.01 . . . . 0.0 109.709 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.5 m -132.9 122.45 24.37 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.458 -169.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD2' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.25 141.05 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.8 -1.813 . . . . 0.0 114.834 169.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 64' ' ' SER . 9.9 m -106.31 125.71 51.34 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 165.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.86 123.51 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 120.195 -1.566 . . . . 0.0 110.543 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 t -112.95 127.71 56.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.577 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.42 43.77 10.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HA ' HH22 ' A' ' 62' ' ' ARG . 2.1 tt -64.82 132.21 48.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.429 . . . . 0.0 110.453 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.458 ' C ' ' N ' ' A' ' 84' ' ' GLU . 11.9 tttp -143.65 174.72 10.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.128 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -46.16 -21.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.542 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' A' ' 82' ' ' LYS . 66.8 mm-40 -69.27 -42.77 75.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.132 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 19.8 m-20 -68.81 -5.64 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.433 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 62.6 tt0 -62.08 121.06 12.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.2 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.22 -179.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.528 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.87 151.61 23.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.162 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -121.72 146.17 47.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 111.068 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.8 m-85 -144.38 148.75 35.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.469 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 103' ' ' GLY . 0.7 OUTLIER -134.43 140.17 46.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.38 136.32 51.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.333 0.587 . . . . 0.0 110.019 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -134.97 -176.39 4.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.546 ' CD1' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.37 0 O-C-N 123.64 0.588 . . . . 0.0 110.479 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.001 0.429 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 91' ' ' CYS . . . -172.2 -146.53 5.38 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.758 ' N ' HE22 ' A' ' 6' ' ' GLN . . . 65.66 -7.03 1.12 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.187 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . -51.96 84.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' GLY . 20.5 m -150.09 125.67 10.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.23 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -83.58 132.37 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.159 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.2 tp -119.74 127.04 52.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.629 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.8 125.75 50.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.264 0.554 . . . . 0.0 110.038 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 65.5 t -88.91 36.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.381 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.746 178.356 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.471 ' H ' ' HB2' ' A' ' 25' ' ' SER . 5.1 mtm . . . . . 0 C--O 1.231 0.087 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -132.6 108.84 9.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -92.12 117.53 29.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.621 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -145.79 165.66 20.17 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.13 151.26 12.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.546 2.164 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.688 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -75.83 -65.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.03 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.688 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 79.1 p -158.82 146.03 17.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.229 0.537 . . . . 0.0 110.373 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.28 146.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.057 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 p -117.07 143.64 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.491 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.32 163.08 26.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.334 0.587 . . . . 0.0 110.475 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -94.67 142.57 24.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.27 113.99 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.416 1.411 . . . . 0.0 111.152 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.12 -5.02 15.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -94.25 177.8 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.1 p -128.96 142.79 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.76 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.32 155.2 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.721 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.63 125.36 42.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.53 146.51 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.367 0.603 . . . . 0.0 110.786 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -117.36 132.68 56.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.814 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.82 116.48 26.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -111.31 134.22 53.06 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.714 ' C ' ' H ' ' A' ' 26' ' ' SER . 61.2 mtp180 -91.34 138.16 31.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.603 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -57.81 3.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.57 176.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.714 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -96.7 -12.87 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.21 -173.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 -1.87 39.4 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.266 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -124.24 124.73 43.08 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.215 0.206 . . . . 0.0 110.82 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.0 pp -128.86 -55.33 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' H ' HG13 ' A' ' 29' ' ' ILE . . . -65.34 -1.16 2.2 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.706 ' H ' ' C ' ' A' ' 29' ' ' ILE . 12.0 p -86.59 -32.24 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 111.698 -2.501 . . . . 0.0 111.075 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.445 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 1.8 m120 -122.46 159.23 28.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.15 123.39 25.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.975 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -103.76 146.89 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.355 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 36' ' ' TRP . 5.4 tt0 -133.32 158.83 41.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 12.7 m95 -129.45 124.14 33.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.929 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CD2' ' OE1' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -110.73 149.55 30.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.17 142.21 49.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.642 HE21 ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -140.36 117.1 10.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.642 ' N ' HE21 ' A' ' 39' ' ' GLN . 2.5 mpt_? . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.491 1.332 0 N-CA-C 111.687 -0.159 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 m -148.7 97.95 2.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.921 0.391 . . . . 0.0 110.117 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 28.8 m -64.25 120.18 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.16 -28.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.956 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -144.95 142.19 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -136.07 148.67 48.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.595 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 53' ' ' ASN . 14.2 tp10 58.96 22.49 10.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.942 1.353 . . . . 0.0 110.243 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 42.73 17.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.813 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -129.44 -47.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.294 0.569 . . . . 0.0 111.409 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.472 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -92.25 140.63 29.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.329 -165.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.6 144.98 32.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.99 150.89 75.83 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.314 1.343 . . . . 0.0 111.275 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.2 p -71.05 -22.35 62.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.6 96.41 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.94 140.79 43.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.572 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -51.78 119.63 5.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.084 1.19 . . . . 0.0 110.581 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.74 1.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.009 -0.432 . . . . 0.0 111.037 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 60' ' ' PRO . 46.4 mtm180 -53.18 -22.34 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.62 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 6.8 m-85 -75.27 129.09 36.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.978 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.0 t -110.17 121.59 45.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.067 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.16 126.15 8.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.528 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.7 p -164.37 166.85 20.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.329 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.2 160.9 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -93.07 163.31 13.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.093 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 m -68.45 30.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.575 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -123.12 -46.33 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 79.0 25.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.787 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -98.33 -19.04 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.601 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' ILE . 30.9 p -158.32 169.94 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.838 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.88 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 8.0 m -99.02 110.99 23.51 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.988 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -101.15 140.45 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.471 ' O ' ' CB ' ' A' ' 64' ' ' SER . 94.9 m -112.56 124.38 52.39 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 163.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.46 109.11 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 O-C-N 119.966 -1.709 . . . . 0.0 110.446 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -99.34 142.42 30.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.392 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.03 44.83 8.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.75 129.91 38.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.217 0.532 . . . . 0.0 110.559 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' GLU . 15.9 tttt -138.77 172.6 12.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.83 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 p -45.88 -19.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.544 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 27.6 tt0 -73.79 -38.45 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.335 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.55 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -68.89 -4.38 16.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 74.4 tt0 -60.43 129.16 40.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.425 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 159.76 173.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -91.02 143.58 26.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.782 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 11.5 m-85 -109.75 150.72 27.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.223 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 49.3 m-85 -146.81 153.77 40.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.369 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 94.3 m -120.73 141.08 50.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 33.6 mt-30 -126.71 137.47 53.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.727 0.694 . . . . 0.0 110.497 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NH2' ' A' ' 24' ' ' ARG . 3.0 t -128.71 143.21 50.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.276 0.56 . . . . 0.0 110.92 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.6 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.25 -157.24 16.96 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.15 53.9 38.91 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.27 107.1 3.36 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.446 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 37.9 m -124.54 129.96 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.027 0.441 . . . . 0.0 110.71 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.21 115.62 25.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.276 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -102.9 122.74 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 111' ' ' LEU . 93.0 m -119.68 114.99 23.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.406 0.622 . . . . 0.0 110.075 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 57.9 t -76.83 30.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.822 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 109' ' ' THR . 77.3 mt . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.567 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.46 0.031 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.26 103.09 7.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -95.46 120.19 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.12 167.93 12.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -53.33 144.91 47.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.672 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.4 p80 -75.88 -51.6 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.82 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -159.27 151.16 20.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 110.809 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.37 155.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.468 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -137.37 152.89 50.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -142.03 162.18 36.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.221 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -92.37 151.08 41.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.907 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.87 117.77 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.781 1.654 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.16 9.74 31.27 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 13' ' ' SER . 72.3 mttt -98.96 -178.7 4.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 110.619 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -122.54 128.07 50.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.212 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.6 139.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.741 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 99.9 m -125.6 133.26 52.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.532 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 1.3 mt -113.06 142.02 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.198 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -117.08 131.72 56.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.556 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -119.59 124.07 45.47 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.1 m -120.53 142.11 49.63 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.954 -1.091 . . . . 0.0 108.24 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.648 ' C ' ' H ' ' A' ' 26' ' ' SER . 28.2 ttm180 -99.74 144.6 28.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.294 168.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 p -60.75 3.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.837 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.648 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.32 -17.78 14.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 -175.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 71.3 23.68 77.79 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 t -119.86 105.27 10.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.646 0.26 . . . . 0.0 111.158 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -135.18 -64.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -65.23 -3.79 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.7 m -97.85 -22.68 16.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.668 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.48 HD21 HH22 ' A' ' 24' ' ' ARG . 35.8 m-20 -126.55 155.08 42.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -73.02 125.53 27.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.059 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.05 148.04 23.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.537 0.685 . . . . 0.0 110.779 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.604 ' NE2' ' HH ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -141.45 169.97 16.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.182 -178.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 70.1 m95 -131.25 146.36 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.5 m-85 -132.9 149.04 52.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -127.5 135.55 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 7.1 tm0? -130.26 143.48 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.489 0.661 . . . . 0.0 109.66 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.53 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.061 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 110.319 -0.685 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -125.35 125.35 43.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 110.666 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -65.39 119.97 11.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.383 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.92 -25.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.007 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 49' ' ' ILE . 7.0 mt -144.34 135.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 64.7 t80 -125.77 164.36 20.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.761 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.6 tt0 45.91 22.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.357 -170.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 43.55 17.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.926 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.573 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -128.87 -46.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 110.647 170.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.439 ' NE2' ' CA ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -96.13 154.48 17.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.27 -1.786 . . . . 0.0 107.82 -165.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.802 HH11 ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -143.73 146.72 36.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.257 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.44 145.48 88.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.389 1.392 . . . . 0.0 110.929 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 m -62.07 -22.09 65.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.132 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.14 97.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.2 142.18 24.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.369 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.15 143.18 98.63 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.479 1.453 . . . . 0.0 111.702 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.4 p30 -62.61 -2.83 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.622 ' NH1' ' CE1' ' A' ' 63' ' ' PHE . 28.8 ptt85 -47.01 -40.21 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.371 0.605 . . . . 0.0 110.576 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' CE1' ' NH1' ' A' ' 62' ' ' ARG . 97.9 m-85 -62.98 129.18 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.422 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 6.1 t -113.79 119.44 37.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.414 0.626 . . . . 0.0 110.909 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.2 112.47 3.59 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.134 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 75' ' ' SER . 7.3 p -149.61 167.48 26.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.51 0.671 . . . . 0.0 110.208 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -143.49 163.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.976 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 70' ' ' SER . 75.8 m-20 -98.77 152.75 19.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.518 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -68.35 31.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.687 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 68' ' ' ASP . 30.1 m -104.12 -46.31 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.578 0.228 . . . . 0.0 110.565 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 85.43 25.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.473 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.05 -37.34 9.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.066 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.404 ' N ' HG12 ' A' ' 29' ' ' ILE . 52.9 p -160.12 166.67 29.37 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.535 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.25 127.01 54.76 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.741 -1.224 . . . . 0.0 109.513 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -121.72 116.07 23.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.39 -172.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -99.02 140.27 33.42 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 118.344 -2.722 . . . . 0.0 117.329 168.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 64' ' ' SER . 61.8 m -106.06 126.28 52.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 163.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.51 112.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 119.798 -1.813 . . . . 0.0 110.918 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.11 137.69 34.81 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.834 -0.541 . . . . 0.0 111.462 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 58.75 3.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.07 135.0 36.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.211 0.529 . . . . 0.0 110.478 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -134.36 176.44 8.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.714 174.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 p -47.65 -19.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 82' ' ' LYS . 9.4 tp10 -70.53 -39.36 74.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.821 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' CB ' HH22 ' A' ' 62' ' ' ARG . 27.6 t0 -67.18 -7.09 20.99 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.399 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 70.5 tt0 -62.41 130.62 46.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.89 175.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -85.03 144.77 28.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.474 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 8.9 m-85 -108.91 154.21 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -150.49 145.48 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 59.4 m -120.28 141.01 50.38 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 5.7 mt-30 -124.45 145.39 49.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 24' ' ' ARG . 53.5 p -135.09 123.73 23.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 110.353 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.604 ' HH ' ' NE2' ' A' ' 35' ' ' GLN . 21.3 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.3 -139.24 10.91 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 45.12 29.67 2.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.13 158.11 5.61 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.9 m -126.06 130.09 50.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.517 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -80.59 110.34 15.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.2 tp -99.39 124.81 44.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.19 124.37 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.092 0.472 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' LEU . 61.2 t -87.63 94.43 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 110' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.234 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.8 mmm . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.899 0.38 . . . . 0.0 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -123.63 107.98 12.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -78.19 113.51 16.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.635 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 52.4 mt-30 -140.37 158.21 66.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.18 140.99 71.12 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.93 1.753 . . . . 0.0 110.38 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -49.25 70.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.18 129.0 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.065 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 11' ' ' SER . 7.4 p -139.28 161.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.155 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 94.1 p -143.43 155.53 44.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.624 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -140.31 153.17 46.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.074 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.26 141.98 74.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.195 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 115.28 2.16 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.715 1.61 . . . . 0.0 111.246 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.37 1.03 33.13 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -98.06 161.51 13.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.8 p -93.0 134.35 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.9 137.46 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -118.64 134.18 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.322 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.455 ' H ' HD23 ' A' ' 76' ' ' LEU . 22.1 mt -99.81 137.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.426 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 m -111.62 116.68 31.2 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -118.92 113.04 20.41 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 m -114.79 140.78 48.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.683 ' C ' ' H ' ' A' ' 26' ' ' SER . 31.8 ttp180 -92.56 136.83 32.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.999 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -59.05 3.74 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.683 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.79 -18.06 14.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.678 -174.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.85 20.05 76.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -123.07 109.62 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.979 0.39 . . . . 0.0 110.773 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.667 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.17 -62.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 -176.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' ILE . . . -65.22 0.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.667 ' H ' ' C ' ' A' ' 29' ' ' ILE . 91.5 p -109.82 -3.13 16.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.566 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -135.9 158.5 44.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.124 0.487 . . . . 0.0 110.874 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.43 129.18 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' HE21 ' A' ' 35' ' ' GLN . 81.9 t -123.14 148.06 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 110.728 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.99 153.93 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.151 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -110.3 135.13 51.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HH ' ' HG1' ' A' ' 47' ' ' THR . 11.4 m-85 -129.17 147.54 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.324 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.421 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -134.38 133.07 40.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.128 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -112.48 116.14 29.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 N-CA-C 111.431 -0.257 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -146.93 105.4 3.8 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.757 -0.59 . . . . 0.0 111.003 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.537 ' HG1' ' HH ' ' A' ' 37' ' ' TYR . 25.8 m -63.38 120.23 11.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.878 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.62 -28.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.735 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.4 149.95 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' ASP . 6.2 t80 -134.76 164.04 28.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.793 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.37 23.87 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.569 1.176 . . . . 0.0 110.754 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.7 p30 44.35 19.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.587 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.551 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -127.85 -45.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.583 HE21 ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -53.54 134.89 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.279 -170.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -137.39 108.65 8.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -70.06 152.8 67.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.853 1.702 . . . . 0.0 112.013 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -70.78 -33.12 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.375 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.23 -47.7 79.97 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.68 132.52 34.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.1 Cg_exo -59.3 142.07 98.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.462 1.441 . . . . 0.0 111.117 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 63' ' ' PHE . 49.9 p-10 -61.21 1.65 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.597 HH22 ' CG ' ' A' ' 85' ' ' ASP . 8.4 ptm180 -49.69 -2.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 61' ' ' ASP . 17.3 m-85 -107.98 146.44 32.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.3 t -130.39 121.03 25.17 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.893 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.79 123.16 7.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.345 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.6 p -158.81 164.51 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.426 -0.455 . . . . 0.0 110.2 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.438 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -135.08 159.92 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.589 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 70' ' ' SER . 30.7 m-20 -96.66 144.18 26.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 p -70.13 27.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.008 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 68' ' ' ASP . 21.2 m -102.23 -36.76 8.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.015 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 82.21 22.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.234 -177.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -95.8 -43.71 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.754 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 29' ' ' ILE . 95.0 p -162.1 174.86 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.009 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.9 126.78 55.07 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.331 -1.48 . . . . 0.0 110.573 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.9 m -118.23 112.31 19.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.569 -171.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -97.02 140.75 31.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 168.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.4 m -110.52 128.25 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 163.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 mt -106.0 109.95 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 119.812 -1.805 . . . . 0.0 110.666 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -98.65 141.25 31.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.555 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.82 32.99 35.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.8 145.79 23.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.987 0.422 . . . . 0.0 110.318 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' ASP . 6.6 tttp -160.66 177.87 10.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.355 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 t -46.01 -19.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 82' ' ' LYS . 77.4 mt-10 -71.85 -40.02 69.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.367 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.597 ' CG ' HH22 ' A' ' 62' ' ' ARG . 18.9 t70 -70.32 -13.12 62.02 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.173 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 32.9 tt0 -58.23 123.14 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.6 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.0 178.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 109.942 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.07 146.38 25.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.2 m-85 -121.88 146.27 47.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 111.083 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.1 m-85 -141.72 149.18 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.17 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.635 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 p -124.85 140.87 52.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.5 mt-30 -116.83 140.06 49.88 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.174 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.9 p -135.07 119.69 18.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 109.896 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.123 175.896 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.2 p90 . . . . . 0 N--CA 1.458 -0.065 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 144.93 -129.8 3.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 84.92 62.57 1.67 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.11 110.14 2.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -117.16 118.89 33.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -78.44 116.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.986 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.8 tp -110.71 126.53 54.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 m -118.97 133.67 55.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.391 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 79.2 t -86.03 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.228 0.537 . . . . 0.0 110.587 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.698 -1.144 . . . . 0.0 110.874 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.8 mmm . . . . . 0 N--CA 1.461 0.094 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.425 HD23 HH21 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -130.87 102.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -91.43 138.41 31.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.69 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 104' ' ' GLY . 15.1 mt-30 -143.87 160.12 51.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.31 128.53 23.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.925 1.75 . . . . 0.0 111.023 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.509 ' CD2' ' H ' ' A' ' 9' ' ' SER . 3.7 p-80 -45.21 -59.24 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.0 110.413 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.509 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 83.2 p -164.67 162.71 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.588 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 11' ' ' SER . 3.0 p -162.42 161.27 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.029 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.442 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 84.1 p -143.2 149.74 38.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.616 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.1 153.15 45.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 147.89 82.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.566 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.76 119.7 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.628 1.552 . . . . 0.0 111.368 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.6 -3.25 26.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -98.27 -170.26 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.541 0.21 . . . . 0.0 110.967 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.5 p -127.26 150.47 49.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.732 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.56 147.82 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.886 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -121.69 134.23 54.96 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.1 mt -108.83 140.08 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -108.38 142.64 38.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.507 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.13 111.63 12.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 m -119.64 140.5 50.52 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.562 -1.336 . . . . 0.0 108.099 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.752 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -107.27 145.0 33.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.238 171.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -57.86 4.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.752 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.03 -18.18 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 -175.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 78.67 -32.16 1.91 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 14.7 m -68.4 110.05 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.548 0.213 . . . . 0.0 111.298 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.5 pp -135.17 -62.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.526 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -62.77 -0.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 29' ' ' ILE . 10.7 p -98.91 -25.29 14.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.804 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 28' ' ' SER . 29.1 p30 -121.26 147.3 45.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -71.39 144.45 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.624 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.48 137.79 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.242 0.544 . . . . 0.0 110.198 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.555 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 4.1 pt20 -120.9 152.18 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 46.4 m95 -122.28 133.07 54.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.146 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.9 m-85 -130.1 149.08 51.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.826 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.589 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -117.96 135.69 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.276 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 N-CA-C 111.022 -0.414 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.8 p -121.66 120.51 34.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.646 0.26 . . . . 0.0 110.381 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.52 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 10.4 m -62.01 117.72 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.831 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.73 -28.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.64 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.22 136.63 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' GLN . 11.0 t80 -125.01 166.23 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.706 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tt0 44.81 22.45 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.145 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.6 p-10 42.9 18.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.167 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.48 -47.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.183 0.516 . . . . 0.0 111.129 168.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.546 ' C ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.06 150.77 20.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.242 -1.799 . . . . 0.0 108.594 -167.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 148.32 65.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.14 147.6 95.21 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.723 1.616 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 m -67.76 -14.91 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -46.28 70.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.67 141.08 23.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -60.01 139.32 87.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.259 1.306 . . . . 0.0 111.631 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -61.17 0.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.603 HH12 ' CB ' ' A' ' 85' ' ' ASP . 8.8 ptm180 -47.16 -24.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.149 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CE1' ' CG ' ' A' ' 62' ' ' ARG . 23.5 m-85 -88.6 142.95 27.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -128.03 124.22 36.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.084 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.42 7.16 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.679 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.3 p -154.97 166.07 34.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.529 . . . . 0.0 111.355 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.6 pp -146.38 153.76 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.85 157.19 16.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.111 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.7 p -70.3 -8.44 50.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.0 m -60.38 -40.82 92.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER 79.0 25.76 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.284 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -97.48 -42.15 7.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.598 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.1 p -165.33 171.32 13.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.054 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.52 127.13 55.04 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.936 -1.103 . . . . 0.0 110.442 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 28.9 m -119.42 117.98 29.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.954 -169.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -97.54 140.59 31.74 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 118.651 -2.53 . . . . 0.0 117.217 168.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' SER . 75.8 m -111.49 127.72 55.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 162.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.9 112.35 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 120.048 -1.657 . . . . 0.0 109.951 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 t -96.85 135.59 38.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.479 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.01 49.22 6.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.66 137.86 48.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 0.0 110.633 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' C ' ' N ' ' A' ' 84' ' ' GLU . 21.2 tttt -144.7 176.93 9.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.905 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -46.84 -20.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.662 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 82' ' ' LYS . 26.2 tt0 -72.7 -39.05 67.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.008 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.603 ' CB ' HH12 ' A' ' 62' ' ' ARG . 6.4 t70 -67.63 -6.9 22.53 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.691 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 62.8 tt0 -63.35 124.65 21.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.28 -178.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 0.0 110.552 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -87.14 136.72 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.675 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.589 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 27.8 m-85 -116.32 135.75 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.742 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.2 p90 -149.26 149.06 30.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.04 151.49 41.89 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.962 0.505 . . . . 0.0 110.924 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 18.7 mt-30 -123.56 147.69 47.05 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 122.213 -0.304 . . . . 0.0 111.338 168.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' NE ' ' A' ' 24' ' ' ARG . 13.7 t -135.25 159.99 39.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.681 0.276 . . . . 0.0 111.587 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.534 ' HH ' ' CD ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.669 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.05 -161.89 34.74 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.069 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.476 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 96.04 34.3 5.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.8 95.01 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -111.27 114.58 27.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 0.0 109.798 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -80.25 108.66 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.422 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.8 tp -102.36 126.0 49.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.552 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -120.72 124.86 46.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.319 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 60.9 t -89.57 34.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.44 179.288 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtp . . . . . 0 CA--C 1.524 -0.052 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.77 104.78 6.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -78.93 126.06 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.177 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.616 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 6.8 mt-30 -145.42 164.46 26.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.83 127.21 25.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.135 1.89 . . . . 0.0 110.737 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.527 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 5.8 p80 -57.74 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.2 p -165.12 135.39 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.083 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.58 154.96 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.317 . . . . 0.0 110.398 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.7 p -138.45 137.58 37.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 31.3 mp0 -128.38 162.49 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.024 0.44 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -78.52 146.31 69.43 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.607 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.88 125.93 19.04 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.117 1.211 . . . . 0.0 111.57 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.85 -4.2 28.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -95.34 171.69 8.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.967 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -115.31 130.88 57.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.413 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -127.79 134.66 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -110.02 128.42 55.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.291 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 mm -98.44 145.06 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.083 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -117.59 116.68 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.318 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' HB2' HE21 ' A' ' 6' ' ' GLN . 42.0 t -118.84 112.28 19.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -116.02 137.6 51.97 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.078 -1.014 . . . . 0.0 108.28 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.688 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.68 142.77 27.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.607 170.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -57.88 2.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.688 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.68 -16.94 14.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.538 -174.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.99 -50.39 4.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.44 ' HG ' HD22 ' A' ' 32' ' ' ASN . 75.0 p -54.28 113.88 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.312 . . . . 0.0 111.166 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.688 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.34 -61.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.181 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.486 ' N ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.5 -0.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.688 ' H ' ' C ' ' A' ' 29' ' ' ILE . 5.9 m -107.01 -18.99 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.623 -1.626 . . . . 0.0 111.798 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.506 ' ND2' ' NH2' ' A' ' 24' ' ' ARG . 38.5 m-20 -116.87 147.82 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -78.88 132.41 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.489 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.73 146.32 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.11 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 8.5 pt20 -123.64 163.1 21.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 30.3 m95 -131.51 131.92 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 7.6 m-85 -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.9 139.98 53.46 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -141.83 141.26 33.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.252 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 110.805 -0.498 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -132.77 137.7 46.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.6 m -73.27 120.25 18.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.528 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.85 -28.0 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.141 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 49' ' ' ILE . 20.1 mt -145.28 149.27 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' O ' ' N ' ' A' ' 52' ' ' ASP . 37.5 t80 -133.94 163.62 29.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.182 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 45.37 23.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.686 0.755 . . . . 0.0 110.827 -173.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' TYR . 10.6 t70 44.73 19.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.594 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.626 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.83 -46.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.861 170.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.626 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -52.72 134.11 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.498 -167.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.694 ' NH1' ' H ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -123.59 108.8 30.93 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -65.66 136.81 47.47 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.618 1.546 . . . . 0.0 111.756 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 m -63.93 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.14 -57.81 12.25 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.08 150.36 58.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.8 Cg_endo -61.55 135.45 57.05 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.067 1.178 . . . . 0.0 111.219 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.79 -0.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.488 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 52.0 mtm180 -48.37 -38.44 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -71.72 134.84 46.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.9 t -124.12 122.71 38.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.694 ' H ' ' NH1' ' A' ' 55' ' ' ARG . . . -107.74 118.9 5.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.627 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.6 p -155.41 164.03 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.935 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.461 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -146.0 157.63 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 70' ' ' SER . 37.0 m-20 -103.03 153.17 20.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.378 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -68.4 1.87 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.042 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 68' ' ' ASP . 58.2 m -65.95 -43.97 86.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.62 27.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.543 -177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.38 -41.09 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.943 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -166.7 175.34 7.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.767 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.78 125.51 50.91 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.812 -1.18 . . . . 0.0 109.881 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 m -115.84 112.73 22.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.744 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -98.3 140.53 32.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 170.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' SER . 89.3 m -107.72 126.7 52.93 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 163.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.8 105.33 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 O-C-N 120.398 -1.439 . . . . 0.0 110.737 173.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -95.45 154.38 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.008 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 32.37 76.78 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.21 128.01 29.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 109.667 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 84' ' ' GLU . 18.9 mttp -139.48 171.1 14.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.055 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -45.94 -18.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.648 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 82' ' ' LYS . 39.9 mt-10 -69.31 -38.56 78.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.529 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.2 m-20 -73.26 -11.34 60.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.241 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 70.5 tt0 -52.92 120.75 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.543 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 159.94 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -86.91 144.87 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -113.18 153.07 28.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -149.95 147.84 28.37 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 8.6 p -132.94 142.8 49.07 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.023 0.529 . . . . 0.0 109.972 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.89 147.31 50.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.648 ' HG ' ' N ' ' A' ' 94' ' ' TYR . 9.0 t -135.24 160.84 37.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.1 0.476 . . . . 0.0 111.226 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.648 ' N ' ' HG ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.56 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.008 0.432 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.86 7.78 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.61 56.52 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.55 110.08 3.27 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.5 m -137.13 127.83 27.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.692 0.282 . . . . 0.0 110.286 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -88.42 99.36 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 tp -91.08 123.67 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -120.77 122.36 40.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.371 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 80.6 t -82.11 40.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.069 178.721 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.604 ' H ' ' HG ' ' A' ' 25' ' ' SER . 9.1 mtt . . . . . 0 N--CA 1.46 0.073 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -133.22 102.95 5.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.5 p -86.4 135.6 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.537 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 30.7 mt-30 -146.19 163.14 31.91 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.715 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.51 140.38 74.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.534 1.49 . . . . 0.0 111.021 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.615 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -51.15 -69.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.257 179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.615 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 35.7 p -161.27 155.2 22.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.792 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 11' ' ' SER . 4.7 p -162.11 161.01 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.787 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 15.1 p -128.65 151.47 49.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.419 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -135.21 143.83 46.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.401 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 138.05 86.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.88 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.48 113.24 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.377 1.385 . . . . 0.0 111.297 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.02 -8.23 16.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -93.05 -177.31 4.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 111.262 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -111.18 140.75 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.131 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.41 138.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.547 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -119.44 129.86 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.92 134.0 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.469 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -100.53 166.3 10.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.298 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -151.33 111.85 4.19 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.669 ' CG2' HH21 ' A' ' 24' ' ' ARG . 19.7 m -115.89 136.22 53.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.903 -1.123 . . . . 0.0 108.065 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.739 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -104.02 143.1 33.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.154 171.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.604 ' HG ' ' H ' ' A' ' 3' ' ' MET . 88.9 p -58.63 5.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.467 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.739 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.37 -18.15 14.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.06 -173.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' C ' HH11 ' A' ' 24' ' ' ARG . . . 68.63 29.06 72.78 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -128.94 98.9 5.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.419 0.609 . . . . 0.0 111.864 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -126.28 -62.27 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 122.584 0.354 . . . . 0.0 111.009 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.505 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.15 1.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.692 ' H ' ' C ' ' A' ' 29' ' ' ILE . 35.6 t -114.11 -28.02 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.027 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -112.99 139.85 48.31 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.9 130.67 42.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.87 141.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.552 0.691 . . . . 0.0 110.667 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.431 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -128.26 150.46 50.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.619 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -106.22 121.0 43.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.457 ' CE1' ' OG1' ' A' ' 47' ' ' THR . 2.2 m-85 -112.38 148.63 33.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 133.44 41.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -125.45 135.03 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.355 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.49 1.303 0 N-CA-C 111.513 -0.226 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -137.59 121.27 17.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.349 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.457 ' OG1' ' CE1' ' A' ' 37' ' ' TYR . 3.4 m -62.29 121.42 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.965 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.16 -28.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.318 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -145.86 140.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' ASP . 5.9 t80 -127.3 164.14 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 44.59 22.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.389 -170.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 43.04 18.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.545 -179.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.564 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.23 -46.91 1.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 0.0 111.52 172.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -80.06 131.37 35.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.712 -165.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -108.57 111.68 61.11 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.465 -174.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.04 145.52 96.57 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.633 1.556 . . . . 0.0 112.176 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -69.41 -20.35 63.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.772 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.83 -31.32 67.68 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.2 141.82 38.33 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.8 Cg_exo -60.41 140.33 91.06 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.268 1.312 . . . . 0.0 111.412 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.3 p-10 -61.04 0.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.638 HH22 ' CB ' ' A' ' 85' ' ' ASP . 41.7 ptt85 -47.42 -24.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.331 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 90.8 m-85 -78.47 150.26 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.83 122.88 33.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.435 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.45 121.54 5.52 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.546 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.3 p -158.98 158.25 32.88 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -138.7 160.32 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.449 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 70' ' ' SER . 97.8 m-20 -103.63 152.9 21.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.769 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 m -72.61 27.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.5 m -97.98 -40.64 8.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.226 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.97 27.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.604 ' O ' ' NH2' ' A' ' 24' ' ' ARG . 39.8 t30 -99.32 -33.67 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.561 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 p -176.9 170.8 2.26 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.013 0.821 . . . . 0.0 110.185 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.4 133.78 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.153 -0.967 . . . . 0.0 109.857 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -127.37 112.56 15.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.088 -0.958 . . . . 0.0 113.192 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -97.13 140.59 31.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 168.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.5 m -107.83 131.25 54.68 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.219 -0.926 . . . . 0.0 113.401 163.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 mt -106.87 110.65 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.163 -1.586 . . . . 0.0 110.37 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -97.51 139.38 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.06 45.86 8.01 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 143.65 51.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.09 0.471 . . . . 0.0 110.525 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' ASP . 10.4 mtpt -153.14 173.18 15.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.686 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 t -45.88 -20.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.579 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 82' ' ' LYS . 48.7 mt-10 -69.38 -40.1 77.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.978 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.638 ' CB ' HH22 ' A' ' 62' ' ' ARG . 4.3 t0 -70.38 -10.44 59.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.211 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 56.4 tt0 -61.13 122.83 16.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.082 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.92 179.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.856 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 148.02 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.911 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.438 ' OH ' ' CG ' ' A' ' 85' ' ' ASP . 17.7 m-85 -115.52 145.79 42.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 12.5 m-85 -144.19 150.35 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.002 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -118.93 142.45 47.76 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 51.9 tt0 -126.54 121.77 33.23 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.81 -0.556 . . . . 0.0 110.937 172.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -135.15 -176.82 4.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.723 0.297 . . . . 0.0 110.619 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 93' ' ' SER . 1.6 m-85 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.61 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 121.131 0.491 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.86 169.37 21.43 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 123.08 18.11 3.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.29 85.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.4 m -112.24 130.36 55.96 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.672 -0.31 . . . . 0.0 110.242 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -90.08 110.83 21.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -104.9 124.75 50.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.099 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.3 m -116.8 123.54 47.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.71 99.98 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.231 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.121 179.005 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 C--O 1.23 0.045 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 105.97 6.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m -89.58 131.61 35.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.115 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.693 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 2.7 mt-30 -146.07 169.87 8.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -65.78 136.55 45.99 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.433 1.422 . . . . 0.0 111.367 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.506 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -48.21 -76.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.765 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -155.38 149.16 25.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.993 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 11' ' ' SER . 7.3 p -159.46 160.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.166 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 12' ' ' GLU . 88.5 p -129.77 146.84 51.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.335 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 11' ' ' SER . 2.1 mp0 -130.53 162.93 28.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.45 140.86 22.55 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.42 117.48 4.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.418 1.412 . . . . 0.0 111.231 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.2 -11.41 14.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.01 159.97 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.701 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.4 p -98.13 148.63 23.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.69 141.2 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.618 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 55.5 m -119.92 129.72 54.48 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.04 134.93 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.17 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -111.11 126.48 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.057 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.28 113.35 21.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.8 m -109.44 135.34 50.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.73 ' C ' ' H ' ' A' ' 26' ' ' SER . 19.3 ttp85 -97.49 141.15 30.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.223 171.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -57.23 3.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.73 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.06 -11.9 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.765 -173.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.48 5.89 25.26 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 m -125.3 111.87 15.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.366 0.267 . . . . 0.0 110.434 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.653 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.8 pp -124.31 -57.09 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.524 ' H ' HG13 ' A' ' 29' ' ' ILE . . . -65.23 -2.58 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 29' ' ' ILE . 14.5 m -89.14 -35.0 16.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 111.603 -2.544 . . . . 0.0 111.479 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.595 ' ND2' HH21 ' A' ' 24' ' ' ARG . 4.0 m-80 -116.83 152.94 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -75.16 140.93 43.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.037 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 67.9 t -126.13 148.02 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.958 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.646 ' NE2' ' HH ' ' A' ' 94' ' ' TYR . 3.7 pt20 -129.38 147.15 51.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.903 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.484 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 23.0 m95 -111.1 122.63 48.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.296 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' N ' ' A' ' 47' ' ' THR . 2.4 m-85 -123.91 144.96 49.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.587 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -147.19 143.9 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.279 177.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 40' ' ' ARG . 2.9 tp-100 -107.07 142.52 36.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.91 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.523 0.135 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -148.9 135.3 19.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.551 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -64.93 129.29 39.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.45 -25.23 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.99 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -145.01 133.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' GLN . 4.0 t80 -122.25 167.33 13.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.447 174.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp10 44.77 22.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.712 0.768 . . . . 0.0 111.419 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 43.16 18.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.05 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.22 -47.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.847 170.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -96.79 159.07 15.12 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.258 -167.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -140.41 149.88 59.07 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 157.63 22.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.584 1.523 . . . . 0.0 111.226 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.8 p -73.98 -7.19 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.456 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.58 -28.18 48.49 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.02 131.34 22.86 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.9 Cg_endo -61.62 140.1 84.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 120.982 1.121 . . . . 0.0 111.021 -175.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD2' ' NE ' ' A' ' 55' ' ' ARG . 2.8 m-20 -61.25 1.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.646 HH22 ' CB ' ' A' ' 85' ' ' ASP . 22.7 ptt85 -42.1 -25.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.3 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 53.4 m-85 -75.4 144.46 42.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.87 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -118.07 122.6 43.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.491 0.663 . . . . 0.0 110.949 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.46 125.06 8.38 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.447 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' SER . 6.5 p -157.76 158.72 35.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.106 0.479 . . . . 0.0 110.849 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.94 161.15 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.25 163.32 13.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.379 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 p -67.92 -7.45 28.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.355 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 71' ' ' SER . 14.4 m -82.38 -48.26 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.28 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 70' ' ' SER . 3.0 p 79.03 22.12 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.661 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.34 -18.92 27.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.566 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 29' ' ' ILE . 54.9 p -163.24 166.5 23.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.249 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.79 115.5 30.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.1 m -104.41 110.76 23.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.461 ' CB ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -102.68 140.42 36.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.725 -1.58 . . . . 0.0 115.252 169.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 98.3 m -104.76 128.11 52.77 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 162.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -103.16 113.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 120.115 -1.616 . . . . 0.0 110.043 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 t -104.62 146.69 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.791 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.83 30.46 57.72 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.99 138.42 49.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 110.518 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 28.3 mttt -150.57 177.74 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 p -46.78 -17.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.387 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 15.6 pt-20 -69.2 -40.55 77.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.351 177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.646 ' CB ' HH22 ' A' ' 62' ' ' ARG . 6.4 t70 -70.99 -8.6 54.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.458 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 57.5 tt0 -63.7 121.4 13.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.348 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 159.71 -175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.22 137.35 32.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.643 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 17.1 m-85 -119.54 134.07 55.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.669 0.271 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.484 ' HH ' ' N ' ' A' ' 39' ' ' GLN . 1.5 p90 -150.89 138.12 19.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.33 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.3 p -118.79 140.43 49.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -114.5 148.64 37.58 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.824 -0.547 . . . . 0.0 109.714 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 p -135.23 152.17 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.914 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.646 ' HH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.677 0.275 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.82 -149.96 6.74 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 75.28 24.29 71.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.57 98.27 0.27 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -129.77 118.16 21.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.325 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.73 120.11 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.1 tp -109.29 123.26 48.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.208 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 114.89 25.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 89.0 t -85.23 40.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 110' ' ' VAL . 10.2 mt . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.665 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.459 ' H ' ' HB2' ' A' ' 25' ' ' SER . 77.4 mtm . . . . . 0 C--O 1.231 0.095 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.81 104.25 8.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 p -88.84 118.73 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.134 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.488 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.66 165.42 21.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.449 ' O ' ' OG1' ' A' ' 106' ' ' THR . 4.4 Cg_exo -52.6 146.7 33.19 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.184 1.923 . . . . 0.0 111.36 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -79.29 -55.91 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.498 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 p -154.84 142.79 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.635 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.89 146.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -126.55 146.39 50.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.737 0.303 . . . . 0.0 110.464 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -132.77 150.2 52.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.231 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.13 139.19 72.39 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.99 124.44 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.144 1.229 . . . . 0.0 110.94 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.43 -11.66 16.4 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -100.33 -171.57 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.774 0.321 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.7 p -125.39 159.56 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.349 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.11 153.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -129.2 132.02 47.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 mt -98.86 149.43 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.075 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -124.96 117.32 23.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.943 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -119.72 120.58 37.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -119.49 142.04 48.64 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.017 -1.677 . . . . 0.0 108.752 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.664 ' C ' ' H ' ' A' ' 26' ' ' SER . 7.3 mtm-85 -87.26 139.78 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.847 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.459 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.7 OUTLIER -60.38 1.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.43 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.664 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -103.24 -17.86 15.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.627 -175.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.92 -41.9 3.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 77.9 p -63.82 113.22 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.59 0.233 . . . . 0.0 110.824 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.6 pp -135.11 -60.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.524 -176.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.523 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -62.8 -0.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 29' ' ' ILE . 53.5 m -109.29 -2.5 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.777 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 31' ' ' SER . 3.1 m120 -133.22 149.96 51.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -81.86 135.26 35.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.437 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.43 ' CG2' HH22 ' A' ' 24' ' ' ARG . 17.5 t -127.61 139.03 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' TRP . 7.2 pt20 -116.96 164.29 14.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.186 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 8.8 m95 -134.96 125.13 26.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 0.0 110.53 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 28.0 m-85 -111.23 149.36 31.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -129.06 124.67 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.6 134.47 47.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.167 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.206 179.088 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.263 -0.322 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -138.16 133.56 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 36.4 m -60.94 120.78 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -96.13 -25.38 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.718 -178.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 19.9 mt -145.08 146.13 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.54 ' H ' HE21 ' A' ' 54' ' ' GLN . 10.4 t80 -132.12 167.26 20.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 44.62 22.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.687 0.756 . . . . 0.0 110.933 -171.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.1 p30 43.13 17.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.03 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.4 -46.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 111.121 172.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 1.7 pp0? -87.93 147.62 24.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.713 -165.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.633 ' N ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -111.23 131.93 21.99 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 58' ' ' GLY . 3.4 Cg_exo -57.68 146.59 84.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.563 1.509 . . . . 0.0 111.183 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -73.38 5.24 3.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.348 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 56' ' ' PRO . . . -95.91 -26.55 11.39 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.67 151.68 45.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.302 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.0 Cg_endo -61.93 143.78 95.84 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.662 1.575 . . . . 0.0 111.653 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.29 -2.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.722 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 80' ' ' GLY . 12.4 mtp-105 -42.13 -38.65 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.068 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.29 137.5 39.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.193 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -129.29 123.07 30.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.314 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.06 129.71 9.96 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.3 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.8 p -158.54 158.45 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.301 0.572 . . . . 0.0 111.198 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.39 160.85 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.641 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.84 153.31 23.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.664 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -4.49 13.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.909 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 71' ' ' SER . 50.2 m -65.44 -46.19 80.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.77 24.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.506 -178.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -100.06 -37.68 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.449 ' H ' HD13 ' A' ' 29' ' ' ILE . 82.1 p -166.07 174.55 9.25 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.8 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.44 123.51 49.49 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.796 -1.19 . . . . 0.0 109.84 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.1 m -112.23 116.59 30.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.722 -170.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.444 ' CD1' ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -97.96 140.36 32.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 118.103 -2.873 . . . . 0.0 116.627 171.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' SER . 7.0 m -112.37 127.54 56.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 164.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -96.66 116.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 120.029 -1.669 . . . . 0.0 110.459 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.54 132.27 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.449 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 75.74 61.08 3.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.52 130.82 36.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 0.0 111.063 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -154.06 176.4 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.113 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -19.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.315 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 82' ' ' LYS . 45.8 mt-10 -71.83 -38.0 70.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.205 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' LYS . 9.9 t70 -74.75 -13.06 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 84.2 tt0 -56.97 123.22 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.74 178.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.733 0.646 . . . . 0.0 109.791 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 85.4 m-20 -91.84 144.49 25.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 24.6 m-85 -110.8 151.17 28.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.986 0.422 . . . . 0.0 110.569 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 31.8 m-85 -149.44 138.35 21.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.653 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.488 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -120.95 140.7 51.5 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.597 0.635 . . . . 0.0 110.28 178.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -125.6 138.28 53.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.165 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.57 ' CB ' ' NH1' ' A' ' 24' ' ' ARG . 17.7 p -135.26 171.04 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 8.4 p90 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.05 -158.7 14.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.034 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 78.97 48.62 6.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.38 91.84 1.16 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 4.2 m -106.88 141.46 38.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -102.98 99.91 9.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.49 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.3 tp -90.24 125.46 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.532 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.95 130.16 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 110.162 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.47 99.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.966 0.412 . . . . 0.0 110.527 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.407 179.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.4 mmm . . . . . 0 C--O 1.23 0.067 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.08 105.98 9.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.081 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.3 115.1 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.723 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.7 mm-40 -142.34 158.21 61.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.438 0.461 . . . . 0.0 110.584 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.95 142.47 93.57 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.662 1.575 . . . . 0.0 110.426 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' N ' ' A' ' 9' ' ' SER . 9.5 p80 -65.86 -53.94 33.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.179 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 9.7 p -161.87 157.26 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.386 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.77 154.64 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.116 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 p -122.5 135.63 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.796 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -122.08 143.59 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.483 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.43 153.06 94.01 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.18 118.41 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.193 1.262 . . . . 0.0 112.103 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.55 -13.57 20.64 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -88.67 161.46 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.559 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.9 p -98.62 138.41 35.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.32 141.66 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.383 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 35.0 m -123.59 130.92 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.58 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.05 134.33 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.386 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 11.0 m -108.77 126.44 53.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.68 111.52 17.29 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.4 m -115.13 141.03 48.56 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.473 -1.392 . . . . 0.0 107.351 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.5 mmm-85 -93.7 139.87 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.264 170.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.8 p -60.53 1.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.371 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.49 -18.37 14.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.58 -173.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.73 -25.18 11.97 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 m -80.35 117.01 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.741 0.305 . . . . 0.0 111.312 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.647 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.34 -64.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.552 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -67.27 -1.08 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.647 ' H ' ' C ' ' A' ' 29' ' ' ILE . 4.3 t -97.56 -22.13 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.04 -1.891 . . . . 0.0 111.917 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.478 ' CB ' HH12 ' A' ' 24' ' ' ARG . 12.8 m120 -118.51 148.51 42.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -175.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.47 137.72 42.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.989 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.44 141.1 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.9 pt20 -119.7 153.26 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -117.76 128.79 55.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 110.34 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' CE2' ' OG1' ' A' ' 47' ' ' THR . 26.2 m-85 -132.6 149.88 52.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.68 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.43 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -121.09 128.79 52.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -108.46 129.74 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.274 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.417 HH21 ' CB ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.607 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.306 0 N-CA-C 110.55 -0.596 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -121.79 138.76 54.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.451 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' OG1' ' CE2' ' A' ' 37' ' ' TYR . 5.7 m -77.4 120.18 22.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.704 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.02 -28.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.832 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 49' ' ' ILE . 15.2 mt -145.18 152.25 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 80.6 t80 -133.5 163.77 28.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.403 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.1 tt0 45.22 23.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.202 1.001 . . . . 0.0 110.44 -172.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.4 p30 44.59 19.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.668 -1.606 . . . . 0.0 109.964 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.6 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.89 -41.38 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.655 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.55 131.85 51.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.56 -1.654 . . . . 0.0 109.254 -167.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.726 HH21 ' H ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -117.31 108.89 42.96 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.99 145.29 49.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.707 1.605 . . . . 0.0 111.418 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 m -73.59 -24.46 60.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.56 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -29.54 72.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.09 148.16 36.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -59.22 128.48 27.73 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.621 1.547 . . . . 0.0 110.655 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.99 -0.85 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.271 . . . . 0.0 111.708 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 60' ' ' PRO . 33.1 mtp180 -43.94 -23.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -79.49 140.79 37.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -127.32 122.84 34.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.726 ' H ' HH21 ' A' ' 55' ' ' ARG . . . -100.1 124.81 8.36 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 113.558 -1.655 . . . . 0.0 110.124 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.1 p -159.67 165.65 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.211 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.452 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -151.49 167.4 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.538 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 70' ' ' SER . 67.2 m-20 -104.1 153.03 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.815 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 m -69.89 13.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.103 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -87.86 -41.5 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.453 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m 79.15 27.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.077 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -98.46 -33.98 10.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.154 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.9 p -165.36 168.62 16.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.753 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.05 130.83 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.832 -1.168 . . . . 0.0 109.641 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 66' ' ' SER . 16.2 m -128.34 112.81 14.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.2 OUTLIER -98.72 140.52 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 118.564 -2.585 . . . . 0.0 116.711 168.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 64' ' ' SER . 85.4 m -99.85 127.55 46.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 162.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -107.9 106.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.107 -1.62 . . . . 0.0 109.701 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 p -102.29 154.95 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.644 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.459 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 79.93 25.62 57.55 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.16 138.32 56.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.12 0.486 . . . . 0.0 110.706 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.9 tttm -149.82 176.9 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.528 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 t -46.38 -21.33 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.45 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.6 mt-10 -72.01 -38.51 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.549 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.534 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.3 OUTLIER -70.63 -12.97 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 79.8 tt0 -52.76 122.72 9.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.364 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 164.42 -178.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.505 0.503 . . . . 0.0 109.874 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.95 132.39 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.72 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HH ' ' CG ' ' A' ' 85' ' ' ASP . 16.2 m-85 -113.15 133.5 55.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -150.96 144.89 25.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.704 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.723 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.53 143.25 46.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -117.06 149.11 40.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 171.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 23.2 t -135.19 163.96 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 111.6 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.207 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.695 0.283 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.49 -160.88 11.48 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 80.73 18.94 69.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.55 85.11 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.5 m -133.84 124.19 26.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -89.93 127.31 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.0 tp -111.65 126.11 54.68 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.46 0.475 . . . . 0.0 110.365 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.7 m -120.99 128.82 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.607 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' OXT' ' A' ' 111' ' ' LEU . 64.0 t -93.7 104.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.428 . . . . 0.0 110.242 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 9.5 mt . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.75 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.403 ' H ' ' HB2' ' A' ' 25' ' ' SER . 2.2 tpp . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.52 103.04 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -78.82 127.44 32.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.581 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.703 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 16.3 mt-30 -143.47 159.76 53.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.72 125.46 18.7 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.498 1.465 . . . . 0.0 110.64 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -60.56 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 p -156.74 153.22 28.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.62 154.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.693 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -130.4 145.77 51.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -135.37 162.51 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -91.5 148.68 37.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.577 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -60.55 118.34 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.438 1.425 . . . . 0.0 111.296 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.37 3.54 29.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -95.01 -173.41 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.1 p -122.65 142.5 50.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.145 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.73 145.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 87.9 m -127.48 122.59 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.023 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.428 ' H ' HD21 ' A' ' 76' ' ' LEU . 35.0 mt -103.36 135.99 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.913 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -106.19 135.61 47.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.335 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 4.1 m -118.72 115.63 24.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.0 m -118.92 140.0 50.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' C ' ' H ' ' A' ' 26' ' ' SER . 45.5 mtp180 -93.21 139.74 30.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.137 169.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 3' ' ' MET . 48.8 m -58.75 1.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.393 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.698 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -103.67 -18.07 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.789 -175.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 77.92 21.76 70.49 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -125.47 113.91 18.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.517 0.198 . . . . 0.0 110.731 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 pp -135.14 -63.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.902 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.514 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -63.88 -3.22 2.3 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.617 ' H ' ' C ' ' A' ' 29' ' ' ILE . 38.6 m -92.98 -21.86 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.372 -2.194 . . . . 0.0 111.226 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -132.61 156.64 46.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.0 110.065 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 23.3 m-85 -82.04 145.11 30.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.91 146.76 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.219 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.639 HE22 ' N ' ' A' ' 37' ' ' TYR . 1.9 pp0? -117.1 163.06 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 27.5 m95 -132.98 126.46 32.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.936 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.639 ' N ' HE22 ' A' ' 35' ' ' GLN . 4.6 m-85 -124.86 149.4 47.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.913 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 1.5 mm100 -124.64 131.02 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.26 137.9 52.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.49 1.27 0 N-CA-C 110.777 -0.509 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.7 m -125.31 116.56 22.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 110.559 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -62.13 122.29 15.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.78 -28.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.548 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -145.02 148.91 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -138.3 143.49 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' ASN . 8.5 tt0 57.68 23.57 9.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.454 1.121 . . . . 0.0 110.17 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.4 t0 44.14 18.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.025 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.6 -46.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.231 165.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -54.54 141.89 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.123 -168.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -125.62 108.86 25.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 119.169 -0.444 . . . . 0.0 109.849 178.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.448 ' N ' HE22 ' A' ' 54' ' ' GLN . 2.8 Cg_exo -60.18 144.31 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.725 1.617 . . . . 0.0 111.575 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -70.64 -26.85 63.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -33.21 86.64 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.03 144.34 28.91 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 62' ' ' ARG . 3.3 Cg_exo -60.37 139.95 89.26 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.459 1.439 . . . . 0.0 110.771 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -60.97 0.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.641 HH22 ' CB ' ' A' ' 85' ' ' ASP . 35.7 ptt85 -50.55 -29.09 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.986 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 63.0 m-85 -78.61 131.8 36.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.486 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 t -112.19 123.66 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.36 122.24 5.31 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 5.9 p -154.97 156.49 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.181 0.515 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.96 159.06 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.13 148.63 25.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.413 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -67.96 -6.43 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 71' ' ' SER . 6.0 m -64.33 -42.64 96.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.916 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 70' ' ' SER . 11.0 p 79.0 31.48 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.649 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -97.3 -43.64 7.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.403 -177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.1 p -167.11 168.35 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.325 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.71 122.79 47.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.8 m -114.52 112.89 23.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.684 -170.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -97.24 140.64 31.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 118.66 -2.525 . . . . 0.0 117.207 168.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.5 m -110.69 127.1 55.17 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.84 113.09 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 120.057 -1.652 . . . . 0.0 110.887 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.76 129.22 45.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.523 0.201 . . . . 0.0 110.728 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.39 58.39 3.13 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.16 138.61 42.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.502 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 84' ' ' GLU . 16.5 mttt -144.74 175.66 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.802 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -45.99 -18.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 82' ' ' LYS . 68.1 mm-40 -69.85 -38.36 76.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.461 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.641 ' CB ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -67.43 -6.91 21.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.529 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 21.9 tt0 -67.21 121.21 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.394 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 162.85 178.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.185 0.516 . . . . 0.0 110.176 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -87.4 134.15 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 10.9 m-85 -113.56 132.79 55.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.9 p90 -151.25 151.87 32.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 103' ' ' GLY . 28.3 p -132.62 143.4 49.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.159 -173.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.526 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 mt-30 -115.3 147.29 40.6 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.7 p -135.21 118.93 17.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.939 0.399 . . . . 0.0 110.844 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.7 p90 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.102 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.4 p90 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.461 0.172 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 141.09 -123.43 2.31 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.39 42.21 9.46 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.13 118.61 11.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -135.91 118.87 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.873 0.368 . . . . 0.0 110.478 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -88.06 115.89 25.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.615 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.56 124.34 50.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.086 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 55.4 m -117.42 113.7 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 90.0 t -78.57 38.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 110.36 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.152 178.63 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.431 ' C ' ' HE ' ' A' ' 24' ' ' ARG . 5.0 ptt? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.532 ' CD1' ' NH1' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -114.66 102.83 10.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.26 127.77 35.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.349 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.6 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.0 161.6 47.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.73 136.43 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.477 2.118 . . . . 0.0 111.676 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -70.36 -45.35 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.845 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -157.56 157.15 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.375 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.06 125.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.5 p -108.0 130.37 55.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.45 164.92 15.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 m -96.6 143.44 26.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.448 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.09 115.07 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.44 1.427 . . . . 0.0 111.039 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.75 -10.77 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -91.85 -171.64 2.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -126.41 153.71 44.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.895 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.33 147.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.099 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -122.25 134.4 54.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.45 ' H ' HD23 ' A' ' 76' ' ' LEU . 5.2 mm -98.88 128.64 50.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -102.38 120.53 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.7 111.84 19.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -178.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 142.17 48.11 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.932 -1.105 . . . . 0.0 108.609 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.677 ' C ' ' H ' ' A' ' 26' ' ' SER . 1.5 mmp_? -89.45 140.18 29.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.782 169.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.1 OUTLIER -59.05 -2.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.124 175.207 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.677 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.79 -18.18 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.072 -175.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 -36.26 3.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -66.78 110.73 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.702 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.5 pp -135.13 -60.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -61.92 1.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.702 ' H ' ' C ' ' A' ' 29' ' ' ILE . 85.1 p -109.02 -26.61 10.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.744 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -103.34 144.17 31.72 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.436 ' O ' ' OG ' ' A' ' 93' ' ' SER . 96.7 m-85 -73.8 119.11 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -174.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.47 143.25 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.782 0.801 . . . . 0.0 110.8 -175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.539 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.6 pm0 -139.09 169.6 17.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.895 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.6 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 64.5 m95 -125.74 128.26 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.207 0.527 . . . . 0.0 110.474 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.534 ' CE1' ' OG1' ' A' ' 47' ' ' THR . 21.7 m-85 -113.99 149.43 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.754 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.39 129.86 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 5.7 tm0? -124.1 142.41 51.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.529 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.159 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.943 -0.445 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -140.84 132.45 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.957 0.408 . . . . 0.0 110.873 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' A' ' 37' ' ' TYR . 4.5 m -62.08 123.54 18.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.917 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.24 -27.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.524 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.4 152.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' ASP . 31.2 t80 -132.87 163.26 29.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.2 tt0 45.94 24.18 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.953 -173.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.3 OUTLIER 44.16 19.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.962 -177.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.643 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.04 -46.1 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.934 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.643 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.94 135.62 48.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.728 -168.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -130.48 108.66 16.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.261 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.17 143.23 64.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.873 1.715 . . . . 0.0 111.58 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.0 m -74.14 -18.54 60.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.66 -51.18 54.17 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -85.24 149.97 53.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.551 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -59.29 135.76 67.67 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.655 0.903 . . . . 0.0 110.171 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' PHE . 47.9 p30 -59.99 0.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.147 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.678 HH12 ' N ' ' A' ' 85' ' ' ASP . 30.8 mtm105 -54.39 4.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.891 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASP . 4.2 m-85 -118.47 143.38 46.75 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.21 -0.306 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -135.28 123.57 23.16 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.073 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.49 119.53 6.29 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.582 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' SER . 12.7 p -153.98 160.46 42.07 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.064 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 163.89 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.119 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 70' ' ' SER . 62.4 m-20 -108.72 146.35 33.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.507 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -67.98 2.73 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.796 174.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 68' ' ' ASP . 28.5 m -71.27 -42.38 68.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 80.83 27.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.566 -178.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.19 -43.6 7.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -164.63 168.44 18.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.403 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 125.17 52.18 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.114 -0.991 . . . . 0.0 109.604 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' SER . 5.5 m -123.38 115.57 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.074 -169.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -95.02 140.58 29.78 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.806 -1.809 . . . . 0.0 115.758 169.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -103.56 128.34 50.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 112.185 166.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -108.36 108.24 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 120.758 -1.213 . . . . 0.0 110.116 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 80' ' ' GLY . 12.7 t -102.96 173.04 6.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.839 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' N ' ' HG ' ' A' ' 79' ' ' SER . . . 58.09 18.8 35.75 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.16 143.38 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.9 tttm -163.49 176.9 9.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.059 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.96 -20.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.586 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' LYS . 97.2 mt-10 -71.85 -38.71 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.559 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.678 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.5 OUTLIER -73.09 -9.29 58.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.251 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 72.2 tt0 -58.41 122.26 12.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.851 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 161.7 -175.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.176 0.513 . . . . 0.0 110.668 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.28 136.13 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.949 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 22.3 m-85 -119.93 132.83 55.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.023 0.439 . . . . 0.0 110.809 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 6.1 p90 -151.21 154.98 37.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.6 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 4.6 m -117.9 141.59 48.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.41 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 55.7 tt0 -117.44 121.52 41.28 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.857 -0.527 . . . . 0.0 109.669 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -135.09 -177.19 4.53 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 -178.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.396 0.617 . . . . 0.0 110.629 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 11.8 p90 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.529 0.204 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.55 -147.37 15.36 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.302 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 62.15 52.49 49.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.42 102.96 1.54 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.445 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 42.1 m -106.84 126.34 52.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.22 98.36 11.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.172 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.0 tp -82.28 122.86 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.155 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 m -120.73 117.33 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 111' ' ' LEU . 95.2 t -81.85 93.53 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.148 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 110' ' ' VAL . 12.2 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.599 -1.191 . . . . 0.0 111.898 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.585 ' O ' ' N ' ' A' ' 25' ' ' SER . 50.0 mtt . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.444 ' CA ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -137.06 118.75 15.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.587 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -71.86 134.43 46.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.629 -172.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.413 ' OE1' ' O ' ' A' ' 21' ' ' SER . 2.8 mm-40 -146.08 157.65 49.65 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.277 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.08 168.67 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.946 . . . . 0.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.754 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -82.89 -66.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.163 179.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.754 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 9.6 m -165.04 162.85 20.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.5 150.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.6 p -130.2 128.32 41.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.137 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.98 162.57 18.31 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.404 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 3.8 m -96.88 147.02 32.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.75 120.0 7.61 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.481 1.454 . . . . 0.0 111.106 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.84 4.96 27.71 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 13' ' ' SER . 61.8 mttm -101.66 -172.94 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.209 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -126.58 145.11 50.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.29 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.02 141.74 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.707 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -123.11 130.27 52.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 135.49 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 2.7 m -106.37 128.59 54.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.986 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.06 121.64 40.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' THR . 91.9 m -125.96 131.1 52.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.753 ' C ' ' H ' ' A' ' 26' ' ' SER . 13.7 ttp180 -81.47 134.21 35.5 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.531 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 3' ' ' MET . 91.6 p -55.48 1.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.488 174.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.753 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.03 -18.05 14.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.19 -172.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.05 21.05 68.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.769 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.54 111.24 14.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.2 0.5 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -135.34 -63.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.67 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -64.04 0.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 29' ' ' ILE . 34.6 m -109.27 -29.6 8.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.158 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.7 OUTLIER -116.81 155.05 29.64 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.15 125.52 27.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.926 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 t -121.03 148.15 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' OE1' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -142.0 160.41 40.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.339 -172.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -119.68 126.59 51.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.317 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.523 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.2 m-85 -108.01 149.11 28.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.866 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -138.1 132.2 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.787 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -133.53 146.61 51.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.753 177.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.611 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.341 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -149.08 143.17 25.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.442 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.523 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -71.88 126.27 29.32 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.946 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.11 -26.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.26 140.76 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' GLN . 50.2 t80 -127.66 152.96 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 11.9 tt0 54.69 23.45 4.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.127 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 43.74 18.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.817 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.44 -46.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.698 . . . . 0.0 109.5 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.504 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -62.69 114.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.758 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.433 ' HE ' ' CB ' ' A' ' 61' ' ' ASP . 25.4 ttp-105 -118.67 108.75 40.77 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -68.21 148.03 73.82 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.97 1.78 . . . . 0.0 111.57 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -74.12 -19.37 60.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.89 92.61 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.5 148.72 44.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 62' ' ' ARG . 4.8 Cg_exo -51.65 121.85 9.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.799 1.666 . . . . 0.0 111.675 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 63' ' ' PHE . 38.6 p-10 -60.91 1.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.418 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.563 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.5 mtp-105 -64.53 16.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.446 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' H ' ' C ' ' A' ' 61' ' ' ASP . 14.4 m-85 -116.9 144.02 45.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -131.66 123.28 27.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.37 126.41 8.72 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.46 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -158.62 164.28 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.257 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.9 161.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.969 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -99.07 178.96 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.658 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 p -91.25 9.14 32.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.023 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' SER . 18.5 m -83.12 -44.41 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.71 28.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.463 -176.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -100.07 -38.63 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.805 -176.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.41 ' H ' HD13 ' A' ' 29' ' ' ILE . 60.4 p -161.3 167.05 26.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.735 -177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.88 124.74 50.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.013 -1.054 . . . . 0.0 109.576 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 6.3 m -115.21 112.64 22.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.702 -171.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -96.72 140.59 31.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 119.345 -2.097 . . . . 0.0 116.515 170.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 78.3 m -108.0 130.21 55.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.905 0.859 . . . . 0.0 113.153 163.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.13 113.55 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 t -99.24 168.0 10.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.085 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.459 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 59.2 38.38 93.1 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 tt -65.37 134.53 53.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.032 0.444 . . . . 0.0 110.97 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' GLU . 9.2 tttt -151.94 176.26 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -19.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.791 174.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 82' ' ' LYS . 65.0 tt0 -74.55 -38.61 62.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.179 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.563 ' CG ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -72.64 -11.41 60.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.9 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 76.7 tt0 -57.42 125.75 24.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.869 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 162.39 176.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.88 142.46 27.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.897 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 13.4 m-85 -113.99 147.62 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.569 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -146.48 154.13 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.631 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.2 t -127.66 140.66 51.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 93' ' ' SER . 8.8 tp60 -128.26 131.99 48.74 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 92' ' ' GLN . 35.4 p -134.99 145.19 47.87 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.054 -0.404 . . . . 0.0 111.172 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.149 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 110.698 -0.112 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.407 ' H ' HD11 ' A' ' 4' ' ' LEU . . . 178.25 -166.84 37.12 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.238 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.22 48.57 4.01 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.26 96.38 0.06 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -105.27 116.33 31.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.45 123.94 30.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.027 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.1 tp -110.86 122.91 49.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.797 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -116.23 120.28 38.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.803 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 60.4 t -91.65 34.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.408 179.282 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.5 mmm . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.78 103.05 7.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.68 121.75 25.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.597 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.78 -177.68 0.69 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 3.8 Cg_exo -74.38 151.83 43.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.188 1.925 . . . . 0.0 111.658 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.649 ' CG ' ' H ' ' A' ' 9' ' ' SER . 19.0 p-80 -82.44 -57.01 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.625 0.25 . . . . 0.0 111.182 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.649 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 30.6 p -152.6 149.04 28.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.582 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.38 153.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.288 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.1 p -132.15 141.85 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.423 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -131.81 158.1 42.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -76.74 148.9 80.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -63.46 120.23 7.58 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.572 1.515 . . . . 0.0 112.044 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.14 -6.3 17.32 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -96.45 164.94 12.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.162 0.506 . . . . 0.0 111.147 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -95.52 132.3 40.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.065 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.51 135.16 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.079 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -120.13 134.88 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.465 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.06 134.29 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.125 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -110.23 125.93 53.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 30.7 m -118.75 125.27 49.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 m -116.88 131.73 56.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.718 ' C ' ' H ' ' A' ' 26' ' ' SER . 41.7 ttt180 -83.86 136.54 34.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.301 171.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.5 m -58.6 2.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.554 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.718 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -104.9 -18.04 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -174.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.17 -32.29 4.14 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 3.1 t -72.47 110.24 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.935 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.5 pp -134.59 -60.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.89 0.3 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.677 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.4 p -110.13 -26.98 9.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.358 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' HH11 ' A' ' 24' ' ' ARG . 98.3 m-20 -104.26 151.3 23.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -81.55 114.76 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.97 148.0 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.404 ' NE2' ' CE2' ' A' ' 37' ' ' TYR . 18.7 tt0 -135.84 156.61 48.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.26 135.36 54.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.427 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -139.06 137.07 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.563 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.0 148.08 52.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.185 0.517 . . . . 0.0 110.098 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.73 140.01 47.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.219 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.491 1.379 0 CA-C-O 120.588 0.162 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.402 ' C ' ' CE1' ' A' ' 37' ' ' TYR . 81.2 p -140.4 126.56 19.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.629 176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.54 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 64.6 m -61.14 121.14 11.75 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.726 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.36 -28.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.928 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.3 mt -145.63 146.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.8 t80 -132.99 159.16 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 50.98 24.03 1.69 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.2 1.0 . . . . 0.0 110.361 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 38.5 t0 44.35 19.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.361 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -127.87 -46.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 170.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 HE21 ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -55.29 140.46 39.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.909 -168.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -142.34 108.68 5.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.295 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -68.37 143.94 59.95 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.407 1.405 . . . . 0.0 111.992 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -69.64 -35.79 75.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.685 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.96 -50.58 26.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -91.54 139.51 25.12 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -57.83 137.18 79.77 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.137 1.225 . . . . 0.0 110.54 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' PHE . 4.0 p-10 -62.75 -0.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.61 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 60' ' ' PRO . 17.9 mtp-105 -38.33 -24.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.495 -175.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 7.2 m-85 -89.77 141.01 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.5 t -126.38 124.36 40.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.951 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.39 117.52 5.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.509 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 75' ' ' SER . 8.1 p -153.93 167.05 31.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.125 0.462 . . . . 0.0 110.722 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.458 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -149.14 160.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -101.15 153.75 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.605 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.0 p -68.09 -7.46 29.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.248 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.7 m -61.96 -42.8 99.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 80.84 27.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.481 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.07 -38.25 8.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.786 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -166.28 171.41 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.042 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.04 135.41 48.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.784 -1.198 . . . . 0.0 109.467 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -130.42 115.69 17.21 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.794 -1.098 . . . . 0.0 112.825 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.99 140.73 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 118.927 -2.358 . . . . 0.0 116.284 169.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.4 m -102.48 126.13 49.42 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.473 -0.767 . . . . 0.0 112.969 162.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.25 103.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 120.79 -1.194 . . . . 0.0 109.788 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -98.98 154.31 18.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 78.21 17.25 78.43 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.91 131.91 22.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.318 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 84' ' ' GLU . 26.6 mttt -148.99 176.09 10.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.818 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -18.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.627 174.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 82' ' ' LYS . 94.0 mt-10 -75.67 -37.0 59.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' LYS . 6.9 t70 -74.3 -10.7 59.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 38.8 tt0 -57.59 123.94 17.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 162.14 -175.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.922 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -89.11 150.01 22.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.563 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 19.1 m-85 -122.26 151.76 40.75 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.543 0.337 . . . . 0.0 110.526 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 37' ' ' TYR . 56.0 m-85 -150.45 137.37 19.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.427 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 16.2 p -118.9 140.66 49.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.951 0.341 . . . . 0.0 111.368 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -118.08 134.71 54.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -135.12 146.99 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.612 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.9 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.63 0.253 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.37 -131.43 6.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.75 24.13 3.94 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.09 164.71 4.79 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 28.8 m -131.81 130.57 41.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.87 112.89 15.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.9 tp -105.83 124.45 49.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.116 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.2 m -117.62 124.76 49.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.119 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.07 99.21 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.204 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.887 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.78 103.87 6.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 5' ' ' THR . 1.6 p -90.41 135.35 33.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.825 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.662 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 30.5 mt-30 -136.55 163.42 49.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.829 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.49 135.46 66.26 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.899 1.733 . . . . 0.0 110.817 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -41.49 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -161.28 157.46 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 11' ' ' SER . 7.3 p -163.62 162.88 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.447 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.458 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 15.1 t -137.07 156.88 47.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.064 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.68 151.78 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.436 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.73 142.32 85.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.528 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.88 113.9 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.459 1.439 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.82 1.34 22.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -94.9 -174.16 3.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.004 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -113.44 127.81 56.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.138 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -118.37 144.06 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -130.58 131.45 45.0 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.97 140.17 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.303 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -113.88 120.08 39.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.421 ' HB2' HE21 ' A' ' 6' ' ' GLN . 31.9 t -120.75 123.6 43.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.6 m -119.69 142.09 48.8 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.019 -1.05 . . . . 0.0 108.278 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 26' ' ' SER . 75.3 mtp85 -92.94 141.1 28.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.685 170.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 p -59.74 2.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.246 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.09 -18.15 14.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.132 -175.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 74.3 8.93 80.68 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.413 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 6.7 t -110.85 105.46 14.29 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.786 -0.244 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -129.61 -63.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -63.53 -0.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.66 ' H ' ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -98.91 -27.05 14.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.719 -178.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -131.71 152.22 51.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -71.07 149.09 46.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.676 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 52' ' ' ASP . 17.1 t -125.5 148.21 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.24 155.41 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.97 131.04 54.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.054 0.454 . . . . 0.0 110.425 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.531 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.2 OUTLIER -127.91 146.19 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.84 136.66 48.87 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -120.49 121.75 39.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.348 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 . . . . . 0 C--N 1.33 -0.258 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.905 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.491 1.324 0 CA-C-O 119.602 -0.249 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -139.92 97.94 3.36 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 121.914 -0.491 . . . . 0.0 110.202 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.531 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 33.9 m -64.83 118.89 9.66 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.94 -28.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.199 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.44 151.47 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' HH ' ' HH ' ' A' ' 94' ' ' TYR . 5.7 t80 -134.13 161.01 36.07 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.0 tt0 48.6 23.86 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.351 0.596 . . . . 0.0 111.217 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.0 t0 44.48 19.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.119 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.677 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -127.93 -46.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.502 . . . . 0.0 109.825 170.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.677 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.52 132.33 44.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.951 -168.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -134.64 108.63 10.97 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.08 149.09 64.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.964 1.776 . . . . 0.0 111.62 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -71.55 -36.75 71.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.698 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.76 42.48 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.6 138.09 33.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.5 Cg_endo -59.89 131.37 39.2 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 CA-C-N 119.88 0.993 . . . . 0.0 110.665 -177.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 63' ' ' PHE . 25.6 p-10 -60.95 1.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 60' ' ' PRO . 13.6 mtm105 -46.65 -5.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.165 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 6.0 m-85 -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.4 t -119.06 124.36 46.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.72 122.46 6.98 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 37.8 p -159.15 163.35 36.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.051 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.91 158.82 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.858 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 70' ' ' SER . 73.5 m-20 -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.864 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.22 30.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 68' ' ' ASP . 6.7 m -107.19 -40.46 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.537 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 83.79 25.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.391 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -42.17 7.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.678 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -164.69 170.73 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.63 133.94 51.35 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 120.61 -1.306 . . . . 0.0 110.177 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 12.5 m -125.47 113.56 17.65 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.055 -0.974 . . . . 0.0 113.092 -171.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.42 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.44 140.6 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 118.591 -2.568 . . . . 0.0 116.994 170.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' SER . 19.5 m -105.1 125.53 51.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 163.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' VAL . 38.4 mm -89.79 103.62 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.565 -1.334 . . . . 0.0 110.724 172.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 m -99.32 141.56 31.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.371 . . . . 0.0 111.486 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.94 15.42 79.1 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.03 135.66 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.57 . . . . 0.0 110.461 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -144.04 176.06 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.302 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.73 -19.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.432 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE1' ' NH2' ' A' ' 62' ' ' ARG . 3.2 tt0 -70.97 -42.02 70.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.352 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 4.6 m-20 -66.86 -7.07 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.22 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 33.0 tt0 -58.99 121.03 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.977 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.5 -175.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -93.0 147.36 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.21 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -116.73 145.33 43.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 14.0 m-85 -145.93 152.62 39.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.859 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.662 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -125.08 140.89 52.49 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -118.98 139.81 51.05 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.487 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 2.4 m -135.09 158.29 44.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 110.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.435 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.9 p90 . . . . . 0 C--O 1.232 0.14 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.83 -150.13 8.66 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' TYR . . . 86.1 35.91 10.58 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.36 110.08 2.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -142.13 137.79 31.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.769 0.319 . . . . 0.0 110.371 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.31 112.72 25.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.565 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.11 125.93 50.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.085 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OG ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -118.88 125.19 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -96.21 103.21 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.209 179.069 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 4.1 m-85 -103.71 170.41 7.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt -132.4 170.01 15.71 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.1 102.77 6.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -92.1 121.08 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.008 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.549 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.55 164.86 25.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 106' ' ' THR . 6.0 Cg_exo -50.15 134.42 36.91 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.246 1.964 . . . . 0.0 111.612 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.546 ' HD1' ' CB ' ' A' ' 9' ' ' SER . 9.7 t-80 -67.0 -68.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.546 ' CB ' ' HD1' ' A' ' 8' ' ' HIS . 53.2 m -148.43 146.04 28.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.9 p -162.52 156.14 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.525 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 86.0 p -133.86 145.55 49.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.384 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -133.82 156.68 47.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.093 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -77.06 136.76 65.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.166 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.56 125.19 17.07 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.583 1.522 . . . . 0.0 111.093 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 -6.68 25.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -94.08 173.52 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.778 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.6 p -100.56 136.62 40.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.225 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.5 137.43 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -125.14 127.59 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' H ' HD22 ' A' ' 76' ' ' LEU . 21.7 mm -104.59 139.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.42 127.71 53.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.379 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 11.2 m -118.62 126.36 51.79 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.8 m -118.93 141.64 48.47 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.719 ' C ' ' H ' ' A' ' 26' ' ' SER . 33.1 mtp85 -94.74 141.11 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.185 170.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.5 t -58.2 0.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.544 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.719 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.25 -18.1 14.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.794 -173.974 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 75.47 21.87 76.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' OD1' ' A' ' 32' ' ' ASN . 10.5 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.673 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.32 -63.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.439 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.96 1.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 29' ' ' ILE . 54.7 m -104.97 -27.08 11.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.378 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.409 HD22 ' HD3' ' A' ' 24' ' ' ARG . 4.0 p-10 -122.2 163.58 19.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.152 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -81.92 142.88 32.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.67 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.02 148.26 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.558 HE21 ' C ' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -133.24 144.52 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.558 ' C ' HE21 ' A' ' 35' ' ' GLN . 97.9 m95 -110.43 135.03 51.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 110.878 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.538 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -128.29 149.11 50.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.03 140.55 52.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.415 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 6.6 tm0? -148.24 144.65 27.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -163.31 153.35 13.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.449 178.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.29 145.15 94.5 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.27 1.313 . . . . 0.0 111.181 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 9.66 82.73 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -151.31 -167.7 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.407 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 p -135.59 155.65 78.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.1 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.27 137.92 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.09 1.86 . . . . 0.0 111.836 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 m -138.78 110.31 7.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.538 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -60.87 121.15 11.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.45 -27.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.408 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mt -145.11 146.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 8.5 t80 -130.96 159.08 38.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.251 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 3.7 tt0 49.3 24.31 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.653 0.74 . . . . 0.0 110.682 -175.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.2 p-10 44.5 19.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.61 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.67 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.0 -46.35 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.378 0.609 . . . . 0.0 109.811 171.235 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.67 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.55 124.79 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.033 -167.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.56 108.8 40.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.462 177.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.56 144.54 55.44 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.475 1.45 . . . . 0.0 111.662 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -67.26 -32.38 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.711 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.99 -58.65 13.44 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.45 137.87 48.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.544 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.2 Cg_exo -59.01 137.92 82.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.966 1.111 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 63' ' ' PHE . 12.0 p-10 -61.5 1.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.445 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.544 ' H ' ' C ' ' A' ' 60' ' ' PRO . 9.1 ptm180 -49.79 -2.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.93 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.558 ' H ' ' C ' ' A' ' 61' ' ' ASP . 47.2 m-85 -104.45 143.65 32.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.31 122.55 34.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.893 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.07 125.29 8.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.497 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.3 p -157.57 161.88 38.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.194 0.521 . . . . 0.0 111.124 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.89 158.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.769 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.8 m-20 -102.65 145.96 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.8 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.91 -3.72 10.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.442 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.3 m -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.068 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 28.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.593 -177.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -98.77 -40.55 8.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -168.17 169.83 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.088 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.32 135.54 49.46 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 120.613 -1.304 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -128.48 115.6 18.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.137 -171.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -98.03 140.72 31.94 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 118.622 -2.549 . . . . 0.0 116.91 168.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.0 m -104.63 129.22 52.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 162.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.45 ' CG2' ' NH2' ' A' ' 62' ' ' ARG . 6.0 mt -109.65 105.94 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 120.179 -1.576 . . . . 0.0 110.193 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 t -88.86 153.13 21.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 61.34 4.06 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.21 137.92 34.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.163 0.506 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' A' ' 84' ' ' GLU . 22.3 mttt -151.45 173.73 14.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.694 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.33 -19.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.497 173.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 82' ' ' LYS . 91.2 mt-10 -68.81 -41.0 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.392 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.543 ' CG ' HH22 ' A' ' 62' ' ' ARG . 16.7 t70 -72.68 -9.9 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.242 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.459 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 82.3 tt0 -56.4 120.97 8.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.812 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 161.88 176.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -88.73 152.86 21.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.668 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 17.6 m-85 -117.67 143.26 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.997 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.3 m-85 -144.58 142.51 30.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.727 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.1 p -134.96 140.86 46.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.829 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -121.16 148.55 44.07 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.76 -0.587 . . . . 0.0 110.482 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 p -135.15 153.37 52.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 110.68 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.67 133.94 9.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.98 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.24 -156.93 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.634 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -77.91 -31.78 51.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -84.96 39.79 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 m120 53.39 -118.42 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.624 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 48.0 81.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 110.07 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.57 135.85 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.8 156.22 41.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.095 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -136.08 147.56 47.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.99 -141.99 4.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.68 53.86 38.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.06 103.5 2.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 34.4 m -126.27 141.7 51.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 110.642 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -104.93 101.15 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.69 124.97 36.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.379 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 m -120.74 124.91 46.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.55 100.94 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.113 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.836 179.612 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.436 HD21 ' N ' ' A' ' 2' ' ' PHE . 2.6 t30 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.436 ' N ' HD21 ' A' ' 1' ' ' ASN . 46.2 m-85 -68.24 143.72 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.345 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.439 ' H ' ' HB2' ' A' ' 25' ' ' SER . 4.4 ptm -155.33 170.02 22.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.38 104.49 9.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.44 ' H ' ' HG1' ' A' ' 5' ' ' THR . 12.0 p -80.17 129.68 34.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.321 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 3.0 mt-30 -145.34 166.68 16.8 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -63.84 133.32 38.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.475 1.45 . . . . 0.0 111.319 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.645 ' CG ' ' H ' ' A' ' 9' ' ' SER . 6.1 p80 -44.19 -60.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.645 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 35.2 p -164.08 160.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -162.95 147.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 p -130.71 132.2 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.849 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.92 158.23 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 m -80.93 140.03 50.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.57 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.38 116.13 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.751 1.634 . . . . 0.0 111.043 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.32 -0.6 18.82 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -107.56 -163.05 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.9 p -136.63 153.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.16 147.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.051 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 131.74 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.85 134.27 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.292 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.8 m -104.92 123.56 47.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.877 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.99 111.91 18.92 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.7 m -116.59 141.97 47.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.9 mtm180 -99.55 143.27 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.071 170.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.439 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -58.24 1.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 176.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.699 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -101.45 -14.05 17.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.784 -174.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.33 27.14 70.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.8 p -124.5 109.53 13.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 110.571 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.558 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -135.17 -64.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.995 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.522 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -66.59 -2.41 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.6 t -100.93 -29.18 12.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.57 -2.104 . . . . 0.0 111.339 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -121.09 148.53 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.0 112.84 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.372 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 22.0 t -102.3 146.3 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.58 HE21 ' CB ' ' A' ' 92' ' ' GLN . 7.1 tt0 -127.97 165.09 20.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 28.2 m95 -130.04 127.43 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.936 0.398 . . . . 0.0 110.914 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.504 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 2.1 m-85 -121.19 148.99 43.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.374 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -126.74 134.79 50.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -112.31 117.54 32.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -113.97 126.94 27.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.687 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.74 144.71 99.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 120.904 1.069 . . . . 0.0 110.673 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.17 87.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 p -155.09 158.96 39.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.655 0.264 . . . . 0.0 110.322 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 p -86.5 158.02 54.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.296 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.9 155.32 18.56 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.794 1.663 . . . . 0.0 110.812 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 126.82 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.436 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.504 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -74.94 120.96 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.099 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.8 t -103.17 -28.4 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.491 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -145.42 151.66 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.801 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 3.5 t80 -140.82 164.86 29.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' ASN . 2.7 tt0 44.84 21.9 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 110.887 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 43.09 18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.614 -177.002 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.79 -46.97 1.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 173.752 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.801 ' OE1' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.01 153.28 40.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.993 -164.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.534 ' NH2' ' O ' ' A' ' 60' ' ' PRO . 3.3 ttt85 -132.0 108.67 14.01 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 120.322 -1.486 . . . . 0.0 109.939 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -69.7 143.0 49.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.446 1.43 . . . . 0.0 111.449 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -73.99 -18.86 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.062 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.46 -38.33 96.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.2 m -103.08 149.95 37.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 122.291 -0.535 . . . . 0.0 109.626 -177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.4 Cg_endo -53.65 125.98 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.795 1.663 . . . . 0.0 111.342 -173.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.486 ' C ' HH21 ' A' ' 55' ' ' ARG . 97.8 m-20 -61.05 2.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.443 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.545 ' H ' ' C ' ' A' ' 60' ' ' PRO . 19.6 mtm105 -69.25 21.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -173.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' O ' ' CZ ' ' A' ' 55' ' ' ARG . 16.9 m-85 -131.32 143.6 50.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.151 0.432 . . . . 0.0 110.626 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 77' ' ' THR . 2.1 t -126.64 123.14 36.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.139 -0.457 . . . . 0.0 111.269 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.21 136.54 13.66 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.374 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.4 p -163.83 159.92 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -141.03 154.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.669 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' C ' ' H ' ' A' ' 70' ' ' SER . 15.9 m-20 -102.98 154.21 19.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.948 176.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.4 p -69.7 7.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.526 ' H ' ' C ' ' A' ' 68' ' ' ASP . 24.4 m -74.19 -43.11 58.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.596 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 70' ' ' SER . 12.7 p 79.5 30.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.657 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.05 -38.14 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.767 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.4 p -169.5 172.39 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.775 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.76 123.81 49.6 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 120.864 -1.147 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' SER . 13.7 m -114.02 112.8 23.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.519 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -96.92 140.48 31.4 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 119.3 -2.125 . . . . 0.0 116.019 169.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.481 ' O ' ' CB ' ' A' ' 64' ' ' SER . 5.6 m -112.64 126.23 55.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 164.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 78' ' ' ILE . 28.5 mm -86.29 114.25 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 120.21 -1.556 . . . . 0.0 110.919 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.9 t -103.76 131.71 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.85 52.92 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.96 133.82 10.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.252 0.548 . . . . 0.0 110.106 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 84' ' ' GLU . 3.0 ttmt -144.17 171.98 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.198 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -19.03 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.831 173.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' H ' ' C ' ' A' ' 82' ' ' LYS . 5.6 mp0 -70.86 -39.38 72.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -69.76 -9.05 53.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.276 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 72.0 tt0 -60.37 122.91 15.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 157.38 -179.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 90' ' ' TYR . 9.8 t0 -87.62 149.89 24.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.9 m-85 -115.28 145.39 42.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 88' ' ' ASP . 67.7 m-85 -143.5 154.1 43.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.215 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.84 141.0 49.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.58 ' CB ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.48 120.74 31.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.615 0.643 . . . . 0.0 109.386 174.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.598 ' HG ' ' CD ' ' A' ' 24' ' ' ARG . 59.7 p -128.54 152.5 48.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.966 0.412 . . . . 0.0 110.649 -178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.01 147.37 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 96' ' ' SER . 19.0 t0 -72.17 -145.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.545 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.6 m -108.34 -35.54 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.07 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 98' ' ' ASN . 82.7 p -88.8 -10.01 49.71 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.277 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.483 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER 148.59 -110.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 O-C-N 123.995 0.809 . . . . 0.0 109.977 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.449 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 24.0 t-80 50.14 71.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.5 m -85.92 126.14 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 16.8 m -149.46 148.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.626 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -135.94 140.41 43.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.23 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.82 -132.47 1.39 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 48.37 47.01 28.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.33 108.78 2.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 92.8 m -133.16 134.57 44.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.841 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.83 124.31 36.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -113.81 131.32 56.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.934 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.3 m -124.29 128.97 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 58.2 t -87.56 34.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.952 -179.791 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -112.97 131.47 55.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.984 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.431 ' H ' ' HB2' ' A' ' 25' ' ' SER . 30.1 mtm -153.94 170.11 21.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.32 103.24 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.48 113.93 11.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.588 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 14.0 tt0 -144.87 141.82 17.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 118.977 -0.535 . . . . 0.0 109.58 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -51.4 137.16 48.08 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 CA-C-N 120.563 1.237 . . . . 0.0 110.954 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 9' ' ' SER . 42.2 p-80 -58.85 -49.43 77.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.629 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' ' CD2' ' A' ' 8' ' ' HIS . 2.4 m -158.7 151.68 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.45 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.6 p -160.29 154.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 t -131.9 149.0 52.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.312 -178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -141.37 162.19 36.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.459 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -85.93 156.8 57.87 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.325 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.71 128.36 19.84 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.69 1.593 . . . . 0.0 112.283 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.77 -5.27 39.94 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -89.4 167.94 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.672 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p -102.75 125.41 49.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.782 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 78' ' ' ILE . 2.6 t -114.44 138.95 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.415 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 32.5 m -128.59 119.78 25.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.931 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.06 132.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -109.07 124.93 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.0 m -118.86 115.4 24.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.4 m -116.96 137.66 52.07 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 26' ' ' SER . 12.7 ttp85 -92.81 139.18 30.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.498 170.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 3' ' ' MET . 16.6 m -58.41 2.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.627 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.71 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.06 -18.13 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.89 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.68 22.98 76.32 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.58 ' C ' HD22 ' A' ' 32' ' ' ASN . 30.1 t -120.82 110.02 15.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.507 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.47 -63.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.799 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -63.35 0.35 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.0 p -103.87 -11.63 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.837 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.602 ' N ' ' ND2' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -132.33 152.07 51.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 109.982 -177.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.98 127.96 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.092 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' HA ' HE21 ' A' ' 35' ' ' GLN . 20.5 t -119.81 146.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.228 0.537 . . . . 0.0 110.719 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.56 156.99 47.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.341 -177.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.538 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 98.0 m95 -113.93 136.69 52.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.445 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.435 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 10.2 m-85 -126.17 149.15 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.42 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -146.13 133.53 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.575 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.07 160.21 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.533 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -146.7 157.4 47.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.08 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.65 139.07 67.6 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.802 1.668 . . . . 0.0 110.633 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' C ' ' HG ' ' A' ' 43' ' ' SER . . . 85.37 5.51 84.99 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.526 ' HG ' ' C ' ' A' ' 42' ' ' GLY . 8.2 m -157.03 176.26 12.99 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.96 176.27 1.56 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.061 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -68.15 148.96 76.03 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.432 2.088 . . . . 0.0 111.924 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 p -132.72 143.31 49.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.435 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 5.5 m -71.7 120.89 17.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.455 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -102.84 -28.66 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.299 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 49' ' ' ILE . 5.9 mt -145.61 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.2 t80 -127.79 166.04 18.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.7 tt0 44.77 22.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.083 0.944 . . . . 0.0 110.6 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.2 p30 43.48 17.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.763 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.09 -47.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 170.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 1.1 pp0? -80.9 126.12 30.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.936 -166.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -121.22 119.29 29.67 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.276 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.26 141.37 97.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.8 1.321 . . . . 0.0 111.64 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -67.3 -5.35 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.54 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.99 59.03 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.24 148.5 35.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 122.587 -0.361 . . . . 0.0 110.845 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -59.35 139.41 89.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.813 1.675 . . . . 0.0 111.568 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -61.05 -0.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 63' ' ' PHE . 42.6 ptt85 -56.12 -31.87 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 0.0 111.313 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 60.3 m-85 -72.25 140.89 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.6 t -128.36 122.61 31.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.89 123.94 7.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.41 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -154.56 158.23 39.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.631 . . . . 0.0 111.29 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pp -143.46 157.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.635 -176.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 70' ' ' SER . 4.6 m-20 -105.16 143.63 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.813 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -0.05 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.955 0.407 . . . . 0.0 110.327 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 68' ' ' ASP . 19.4 m -70.58 -40.77 73.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.02 29.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.397 -177.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -98.93 -39.7 8.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.579 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.5 p -167.78 169.55 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.889 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.36 130.29 55.21 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.544 -1.348 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' SER . 9.1 m -129.94 114.78 16.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.143 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -97.95 140.53 32.16 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 118.645 -2.534 . . . . 0.0 116.166 167.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 64' ' ' SER . 86.2 m -100.12 128.03 46.27 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 162.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -105.44 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 120.684 -1.26 . . . . 0.0 110.072 174.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.78 170.94 10.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.032 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.36 56.63 4.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tt -79.38 136.47 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.536 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' GLU . 14.0 mttp -145.66 -176.6 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.399 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -47.3 -18.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.509 171.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 82' ' ' LYS . 77.9 tt0 -69.97 -41.63 74.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.233 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.517 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 14.5 t70 -74.3 -3.65 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 73.6 tt0 -69.16 124.14 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.76 -175.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.817 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -88.55 135.38 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.239 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 85' ' ' ASP . 13.5 m-85 -114.27 139.95 49.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.028 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.4 m-85 -129.52 154.15 47.31 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.538 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -118.53 140.68 49.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -123.81 116.47 23.02 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 p -135.41 141.68 45.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' CB ' ' N ' ' A' ' 100' ' ' VAL . 9.7 p90 -159.51 144.97 15.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.703 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -110.8 -148.25 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.093 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 t -72.46 -41.58 65.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.988 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 -6.64 58.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 110.715 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.627 HD21 ' H ' ' A' ' 98' ' ' ASN . 0.0 OUTLIER -101.54 -69.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.381 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.499 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 3.5 t-80 78.8 -10.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.883 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER 170.66 114.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.82 148.3 26.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -129.32 137.96 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.486 0.184 . . . . 0.0 110.593 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.24 -154.41 11.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.76 40.17 97.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.67 96.96 0.87 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 63.3 m -120.48 131.39 54.72 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.89 117.43 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 29.8 tp -100.32 125.22 46.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.74 109.64 17.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 61.6 t -84.37 44.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.615 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.236 178.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.727 ' H1 ' HD21 ' A' ' 1' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.67 122.15 11.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.432 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 3.8 ttt -161.33 170.1 20.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.206 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.432 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.3 OUTLIER -129.41 103.15 6.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -83.38 119.71 24.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.875 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.5 tt0 -144.98 145.54 27.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.649 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -49.94 136.59 36.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.257 1.128 . . . . 0.0 111.209 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.537 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.69 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 5.1 m -156.41 160.18 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.683 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.84 146.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.912 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p -141.08 145.87 36.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.589 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -142.95 154.24 43.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -78.04 140.67 62.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.635 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.06 123.98 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.737 1.624 . . . . 0.0 111.021 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.79 22.41 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -97.88 -171.73 2.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.662 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p -119.89 142.42 48.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.47 142.41 44.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.079 0.466 . . . . 0.0 110.611 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -128.62 134.45 48.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.434 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.529 ' H ' HD21 ' A' ' 76' ' ' LEU . 5.4 mm -105.8 146.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.179 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -124.06 122.8 38.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.5 117.91 30.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 m -117.01 142.11 47.38 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.733 ' C ' ' H ' ' A' ' 26' ' ' SER . 50.9 mtt85 -98.59 140.53 32.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.315 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -58.54 3.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.733 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.33 -17.11 15.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.603 -174.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.48 -41.3 2.49 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -65.42 111.0 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.054 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.709 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.12 -59.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.505 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -60.66 1.09 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.709 ' H ' ' C ' ' A' ' 29' ' ' ILE . 7.8 t -107.92 -30.23 8.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.901 -1.5 . . . . 0.0 111.568 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 95' ' ' ASP . 42.5 m-80 -111.86 143.11 43.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.4 m-85 -73.95 134.31 43.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.888 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' CG2' ' NH2' ' A' ' 24' ' ' ARG . 1.5 t -121.0 145.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.354 0.597 . . . . 0.0 109.944 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.7 153.23 45.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.463 -176.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 29.3 m95 -129.99 132.34 46.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 110.519 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.53 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 32.3 m-85 -119.29 149.39 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.633 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.547 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -131.37 129.27 41.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 43' ' ' SER . 52.7 tp60 -113.56 124.83 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.749 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.14 148.95 59.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 139.28 89.8 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.418 1.412 . . . . 0.0 110.559 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' C ' ' HG ' ' A' ' 43' ' ' SER . . . 74.62 10.03 82.66 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 7.6 m -148.71 143.0 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 110.589 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 175.95 4.01 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.123 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.84 142.25 42.75 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.19 1.927 . . . . 0.0 111.458 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.5 p -139.25 134.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.507 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.53 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 4.4 m -70.29 118.79 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.162 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.88 -21.82 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.338 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.4 mt -144.56 143.16 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 52' ' ' ASP . 76.8 t80 -133.12 167.22 20.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.314 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 53' ' ' ASN . 10.0 tp10 44.67 23.51 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.043 0.925 . . . . 0.0 110.241 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.2 t70 44.22 19.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.255 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' ND2' ' NE2' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -128.04 -45.18 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.783 168.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.629 ' NE2' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.31 143.89 17.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.36 -170.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -146.82 108.57 4.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 118.989 -0.529 . . . . 0.0 109.866 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.21 148.89 56.76 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.534 1.489 . . . . 0.0 111.95 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -74.13 -30.2 62.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.38 -47.12 63.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.51 145.31 31.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.1 Cg_endo -53.01 117.99 4.33 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.915 1.744 . . . . 0.0 111.293 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 63' ' ' PHE . 18.5 p-10 -60.78 0.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.644 HH12 ' N ' ' A' ' 85' ' ' ASP . 47.2 mtm105 -46.12 -11.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.996 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 3.4 m-85 -105.4 143.08 34.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.6 t -124.75 122.86 38.66 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.81 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.19 121.77 7.0 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.47 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.1 p -157.29 163.75 38.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -139.1 155.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.522 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -100.18 152.06 20.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.836 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.7 m -67.94 -8.56 38.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' SER . 58.0 m -61.34 -41.17 96.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER 79.6 27.29 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.347 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -98.55 -41.75 7.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.413 ' H ' HD13 ' A' ' 29' ' ' ILE . 62.7 p -164.43 174.85 10.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.67 47.78 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.614 -1.303 . . . . 0.0 110.011 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 66' ' ' SER . 69.1 m -116.77 116.67 27.93 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.839 -169.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.529 HD21 ' H ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -97.82 140.58 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 118.474 -2.642 . . . . 0.0 117.386 170.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 64' ' ' SER . 4.5 m -107.85 127.39 53.68 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 163.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -104.18 109.92 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 120.08 -1.638 . . . . 0.0 110.21 172.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.99 155.75 16.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.332 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.06 42.22 96.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.21 136.86 57.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -151.83 177.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.262 177.397 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.93 -21.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.521 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.8 mt-10 -70.22 -40.69 74.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.261 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.644 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.9 OUTLIER -70.82 -9.03 56.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.145 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 39.5 tt0 -64.18 125.22 23.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.183 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 163.1 -175.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.039 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.085 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.547 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 16.2 m-85 -115.25 146.82 41.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.459 . . . . 0.0 111.08 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.6 m-85 -144.79 149.01 34.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.077 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -140.7 140.18 34.86 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.432 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 mt-30 -133.16 149.02 52.09 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.62 ' CB ' ' HE ' ' A' ' 24' ' ' ARG . 15.1 m -135.19 126.76 28.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.389 . . . . 0.0 110.938 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 35' ' ' GLN . 12.3 p90 -159.14 130.98 6.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.849 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 0.8 OUTLIER -98.87 -153.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.488 178.111 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -16.37 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -87.66 39.44 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m120 49.89 -128.41 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.698 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 49.69 82.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.348 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -85.91 116.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.11 125.84 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.839 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -116.28 140.34 49.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.225 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.52 -145.0 4.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.38 12.78 83.98 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.15 99.33 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.446 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 16.4 m -142.42 141.76 32.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.005 0.431 . . . . 0.0 110.26 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -106.19 119.16 38.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 tp -104.04 122.61 45.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 111' ' ' LEU . 1.2 m -117.29 111.66 19.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 110' ' ' VAL . 47.6 t -82.76 31.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.779 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 109' ' ' THR . 13.7 mt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.984 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.446 ' C ' HD21 ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.42 ' H ' ' H2 ' ' A' ' 1' ' ' ASN . 84.2 m-85 -73.47 103.77 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.145 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtm -137.52 169.89 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.79 118.82 25.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -85.88 120.47 27.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.783 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.698 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.6 tt0 -145.48 141.94 17.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.45 160.76 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.247 1.298 . . . . 0.0 111.773 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.43 ' ND1' ' OG ' ' A' ' 9' ' ' SER . 3.3 t-80 -81.29 -56.56 3.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.43 ' OG ' ' ND1' ' A' ' 8' ' ' HIS . 59.6 p -156.31 150.55 25.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.48 149.62 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 p -120.26 137.62 54.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -117.01 155.38 29.29 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 m -82.99 131.99 52.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.978 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.4 116.77 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.665 1.577 . . . . 0.0 111.018 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.53 -1.97 20.25 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -101.93 -171.74 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.242 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 p -125.85 146.77 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.205 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.83 150.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.553 ' OG1' ' O ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -126.26 137.31 53.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.54 150.45 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -125.83 114.93 19.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.812 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.698 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 50.5 m -118.69 113.76 21.68 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.2 m -113.31 141.22 47.28 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.02 -1.05 . . . . 0.0 108.272 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.693 ' C ' ' H ' ' A' ' 26' ' ' SER . 40.5 mtp85 -89.53 137.24 32.5 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.32 -0.862 . . . . 0.0 110.377 170.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -60.97 2.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.48 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -102.75 -16.93 15.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.499 -175.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.03 22.84 70.44 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 m -125.89 111.06 14.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.496 0.189 . . . . 0.0 110.829 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.701 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.31 -61.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.14 -0.35 . . . . 0.0 111.584 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -61.0 1.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.701 ' H ' ' C ' ' A' ' 29' ' ' ILE . 94.0 p -109.77 -9.83 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.483 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 28' ' ' SER . 2.7 m120 -124.69 145.7 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.27 134.84 45.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.0 t -130.06 147.93 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.509 0.671 . . . . 0.0 111.164 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -137.88 153.39 49.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.108 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -117.58 120.75 39.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -121.48 149.31 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.229 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.34 137.21 47.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 135.48 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.76 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -123.81 125.76 25.84 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.983 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.6 141.65 95.38 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.225 1.283 . . . . 0.0 110.843 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.99 -8.57 79.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -154.88 162.49 41.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.33 176.45 3.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.0 148.74 51.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.307 2.004 . . . . 0.0 111.703 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 m -120.63 121.72 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.139 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.9 m -62.13 120.59 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.793 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 t -101.14 -28.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.007 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -145.23 149.35 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 52' ' ' ASP . 62.7 t80 -134.3 160.85 36.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.033 172.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 6.6 tt0 47.19 24.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.326 0.584 . . . . 0.0 111.136 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.6 p30 44.42 19.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.602 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.734 HD21 HE22 ' A' ' 54' ' ' GLN . 0.4 OUTLIER -127.76 -46.19 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.432 0.634 . . . . 0.0 109.56 170.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.734 HE22 HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.65 135.52 40.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.599 -167.55 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 108.79 18.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -63.36 148.71 92.59 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.96 1.774 . . . . 0.0 111.771 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 t -64.15 -29.54 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.86 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.34 -49.57 71.69 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -96.03 129.63 33.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.5 Cg_endo -62.91 164.34 19.4 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.641 1.561 . . . . 0.0 111.901 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -59.54 1.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.081 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.631 ' NE ' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -39.59 -37.08 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 44.3 m-85 -89.53 143.75 26.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.5 t -136.93 122.97 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.221 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.12 125.93 7.09 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.562 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 68.8 p -159.43 161.35 35.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.069 0.462 . . . . 0.0 111.023 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -137.02 161.31 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.646 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 70' ' ' SER . 86.6 m-20 -102.39 154.9 18.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.717 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -68.87 10.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 68' ' ' ASP . 26.1 m -80.49 -42.94 21.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.88 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.0 28.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.444 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -99.69 -38.12 8.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.607 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.9 p -167.95 166.26 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.545 177.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.97 134.18 51.24 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.063 -1.023 . . . . 0.0 109.655 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 7.4 m -134.07 120.07 19.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.79 140.35 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.296 -1.503 . . . . 0.0 114.101 167.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 57.6 m -106.6 128.84 54.46 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 164.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -104.82 116.56 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 120.82 -1.175 . . . . 0.0 109.672 171.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 t -98.82 127.98 44.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.704 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 69.65 1.38 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.7 tt -85.4 127.84 34.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.383 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' A' ' 84' ' ' GLU . 8.3 mtmt -137.05 -177.0 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.8 0.334 . . . . 0.0 110.636 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -19.36 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.316 171.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 82' ' ' LYS . 52.7 tp10 -67.2 -41.18 86.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.849 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 1.3 m-20 -68.99 -19.05 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.082 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.492 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 68.3 tt0 -51.16 120.83 5.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.669 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.87 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.317 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.76 143.7 26.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.18 139.64 50.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.158 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -137.8 142.49 40.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.764 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.463 ' SG ' ' HA3' ' A' ' 103' ' ' GLY . 5.7 p -121.84 140.46 52.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 40.1 mt-30 -124.25 128.75 49.63 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.214 -0.304 . . . . 0.0 110.478 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 155.61 50.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.682 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.428 ' HH ' ' NE2' ' A' ' 35' ' ' GLN . 2.8 p90 -159.34 130.79 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.175 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.415 ' N ' ' HB2' ' A' ' 98' ' ' ASN . 16.0 m-20 -89.92 -149.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -42.18 79.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.667 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.9 m -107.3 38.15 2.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.766 0.317 . . . . 0.0 110.845 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 100' ' ' VAL . 1.5 m-80 -125.11 -58.61 1.45 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.169 0.509 . . . . 0.0 111.348 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.527 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 0.1 OUTLIER 61.69 -10.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.929 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER 172.48 122.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 118.153 0.433 . . . . 0.0 110.214 177.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.5 173.07 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.09 173.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.1 p90 -113.0 143.97 43.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.6 . . . . 0.0 109.97 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.463 ' HA3' ' SG ' ' A' ' 91' ' ' CYS . . . -103.49 27.7 18.74 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.469 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.55 63.27 5.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.233 -0.985 . . . . 0.0 110.74 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.55 149.46 8.23 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.598 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.8 m -111.04 141.47 44.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -81.55 123.94 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.504 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 tp -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.565 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.5 m -123.73 121.46 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.406 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 111' ' ' LEU . 39.0 t -83.76 96.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 110' ' ' VAL . 7.0 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.725 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.566 ' ND2' ' N ' ' A' ' 2' ' ' PHE . 2.1 t30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' N ' ' ND2' ' A' ' 1' ' ' ASN . 14.7 m-85 -126.69 116.66 21.31 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.4 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 13.0 ttp -150.72 169.96 20.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.5 OUTLIER -119.4 103.02 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 130.89 35.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.493 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.758 HE22 ' N ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -146.34 164.41 24.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.023 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.85 145.29 51.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.398 2.066 . . . . 0.0 110.869 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.25 -73.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.503 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 49.0 m -161.47 159.35 27.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.605 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.24 155.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.467 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.0 p -125.6 137.3 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.373 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.12 161.93 18.64 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -89.94 142.29 28.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.312 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.3 114.9 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.576 1.517 . . . . 0.0 111.452 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.43 -20.3 16.03 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.56 -169.42 1.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.5 p -129.61 153.89 47.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.42 152.23 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -124.27 134.05 53.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.948 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.2 mt -101.85 143.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.584 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -119.59 127.96 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.737 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -118.46 112.52 20.06 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.9 m -113.22 140.58 47.83 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.707 -1.246 . . . . 0.0 108.02 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.713 ' C ' ' H ' ' A' ' 26' ' ' SER . 20.2 mtp85 -94.1 139.35 31.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.011 170.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -59.13 1.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.542 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.713 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.94 -18.2 14.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.546 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 86.57 -19.16 29.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.409 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 1.1 t -87.12 116.78 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.978 -0.719 . . . . 0.0 110.543 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.689 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.42 -61.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -60.34 -0.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.689 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.8 t -97.23 -26.66 14.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.268 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 28' ' ' SER . 2.4 p30 -114.85 141.46 47.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.25 144.38 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.46 140.71 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.446 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 13.6 pt20 -121.44 152.54 38.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.363 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.18 142.31 46.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.502 ' CE2' ' OG1' ' A' ' 47' ' ' THR . 26.8 m-85 -139.14 149.24 44.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.89 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.409 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -131.18 141.54 50.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.423 HE21 ' N ' ' A' ' 45' ' ' PRO . 1.4 tt0 -125.75 135.35 51.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.358 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.46 ' NH2' ' HG ' ' A' ' 43' ' ' SER . 14.6 mtm-85 -123.93 149.71 60.6 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.225 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -55.67 134.05 61.7 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.537 1.492 . . . . 0.0 110.814 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.12 2.86 84.1 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.46 ' HG ' ' NH2' ' A' ' 40' ' ' ARG . 42.3 t -138.83 146.6 41.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.05 0.452 . . . . 0.0 110.307 -177.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.435 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -80.8 178.29 2.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -178.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -69.41 150.44 70.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.352 2.035 . . . . 0.0 111.865 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 m -132.83 126.69 32.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.351 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.502 ' OG1' ' CE2' ' A' ' 37' ' ' TYR . 7.0 m -64.14 119.02 9.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.176 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 t -101.29 -29.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.048 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' CG1' HH11 ' A' ' 55' ' ' ARG . 14.9 mt -145.35 150.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.3 t80 -136.22 163.9 29.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.888 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp10 44.68 24.27 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.834 0.826 . . . . 0.0 110.682 -172.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' TYR . 33.7 t0 43.97 20.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.015 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.754 HD21 HE22 ' A' ' 54' ' ' GLN . 0.9 OUTLIER -128.06 -46.13 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 169.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.754 HE22 HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.97 131.06 26.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.124 -168.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.751 ' NH2' ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -116.43 108.82 44.8 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 48' ' ' VAL . 5.7 Cg_exo -65.91 147.24 84.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.965 1.777 . . . . 0.0 111.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 p -70.81 -36.58 73.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.67 -43.12 86.31 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.0 m -98.1 127.74 35.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.4 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.7 Cg_exo -62.78 161.93 27.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.322 1.348 . . . . 0.0 111.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' C ' HH21 ' A' ' 55' ' ' ARG . 47.3 t0 -60.12 3.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.412 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -48.02 -27.59 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.633 -175.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.751 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 31.8 m-85 -92.07 136.55 33.08 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.215 -0.303 . . . . 0.0 110.663 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.4 t -125.12 123.85 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.933 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.67 131.74 10.65 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.128 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.7 p -161.63 172.43 16.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.304 0.574 . . . . 0.0 111.224 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -149.56 163.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.229 -175.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.85 152.76 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.698 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 p -68.02 -8.32 36.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.42 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.3 m -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.886 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.03 27.73 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 -178.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -99.13 -37.07 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.224 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 85.5 p -165.96 166.76 17.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.406 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.01 130.04 55.47 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.084 -1.01 . . . . 0.0 109.709 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.5 m -132.9 122.45 24.37 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.458 -169.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD2' ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.25 141.05 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.8 -1.813 . . . . 0.0 114.834 169.297 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 64' ' ' SER . 9.9 m -106.31 125.71 51.34 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 165.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.9 mm -86.86 123.51 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 120.195 -1.566 . . . . 0.0 110.543 171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 t -112.95 127.71 56.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.577 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.42 43.77 10.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.454 ' HA ' HH22 ' A' ' 62' ' ' ARG . 2.1 tt -64.82 132.21 48.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.429 . . . . 0.0 110.453 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.458 ' C ' ' N ' ' A' ' 84' ' ' GLU . 11.9 tttp -143.65 174.72 10.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.128 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -46.16 -21.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.542 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' A' ' 82' ' ' LYS . 66.8 mm-40 -69.27 -42.77 75.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.132 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 19.8 m-20 -68.81 -5.64 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.433 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 62.6 tt0 -62.08 121.06 12.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.2 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.22 -179.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.528 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.87 151.61 23.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.162 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -121.72 146.17 47.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 111.068 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.8 m-85 -144.38 148.75 35.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.469 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 103' ' ' GLY . 0.7 OUTLIER -134.43 140.17 46.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.38 136.32 51.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.333 0.587 . . . . 0.0 110.019 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -134.97 -176.39 4.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.546 ' CD1' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -149.02 135.05 19.06 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 123.64 0.588 . . . . 0.0 110.479 174.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 96' ' ' SER . 31.5 t0 -134.85 -145.99 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.992 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.567 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 4.7 t -46.62 -14.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.524 0.202 . . . . 0.0 110.694 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 95' ' ' ASP . 11.0 p -81.41 -7.12 59.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.931 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.6 m120 63.76 111.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.341 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 42.21 31.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.404 ' O ' ' OG ' ' A' ' 97' ' ' SER . 70.0 t -152.64 111.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 118.565 0.62 . . . . 0.0 111.84 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.78 136.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 166.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 2.9 p90 -119.24 148.98 42.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.001 0.429 . . . . 0.0 111.133 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 91' ' ' CYS . . . -172.2 -146.53 5.38 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.758 ' N ' HE22 ' A' ' 6' ' ' GLN . . . 65.66 -7.03 1.12 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.187 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . -51.96 84.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' GLY . 20.5 m -150.09 125.67 10.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.23 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -83.58 132.37 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.159 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.2 tp -119.74 127.04 52.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.629 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.8 125.75 50.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.264 0.554 . . . . 0.0 110.038 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 65.5 t -88.91 36.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.381 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.746 178.356 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.664 HD21 ' N ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.664 ' N ' HD21 ' A' ' 1' ' ' ASN . 16.7 m-85 -150.65 124.85 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.471 ' H ' ' HB2' ' A' ' 25' ' ' SER . 5.1 mtm -128.73 169.99 13.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -132.6 108.84 9.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -92.12 117.53 29.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.621 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -145.79 165.66 20.17 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.13 151.26 12.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.546 2.164 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.688 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -75.83 -65.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.03 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.688 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 79.1 p -158.82 146.03 17.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.229 0.537 . . . . 0.0 110.373 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.28 146.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.057 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 p -117.07 143.64 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.491 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.32 163.08 26.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.334 0.587 . . . . 0.0 110.475 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -94.67 142.57 24.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.27 113.99 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.416 1.411 . . . . 0.0 111.152 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.12 -5.02 15.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -94.25 177.8 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.1 p -128.96 142.79 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.76 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.32 155.2 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.721 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.63 125.36 42.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.53 146.51 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.367 0.603 . . . . 0.0 110.786 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -117.36 132.68 56.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.814 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.82 116.48 26.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -111.31 134.22 53.06 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.714 ' C ' ' H ' ' A' ' 26' ' ' SER . 61.2 mtp180 -91.34 138.16 31.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.603 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -57.81 3.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.57 176.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.714 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -96.7 -12.87 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.21 -173.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 -1.87 39.4 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.266 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -124.24 124.73 43.08 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.215 0.206 . . . . 0.0 110.82 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.706 ' C ' ' H ' ' A' ' 31' ' ' SER . 2.0 pp -128.86 -55.33 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' H ' HG13 ' A' ' 29' ' ' ILE . . . -65.34 -1.16 2.2 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.706 ' H ' ' C ' ' A' ' 29' ' ' ILE . 12.0 p -86.59 -32.24 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 111.698 -2.501 . . . . 0.0 111.075 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.445 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 1.8 m120 -122.46 159.23 28.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.15 123.39 25.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.975 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -103.76 146.89 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.355 -178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 36' ' ' TRP . 5.4 tt0 -133.32 158.83 41.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 12.7 m95 -129.45 124.14 33.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.929 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CD2' ' OE1' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -110.73 149.55 30.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.17 142.21 49.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.329 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -140.36 117.1 10.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.642 ' N ' HE21 ' A' ' 39' ' ' GLN . 2.5 mpt_? -84.53 175.87 4.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.84 126.24 20.66 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 CA-C-O 121.963 0.735 . . . . 0.0 111.107 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 -35.65 0.26 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 113.654 -1.612 . . . . 0.0 114.824 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.414 ' C ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -158.91 115.91 2.75 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.938 1.869 . . . . 0.0 112.688 170.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.688 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -170.75 92.7 0.46 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 119.05 0.841 . . . . 0.0 111.763 169.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.24 121.13 4.27 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.46 1.44 . . . . 0.0 111.687 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 m -148.7 97.95 2.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.921 0.391 . . . . 0.0 110.117 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 28.8 m -64.25 120.18 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.16 -28.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.956 -174.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -144.95 142.19 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -136.07 148.67 48.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.595 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 53' ' ' ASN . 14.2 tp10 58.96 22.49 10.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.942 1.353 . . . . 0.0 110.243 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 42.73 17.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.813 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -129.44 -47.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.294 0.569 . . . . 0.0 111.409 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.472 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -92.25 140.63 29.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.329 -165.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.6 144.98 32.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.99 150.89 75.83 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.314 1.343 . . . . 0.0 111.275 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.2 p -71.05 -22.35 62.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.6 96.41 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.94 140.79 43.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.572 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -51.78 119.63 5.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.084 1.19 . . . . 0.0 110.581 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.74 1.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.009 -0.432 . . . . 0.0 111.037 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.572 ' H ' ' C ' ' A' ' 60' ' ' PRO . 46.4 mtm180 -53.18 -22.34 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.62 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 6.8 m-85 -75.27 129.09 36.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.978 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.0 t -110.17 121.59 45.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.067 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.16 126.15 8.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.528 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.7 p -164.37 166.85 20.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.329 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.2 160.9 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -93.07 163.31 13.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.093 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 m -68.45 30.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.575 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -123.12 -46.33 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 79.0 25.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.787 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -98.33 -19.04 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.601 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' ILE . 30.9 p -158.32 169.94 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.838 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.88 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 8.0 m -99.02 110.99 23.51 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.988 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.458 ' HA ' ' O ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -101.15 140.45 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.471 ' O ' ' CB ' ' A' ' 64' ' ' SER . 94.9 m -112.56 124.38 52.39 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 163.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.46 109.11 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 O-C-N 119.966 -1.709 . . . . 0.0 110.446 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -99.34 142.42 30.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.392 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.03 44.83 8.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tt -74.75 129.91 38.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.217 0.532 . . . . 0.0 110.559 176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' GLU . 15.9 tttt -138.77 172.6 12.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.83 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 29.7 p -45.88 -19.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.544 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 27.6 tt0 -73.79 -38.45 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.335 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.55 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -68.89 -4.38 16.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 74.4 tt0 -60.43 129.16 40.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.425 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 159.76 173.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -91.02 143.58 26.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.782 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 11.5 m-85 -109.75 150.72 27.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.223 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 49.3 m-85 -146.81 153.77 40.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.369 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 94.3 m -120.73 141.08 50.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 33.6 mt-30 -126.71 137.47 53.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.727 0.694 . . . . 0.0 110.497 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NH2' ' A' ' 24' ' ' ARG . 3.0 t -128.71 143.21 50.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.276 0.56 . . . . 0.0 110.92 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.67 135.64 9.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.3 m-20 -105.02 -175.89 2.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.831 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -54.01 -32.13 53.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.628 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.491 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 7.2 t -80.34 38.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.891 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 46.61 -113.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 97' ' ' SER . 27.4 m170 44.85 81.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.857 0.361 . . . . 0.0 110.587 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 m -86.13 129.46 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.92 158.54 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.918 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -136.36 144.62 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.134 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.25 -157.24 16.96 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.15 53.9 38.91 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.27 107.1 3.36 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.446 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 37.9 m -124.54 129.96 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.027 0.441 . . . . 0.0 110.71 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.21 115.62 25.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.276 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -102.9 122.74 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.538 ' C ' ' H ' ' A' ' 111' ' ' LEU . 93.0 m -119.68 114.99 23.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.406 0.622 . . . . 0.0 110.075 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.458 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 57.9 t -76.83 30.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.822 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 109' ' ' THR . 77.3 mt . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.567 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.85 130.23 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.574 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 ttt -140.62 170.23 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.26 103.09 7.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -95.46 120.19 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.12 167.93 12.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -53.33 144.91 47.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.672 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.4 p80 -75.88 -51.6 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.82 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -159.27 151.16 20.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 110.809 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.4 p -161.37 155.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.468 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.6 p -137.37 152.89 50.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -142.03 162.18 36.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.221 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -92.37 151.08 41.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.907 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.87 117.77 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.781 1.654 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.16 9.74 31.27 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.411 ' HD2' ' H ' ' A' ' 13' ' ' SER . 72.3 mttt -98.96 -178.7 4.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 110.619 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.6 p -122.54 128.07 50.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.212 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.6 139.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.741 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 99.9 m -125.6 133.26 52.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.532 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 1.3 mt -113.06 142.02 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.198 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -117.08 131.72 56.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.556 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -119.59 124.07 45.47 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.1 m -120.53 142.11 49.63 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.954 -1.091 . . . . 0.0 108.24 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.648 ' C ' ' H ' ' A' ' 26' ' ' SER . 28.2 ttm180 -99.74 144.6 28.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.294 168.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 p -60.75 3.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.837 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.648 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.32 -17.78 14.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 -175.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 71.3 23.68 77.79 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 t -119.86 105.27 10.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.646 0.26 . . . . 0.0 111.158 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.604 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -135.18 -64.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -65.23 -3.79 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.604 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.7 m -97.85 -22.68 16.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.668 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.48 HD21 HH22 ' A' ' 24' ' ' ARG . 35.8 m-20 -126.55 155.08 42.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -73.02 125.53 27.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.059 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.05 148.04 23.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.537 0.685 . . . . 0.0 110.779 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.604 ' NE2' ' HH ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -141.45 169.97 16.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.182 -178.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 70.1 m95 -131.25 146.36 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.5 m-85 -132.9 149.04 52.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -127.5 135.55 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 7.1 tm0? -130.26 143.48 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.489 0.661 . . . . 0.0 109.66 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.53 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 1.0 OUTLIER -144.55 158.24 54.21 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.061 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -52.08 130.84 36.69 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.817 1.678 . . . . 0.0 110.677 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -32.84 1.63 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 41' ' ' PRO . 28.3 t -76.57 171.66 14.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -121.82 156.18 59.44 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.318 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.87 124.05 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.313 2.009 . . . . 0.0 110.319 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -125.35 125.35 43.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 110.666 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -65.39 119.97 11.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.383 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.92 -25.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.007 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 49' ' ' ILE . 7.0 mt -144.34 135.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 64.7 t80 -125.77 164.36 20.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.761 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.6 tt0 45.91 22.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.357 -170.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 43.55 17.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.926 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.573 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -128.87 -46.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 110.647 170.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' NE2' ' CA ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -96.13 154.48 17.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.27 -1.786 . . . . 0.0 107.82 -165.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.802 HH11 ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -143.73 146.72 36.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.257 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.44 145.48 88.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.389 1.392 . . . . 0.0 110.929 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 m -62.07 -22.09 65.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.132 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.14 97.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.2 142.18 24.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.369 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.15 143.18 98.63 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.479 1.453 . . . . 0.0 111.702 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.4 p30 -62.61 -2.83 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.622 ' NH1' ' CE1' ' A' ' 63' ' ' PHE . 28.8 ptt85 -47.01 -40.21 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.371 0.605 . . . . 0.0 110.576 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' CE1' ' NH1' ' A' ' 62' ' ' ARG . 97.9 m-85 -62.98 129.18 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.422 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 6.1 t -113.79 119.44 37.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.414 0.626 . . . . 0.0 110.909 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.2 112.47 3.59 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.134 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 75' ' ' SER . 7.3 p -149.61 167.48 26.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.51 0.671 . . . . 0.0 110.208 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.471 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -143.49 163.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.976 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 70' ' ' SER . 75.8 m-20 -98.77 152.75 19.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.518 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -68.35 31.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.687 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 68' ' ' ASP . 30.1 m -104.12 -46.31 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.578 0.228 . . . . 0.0 110.565 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 85.43 25.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.473 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.05 -37.34 9.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.066 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.404 ' N ' HG12 ' A' ' 29' ' ' ILE . 52.9 p -160.12 166.67 29.37 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.535 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.25 127.01 54.76 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.741 -1.224 . . . . 0.0 109.513 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -121.72 116.07 23.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.39 -172.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.6 OUTLIER -99.02 140.27 33.42 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 118.344 -2.722 . . . . 0.0 117.329 168.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 64' ' ' SER . 61.8 m -106.06 126.28 52.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 163.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -97.51 112.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 119.798 -1.813 . . . . 0.0 110.918 170.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.11 137.69 34.81 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.834 -0.541 . . . . 0.0 111.462 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 58.75 3.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.07 135.0 36.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.211 0.529 . . . . 0.0 110.478 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -134.36 176.44 8.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.714 174.876 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 p -47.65 -19.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 82' ' ' LYS . 9.4 tp10 -70.53 -39.36 74.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.821 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' CB ' HH22 ' A' ' 62' ' ' ARG . 27.6 t0 -67.18 -7.09 20.99 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.399 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 70.5 tt0 -62.41 130.62 46.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.89 175.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -85.03 144.77 28.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.474 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 8.9 m-85 -108.91 154.21 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -150.49 145.48 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 59.4 m -120.28 141.01 50.38 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 5.7 mt-30 -124.45 145.39 49.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 24' ' ' ARG . 53.5 p -135.09 123.73 23.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 110.353 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.604 ' HH ' ' NE2' ' A' ' 35' ' ' GLN . 21.3 p90 -159.25 131.67 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -99.22 -148.46 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.871 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 m -84.2 -26.52 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.615 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.43 35.85 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.334 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.68 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER 51.44 -136.48 1.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.0 m170 48.71 82.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.4 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.16 138.34 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.199 0.523 . . . . 0.0 110.852 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.73 131.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.126 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.29 166.83 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.736 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.3 -139.24 10.91 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 45.12 29.67 2.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.13 158.11 5.61 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.9 m -126.06 130.09 50.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.517 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -80.59 110.34 15.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.2 tp -99.39 124.81 44.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.19 124.37 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.092 0.472 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' LEU . 61.2 t -87.63 94.43 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 110' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.234 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.538 HD21 ' H ' ' A' ' 2' ' ' PHE . 11.1 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.538 ' H ' HD21 ' A' ' 1' ' ' ASN . 72.7 m-85 -84.41 133.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.8 mmm -146.96 168.45 21.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 110.308 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -123.63 107.98 12.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -78.19 113.51 16.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.635 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 52.4 mt-30 -140.37 158.21 66.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.18 140.99 71.12 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.93 1.753 . . . . 0.0 110.38 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -49.25 70.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.18 129.0 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.065 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 11' ' ' SER . 7.4 p -139.28 161.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.155 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 94.1 p -143.43 155.53 44.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.624 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -140.31 153.17 46.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.074 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.26 141.98 74.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.195 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 115.28 2.16 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.715 1.61 . . . . 0.0 111.246 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.37 1.03 33.13 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -98.06 161.51 13.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.8 p -93.0 134.35 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.9 137.46 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -118.64 134.18 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.322 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.455 ' H ' HD23 ' A' ' 76' ' ' LEU . 22.1 mt -99.81 137.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.426 177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 m -111.62 116.68 31.2 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -118.92 113.04 20.41 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 m -114.79 140.78 48.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.683 ' C ' ' H ' ' A' ' 26' ' ' SER . 31.8 ttp180 -92.56 136.83 32.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.999 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -59.05 3.74 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.683 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.79 -18.06 14.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.678 -174.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.85 20.05 76.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -123.07 109.62 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.979 0.39 . . . . 0.0 110.773 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.667 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.17 -62.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 -176.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.474 ' N ' ' CD1' ' A' ' 29' ' ' ILE . . . -65.22 0.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.667 ' H ' ' C ' ' A' ' 29' ' ' ILE . 91.5 p -109.82 -3.13 16.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.566 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -135.9 158.5 44.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.124 0.487 . . . . 0.0 110.874 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.43 129.18 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.408 ' HA ' HE21 ' A' ' 35' ' ' GLN . 81.9 t -123.14 148.06 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 110.728 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.99 153.93 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.151 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -110.3 135.13 51.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HH ' ' HG1' ' A' ' 47' ' ' THR . 11.4 m-85 -129.17 147.54 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.324 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.421 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -134.38 133.07 40.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.128 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -112.48 116.14 29.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -173.83 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -69.72 125.62 12.38 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 CA-C-N 120.449 1.196 . . . . 0.0 110.094 -172.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.25 -36.12 0.25 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 112.876 -1.965 . . . . 0.0 114.927 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 m -159.38 92.15 1.05 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.155 1.977 . . . . 0.0 114.477 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -170.77 91.89 0.47 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 118.07 -1.452 . . . . 0.0 111.727 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -76.75 135.39 15.9 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.84 2.36 . . . . 0.0 111.431 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -146.93 105.4 3.8 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.757 -0.59 . . . . 0.0 111.003 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.537 ' HG1' ' HH ' ' A' ' 37' ' ' TYR . 25.8 m -63.38 120.23 11.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.878 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.62 -28.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.735 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.4 149.95 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' ASP . 6.2 t80 -134.76 164.04 28.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.793 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.37 23.87 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.569 1.176 . . . . 0.0 110.754 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.7 p30 44.35 19.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.587 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.551 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -127.85 -45.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.583 HE21 ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -53.54 134.89 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.279 -170.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -137.39 108.65 8.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -70.06 152.8 67.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.853 1.702 . . . . 0.0 112.013 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -70.78 -33.12 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.375 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.23 -47.7 79.97 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -90.68 132.52 34.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.1 Cg_exo -59.3 142.07 98.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.462 1.441 . . . . 0.0 111.117 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.584 ' C ' ' H ' ' A' ' 63' ' ' PHE . 49.9 p-10 -61.21 1.65 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.597 HH22 ' CG ' ' A' ' 85' ' ' ASP . 8.4 ptm180 -49.69 -2.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.584 ' H ' ' C ' ' A' ' 61' ' ' ASP . 17.3 m-85 -107.98 146.44 32.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.3 t -130.39 121.03 25.17 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.893 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.79 123.16 7.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.345 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.6 p -158.81 164.51 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.426 -0.455 . . . . 0.0 110.2 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.438 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -135.08 159.92 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.589 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.572 ' C ' ' H ' ' A' ' 70' ' ' SER . 30.7 m-20 -96.66 144.18 26.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 p -70.13 27.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.008 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 68' ' ' ASP . 21.2 m -102.23 -36.76 8.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.015 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 82.21 22.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.234 -177.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -95.8 -43.71 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.754 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 29' ' ' ILE . 95.0 p -162.1 174.86 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.009 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.9 126.78 55.07 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.331 -1.48 . . . . 0.0 110.573 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.9 m -118.23 112.31 19.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.569 -171.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -97.02 140.75 31.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 168.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.4 m -110.52 128.25 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 163.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 mt -106.0 109.95 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 119.812 -1.805 . . . . 0.0 110.666 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -98.65 141.25 31.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.555 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.82 32.99 35.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 tt -55.8 145.79 23.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.987 0.422 . . . . 0.0 110.318 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' ASP . 6.6 tttp -160.66 177.87 10.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.355 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 t -46.01 -19.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 82' ' ' LYS . 77.4 mt-10 -71.85 -40.02 69.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.367 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.597 ' CG ' HH22 ' A' ' 62' ' ' ARG . 18.9 t70 -70.32 -13.12 62.02 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.173 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 32.9 tt0 -58.23 123.14 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.6 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.0 178.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 109.942 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.07 146.38 25.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.2 m-85 -121.88 146.27 47.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 111.083 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.1 m-85 -141.72 149.18 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.17 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.635 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 p -124.85 140.87 52.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.5 mt-30 -116.83 140.06 49.88 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.174 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 101' ' ' VAL . 60.9 p -135.07 119.69 18.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -158.96 153.91 25.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.123 175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -128.62 -146.54 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.655 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -22.74 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.288 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.9 p -82.63 14.07 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 99' ' ' HIS . 1.1 m120 44.69 -136.17 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.35 -176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 98' ' ' ASN . 75.6 m80 37.2 70.12 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.229 0.538 . . . . 0.0 110.825 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 101' ' ' VAL . 1.8 p -160.3 -171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.253 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.478 ' O ' ' O ' ' A' ' 93' ' ' SER . 1.3 m -155.37 -179.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.663 0.744 . . . . 0.0 111.619 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -157.22 151.63 25.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.235 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 144.93 -129.8 3.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 84.92 62.57 1.67 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.11 110.14 2.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -117.16 118.89 33.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -78.44 116.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.986 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.8 tp -110.71 126.53 54.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 m -118.97 133.67 55.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.391 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 79.2 t -86.03 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.228 0.537 . . . . 0.0 110.587 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.698 -1.144 . . . . 0.0 110.874 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.673 HD21 ' N ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.673 ' N ' HD21 ' A' ' 1' ' ' ASN . 54.1 m-85 -118.08 127.85 54.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.023 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.8 mmm -128.73 170.03 13.8 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.425 HD23 HH21 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -130.87 102.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -91.43 138.41 31.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.69 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 104' ' ' GLY . 15.1 mt-30 -143.87 160.12 51.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.31 128.53 23.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.925 1.75 . . . . 0.0 111.023 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.509 ' CD2' ' H ' ' A' ' 9' ' ' SER . 3.7 p-80 -45.21 -59.24 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.0 110.413 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.509 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 83.2 p -164.67 162.71 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.588 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 11' ' ' SER . 3.0 p -162.42 161.27 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.029 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.442 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 84.1 p -143.2 149.74 38.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.616 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.1 153.15 45.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 147.89 82.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.566 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.76 119.7 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.628 1.552 . . . . 0.0 111.368 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.6 -3.25 26.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -98.27 -170.26 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.541 0.21 . . . . 0.0 110.967 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.5 p -127.26 150.47 49.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.732 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.56 147.82 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.886 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -121.69 134.23 54.96 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.1 mt -108.83 140.08 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -108.38 142.64 38.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.507 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.13 111.63 12.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 m -119.64 140.5 50.52 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.562 -1.336 . . . . 0.0 108.099 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.752 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -107.27 145.0 33.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.238 171.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -57.86 4.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.752 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.03 -18.18 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 -175.281 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 78.67 -32.16 1.91 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 14.7 m -68.4 110.05 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.548 0.213 . . . . 0.0 111.298 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.694 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.5 pp -135.17 -62.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.526 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -62.77 -0.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.694 ' H ' ' C ' ' A' ' 29' ' ' ILE . 10.7 p -98.91 -25.29 14.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.804 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 28' ' ' SER . 29.1 p30 -121.26 147.3 45.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -71.39 144.45 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.624 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.48 137.79 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.242 0.544 . . . . 0.0 110.198 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.555 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 4.1 pt20 -120.9 152.18 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 46.4 m95 -122.28 133.07 54.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.146 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.9 m-85 -130.1 149.08 51.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.826 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.589 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -117.96 135.69 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.276 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.28 156.21 46.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -55.49 129.4 34.92 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.808 1.672 . . . . 0.0 111.129 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.33 -7.21 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 m -113.18 126.11 55.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.268 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.62 164.72 54.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.41 131.07 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.289 1.993 . . . . 0.0 111.022 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.8 p -121.66 120.51 34.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.646 0.26 . . . . 0.0 110.381 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.52 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 10.4 m -62.01 117.72 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.831 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.73 -28.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.64 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.22 136.63 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' GLN . 11.0 t80 -125.01 166.23 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.706 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tt0 44.81 22.45 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.145 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.6 p-10 42.9 18.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.167 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.48 -47.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.183 0.516 . . . . 0.0 111.129 168.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.546 ' C ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.06 150.77 20.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.242 -1.799 . . . . 0.0 108.594 -167.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 148.32 65.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.14 147.6 95.21 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.723 1.616 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 m -67.76 -14.91 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -46.28 70.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.67 141.08 23.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -60.01 139.32 87.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.259 1.306 . . . . 0.0 111.631 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -61.17 0.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.603 HH12 ' CB ' ' A' ' 85' ' ' ASP . 8.8 ptm180 -47.16 -24.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.149 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CE1' ' CG ' ' A' ' 62' ' ' ARG . 23.5 m-85 -88.6 142.95 27.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -128.03 124.22 36.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.084 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.42 7.16 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.679 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.3 p -154.97 166.07 34.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.529 . . . . 0.0 111.355 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.466 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.6 pp -146.38 153.76 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.85 157.19 16.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.111 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.7 p -70.3 -8.44 50.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.0 m -60.38 -40.82 92.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER 79.0 25.76 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.284 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -97.48 -42.15 7.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.598 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.1 p -165.33 171.32 13.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.054 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.52 127.13 55.04 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.936 -1.103 . . . . 0.0 110.442 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 28.9 m -119.42 117.98 29.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.954 -169.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -97.54 140.59 31.74 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 118.651 -2.53 . . . . 0.0 117.217 168.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' SER . 75.8 m -111.49 127.72 55.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 162.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.9 112.35 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 120.048 -1.657 . . . . 0.0 109.951 174.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 t -96.85 135.59 38.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.479 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.01 49.22 6.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.66 137.86 48.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 0.0 110.633 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' C ' ' N ' ' A' ' 84' ' ' GLU . 21.2 tttt -144.7 176.93 9.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.905 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -46.84 -20.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.662 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 82' ' ' LYS . 26.2 tt0 -72.7 -39.05 67.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.008 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.603 ' CB ' HH12 ' A' ' 62' ' ' ARG . 6.4 t70 -67.63 -6.9 22.53 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.691 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 62.8 tt0 -63.35 124.65 21.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.28 -178.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 0.0 110.552 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -87.14 136.72 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.675 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.589 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 27.8 m-85 -116.32 135.75 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.742 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.2 p90 -149.26 149.06 30.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.04 151.49 41.89 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.962 0.505 . . . . 0.0 110.924 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 18.7 mt-30 -123.56 147.69 47.05 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 122.213 -0.304 . . . . 0.0 111.338 168.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' NE ' ' A' ' 24' ' ' ARG . 13.7 t -135.25 159.99 39.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.681 0.276 . . . . 0.0 111.587 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.534 ' HH ' ' CD ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -157.73 132.62 8.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.669 176.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.84 174.99 6.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 98' ' ' ASN . 0.3 OUTLIER -49.27 -37.44 23.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.905 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 45.9 m -79.28 39.9 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.365 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.697 ' N ' HD21 ' A' ' 98' ' ' ASN . 1.1 m120 58.57 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.442 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 97' ' ' SER . 58.8 m170 40.02 78.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.04 0.448 . . . . 0.0 111.131 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 m -87.15 117.48 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 0.0 109.978 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 m -134.14 145.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.147 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -136.31 144.56 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.05 -161.89 34.74 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.069 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 96.04 34.3 5.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.8 95.01 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -111.27 114.58 27.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 0.0 109.798 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -80.25 108.66 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.422 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.8 tp -102.36 126.0 49.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.552 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -120.72 124.86 46.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.319 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 60.9 t -89.57 34.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.44 179.288 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.473 HD21 ' N ' ' A' ' 2' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.473 ' N ' HD21 ' A' ' 1' ' ' ASN . 35.8 m-85 -83.55 161.52 21.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.5 mtp -138.89 169.61 17.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.2 mp -132.77 104.78 6.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -78.93 126.06 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.177 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.616 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 6.8 mt-30 -145.42 164.46 26.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.83 127.21 25.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.135 1.89 . . . . 0.0 110.737 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.527 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 5.8 p80 -57.74 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.2 p -165.12 135.39 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.083 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.58 154.96 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.317 . . . . 0.0 110.398 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.7 p -138.45 137.58 37.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 31.3 mp0 -128.38 162.49 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.024 0.44 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -78.52 146.31 69.43 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.607 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.88 125.93 19.04 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.117 1.211 . . . . 0.0 111.57 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.85 -4.2 28.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -95.34 171.69 8.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.967 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -115.31 130.88 57.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.413 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -127.79 134.66 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -110.02 128.42 55.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.291 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 mm -98.44 145.06 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.083 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -117.59 116.68 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.318 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' HB2' HE21 ' A' ' 6' ' ' GLN . 42.0 t -118.84 112.28 19.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -116.02 137.6 51.97 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.078 -1.014 . . . . 0.0 108.28 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.688 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.68 142.77 27.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.607 170.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -57.88 2.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.688 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.68 -16.94 14.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.538 -174.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.99 -50.39 4.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.44 ' HG ' HD22 ' A' ' 32' ' ' ASN . 75.0 p -54.28 113.88 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.312 . . . . 0.0 111.166 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.688 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.4 pp -135.34 -61.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.181 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.486 ' N ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.5 -0.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.688 ' H ' ' C ' ' A' ' 29' ' ' ILE . 5.9 m -107.01 -18.99 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.623 -1.626 . . . . 0.0 111.798 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' ND2' ' NH2' ' A' ' 24' ' ' ARG . 38.5 m-20 -116.87 147.82 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -78.88 132.41 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.489 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.73 146.32 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.11 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 8.5 pt20 -123.64 163.1 21.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 30.3 m95 -131.51 131.92 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 7.6 m-85 -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.9 139.98 53.46 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -141.83 141.26 33.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.29 156.19 9.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.48 135.39 67.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.633 1.555 . . . . 0.0 110.916 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.0 -2.0 75.06 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 m -151.26 138.8 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.734 0.302 . . . . 0.0 110.521 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.53 165.47 41.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.074 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.06 135.46 66.52 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.003 1.802 . . . . 0.0 110.805 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -132.77 137.7 46.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.6 m -73.27 120.25 18.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.528 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.85 -28.0 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.141 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.418 HD11 HG23 ' A' ' 49' ' ' ILE . 20.1 mt -145.28 149.27 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' O ' ' N ' ' A' ' 52' ' ' ASP . 37.5 t80 -133.94 163.62 29.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.182 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 45.37 23.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.686 0.755 . . . . 0.0 110.827 -173.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' TYR . 10.6 t70 44.73 19.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.594 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.626 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.83 -46.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.861 170.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.626 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -52.72 134.11 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.498 -167.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.694 ' NH1' ' H ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -123.59 108.8 30.93 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -65.66 136.81 47.47 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.618 1.546 . . . . 0.0 111.756 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 m -63.93 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.14 -57.81 12.25 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.08 150.36 58.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.8 Cg_endo -61.55 135.45 57.05 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.067 1.178 . . . . 0.0 111.219 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.79 -0.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.488 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 52.0 mtm180 -48.37 -38.44 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -71.72 134.84 46.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.9 t -124.12 122.71 38.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.694 ' H ' ' NH1' ' A' ' 55' ' ' ARG . . . -107.74 118.9 5.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.627 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.6 p -155.41 164.03 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.935 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.461 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -146.0 157.63 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 70' ' ' SER . 37.0 m-20 -103.03 153.17 20.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.378 176.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -68.4 1.87 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.042 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.42 ' H ' ' C ' ' A' ' 68' ' ' ASP . 58.2 m -65.95 -43.97 86.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 177.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.62 27.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.543 -177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.38 -41.09 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.943 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.4 p -166.7 175.34 7.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.767 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.78 125.51 50.91 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.812 -1.18 . . . . 0.0 109.881 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 m -115.84 112.73 22.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.744 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.4 OUTLIER -98.3 140.53 32.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 170.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' SER . 89.3 m -107.72 126.7 52.93 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 163.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.8 105.33 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 O-C-N 120.398 -1.439 . . . . 0.0 110.737 173.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.6 t -95.45 154.38 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.008 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 32.37 76.78 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 176.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.21 128.01 29.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 109.667 176.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 84' ' ' GLU . 18.9 mttp -139.48 171.1 14.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.055 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -45.94 -18.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.648 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 82' ' ' LYS . 39.9 mt-10 -69.31 -38.56 78.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.529 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.2 m-20 -73.26 -11.34 60.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.241 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 70.5 tt0 -52.92 120.75 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.543 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 159.94 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -86.91 144.87 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -113.18 153.07 28.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -149.95 147.84 28.37 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 8.6 p -132.94 142.8 49.07 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.023 0.529 . . . . 0.0 109.972 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.89 147.31 50.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.648 ' HG ' ' N ' ' A' ' 94' ' ' TYR . 9.0 t -135.24 160.84 37.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.1 0.476 . . . . 0.0 111.226 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.648 ' N ' ' HG ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -158.42 136.61 10.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.56 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 13.6 m-20 -97.73 177.34 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.985 0.421 . . . . 0.0 110.982 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.494 ' C ' ' H ' ' A' ' 98' ' ' ASN . 4.7 t -60.56 -38.67 85.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.8 m -76.17 32.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.578 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 96' ' ' SER . 3.3 m120 67.34 -124.86 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.478 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 56.74 76.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -89.19 122.3 40.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.122 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.15 156.21 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.283 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -134.08 160.67 37.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.007 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.86 7.78 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.61 56.52 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.55 110.08 3.27 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.5 m -137.13 127.83 27.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.692 0.282 . . . . 0.0 110.286 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -88.42 99.36 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.9 tp -91.08 123.67 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -120.77 122.36 40.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.371 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.447 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 80.6 t -82.11 40.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.069 178.721 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.572 HD21 ' N ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.572 ' N ' HD21 ' A' ' 1' ' ' ASN . 17.9 m-85 -114.07 160.31 19.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.202 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.604 ' H ' ' HG ' ' A' ' 25' ' ' SER . 9.1 mtt -129.4 169.98 14.24 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' CD2' ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -133.22 102.95 5.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.5 p -86.4 135.6 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 30.7 mt-30 -146.19 163.14 31.91 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.715 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.51 140.38 74.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.534 1.49 . . . . 0.0 111.021 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.615 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -51.15 -69.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.257 179.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.615 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 35.7 p -161.27 155.2 22.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.792 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 ' CG2' ' N ' ' A' ' 11' ' ' SER . 4.7 p -162.11 161.01 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.787 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 15.1 p -128.65 151.47 49.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.419 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -135.21 143.83 46.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.401 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 138.05 86.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.88 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.48 113.24 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.377 1.385 . . . . 0.0 111.297 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.02 -8.23 16.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -93.05 -177.31 4.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 111.262 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.1 p -111.18 140.75 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.131 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.41 138.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.547 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -119.44 129.86 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.92 134.0 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.469 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -100.53 166.3 10.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.298 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -151.33 111.85 4.19 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.669 ' CG2' HH21 ' A' ' 24' ' ' ARG . 19.7 m -115.89 136.22 53.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.903 -1.123 . . . . 0.0 108.065 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.739 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -104.02 143.1 33.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.154 171.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.604 ' HG ' ' H ' ' A' ' 3' ' ' MET . 88.9 p -58.63 5.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.467 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.739 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.37 -18.15 14.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.06 -173.317 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' C ' HH11 ' A' ' 24' ' ' ARG . . . 68.63 29.06 72.78 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -128.94 98.9 5.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.419 0.609 . . . . 0.0 111.864 -175.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.692 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -126.28 -62.27 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 122.584 0.354 . . . . 0.0 111.009 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.15 1.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.692 ' H ' ' C ' ' A' ' 29' ' ' ILE . 35.6 t -114.11 -28.02 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.027 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -112.99 139.85 48.31 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.9 130.67 42.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.87 141.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.552 0.691 . . . . 0.0 110.667 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.431 ' OE1' ' OH ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -128.26 150.46 50.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.619 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -106.22 121.0 43.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.457 ' CE1' ' OG1' ' A' ' 47' ' ' THR . 2.2 m-85 -112.38 148.63 33.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 133.44 41.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 43' ' ' SER . 2.3 tm0? -125.45 135.03 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.355 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -133.68 135.04 24.2 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.3 Cg_exo -55.47 137.44 77.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.184 1.256 . . . . 0.0 110.776 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.51 -16.26 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.632 ' HG ' ' N ' ' A' ' 44' ' ' SER . 4.5 t -144.23 161.74 38.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.608 0.242 . . . . 0.0 110.381 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.632 ' N ' ' HG ' ' A' ' 43' ' ' SER . 0.7 OUTLIER -81.97 178.09 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.095 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.8 Cg_exo -72.68 156.35 53.46 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.559 2.173 . . . . 0.0 111.513 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -137.59 121.27 17.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.349 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.457 ' OG1' ' CE1' ' A' ' 37' ' ' TYR . 3.4 m -62.29 121.42 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.965 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.16 -28.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.318 -177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -145.86 140.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' ASP . 5.9 t80 -127.3 164.14 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 44.59 22.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.389 -170.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 43.04 18.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.545 -179.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.564 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.23 -46.91 1.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 0.0 111.52 172.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -80.06 131.37 35.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.712 -165.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -108.57 111.68 61.11 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.465 -174.435 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.04 145.52 96.57 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.633 1.556 . . . . 0.0 112.176 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -69.41 -20.35 63.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.772 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.83 -31.32 67.68 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.2 141.82 38.33 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.8 Cg_exo -60.41 140.33 91.06 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.268 1.312 . . . . 0.0 111.412 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.3 p-10 -61.04 0.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.638 HH22 ' CB ' ' A' ' 85' ' ' ASP . 41.7 ptt85 -47.42 -24.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.331 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 90.8 m-85 -78.47 150.26 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.83 122.88 33.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.435 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.45 121.54 5.52 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.546 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.3 p -158.98 158.25 32.88 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -138.7 160.32 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.449 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 70' ' ' SER . 97.8 m-20 -103.63 152.9 21.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.769 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 m -72.61 27.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.5 m -97.98 -40.64 8.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.226 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.97 27.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.604 ' O ' ' NH2' ' A' ' 24' ' ' ARG . 39.8 t30 -99.32 -33.67 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.561 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.8 p -176.9 170.8 2.26 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.013 0.821 . . . . 0.0 110.185 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.4 133.78 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.153 -0.967 . . . . 0.0 109.857 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -127.37 112.56 15.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.088 -0.958 . . . . 0.0 113.192 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -97.13 140.59 31.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 168.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.5 m -107.83 131.25 54.68 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.219 -0.926 . . . . 0.0 113.401 163.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.0 mt -106.87 110.65 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.163 -1.586 . . . . 0.0 110.37 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -97.51 139.38 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 175.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.06 45.86 8.01 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 143.65 51.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.09 0.471 . . . . 0.0 110.525 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' ASP . 10.4 mtpt -153.14 173.18 15.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.686 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 t -45.88 -20.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.579 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 82' ' ' LYS . 48.7 mt-10 -69.38 -40.1 77.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.978 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.638 ' CB ' HH22 ' A' ' 62' ' ' ARG . 4.3 t0 -70.38 -10.44 59.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.211 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 56.4 tt0 -61.13 122.83 16.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.082 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.92 179.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.856 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 148.02 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.911 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.438 ' OH ' ' CG ' ' A' ' 85' ' ' ASP . 17.7 m-85 -115.52 145.79 42.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 12.5 m-85 -144.19 150.35 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.002 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -118.93 142.45 47.76 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 51.9 tt0 -126.54 121.77 33.23 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.81 -0.556 . . . . 0.0 110.937 172.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -135.15 -176.82 4.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.723 0.297 . . . . 0.0 110.619 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 93' ' ' SER . 1.6 m-85 -142.85 130.9 21.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.61 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 97' ' ' SER . 37.5 t0 -126.4 -145.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.985 176.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.514 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -49.46 -13.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.635 -177.443 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 95' ' ' ASP . 10.3 t -83.45 5.25 24.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.569 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER 46.1 102.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.082 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 62.92 31.01 16.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.198 174.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.5 t -150.89 111.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 O-C-N 121.681 -0.637 . . . . 0.0 112.382 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.2 t -177.55 139.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 166.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -159.33 151.13 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.118 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.86 169.37 21.43 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 123.08 18.11 3.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.29 85.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.4 m -112.24 130.36 55.96 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.672 -0.31 . . . . 0.0 110.242 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -90.08 110.83 21.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -104.9 124.75 50.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.099 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.3 m -116.8 123.54 47.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.71 99.98 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.231 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.121 179.005 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 25' ' ' SER . 1.5 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.8 p90 -160.44 96.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.865 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.0 mtt -151.95 170.11 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 105.97 6.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m -89.58 131.61 35.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.115 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.693 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 2.7 mt-30 -146.07 169.87 8.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -65.78 136.55 45.99 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.433 1.422 . . . . 0.0 111.367 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.506 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -48.21 -76.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.765 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -155.38 149.16 25.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.993 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' A' ' 11' ' ' SER . 7.3 p -159.46 160.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.166 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' O ' ' OE2' ' A' ' 12' ' ' GLU . 88.5 p -129.77 146.84 51.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.335 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 11' ' ' SER . 2.1 mp0 -130.53 162.93 28.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.45 140.86 22.55 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.42 117.48 4.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.418 1.412 . . . . 0.0 111.231 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.2 -11.41 14.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.01 159.97 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.701 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.4 p -98.13 148.63 23.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.69 141.2 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.618 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 55.5 m -119.92 129.72 54.48 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.04 134.93 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.17 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -111.11 126.48 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.057 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.28 113.35 21.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.8 m -109.44 135.34 50.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.73 ' C ' ' H ' ' A' ' 26' ' ' SER . 19.3 ttp85 -97.49 141.15 30.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.223 171.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.491 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 27.3 t -57.23 3.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.991 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.73 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.06 -11.9 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.765 -173.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.48 5.89 25.26 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 m -125.3 111.87 15.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.366 0.267 . . . . 0.0 110.434 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.653 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.8 pp -124.31 -57.09 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.524 ' H ' HG13 ' A' ' 29' ' ' ILE . . . -65.23 -2.58 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 29' ' ' ILE . 14.5 m -89.14 -35.0 16.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 111.603 -2.544 . . . . 0.0 111.479 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.595 ' ND2' HH21 ' A' ' 24' ' ' ARG . 4.0 m-80 -116.83 152.94 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -75.16 140.93 43.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.037 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 67.9 t -126.13 148.02 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.958 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.646 ' NE2' ' HH ' ' A' ' 94' ' ' TYR . 3.7 pt20 -129.38 147.15 51.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.903 178.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 23.0 m95 -111.1 122.63 48.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.296 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' N ' ' A' ' 47' ' ' THR . 2.4 m-85 -123.91 144.96 49.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.587 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -147.19 143.9 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.279 177.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 40' ' ' ARG . 2.9 tp-100 -107.07 142.52 36.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -135.78 146.57 57.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.91 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.24 152.52 65.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.574 1.516 . . . . 0.0 111.31 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.7 58.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.86 157.01 34.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.421 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.74 179.84 1.77 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.245 -179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.65 150.41 56.72 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.522 2.148 . . . . 0.0 112.026 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -148.9 135.3 19.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.551 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -64.93 129.29 39.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.45 -25.23 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.99 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 mt -145.01 133.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' GLN . 4.0 t80 -122.25 167.33 13.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.447 174.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tp10 44.77 22.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.712 0.768 . . . . 0.0 111.419 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 43.16 18.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.05 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.576 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.22 -47.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.847 170.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -96.79 159.07 15.12 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.258 -167.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -140.41 149.88 59.07 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 157.63 22.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.584 1.523 . . . . 0.0 111.226 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.8 p -73.98 -7.19 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.456 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.58 -28.18 48.49 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.5 m -113.02 131.34 22.86 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -175.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.9 Cg_endo -61.62 140.1 84.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 120.982 1.121 . . . . 0.0 111.021 -175.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD2' ' NE ' ' A' ' 55' ' ' ARG . 2.8 m-20 -61.25 1.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.646 HH22 ' CB ' ' A' ' 85' ' ' ASP . 22.7 ptt85 -42.1 -25.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.3 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 53.4 m-85 -75.4 144.46 42.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.87 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -118.07 122.6 43.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.491 0.663 . . . . 0.0 110.949 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.46 125.06 8.38 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.447 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' SER . 6.5 p -157.76 158.72 35.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.106 0.479 . . . . 0.0 110.849 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.94 161.15 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.25 163.32 13.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.379 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 p -67.92 -7.45 28.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.355 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 71' ' ' SER . 14.4 m -82.38 -48.26 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.28 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 70' ' ' SER . 3.0 p 79.03 22.12 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.661 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.34 -18.92 27.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.566 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 29' ' ' ILE . 54.9 p -163.24 166.5 23.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.249 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.79 115.5 30.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.1 m -104.41 110.76 23.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.461 ' CB ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -102.68 140.42 36.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.725 -1.58 . . . . 0.0 115.252 169.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 98.3 m -104.76 128.11 52.77 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 162.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mt -103.16 113.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 120.115 -1.616 . . . . 0.0 110.043 173.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 t -104.62 146.69 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.791 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.83 30.46 57.72 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.99 138.42 49.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 110.518 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 28.3 mttt -150.57 177.74 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 p -46.78 -17.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.387 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 15.6 pt-20 -69.2 -40.55 77.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.351 177.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.646 ' CB ' HH22 ' A' ' 62' ' ' ARG . 6.4 t70 -70.99 -8.6 54.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.458 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.479 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 57.5 tt0 -63.7 121.4 13.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.348 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 159.71 -175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.22 137.35 32.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.643 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 17.1 m-85 -119.54 134.07 55.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.669 0.271 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.484 ' HH ' ' N ' ' A' ' 39' ' ' GLN . 1.5 p90 -150.89 138.12 19.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.33 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.3 p -118.79 140.43 49.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -114.5 148.64 37.58 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.824 -0.547 . . . . 0.0 109.714 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 p -135.23 152.17 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.914 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.646 ' HH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -159.04 138.98 11.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.302 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' NH2' ' A' ' 24' ' ' ARG . 13.5 m-20 -99.05 178.24 4.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -20.67 64.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.651 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.3 p -90.81 32.33 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.431 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 57.27 -159.1 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.2 t60 75.55 69.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.27 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 m -86.93 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.599 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.93 151.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -118.07 144.04 45.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.401 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.82 -149.96 6.74 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 75.28 24.29 71.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.57 98.27 0.27 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -129.77 118.16 21.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.325 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.73 120.11 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.1 tp -109.29 123.26 48.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.208 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 114.89 25.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 89.0 t -85.23 40.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 110' ' ' VAL . 10.2 mt . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.665 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 21.8 p90 -139.63 86.61 2.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.459 ' H ' ' HB2' ' A' ' 25' ' ' SER . 77.4 mtm -147.66 166.46 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.1 mp -124.81 104.25 8.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 p -88.84 118.73 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.134 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.488 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.66 165.42 21.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.449 ' O ' ' OG1' ' A' ' 106' ' ' THR . 4.4 Cg_exo -52.6 146.7 33.19 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.184 1.923 . . . . 0.0 111.36 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -79.29 -55.91 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.498 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 p -154.84 142.79 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.635 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.89 146.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -126.55 146.39 50.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.737 0.303 . . . . 0.0 110.464 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -132.77 150.2 52.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.231 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.13 139.19 72.39 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.99 124.44 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.144 1.229 . . . . 0.0 110.94 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.43 -11.66 16.4 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -100.33 -171.57 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.774 0.321 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.7 p -125.39 159.56 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.349 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.11 153.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -129.2 132.02 47.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.7 mt -98.86 149.43 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.075 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -124.96 117.32 23.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.943 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 4.0 t -119.72 120.58 37.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -119.49 142.04 48.64 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.017 -1.677 . . . . 0.0 108.752 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.664 ' C ' ' H ' ' A' ' 26' ' ' SER . 7.3 mtm-85 -87.26 139.78 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.847 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.459 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.7 OUTLIER -60.38 1.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.43 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.664 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -103.24 -17.86 15.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.627 -175.768 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.92 -41.9 3.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 77.9 p -63.82 113.22 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.59 0.233 . . . . 0.0 110.824 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.6 pp -135.11 -60.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.524 -176.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.523 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -62.8 -0.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 29' ' ' ILE . 53.5 m -109.29 -2.5 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.777 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 31' ' ' SER . 3.1 m120 -133.22 149.96 51.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -81.86 135.26 35.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.437 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.43 ' CG2' HH22 ' A' ' 24' ' ' ARG . 17.5 t -127.61 139.03 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' TRP . 7.2 pt20 -116.96 164.29 14.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.186 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 8.8 m95 -134.96 125.13 26.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 0.0 110.53 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 28.0 m-85 -111.23 149.36 31.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -129.06 124.67 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.6 134.47 47.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.167 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -125.73 149.55 65.82 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.206 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.51 130.54 40.6 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.482 1.455 . . . . 0.0 110.713 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.01 10.0 85.24 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 m -133.38 173.86 11.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.6 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.94 165.37 12.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.31 144.27 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.671 1.581 . . . . 0.0 111.263 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -138.16 133.56 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 36.4 m -60.94 120.78 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' TRP . 0.9 OUTLIER -96.13 -25.38 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.718 -178.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 19.9 mt -145.08 146.13 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' H ' HE21 ' A' ' 54' ' ' GLN . 10.4 t80 -132.12 167.26 20.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 44.62 22.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.687 0.756 . . . . 0.0 110.933 -171.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.1 p30 43.13 17.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.03 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.4 -46.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 111.121 172.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 1.7 pp0? -87.93 147.62 24.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.713 -165.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.633 ' N ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -111.23 131.93 21.99 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 58' ' ' GLY . 3.4 Cg_exo -57.68 146.59 84.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.563 1.509 . . . . 0.0 111.183 174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -73.38 5.24 3.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.348 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 56' ' ' PRO . . . -95.91 -26.55 11.39 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.67 151.68 45.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.302 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.0 Cg_endo -61.93 143.78 95.84 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.662 1.575 . . . . 0.0 111.653 178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.29 -2.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.722 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 80' ' ' GLY . 12.4 mtp-105 -42.13 -38.65 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.068 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -76.29 137.5 39.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.193 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -129.29 123.07 30.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.314 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.06 129.71 9.96 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.3 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.8 p -158.54 158.45 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.301 0.572 . . . . 0.0 111.198 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.39 160.85 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.641 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.84 153.31 23.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.664 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -4.49 13.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.909 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 71' ' ' SER . 50.2 m -65.44 -46.19 80.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.77 24.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.506 -178.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -100.06 -37.68 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.449 ' H ' HD13 ' A' ' 29' ' ' ILE . 82.1 p -166.07 174.55 9.25 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.8 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.44 123.51 49.49 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.796 -1.19 . . . . 0.0 109.84 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.1 m -112.23 116.59 30.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.722 -170.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.444 ' CD1' ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -97.96 140.36 32.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 118.103 -2.873 . . . . 0.0 116.627 171.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' SER . 7.0 m -112.37 127.54 56.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 164.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.1 mt -96.66 116.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 120.029 -1.669 . . . . 0.0 110.459 171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.54 132.27 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.449 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 75.74 61.08 3.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.52 130.82 36.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 0.0 111.063 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -154.06 176.4 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.113 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -19.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.315 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' A' ' 82' ' ' LYS . 45.8 mt-10 -71.83 -38.0 70.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.205 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' LYS . 9.9 t70 -74.75 -13.06 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.468 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 84.2 tt0 -56.97 123.22 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 160.74 178.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.733 0.646 . . . . 0.0 109.791 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 85.4 m-20 -91.84 144.49 25.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 24.6 m-85 -110.8 151.17 28.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.986 0.422 . . . . 0.0 110.569 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 31.8 m-85 -149.44 138.35 21.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.653 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.488 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -120.95 140.7 51.5 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.597 0.635 . . . . 0.0 110.28 178.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -125.6 138.28 53.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.165 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.57 ' CB ' ' NH1' ' A' ' 24' ' ' ARG . 17.7 p -135.26 171.04 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' CD1' ' N ' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -158.51 132.29 7.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.95 -179.63 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.039 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -59.68 -38.43 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -81.99 39.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 62.84 -107.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.66 80.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.696 0.284 . . . . 0.0 110.362 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.51 123.27 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 m -136.55 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 8.4 p90 -112.95 137.2 51.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.05 -158.7 14.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.034 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 78.97 48.62 6.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.38 91.84 1.16 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 4.2 m -106.88 141.46 38.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -102.98 99.91 9.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.49 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.3 tp -90.24 125.46 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.532 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.95 130.16 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 110.162 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 65.0 t -97.47 99.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.966 0.412 . . . . 0.0 110.527 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.407 179.708 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.511 HD21 ' N ' ' A' ' 2' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.511 ' N ' HD21 ' A' ' 1' ' ' ASN . 2.0 m-85 -131.54 106.86 8.47 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.4 mmm -137.84 168.93 18.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.08 105.98 9.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.081 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.3 115.1 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.723 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.7 mm-40 -142.34 158.21 61.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.438 0.461 . . . . 0.0 110.584 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.95 142.47 93.57 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.662 1.575 . . . . 0.0 110.426 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' N ' ' A' ' 9' ' ' SER . 9.5 p80 -65.86 -53.94 33.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.179 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 9.7 p -161.87 157.26 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.386 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -164.77 154.64 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.116 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 p -122.5 135.63 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.796 178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -122.08 143.59 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.483 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.43 153.06 94.01 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.18 118.41 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.193 1.262 . . . . 0.0 112.103 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.55 -13.57 20.64 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -88.67 161.46 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.559 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.9 p -98.62 138.41 35.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.32 141.66 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.383 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 35.0 m -123.59 130.92 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.58 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.05 134.33 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.386 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 11.0 m -108.77 126.44 53.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.68 111.52 17.29 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.4 m -115.13 141.03 48.56 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.473 -1.392 . . . . 0.0 107.351 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.681 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.5 mmm-85 -93.7 139.87 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.264 170.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.8 p -60.53 1.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.371 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.681 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.49 -18.37 14.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.58 -173.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.73 -25.18 11.97 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 m -80.35 117.01 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.741 0.305 . . . . 0.0 111.312 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.647 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -135.34 -64.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.552 ' H ' ' CD1' ' A' ' 29' ' ' ILE . . . -67.27 -1.08 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.647 ' H ' ' C ' ' A' ' 29' ' ' ILE . 4.3 t -97.56 -22.13 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.04 -1.891 . . . . 0.0 111.917 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' CB ' HH12 ' A' ' 24' ' ' ARG . 12.8 m120 -118.51 148.51 42.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -175.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.47 137.72 42.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.989 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.44 141.1 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.9 pt20 -119.7 153.26 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -117.76 128.79 55.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 110.34 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' CE2' ' OG1' ' A' ' 47' ' ' THR . 26.2 m-85 -132.6 149.88 52.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.68 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.43 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -121.09 128.79 52.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -108.46 129.74 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.274 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.417 HH21 ' CB ' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -144.6 142.7 19.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.607 177.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.82 147.36 95.49 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.117 1.878 . . . . 0.0 110.96 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 8.88 82.82 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -156.71 140.21 15.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.48 . . . . 0.0 110.506 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 156.36 81.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.465 -178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.14 142.7 65.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.281 1.987 . . . . 0.0 110.55 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -121.79 138.76 54.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.451 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' OG1' ' CE2' ' A' ' 37' ' ' TYR . 5.7 m -77.4 120.18 22.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.704 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.02 -28.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.832 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 49' ' ' ILE . 15.2 mt -145.18 152.25 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 80.6 t80 -133.5 163.77 28.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.403 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.1 tt0 45.22 23.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.202 1.001 . . . . 0.0 110.44 -172.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.4 p30 44.59 19.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.668 -1.606 . . . . 0.0 109.964 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.6 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.89 -41.38 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.37 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.655 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.55 131.85 51.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.56 -1.654 . . . . 0.0 109.254 -167.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.726 HH21 ' H ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -117.31 108.89 42.96 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.99 145.29 49.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.707 1.605 . . . . 0.0 111.418 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 m -73.59 -24.46 60.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.56 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -29.54 72.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.09 148.16 36.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -59.22 128.48 27.73 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.621 1.547 . . . . 0.0 110.655 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.99 -0.85 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.271 . . . . 0.0 111.708 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' A' ' 60' ' ' PRO . 33.1 mtp180 -43.94 -23.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -79.49 140.79 37.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -127.32 122.84 34.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.726 ' H ' HH21 ' A' ' 55' ' ' ARG . . . -100.1 124.81 8.36 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 113.558 -1.655 . . . . 0.0 110.124 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.1 p -159.67 165.65 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.211 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.452 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -151.49 167.4 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.538 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 70' ' ' SER . 67.2 m-20 -104.1 153.03 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.815 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 m -69.89 13.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.103 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -87.86 -41.5 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.453 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m 79.15 27.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.077 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -98.46 -33.98 10.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.154 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 90.9 p -165.36 168.62 16.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.753 178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.05 130.83 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.832 -1.168 . . . . 0.0 109.641 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 66' ' ' SER . 16.2 m -128.34 112.81 14.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' A' ' 19' ' ' THR . 0.2 OUTLIER -98.72 140.52 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 118.564 -2.585 . . . . 0.0 116.711 168.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 64' ' ' SER . 85.4 m -99.85 127.55 46.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 162.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -107.9 106.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.107 -1.62 . . . . 0.0 109.701 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 p -102.29 154.95 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.644 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 79.93 25.62 57.55 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.16 138.32 56.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.12 0.486 . . . . 0.0 110.706 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.9 tttm -149.82 176.9 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.528 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 t -46.38 -21.33 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.45 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.6 mt-10 -72.01 -38.51 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.549 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.534 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.3 OUTLIER -70.63 -12.97 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 79.8 tt0 -52.76 122.72 9.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.364 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 164.42 -178.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.505 0.503 . . . . 0.0 109.874 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.95 132.39 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.72 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.502 ' HH ' ' CG ' ' A' ' 85' ' ' ASP . 16.2 m-85 -113.15 133.5 55.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -150.96 144.89 25.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.704 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.723 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.53 143.25 46.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.061 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -117.06 149.11 40.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 171.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 23.2 t -135.19 163.96 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 111.6 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -158.75 135.05 9.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.207 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 24' ' ' ARG . 96.5 m-20 -85.05 172.83 10.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 176.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -60.66 -35.24 75.75 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.126 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -80.11 34.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.447 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 67.05 -135.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.7 m170 60.54 81.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.268 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 m -87.17 135.42 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 p -142.28 153.66 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -113.73 147.63 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.839 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.49 -160.88 11.48 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 80.73 18.94 69.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.55 85.11 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.5 m -133.84 124.19 26.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -89.93 127.31 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.0 tp -111.65 126.11 54.68 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.46 0.475 . . . . 0.0 110.365 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.7 m -120.99 128.82 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.607 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' OXT' ' A' ' 111' ' ' LEU . 64.0 t -93.7 104.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.428 . . . . 0.0 110.242 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 9.5 mt . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.75 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.765 HD21 ' N ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.765 ' N ' HD21 ' A' ' 1' ' ' ASN . 95.0 m-85 -144.6 83.34 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.648 0.261 . . . . 0.0 110.305 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.403 ' H ' ' HB2' ' A' ' 25' ' ' SER . 2.2 tpp -156.6 169.99 23.41 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.52 103.04 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -78.82 127.44 32.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.581 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.703 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 16.3 mt-30 -143.47 159.76 53.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.72 125.46 18.7 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.498 1.465 . . . . 0.0 110.64 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -60.56 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 p -156.74 153.22 28.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.62 154.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.693 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -130.4 145.77 51.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -135.37 162.51 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -91.5 148.68 37.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.577 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -60.55 118.34 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.438 1.425 . . . . 0.0 111.296 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.37 3.54 29.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -95.01 -173.41 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.1 p -122.65 142.5 50.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.145 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.73 145.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 76' ' ' LEU . 87.9 m -127.48 122.59 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.023 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.428 ' H ' HD21 ' A' ' 76' ' ' LEU . 35.0 mt -103.36 135.99 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.913 178.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -106.19 135.61 47.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.335 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 4.1 m -118.72 115.63 24.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.0 m -118.92 140.0 50.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' C ' ' H ' ' A' ' 26' ' ' SER . 45.5 mtp180 -93.21 139.74 30.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.137 169.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 3' ' ' MET . 48.8 m -58.75 1.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.393 176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.698 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -103.67 -18.07 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.789 -175.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 77.92 21.76 70.49 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -125.47 113.91 18.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.517 0.198 . . . . 0.0 110.731 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.617 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.1 pp -135.14 -63.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.902 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.514 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -63.88 -3.22 2.3 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.617 ' H ' ' C ' ' A' ' 29' ' ' ILE . 38.6 m -92.98 -21.86 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.372 -2.194 . . . . 0.0 111.226 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -132.61 156.64 46.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.0 110.065 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 23.3 m-85 -82.04 145.11 30.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.91 146.76 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.219 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.639 HE22 ' N ' ' A' ' 37' ' ' TYR . 1.9 pp0? -117.1 163.06 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 27.5 m95 -132.98 126.46 32.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.936 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.639 ' N ' HE22 ' A' ' 35' ' ' GLN . 4.6 m-85 -124.86 149.4 47.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.913 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 1.5 mm100 -124.64 131.02 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.26 137.9 52.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.563 HH21 ' HG ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -153.83 149.82 21.72 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.49 140.22 93.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.564 1.509 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.05 86.25 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.563 ' HG ' HH21 ' A' ' 40' ' ' ARG . 1.4 t -147.04 163.84 34.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.49 160.79 28.08 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.01 129.49 33.51 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.198 1.932 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.7 m -125.31 116.56 22.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 110.559 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -62.13 122.29 15.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.78 -28.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.548 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -145.02 148.91 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -138.3 143.49 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' ASN . 8.5 tt0 57.68 23.57 9.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.454 1.121 . . . . 0.0 110.17 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.4 t0 44.14 18.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.025 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.6 -46.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.231 165.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -54.54 141.89 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.123 -168.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -125.62 108.86 25.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 119.169 -0.444 . . . . 0.0 109.849 178.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.448 ' N ' HE22 ' A' ' 54' ' ' GLN . 2.8 Cg_exo -60.18 144.31 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.725 1.617 . . . . 0.0 111.575 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -70.64 -26.85 63.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -33.21 86.64 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.03 144.34 28.91 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 62' ' ' ARG . 3.3 Cg_exo -60.37 139.95 89.26 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.459 1.439 . . . . 0.0 110.771 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -60.97 0.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.641 HH22 ' CB ' ' A' ' 85' ' ' ASP . 35.7 ptt85 -50.55 -29.09 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.986 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 63.0 m-85 -78.61 131.8 36.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.486 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 t -112.19 123.66 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.36 122.24 5.31 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 5.9 p -154.97 156.49 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.181 0.515 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.96 159.06 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.13 148.63 25.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.413 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -67.96 -6.43 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.474 ' O ' ' OG ' ' A' ' 71' ' ' SER . 6.0 m -64.33 -42.64 96.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.916 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.474 ' OG ' ' O ' ' A' ' 70' ' ' SER . 11.0 p 79.0 31.48 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.649 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -97.3 -43.64 7.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.403 -177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 60.1 p -167.11 168.35 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.325 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.71 122.79 47.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.8 m -114.52 112.89 23.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.684 -170.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -97.24 140.64 31.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 118.66 -2.525 . . . . 0.0 117.207 168.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.5 m -110.69 127.1 55.17 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.4 mm -93.84 113.09 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 120.057 -1.652 . . . . 0.0 110.887 171.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.76 129.22 45.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.523 0.201 . . . . 0.0 110.728 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.39 58.39 3.13 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tt -75.16 138.61 42.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.502 177.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.547 ' C ' ' H ' ' A' ' 84' ' ' GLU . 16.5 mttt -144.74 175.66 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.802 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -45.99 -18.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 82' ' ' LYS . 68.1 mm-40 -69.85 -38.36 76.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.461 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.641 ' CB ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -67.43 -6.91 21.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.529 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 21.9 tt0 -67.21 121.21 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.394 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 162.85 178.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.185 0.516 . . . . 0.0 110.176 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -87.4 134.15 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 10.9 m-85 -113.56 132.79 55.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.9 p90 -151.25 151.87 32.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 103' ' ' GLY . 28.3 p -132.62 143.4 49.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.159 -173.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.526 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 mt-30 -115.3 147.29 40.6 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.7 p -135.21 118.93 17.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.939 0.399 . . . . 0.0 110.844 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.7 p90 -159.28 131.08 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.102 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.64 -159.98 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.986 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -12.7 46.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.038 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 m -90.02 0.31 57.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 53.44 -165.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.712 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.32 29.96 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 178.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.92 -171.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.722 -178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 93' ' ' SER . 27.4 m -148.42 -178.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.437 . . . . 0.0 111.354 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -151.27 163.43 38.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 141.09 -123.43 2.31 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.39 42.21 9.46 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.13 118.61 11.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -135.91 118.87 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.873 0.368 . . . . 0.0 110.478 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -88.06 115.89 25.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.615 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.56 124.34 50.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.086 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 55.4 m -117.42 113.7 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 90.0 t -78.57 38.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 110.36 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.152 178.63 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.497 ' C ' HD21 ' A' ' 1' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -130.67 146.23 52.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.431 ' C ' ' HE ' ' A' ' 24' ' ' ARG . 5.0 ptt? -157.03 169.64 24.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.031 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.532 ' CD1' ' NH1' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -114.66 102.83 10.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.26 127.77 35.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.349 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.6 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.0 161.6 47.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.147 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -47.73 136.43 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.477 2.118 . . . . 0.0 111.676 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -70.36 -45.35 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.845 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -157.56 157.15 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.375 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.06 125.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.5 p -108.0 130.37 55.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.45 164.92 15.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 m -96.6 143.44 26.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.448 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.09 115.07 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.44 1.427 . . . . 0.0 111.039 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.75 -10.77 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -91.85 -171.64 2.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -126.41 153.71 44.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.895 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.33 147.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.099 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -122.25 134.4 54.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.45 ' H ' HD23 ' A' ' 76' ' ' LEU . 5.2 mm -98.88 128.64 50.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -102.38 120.53 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.7 111.84 19.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -178.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 142.17 48.11 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.932 -1.105 . . . . 0.0 108.609 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.677 ' C ' ' H ' ' A' ' 26' ' ' SER . 1.5 mmp_? -89.45 140.18 29.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.782 169.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.41 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.1 OUTLIER -59.05 -2.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.124 175.207 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.677 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.79 -18.18 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.072 -175.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 -36.26 3.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -66.78 110.73 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.702 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.5 pp -135.13 -60.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -61.92 1.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.702 ' H ' ' C ' ' A' ' 29' ' ' ILE . 85.1 p -109.02 -26.61 10.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.744 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -103.34 144.17 31.72 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.374 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.436 ' O ' ' OG ' ' A' ' 93' ' ' SER . 96.7 m-85 -73.8 119.11 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -174.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -121.47 143.25 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.782 0.801 . . . . 0.0 110.8 -175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.539 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.6 pm0 -139.09 169.6 17.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.895 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.6 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 64.5 m95 -125.74 128.26 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.207 0.527 . . . . 0.0 110.474 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.534 ' CE1' ' OG1' ' A' ' 47' ' ' THR . 21.7 m-85 -113.99 149.43 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.754 178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.39 129.86 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 5.7 tm0? -124.1 142.41 51.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.529 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -167.75 147.04 4.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.159 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.43 148.89 69.28 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.222 1.281 . . . . 0.0 110.765 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 -17.26 48.38 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.645 ' HG ' ' H ' ' A' ' 44' ' ' SER . 39.8 t -153.44 -168.95 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.645 ' H ' ' HG ' ' A' ' 43' ' ' SER . 0.2 OUTLIER -111.16 161.27 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.1 143.52 73.75 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.807 1.671 . . . . 0.0 110.943 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -140.84 132.45 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.957 0.408 . . . . 0.0 110.873 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' A' ' 37' ' ' TYR . 4.5 m -62.08 123.54 18.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.917 177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.24 -27.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.524 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.4 152.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' ASP . 31.2 t80 -132.87 163.26 29.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.2 tt0 45.94 24.18 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.953 -173.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.3 OUTLIER 44.16 19.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.962 -177.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.643 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.04 -46.1 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.934 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.643 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.94 135.62 48.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.728 -168.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -130.48 108.66 16.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.261 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.17 143.23 64.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.873 1.715 . . . . 0.0 111.58 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.0 m -74.14 -18.54 60.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.66 -51.18 54.17 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -85.24 149.97 53.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.551 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -59.29 135.76 67.67 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.655 0.903 . . . . 0.0 110.171 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' PHE . 47.9 p30 -59.99 0.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.147 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.678 HH12 ' N ' ' A' ' 85' ' ' ASP . 30.8 mtm105 -54.39 4.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.891 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASP . 4.2 m-85 -118.47 143.38 46.75 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.21 -0.306 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -135.28 123.57 23.16 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.073 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.49 119.53 6.29 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.582 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' SER . 12.7 p -153.98 160.46 42.07 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.064 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 163.89 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.119 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.478 ' C ' ' H ' ' A' ' 70' ' ' SER . 62.4 m-20 -108.72 146.35 33.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.507 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -67.98 2.73 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.796 174.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 68' ' ' ASP . 28.5 m -71.27 -42.38 68.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 80.83 27.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.566 -178.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.19 -43.6 7.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.7 p -164.63 168.44 18.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.403 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 125.17 52.18 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.114 -0.991 . . . . 0.0 109.604 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' SER . 5.5 m -123.38 115.57 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.074 -169.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -95.02 140.58 29.78 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.806 -1.809 . . . . 0.0 115.758 169.765 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -103.56 128.34 50.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 112.185 166.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.1 mt -108.36 108.24 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 120.758 -1.213 . . . . 0.0 110.116 172.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 80' ' ' GLY . 12.7 t -102.96 173.04 6.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.839 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' N ' ' HG ' ' A' ' 79' ' ' SER . . . 58.09 18.8 35.75 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.16 143.38 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.9 tttm -163.49 176.9 9.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.059 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.96 -20.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.586 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' LYS . 97.2 mt-10 -71.85 -38.71 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.559 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.678 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.5 OUTLIER -73.09 -9.29 58.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.251 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.463 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 72.2 tt0 -58.41 122.26 12.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.851 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 161.7 -175.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.176 0.513 . . . . 0.0 110.668 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.28 136.13 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.949 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 22.3 m-85 -119.93 132.83 55.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.023 0.439 . . . . 0.0 110.809 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 6.1 p90 -151.21 154.98 37.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.6 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 4.6 m -117.9 141.59 48.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.41 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 55.7 tt0 -117.44 121.52 41.28 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.857 -0.527 . . . . 0.0 109.669 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.53 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.6 OUTLIER -135.09 -177.19 4.53 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 -178.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -147.69 130.86 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.396 0.617 . . . . 0.0 110.629 175.437 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 96' ' ' SER . 34.2 t0 -131.67 -145.58 0.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.134 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.508 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -45.36 -12.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.019 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.503 ' N ' ' C ' ' A' ' 95' ' ' ASP . 32.2 m -81.01 -6.36 58.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.768 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER 61.76 109.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.005 177.277 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 37.97 40.28 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.668 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' O ' ' CG1' ' A' ' 100' ' ' VAL . 6.7 p -164.77 112.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG13 HH22 ' A' ' 24' ' ' ARG . 0.9 OUTLIER -176.87 140.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 11.8 p90 -165.29 161.12 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.159 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.55 -147.37 15.36 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.302 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 62.15 52.49 49.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.42 102.96 1.54 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.445 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 42.1 m -106.84 126.34 52.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.22 98.36 11.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.172 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.0 tp -82.28 122.86 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.155 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 m -120.73 117.33 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 111' ' ' LEU . 95.2 t -81.85 93.53 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.148 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 110' ' ' VAL . 12.2 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.599 -1.191 . . . . 0.0 111.898 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.496 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.6 ' CG ' ' NE2' ' A' ' 99' ' ' HIS . 1.1 m-85 -146.97 141.0 26.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.318 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.585 ' O ' ' N ' ' A' ' 25' ' ' SER . 50.0 mtt -151.24 170.52 19.27 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.444 ' CA ' ' O ' ' A' ' 23' ' ' THR . 0.4 OUTLIER -137.06 118.75 15.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.587 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -71.86 134.43 46.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.629 -172.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.413 ' OE1' ' O ' ' A' ' 21' ' ' SER . 2.8 mm-40 -146.08 157.65 49.65 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.277 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.08 168.67 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.946 . . . . 0.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.754 ' HD1' ' H ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -82.89 -66.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.163 179.667 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.754 ' H ' ' HD1' ' A' ' 8' ' ' HIS . 9.6 m -165.04 162.85 20.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.5 150.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.6 p -130.2 128.32 41.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.137 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.98 162.57 18.31 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.404 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 3.8 m -96.88 147.02 32.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.75 120.0 7.61 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.481 1.454 . . . . 0.0 111.106 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.84 4.96 27.71 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 13' ' ' SER . 61.8 mttm -101.66 -172.94 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.209 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -126.58 145.11 50.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.29 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.02 141.74 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.707 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -123.11 130.27 52.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 135.49 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 2.7 m -106.37 128.59 54.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.986 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.06 121.64 40.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' THR . 91.9 m -125.96 131.1 52.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.753 ' C ' ' H ' ' A' ' 26' ' ' SER . 13.7 ttp180 -81.47 134.21 35.5 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.531 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 3' ' ' MET . 91.6 p -55.48 1.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.488 174.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.753 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.03 -18.05 14.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.19 -172.045 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.05 21.05 68.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.769 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.54 111.24 14.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.2 0.5 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.661 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.2 pp -135.34 -63.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.67 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -64.04 0.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 29' ' ' ILE . 34.6 m -109.27 -29.6 8.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.158 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.633 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.7 OUTLIER -116.81 155.05 29.64 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.15 125.52 27.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.926 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 t -121.03 148.15 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' OE1' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -142.0 160.41 40.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.339 -172.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -119.68 126.59 51.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.317 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.2 m-85 -108.01 149.11 28.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.866 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -138.1 132.2 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.787 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -133.53 146.61 51.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.753 177.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.611 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -152.28 174.84 3.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.27 141.33 42.89 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.934 1.756 . . . . 0.0 111.61 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.36 0.75 82.14 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 p -154.02 176.32 12.35 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.2 163.09 24.75 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.486 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -55.26 138.77 80.28 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.558 2.172 . . . . 0.0 111.48 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -149.08 143.17 25.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.442 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.523 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -71.88 126.27 29.32 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.946 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -95.11 -26.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.26 140.76 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' GLN . 50.2 t80 -127.66 152.96 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 11.9 tt0 54.69 23.45 4.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.127 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 43.74 18.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.817 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.44 -46.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.698 . . . . 0.0 109.5 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.504 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -62.69 114.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.758 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.433 ' HE ' ' CB ' ' A' ' 61' ' ' ASP . 25.4 ttp-105 -118.67 108.75 40.77 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -68.21 148.03 73.82 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.97 1.78 . . . . 0.0 111.57 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -74.12 -19.37 60.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.89 92.61 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.5 148.72 44.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.542 ' C ' ' H ' ' A' ' 62' ' ' ARG . 4.8 Cg_exo -51.65 121.85 9.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.799 1.666 . . . . 0.0 111.675 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.597 ' C ' ' H ' ' A' ' 63' ' ' PHE . 38.6 p-10 -60.91 1.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.418 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.563 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.5 mtp-105 -64.53 16.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.446 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' H ' ' C ' ' A' ' 61' ' ' ASP . 14.4 m-85 -116.9 144.02 45.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -131.66 123.28 27.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.37 126.41 8.72 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.46 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -158.62 164.28 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.257 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.9 161.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.969 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -99.07 178.96 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.658 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 p -91.25 9.14 32.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.023 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' SER . 18.5 m -83.12 -44.41 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.71 28.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.463 -176.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -100.07 -38.63 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.805 -176.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.41 ' H ' HD13 ' A' ' 29' ' ' ILE . 60.4 p -161.3 167.05 26.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.735 -177.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.88 124.74 50.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.013 -1.054 . . . . 0.0 109.576 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 6.3 m -115.21 112.64 22.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.702 -171.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.3 OUTLIER -96.72 140.59 31.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 119.345 -2.097 . . . . 0.0 116.515 170.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 78.3 m -108.0 130.21 55.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.905 0.859 . . . . 0.0 113.153 163.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -108.13 113.55 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 174.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 t -99.24 168.0 10.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.085 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 59.2 38.38 93.1 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.5 tt -65.37 134.53 53.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.032 0.444 . . . . 0.0 110.97 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 84' ' ' GLU . 9.2 tttt -151.94 176.26 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -19.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.791 174.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 82' ' ' LYS . 65.0 tt0 -74.55 -38.61 62.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.179 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' CG ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -72.64 -11.41 60.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.9 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.455 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 76.7 tt0 -57.42 125.75 24.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.869 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 162.39 176.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.88 142.46 27.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.897 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 13.4 m-85 -113.99 147.62 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.569 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -146.48 154.13 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.631 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.2 t -127.66 140.66 51.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 93' ' ' SER . 8.8 tp60 -128.26 131.99 48.74 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 92' ' ' GLN . 35.4 p -134.99 145.19 47.87 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.054 -0.404 . . . . 0.0 111.172 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -154.79 150.65 27.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.149 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -109.94 -165.66 1.03 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.937 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 98' ' ' ASN . 6.0 m -72.37 -40.54 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.373 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -76.28 38.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.432 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 96' ' ' SER . 84.9 m-20 56.2 -114.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.567 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.6 ' NE2' ' CG ' ' A' ' 2' ' ' PHE . 7.3 t-160 43.97 75.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.477 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.1 m -102.99 129.9 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.829 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.51 155.4 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.438 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -146.25 152.65 39.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.407 ' H ' HD11 ' A' ' 4' ' ' LEU . . . 178.25 -166.84 37.12 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.238 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.22 48.57 4.01 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.26 96.38 0.06 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -105.27 116.33 31.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.45 123.94 30.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.027 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.1 tp -110.86 122.91 49.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.797 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -116.23 120.28 38.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.803 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' A' ' 110' ' ' VAL . 60.4 t -91.65 34.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.408 179.282 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.672 ' ND2' ' H ' ' A' ' 2' ' ' PHE . 3.7 t30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.672 ' H ' ' ND2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -142.35 106.88 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.5 mmm -148.12 169.29 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.78 103.05 7.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.68 121.75 25.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.597 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.78 -177.68 0.69 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 3.8 Cg_exo -74.38 151.83 43.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.188 1.925 . . . . 0.0 111.658 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.649 ' CG ' ' H ' ' A' ' 9' ' ' SER . 19.0 p-80 -82.44 -57.01 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.625 0.25 . . . . 0.0 111.182 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.649 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 30.6 p -152.6 149.04 28.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.582 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.38 153.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.288 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.1 p -132.15 141.85 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.423 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -131.81 158.1 42.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -76.74 148.9 80.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -63.46 120.23 7.58 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.572 1.515 . . . . 0.0 112.044 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.14 -6.3 17.32 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -96.45 164.94 12.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.162 0.506 . . . . 0.0 111.147 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -95.52 132.3 40.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.065 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.51 135.16 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.079 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -120.13 134.88 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.465 178.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.06 134.29 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.125 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -110.23 125.93 53.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 30.7 m -118.75 125.27 49.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 m -116.88 131.73 56.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.718 ' C ' ' H ' ' A' ' 26' ' ' SER . 41.7 ttt180 -83.86 136.54 34.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.301 171.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.5 m -58.6 2.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.554 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.718 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -104.9 -18.04 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -174.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.17 -32.29 4.14 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 3.1 t -72.47 110.24 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.935 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.677 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.5 pp -134.59 -60.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' N ' ' CD1' ' A' ' 29' ' ' ILE . . . -62.89 0.3 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.677 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.4 p -110.13 -26.98 9.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.358 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' HH11 ' A' ' 24' ' ' ARG . 98.3 m-20 -104.26 151.3 23.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -81.55 114.76 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.97 148.0 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.404 ' NE2' ' CE2' ' A' ' 37' ' ' TYR . 18.7 tt0 -135.84 156.61 48.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.26 135.36 54.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.427 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -139.06 137.07 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.563 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.0 148.08 52.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.185 0.517 . . . . 0.0 110.098 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.73 140.01 47.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.219 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.98 148.27 40.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.8 Cg_exo -57.81 135.21 67.67 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.817 1.678 . . . . 0.0 111.261 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.83 -12.98 4.49 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 41' ' ' PRO . 1.8 t -120.67 150.8 40.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.038 0.447 . . . . 0.0 110.579 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -78.3 179.8 1.59 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.826 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.3 Cg_exo -72.43 156.24 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.557 2.171 . . . . 0.0 112.039 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.402 ' C ' ' CE1' ' A' ' 37' ' ' TYR . 81.2 p -140.4 126.56 19.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.629 176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.54 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 64.6 m -61.14 121.14 11.75 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.726 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.4 t -101.36 -28.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.928 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.3 mt -145.63 146.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 172.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.8 t80 -132.99 159.16 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 50.98 24.03 1.69 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.2 1.0 . . . . 0.0 110.361 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 38.5 t0 44.35 19.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.361 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -127.87 -46.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 170.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 HE21 ' N ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -55.29 140.46 39.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.909 -168.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -142.34 108.68 5.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.295 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -68.37 143.94 59.95 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.407 1.405 . . . . 0.0 111.992 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -69.64 -35.79 75.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.685 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.96 -50.58 26.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -91.54 139.51 25.12 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -57.83 137.18 79.77 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.137 1.225 . . . . 0.0 110.54 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' PHE . 4.0 p-10 -62.75 -0.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.61 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 60' ' ' PRO . 17.9 mtp-105 -38.33 -24.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.495 -175.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 7.2 m-85 -89.77 141.01 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.5 t -126.38 124.36 40.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.951 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.39 117.52 5.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.509 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 75' ' ' SER . 8.1 p -153.93 167.05 31.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.125 0.462 . . . . 0.0 110.722 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.458 ' C ' ' CD1' ' A' ' 67' ' ' ILE . 2.5 pp -149.14 160.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -101.15 153.75 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.605 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.0 p -68.09 -7.46 29.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.248 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.7 m -61.96 -42.8 99.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 80.84 27.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.481 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.07 -38.25 8.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.786 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.414 ' H ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -166.28 171.41 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.042 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.04 135.41 48.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.784 -1.198 . . . . 0.0 109.467 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -130.42 115.69 17.21 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.794 -1.098 . . . . 0.0 112.825 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.422 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -96.99 140.73 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 118.927 -2.358 . . . . 0.0 116.284 169.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.4 m -102.48 126.13 49.42 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.473 -0.767 . . . . 0.0 112.969 162.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.25 103.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 120.79 -1.194 . . . . 0.0 109.788 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -98.98 154.31 18.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 78.21 17.25 78.43 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.91 131.91 22.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.318 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 84' ' ' GLU . 26.6 mttt -148.99 176.09 10.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.818 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -18.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.627 174.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 82' ' ' LYS . 94.0 mt-10 -75.67 -37.0 59.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 82' ' ' LYS . 6.9 t70 -74.3 -10.7 59.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.49 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 38.8 tt0 -57.59 123.94 17.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 162.14 -175.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.922 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -89.11 150.01 22.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.563 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 19.1 m-85 -122.26 151.76 40.75 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.543 0.337 . . . . 0.0 110.526 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 37' ' ' TYR . 56.0 m-85 -150.45 137.37 19.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.427 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 16.2 p -118.9 140.66 49.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.951 0.341 . . . . 0.0 111.368 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -118.08 134.71 54.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -135.12 146.99 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.612 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.91 133.96 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -87.3 -175.87 5.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.193 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.468 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.8 m -65.26 -41.98 93.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.959 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 m -77.72 37.89 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.492 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.9 OUTLIER 70.21 -127.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.544 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 64.59 78.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.599 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.15 119.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.37 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.49 141.22 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.233 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -154.1 161.39 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.359 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.37 -131.43 6.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.75 24.13 3.94 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.09 164.71 4.79 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 28.8 m -131.81 130.57 41.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.87 112.89 15.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.9 tp -105.83 124.45 49.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.116 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.2 m -117.62 124.76 49.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.119 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.07 99.21 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.204 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.887 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 12.9 t30 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.38 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.32 168.17 21.75 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -133.78 103.87 6.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.491 ' H ' ' HG1' ' A' ' 5' ' ' THR . 1.6 p -90.41 135.35 33.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.825 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.662 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 30.5 mt-30 -136.55 163.42 49.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.829 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.49 135.46 66.26 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.899 1.733 . . . . 0.0 110.817 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -41.49 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -161.28 157.46 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' CG2' ' N ' ' A' ' 11' ' ' SER . 7.3 p -163.62 162.88 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.447 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.458 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 15.1 t -137.07 156.88 47.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.064 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.68 151.78 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.436 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.73 142.32 85.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.528 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.88 113.9 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.459 1.439 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.82 1.34 22.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -94.9 -174.16 3.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.004 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -113.44 127.81 56.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.138 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -118.37 144.06 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -130.58 131.45 45.0 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.97 140.17 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.303 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -113.88 120.08 39.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.421 ' HB2' HE21 ' A' ' 6' ' ' GLN . 31.9 t -120.75 123.6 43.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.6 m -119.69 142.09 48.8 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.019 -1.05 . . . . 0.0 108.278 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 26' ' ' SER . 75.3 mtp85 -92.94 141.1 28.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.685 170.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 p -59.74 2.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.246 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.09 -18.15 14.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.132 -175.417 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 74.3 8.93 80.68 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.413 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 6.7 t -110.85 105.46 14.29 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.786 -0.244 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.66 ' C ' ' H ' ' A' ' 31' ' ' SER . 1.3 pp -129.61 -63.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' H ' ' CG1' ' A' ' 29' ' ' ILE . . . -63.53 -0.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.66 ' H ' ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -98.91 -27.05 14.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.719 -178.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 95' ' ' ASP . 78.4 m-20 -131.71 152.22 51.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -71.07 149.09 46.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.676 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 52' ' ' ASP . 17.1 t -125.5 148.21 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.24 155.41 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.97 131.04 54.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.054 0.454 . . . . 0.0 110.425 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.531 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.2 OUTLIER -127.91 146.19 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.84 136.66 48.87 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.767 HE22 ' H ' ' A' ' 44' ' ' SER . 7.2 tp-100 -120.49 121.75 39.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.348 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 44' ' ' SER . 16.2 mtt180 -79.83 -168.67 0.19 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 40' ' ' ARG . 5.6 Cg_exo -68.89 125.75 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 CA-C-N 121.419 1.542 . . . . 0.0 110.779 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.12 -36.14 0.25 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 113.225 -1.807 . . . . 0.0 114.529 164.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 p -159.38 103.21 1.59 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.336 1.568 . . . . 0.0 112.762 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.767 ' H ' HE22 ' A' ' 39' ' ' GLN . 26.0 t -170.7 92.35 0.47 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 119.462 1.028 . . . . 0.0 112.162 171.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.09 127.92 7.95 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.224 1.949 . . . . 0.0 111.456 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -139.92 97.94 3.36 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 121.914 -0.491 . . . . 0.0 110.202 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.531 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 33.9 m -64.83 118.89 9.66 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.94 -28.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.199 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.44 151.47 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' HH ' ' HH ' ' A' ' 94' ' ' TYR . 5.7 t80 -134.13 161.01 36.07 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.0 tt0 48.6 23.86 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.351 0.596 . . . . 0.0 111.217 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.0 t0 44.48 19.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.119 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.677 HD21 ' NE2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -127.93 -46.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.502 . . . . 0.0 109.825 170.483 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.677 ' NE2' HD21 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.52 132.33 44.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.951 -168.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -134.64 108.63 10.97 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.08 149.09 64.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.964 1.776 . . . . 0.0 111.62 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -71.55 -36.75 71.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.698 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.76 42.48 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 m -86.6 138.09 33.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.5 Cg_endo -59.89 131.37 39.2 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 CA-C-N 119.88 0.993 . . . . 0.0 110.665 -177.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 63' ' ' PHE . 25.6 p-10 -60.95 1.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' A' ' 60' ' ' PRO . 13.6 mtm105 -46.65 -5.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.165 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 6.0 m-85 -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.4 t -119.06 124.36 46.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.72 122.46 6.98 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 37.8 p -159.15 163.35 36.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.051 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.91 158.82 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.858 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 70' ' ' SER . 73.5 m-20 -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.864 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.22 30.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 68' ' ' ASP . 6.7 m -107.19 -40.46 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.537 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 83.79 25.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.391 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -42.17 7.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.678 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.1 p -164.69 170.73 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.976 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.63 133.94 51.35 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 120.61 -1.306 . . . . 0.0 110.177 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 12.5 m -125.47 113.56 17.65 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.055 -0.974 . . . . 0.0 113.092 -171.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.42 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.44 140.6 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 118.591 -2.568 . . . . 0.0 116.994 170.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' SER . 19.5 m -105.1 125.53 51.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 163.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 18' ' ' VAL . 38.4 mm -89.79 103.62 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.565 -1.334 . . . . 0.0 110.724 172.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 m -99.32 141.56 31.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.371 . . . . 0.0 111.486 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.94 15.42 79.1 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.03 135.66 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.57 . . . . 0.0 110.461 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' C ' ' H ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -144.04 176.06 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.302 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -49.73 -19.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.432 175.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE1' ' NH2' ' A' ' 62' ' ' ARG . 3.2 tt0 -70.97 -42.02 70.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.352 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 4.6 m-20 -66.86 -7.07 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.22 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 87' ' ' ALA . 33.0 tt0 -58.99 121.03 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.977 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 86' ' ' GLU . . . 158.5 -175.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -93.0 147.36 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.21 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -116.73 145.33 43.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 14.0 m-85 -145.93 152.62 39.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.859 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.662 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -125.08 140.89 52.49 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -118.98 139.81 51.05 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.487 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 2.4 m -135.09 158.29 44.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 110.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -157.25 138.21 13.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.435 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' CG ' ' ND2' ' A' ' 32' ' ' ASN . 0.7 OUTLIER -106.18 -170.99 1.81 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.67 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.9 m -62.17 -42.03 98.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.237 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.6 40.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.278 0.561 . . . . 0.0 110.146 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 96' ' ' SER . 1.1 m-80 54.64 -101.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.008 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 43.06 70.84 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.25 121.51 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.116 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.66 157.64 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.425 . . . . 0.0 110.619 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.9 p90 -134.23 142.7 47.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.074 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.83 -150.13 8.66 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' TYR . . . 86.1 35.91 10.58 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.36 110.08 2.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -142.13 137.79 31.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.769 0.319 . . . . 0.0 110.371 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.31 112.72 25.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.565 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.11 125.93 50.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.085 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.445 ' O ' ' OG ' ' A' ' 11' ' ' SER . 0.2 OUTLIER -118.88 125.19 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -96.21 103.21 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.209 179.069 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 C--O 1.228 -0.057 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.1 102.77 6.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -92.1 121.08 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.008 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.632 HE21 ' CB ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -144.55 164.86 25.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.15 134.42 36.91 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.246 1.964 . . . . 0.0 111.612 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.485 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 9.7 t-80 -67.0 -68.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.2 m -148.43 146.04 28.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 11' ' ' SER . 7.9 p -162.52 156.14 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.525 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' HG22 ' A' ' 10' ' ' VAL . 86.0 p -133.86 145.55 49.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.384 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -133.82 156.68 47.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.093 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -77.06 136.76 65.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.166 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.56 125.19 17.07 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.583 1.522 . . . . 0.0 111.093 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 -6.68 25.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -94.08 173.52 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.778 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.6 p -100.56 136.62 40.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.225 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.5 137.43 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -125.14 127.59 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.59 139.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.42 127.71 53.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.379 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -118.62 126.36 51.79 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.8 m -118.93 141.64 48.47 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 26' ' ' SER . 33.1 mtp85 -94.74 141.11 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.185 170.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.5 t -58.2 0.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.544 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.635 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.25 -18.1 14.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.794 -173.974 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 75.47 21.87 76.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' OD1' ' A' ' 32' ' ' ASN . 10.5 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.32 -63.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.439 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.96 1.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 29' ' ' ILE . 54.7 m -104.97 -27.08 11.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.378 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 28' ' ' SER . 4.0 p-10 -122.2 163.58 19.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.152 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -81.92 142.88 32.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.67 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.02 148.26 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.571 HE22 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -133.24 144.52 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.43 135.03 51.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 110.878 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.515 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -128.29 149.11 50.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.03 140.55 52.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.415 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 6.6 tm0? -148.24 144.65 27.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.449 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.663 0.193 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 m -138.78 110.31 7.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.515 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -60.87 121.15 11.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.45 -27.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.408 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mt -145.11 146.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 8.5 t80 -130.96 159.08 38.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.251 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 3.7 tt0 49.3 24.31 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.653 0.74 . . . . 0.0 110.682 -175.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.2 p-10 44.5 19.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.61 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.1 t-20 -128.0 -46.35 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.378 0.609 . . . . 0.0 109.811 171.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 124.79 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.033 -167.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.56 108.8 40.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.462 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.56 144.54 55.44 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.475 1.45 . . . . 0.0 111.662 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -67.26 -32.38 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.711 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.99 -58.65 13.44 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.45 137.87 48.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.2 Cg_exo -59.01 137.92 82.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.966 1.111 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 63' ' ' PHE . 12.0 p-10 -61.5 1.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.445 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.559 HH22 ' CG ' ' A' ' 85' ' ' ASP . 9.1 ptm180 -49.79 -2.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.93 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.56 ' H ' ' C ' ' A' ' 61' ' ' ASP . 47.2 m-85 -104.45 143.65 32.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.31 122.55 34.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.893 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.07 125.29 8.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.497 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.3 p -157.57 161.88 38.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.194 0.521 . . . . 0.0 111.124 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.623 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.7 pp -141.89 158.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.8 m-20 -102.65 145.96 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.8 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.91 -3.72 10.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.442 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.3 m -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.068 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 28.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.593 -177.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -98.77 -40.55 8.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.52 ' O ' HD13 ' A' ' 29' ' ' ILE . 80.3 p -168.17 169.83 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.088 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.32 135.54 49.46 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 120.613 -1.304 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -128.48 115.6 18.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.137 -171.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.03 140.72 31.94 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 118.622 -2.549 . . . . 0.0 116.91 168.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.0 m -104.63 129.22 52.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 162.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.584 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.0 mt -109.65 105.94 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 120.179 -1.576 . . . . 0.0 110.193 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 t -88.86 153.13 21.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 61.34 4.06 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.21 137.92 34.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.163 0.506 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 84' ' ' GLU . 22.3 mttt -151.45 173.73 14.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.694 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.33 -19.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.497 173.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 82' ' ' LYS . 91.2 mt-10 -68.81 -41.0 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.392 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.559 ' CG ' HH22 ' A' ' 62' ' ' ARG . 16.7 t70 -72.68 -9.9 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.242 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 82.3 tt0 -56.4 120.97 8.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.812 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.88 176.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -88.73 152.86 21.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.668 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 17.6 m-85 -117.67 143.26 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.997 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.3 m-85 -144.58 142.51 30.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.727 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.1 p -134.96 140.86 46.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.829 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.571 ' HG3' HE22 ' A' ' 35' ' ' GLN . 56.6 mt-30 -121.16 148.55 44.07 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.76 -0.587 . . . . 0.0 110.482 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 p -135.15 153.37 52.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 110.68 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.98 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.2 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.694 0.283 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.99 -141.99 4.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.619 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . 62.68 53.86 38.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.06 103.5 2.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.632 ' CB ' HE21 ' A' ' 6' ' ' GLN . 34.4 m -126.27 141.7 51.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 110.642 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -104.93 101.15 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.69 124.97 36.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.379 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 m -120.74 124.91 46.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.55 100.94 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.113 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.836 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 ptm . . . . . 0 C--O 1.231 0.105 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.38 104.49 9.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -80.17 129.68 34.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.321 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.568 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 3.0 mt-30 -145.34 166.68 16.8 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -63.84 133.32 38.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.475 1.45 . . . . 0.0 111.319 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.674 ' CG ' ' H ' ' A' ' 9' ' ' SER . 6.1 p80 -44.19 -60.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.674 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 35.2 p -164.08 160.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -162.95 147.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 p -130.71 132.2 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.849 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.92 158.23 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 m -80.93 140.03 50.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.57 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.38 116.13 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.751 1.634 . . . . 0.0 111.043 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.32 -0.6 18.82 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -107.56 -163.05 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.9 p -136.63 153.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.16 147.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.051 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 131.74 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.85 134.27 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.292 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.8 m -104.92 123.56 47.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.877 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.99 111.91 18.92 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.7 m -116.59 141.97 47.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.9 mtm180 -99.55 143.27 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.071 170.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 1.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -101.45 -14.05 17.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.784 -174.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.33 27.14 70.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.8 p -124.5 109.53 13.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 110.571 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.17 -64.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.995 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.72 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -66.59 -2.41 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.6 t -100.93 -29.18 12.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.57 -2.104 . . . . 0.0 111.339 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -121.09 148.53 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.0 112.84 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.372 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 22.0 t -102.3 146.3 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.598 HE21 ' CB ' ' A' ' 92' ' ' GLN . 7.1 tt0 -127.97 165.09 20.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 28.2 m95 -130.04 127.43 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.936 0.398 . . . . 0.0 110.914 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 2.1 m-85 -121.19 148.99 43.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.374 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -126.74 134.79 50.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.31 117.54 32.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.687 -179.567 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.49 1.278 0 N-CA-C 110.812 -0.495 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 126.82 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.436 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.492 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -74.94 120.96 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.099 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.691 ' HA ' HG21 ' A' ' 59' ' ' VAL . 23.8 t -103.17 -28.4 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.491 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -145.42 151.66 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.801 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 3.5 t80 -140.82 164.86 29.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' ASN . 2.7 tt0 44.84 21.9 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 110.887 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 43.09 18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.614 -177.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.79 -46.97 1.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 173.752 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.801 ' OE1' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.01 153.28 40.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.993 -164.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.534 ' CZ ' ' O ' ' A' ' 63' ' ' PHE . 3.3 ttt85 -132.0 108.67 14.01 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 120.322 -1.486 . . . . 0.0 109.939 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -69.7 143.0 49.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.446 1.43 . . . . 0.0 111.449 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -73.99 -18.86 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.062 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.46 -38.33 96.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 48' ' ' VAL . 17.2 m -103.08 149.95 37.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 122.291 -0.535 . . . . 0.0 109.626 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 2.4 Cg_endo -53.65 125.98 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.795 1.663 . . . . 0.0 111.342 -173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' CA ' HH21 ' A' ' 55' ' ' ARG . 97.8 m-20 -61.05 2.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.443 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 19.6 mtm105 -69.25 21.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -173.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' O ' ' CZ ' ' A' ' 55' ' ' ARG . 16.9 m-85 -131.32 143.6 50.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.151 0.432 . . . . 0.0 110.626 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 77' ' ' THR . 2.1 t -126.64 123.14 36.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.139 -0.457 . . . . 0.0 111.269 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.21 136.54 13.66 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.374 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.4 p -163.83 159.92 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD13 ' CB ' ' A' ' 30' ' ' ALA . 2.5 pp -141.03 154.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.669 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 70' ' ' SER . 15.9 m-20 -102.98 154.21 19.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.948 176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.4 p -69.7 7.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 68' ' ' ASP . 24.4 m -74.19 -43.11 58.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.596 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 70' ' ' SER . 12.7 p 79.5 30.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.657 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.05 -38.14 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.767 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.591 ' O ' HD13 ' A' ' 29' ' ' ILE . 67.4 p -169.5 172.39 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.775 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.76 123.81 49.6 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 120.864 -1.147 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' SER . 13.7 m -114.02 112.8 23.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.519 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.92 140.48 31.4 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 119.3 -2.125 . . . . 0.0 116.019 169.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.481 ' O ' ' CB ' ' A' ' 64' ' ' SER . 5.6 m -112.64 126.23 55.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 164.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.698 ' CD1' HD21 ' A' ' 76' ' ' LEU . 28.5 mm -86.29 114.25 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 120.21 -1.556 . . . . 0.0 110.919 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.9 t -103.76 131.71 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.85 52.92 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.96 133.82 10.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.252 0.548 . . . . 0.0 110.106 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.0 ttmt -144.17 171.98 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.198 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.03 -19.03 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.831 173.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 5.6 mp0 -70.86 -39.38 72.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -69.76 -9.05 53.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.276 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.0 tt0 -60.37 122.91 15.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 157.38 -179.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 90' ' ' TYR . 9.8 t0 -87.62 149.89 24.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.9 m-85 -115.28 145.39 42.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 88' ' ' ASP . 67.7 m-85 -143.5 154.1 43.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.215 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.84 141.0 49.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.598 ' CB ' HE21 ' A' ' 35' ' ' GLN . 1.5 mm-40 -125.48 120.74 31.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.615 0.643 . . . . 0.0 109.386 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.7 p -128.54 152.5 48.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.966 0.412 . . . . 0.0 110.649 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.73 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.746 0.308 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.82 -132.47 1.39 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 48.37 47.01 28.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.33 108.78 2.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -133.16 134.57 44.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.841 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.83 124.31 36.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -113.81 131.32 56.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.934 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 111' ' ' LEU . 88.3 m -124.29 128.97 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 110' ' ' VAL . 58.2 t -87.56 34.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' H ' HG22 ' A' ' 109' ' ' THR . 13.7 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.952 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 30.1 mtm . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.32 103.24 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.48 113.93 11.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.588 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 14.0 tt0 -144.87 141.82 17.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 118.977 -0.535 . . . . 0.0 109.58 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 106' ' ' THR . 6.0 Cg_exo -51.4 137.16 48.08 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 CA-C-N 120.563 1.237 . . . . 0.0 110.954 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 9' ' ' SER . 42.2 p-80 -58.85 -49.43 77.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.629 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' ' CD2' ' A' ' 8' ' ' HIS . 2.4 m -158.7 151.68 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.45 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 11' ' ' SER . 6.6 p -160.29 154.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 10' ' ' VAL . 1.8 t -131.9 149.0 52.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.312 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -141.37 162.19 36.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.459 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -85.93 156.8 57.87 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.325 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.71 128.36 19.84 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.69 1.593 . . . . 0.0 112.283 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.77 -5.27 39.94 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -89.4 167.94 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.672 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p -102.75 125.41 49.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.782 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.44 138.95 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 76' ' ' LEU . 32.5 m -128.59 119.78 25.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.931 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.06 132.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -109.07 124.93 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.0 m -118.86 115.4 24.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.4 m -116.96 137.66 52.07 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.659 ' C ' ' H ' ' A' ' 26' ' ' SER . 12.7 ttp85 -92.81 139.18 30.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.498 170.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.41 2.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.627 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.06 -18.13 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.89 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.68 22.98 76.32 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.428 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 30.1 t -120.82 110.02 15.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.507 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.47 -63.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.799 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.35 0.35 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.0 p -103.87 -11.63 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.837 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -132.33 152.07 51.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 109.982 -177.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.98 127.96 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.092 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.81 146.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.228 0.537 . . . . 0.0 110.719 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.463 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -138.56 156.99 47.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.341 -177.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.538 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 98.0 m95 -113.93 136.69 52.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.445 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 10.2 m-85 -126.17 149.15 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.42 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -146.13 133.53 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.575 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 1.7 pp0? -130.07 160.21 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.533 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.08 178.527 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.491 1.333 0 CA-C-O 120.587 0.161 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 p -132.72 143.31 49.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.424 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 5.5 m -71.7 120.89 17.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.455 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -102.84 -28.66 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.299 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mt -145.61 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.2 t80 -127.79 166.04 18.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.7 tt0 44.77 22.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.083 0.944 . . . . 0.0 110.6 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.2 p30 43.48 17.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.763 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -129.09 -47.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 170.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.9 126.12 30.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.936 -166.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -121.22 119.29 29.67 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.276 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.26 141.37 97.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.8 1.321 . . . . 0.0 111.64 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -67.3 -5.35 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.54 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.99 59.03 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.24 148.5 35.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 122.587 -0.361 . . . . 0.0 110.845 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -59.35 139.41 89.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.813 1.675 . . . . 0.0 111.568 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -61.05 -0.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 63' ' ' PHE . 42.6 ptt85 -56.12 -31.87 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 0.0 111.313 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 60.3 m-85 -72.25 140.89 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.6 t -128.36 122.61 31.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.89 123.94 7.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.41 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -154.56 158.23 39.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.631 . . . . 0.0 111.29 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -143.46 157.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.635 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 m-20 -105.16 143.63 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.813 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -0.05 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.955 0.407 . . . . 0.0 110.327 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.4 m -70.58 -40.77 73.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.02 29.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.397 -177.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -98.93 -39.7 8.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.579 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' ILE . 92.5 p -167.78 169.55 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.889 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.36 130.29 55.21 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.544 -1.348 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' SER . 9.1 m -129.94 114.78 16.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.143 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -97.95 140.53 32.16 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 118.645 -2.534 . . . . 0.0 116.166 167.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 64' ' ' SER . 86.2 m -100.12 128.03 46.27 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 162.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -105.44 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 120.684 -1.26 . . . . 0.0 110.072 174.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.78 170.94 10.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.032 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.36 56.63 4.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 110' ' ' VAL . 1.8 tt -79.38 136.47 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.536 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.467 ' C ' ' N ' ' A' ' 84' ' ' GLU . 14.0 mttp -145.66 -176.6 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.399 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -47.3 -18.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.509 171.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 82' ' ' LYS . 77.9 tt0 -69.97 -41.63 74.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.233 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 14.5 t70 -74.3 -3.65 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.6 tt0 -69.16 124.14 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.76 -175.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.817 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -88.55 135.38 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.239 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 85' ' ' ASP . 13.5 m-85 -114.27 139.95 49.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.028 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.4 m-85 -129.52 154.15 47.31 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.538 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -118.53 140.68 49.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 116.47 23.02 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 p -135.41 141.68 45.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.463 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 9.7 p90 . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.703 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.6 p90 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.486 0.184 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.24 -154.41 11.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.76 40.17 97.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.67 96.96 0.87 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 7' ' ' PRO . 63.3 m -120.48 131.39 54.72 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.89 117.43 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 29.8 tp -100.32 125.22 46.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.74 109.64 17.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 61.6 t -84.37 44.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.615 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.236 178.891 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 3.8 ttt . . . . . 0 C--O 1.231 0.081 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.3 OUTLIER -129.41 103.15 6.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -83.38 119.71 24.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.875 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.5 tt0 -144.98 145.54 27.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.649 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -49.94 136.59 36.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.257 1.128 . . . . 0.0 111.209 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.537 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 5.1 m -156.41 160.18 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.683 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.84 146.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.912 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p -141.08 145.87 36.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.589 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -142.95 154.24 43.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -78.04 140.67 62.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.635 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.06 123.98 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.737 1.624 . . . . 0.0 111.021 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.79 22.41 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -97.88 -171.73 2.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.662 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p -119.89 142.42 48.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.47 142.41 44.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.079 0.466 . . . . 0.0 110.611 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -128.62 134.45 48.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.434 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mm -105.8 146.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.179 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -124.06 122.8 38.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.5 117.91 30.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 m -117.01 142.11 47.38 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.683 ' HE ' ' CB ' ' A' ' 93' ' ' SER . 50.9 mtt85 -98.59 140.53 32.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.315 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -58.54 3.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.33 -17.11 15.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.603 -174.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.48 -41.3 2.49 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -65.42 111.0 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.054 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.12 -59.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.505 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.758 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.66 1.09 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 29' ' ' ILE . 7.8 t -107.92 -30.23 8.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.901 -1.5 . . . . 0.0 111.568 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -111.86 143.11 43.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.4 m-85 -73.95 134.31 43.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.888 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' CG2' ' NH2' ' A' ' 24' ' ' ARG . 1.5 t -121.0 145.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.354 0.597 . . . . 0.0 109.944 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.7 153.23 45.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.463 -176.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 29.3 m95 -129.99 132.34 46.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 110.519 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 32.3 m-85 -119.29 149.39 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.633 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.548 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -131.37 129.27 41.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -113.56 124.83 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.491 1.332 0 N-CA-C 111.458 -0.247 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.5 p -139.25 134.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.507 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 4.4 m -70.29 118.79 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.162 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.88 -21.82 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.338 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.4 mt -144.56 143.16 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 52' ' ' ASP . 76.8 t80 -133.12 167.22 20.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.314 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 53' ' ' ASN . 10.0 tp10 44.67 23.51 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.043 0.925 . . . . 0.0 110.241 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.2 t70 44.22 19.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.255 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.04 -45.18 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.783 168.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -53.31 143.89 17.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.36 -170.115 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -146.82 108.57 4.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 118.989 -0.529 . . . . 0.0 109.866 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.21 148.89 56.76 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.534 1.489 . . . . 0.0 111.95 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -74.13 -30.2 62.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.38 -47.12 63.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.51 145.31 31.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.1 Cg_endo -53.01 117.99 4.33 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.915 1.744 . . . . 0.0 111.293 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' PHE . 18.5 p-10 -60.78 0.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.697 HH12 ' N ' ' A' ' 85' ' ' ASP . 47.2 mtm105 -46.12 -11.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.996 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 3.4 m-85 -105.4 143.08 34.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.6 t -124.75 122.86 38.66 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.81 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.19 121.77 7.0 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.47 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.1 p -157.29 163.75 38.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -139.1 155.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.522 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -100.18 152.06 20.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.836 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.7 m -67.94 -8.56 38.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' SER . 58.0 m -61.34 -41.17 96.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER 79.6 27.29 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.347 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -98.55 -41.75 7.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.648 ' C ' HD13 ' A' ' 29' ' ' ILE . 62.7 p -164.43 174.85 10.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.67 47.78 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.614 -1.303 . . . . 0.0 110.011 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 66' ' ' SER . 69.1 m -116.77 116.67 27.93 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.839 -169.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.82 140.58 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 118.474 -2.642 . . . . 0.0 117.386 170.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 64' ' ' SER . 4.5 m -107.85 127.39 53.68 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 163.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -104.18 109.92 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 120.08 -1.638 . . . . 0.0 110.21 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.99 155.75 16.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.332 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.06 42.22 96.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.21 136.86 57.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -151.83 177.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.262 177.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.93 -21.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.521 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.8 mt-10 -70.22 -40.69 74.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.261 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.9 OUTLIER -70.82 -9.03 56.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.145 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 39.5 tt0 -64.18 125.22 23.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.183 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 163.1 -175.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.039 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.085 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.548 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 16.2 m-85 -115.25 146.82 41.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.459 . . . . 0.0 111.08 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.6 m-85 -144.79 149.01 34.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.077 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.402 ' N ' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -140.7 140.18 34.86 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.432 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 mt-30 -133.16 149.02 52.09 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.683 ' CB ' ' HE ' ' A' ' 24' ' ' ARG . 15.1 m -135.19 126.76 28.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.389 . . . . 0.0 110.938 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 35' ' ' GLN . 12.3 p90 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.849 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.723 0.297 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.52 -145.0 4.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 91' ' ' CYS . . . 76.38 12.78 83.98 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.15 99.33 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.4 m -142.42 141.76 32.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.005 0.431 . . . . 0.0 110.26 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -106.19 119.16 38.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 tp -104.04 122.61 45.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -117.29 111.66 19.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 110' ' ' VAL . 47.6 t -82.76 31.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.779 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.984 -179.18 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 CA--C 1.522 -0.111 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.508 HD13 ' HA2' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -126.79 118.82 25.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -85.88 120.47 27.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.783 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.58 ' NE2' ' O ' ' A' ' 103' ' ' GLY . 7.5 tt0 -145.48 141.94 17.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.45 160.76 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.247 1.298 . . . . 0.0 111.773 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.29 -56.56 3.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -156.31 150.55 25.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.48 149.62 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 p -120.26 137.62 54.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -117.01 155.38 29.29 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 m -82.99 131.99 52.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.978 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.4 116.77 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.665 1.577 . . . . 0.0 111.018 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.53 -1.97 20.25 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -101.93 -171.74 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.242 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 p -125.85 146.77 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.205 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.83 150.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -126.26 137.31 53.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.54 150.45 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -125.83 114.93 19.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.812 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 50.5 m -118.69 113.76 21.68 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' HD23 ' A' ' 4' ' ' LEU . 57.2 m -113.31 141.22 47.28 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.02 -1.05 . . . . 0.0 108.272 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 26' ' ' SER . 40.5 mtp85 -89.53 137.24 32.5 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.32 -0.862 . . . . 0.0 110.377 170.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -60.97 2.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.48 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.613 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -102.75 -16.93 15.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.499 -175.072 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.03 22.84 70.44 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 m -125.89 111.06 14.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.496 0.189 . . . . 0.0 110.829 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.31 -61.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.14 -0.35 . . . . 0.0 111.584 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.76 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.0 1.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 29' ' ' ILE . 94.0 p -109.77 -9.83 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.483 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 28' ' ' SER . 2.7 m120 -124.69 145.7 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.27 134.84 45.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.0 t -130.06 147.93 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.509 0.671 . . . . 0.0 111.164 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -137.88 153.39 49.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.108 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -117.58 120.75 39.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HE1' HG23 ' A' ' 47' ' ' THR . 9.0 m-85 -121.48 149.31 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.229 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.34 137.21 47.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 135.48 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.76 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.983 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 N--CA 1.49 1.323 0 CA-C-O 120.704 0.21 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 m -120.63 121.72 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.139 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.413 HG23 ' HE1' ' A' ' 37' ' ' TYR . 29.9 m -62.13 120.59 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.793 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.568 HG13 HG21 ' A' ' 59' ' ' VAL . 2.4 t -101.14 -28.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.007 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -145.23 149.35 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 52' ' ' ASP . 62.7 t80 -134.3 160.85 36.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.033 172.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 6.6 tt0 47.19 24.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.326 0.584 . . . . 0.0 111.136 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.6 p30 44.42 19.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.602 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -127.76 -46.19 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.432 0.634 . . . . 0.0 109.56 170.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -53.65 135.52 40.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.599 -167.55 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 108.79 18.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -63.36 148.71 92.59 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.96 1.774 . . . . 0.0 111.771 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 t -64.15 -29.54 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.86 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.34 -49.57 71.69 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.568 HG21 HG13 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -96.03 129.63 33.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.5 Cg_endo -62.91 164.34 19.4 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.641 1.561 . . . . 0.0 111.901 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -59.54 1.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.081 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.631 ' NE ' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -39.59 -37.08 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 44.3 m-85 -89.53 143.75 26.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.5 t -136.93 122.97 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.221 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.12 125.93 7.09 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.562 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 68.8 p -159.43 161.35 35.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.069 0.462 . . . . 0.0 111.023 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -137.02 161.31 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.646 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 70' ' ' SER . 86.6 m-20 -102.39 154.9 18.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.717 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -68.87 10.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 68' ' ' ASP . 26.1 m -80.49 -42.94 21.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.88 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.0 28.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.444 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -99.69 -38.12 8.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.607 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' HD13 ' A' ' 29' ' ' ILE . 88.9 p -167.95 166.26 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.97 134.18 51.24 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.063 -1.023 . . . . 0.0 109.655 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 7.4 m -134.07 120.07 19.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.79 140.35 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.296 -1.503 . . . . 0.0 114.101 167.263 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 57.6 m -106.6 128.84 54.46 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 164.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 78' ' ' ILE . 2.0 mt -104.82 116.56 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 120.82 -1.175 . . . . 0.0 109.672 171.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 t -98.82 127.98 44.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.704 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 69.65 1.38 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.7 tt -85.4 127.84 34.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.383 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' C ' ' N ' ' A' ' 84' ' ' GLU . 8.3 mtmt -137.05 -177.0 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.8 0.334 . . . . 0.0 110.636 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -19.36 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.316 171.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' C ' ' A' ' 82' ' ' LYS . 52.7 tp10 -67.2 -41.18 86.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.849 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 1.3 m-20 -68.99 -19.05 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.082 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 68.3 tt0 -51.16 120.83 5.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.669 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.87 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.317 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.76 143.7 26.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.18 139.64 50.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.158 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -137.8 142.49 40.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.764 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.477 ' SG ' ' HA3' ' A' ' 103' ' ' GLY . 5.7 p -121.84 140.46 52.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.551 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 40.1 mt-30 -124.25 128.75 49.63 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.214 -0.304 . . . . 0.0 110.478 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 155.61 50.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.682 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE2' ' NE2' ' A' ' 35' ' ' GLN . 2.8 p90 . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.175 175.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.359 0.6 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.58 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . -103.49 27.7 18.74 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.469 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.523 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . 54.55 63.27 5.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.233 -0.985 . . . . 0.0 110.74 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.55 149.46 8.23 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.598 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.8 m -111.04 141.47 44.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -81.55 123.94 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.504 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 tp -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.565 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.5 m -123.73 121.46 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.406 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 82' ' ' LYS . 39.0 t -83.76 96.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 110' ' ' VAL . 7.0 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.725 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.0 ttp . . . . . 0 C--O 1.231 0.092 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 103' ' ' GLY . 0.5 OUTLIER -119.4 103.02 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 130.89 35.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.493 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.834 HE22 ' H ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -146.34 164.41 24.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.023 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.85 145.29 51.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.398 2.066 . . . . 0.0 110.869 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.587 ' CD2' ' C ' ' A' ' 8' ' ' HIS . 1.9 t-80 -59.25 -73.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.503 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 49.0 m -161.47 159.35 27.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.605 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.24 155.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.467 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' HD21 ' A' ' 111' ' ' LEU . 5.0 p -125.6 137.3 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.373 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.12 161.93 18.64 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -89.94 142.29 28.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.312 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.3 114.9 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.576 1.517 . . . . 0.0 111.452 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.43 -20.3 16.03 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.56 -169.42 1.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.5 p -129.61 153.89 47.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.42 152.23 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -124.27 134.05 53.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.948 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.2 mt -101.85 143.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.584 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -119.59 127.96 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.737 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -118.46 112.52 20.06 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.9 m -113.22 140.58 47.83 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.707 -1.246 . . . . 0.0 108.02 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 20.2 mtp85 -94.1 139.35 31.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.011 170.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -59.13 1.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.542 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.94 -18.2 14.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.546 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 86.57 -19.16 29.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.409 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 1.1 t -87.12 116.78 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.978 -0.719 . . . . 0.0 110.543 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.42 -61.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.34 -0.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.8 t -97.23 -26.66 14.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.268 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 28' ' ' SER . 2.4 p30 -114.85 141.46 47.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.25 144.38 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.46 140.71 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.446 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 13.6 pt20 -121.44 152.54 38.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.363 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.18 142.31 46.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.486 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.8 m-85 -139.14 149.24 44.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.89 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.409 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -131.18 141.54 50.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -125.75 135.35 51.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.358 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.225 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.491 1.336 0 CA-C-O 120.421 0.092 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 m -132.83 126.69 32.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.351 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.0 m -64.14 119.02 9.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.176 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 t -101.29 -29.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.048 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 mt -145.35 150.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.3 t80 -136.22 163.9 29.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.888 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp10 44.68 24.27 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.834 0.826 . . . . 0.0 110.682 -172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' TYR . 33.7 t0 43.97 20.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.015 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -128.06 -46.13 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 169.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.97 131.06 26.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.124 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.766 ' NH2' ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -116.43 108.82 44.8 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 48' ' ' VAL . 5.7 Cg_exo -65.91 147.24 84.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.965 1.777 . . . . 0.0 111.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 p -70.81 -36.58 73.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.67 -43.12 86.31 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.0 m -98.1 127.74 35.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.4 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.7 Cg_exo -62.78 161.93 27.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.322 1.348 . . . . 0.0 111.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.606 ' C ' HH21 ' A' ' 55' ' ' ARG . 47.3 t0 -60.12 3.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.412 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -48.02 -27.59 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.633 -175.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.766 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 31.8 m-85 -92.07 136.55 33.08 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.215 -0.303 . . . . 0.0 110.663 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.4 t -125.12 123.85 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.933 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.67 131.74 10.65 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.128 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.7 p -161.63 172.43 16.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.304 0.574 . . . . 0.0 111.224 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 30' ' ' ALA . 3.6 pt -149.56 163.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.229 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.85 152.76 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.698 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 p -68.02 -8.32 36.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.42 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.3 m -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.886 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.03 27.73 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 -178.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -99.13 -37.07 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.224 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.755 ' C ' HD13 ' A' ' 29' ' ' ILE . 85.5 p -165.96 166.76 17.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.406 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.01 130.04 55.47 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.084 -1.01 . . . . 0.0 109.709 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.5 m -132.9 122.45 24.37 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.458 -169.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.25 141.05 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.8 -1.813 . . . . 0.0 114.834 169.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 64' ' ' SER . 9.9 m -106.31 125.71 51.34 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 165.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.702 ' CD1' HD21 ' A' ' 76' ' ' LEU . 30.9 mm -86.86 123.51 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 120.195 -1.566 . . . . 0.0 110.543 171.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 t -112.95 127.71 56.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.577 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.42 43.77 10.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HA ' HH22 ' A' ' 62' ' ' ARG . 2.1 tt -64.82 132.21 48.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.429 . . . . 0.0 110.453 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.458 ' C ' ' N ' ' A' ' 84' ' ' GLU . 11.9 tttp -143.65 174.72 10.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.128 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -46.16 -21.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.542 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' A' ' 82' ' ' LYS . 66.8 mm-40 -69.27 -42.77 75.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.132 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 19.8 m-20 -68.81 -5.64 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.433 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.6 tt0 -62.08 121.06 12.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.2 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.22 -179.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.528 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.87 151.61 23.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.162 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -121.72 146.17 47.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 111.068 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.8 m-85 -144.38 148.75 35.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.469 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 103' ' ' GLY . 0.7 OUTLIER -134.43 140.17 46.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.38 136.32 51.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.333 0.587 . . . . 0.0 110.019 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -134.97 -176.39 4.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.546 ' CD1' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.37 0 O-C-N 123.64 0.588 . . . . 0.0 110.479 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.001 0.429 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 4' ' ' LEU . . . -172.2 -146.53 5.38 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.834 ' H ' HE22 ' A' ' 6' ' ' GLN . . . 65.66 -7.03 1.12 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.187 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . -51.96 84.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' GLY . 20.5 m -150.09 125.67 10.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.23 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -83.58 132.37 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.159 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.2 tp -119.74 127.04 52.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.629 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.8 125.75 50.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.264 0.554 . . . . 0.0 110.038 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 110' ' ' VAL . 65.5 t -88.91 36.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.381 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.548 HD21 ' OG ' ' A' ' 11' ' ' SER . 83.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.746 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.765 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.1 mtm . . . . . 0 C--O 1.231 0.087 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 3' ' ' MET . 8.2 mp -132.6 108.84 9.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -92.12 117.53 29.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.621 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -145.79 165.66 20.17 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.13 151.26 12.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.546 2.164 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.563 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -75.83 -65.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.03 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -158.82 146.03 17.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.229 0.537 . . . . 0.0 110.373 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.28 146.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.057 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 p -117.07 143.64 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.491 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.32 163.08 26.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.334 0.587 . . . . 0.0 110.475 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -94.67 142.57 24.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.27 113.99 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.416 1.411 . . . . 0.0 111.152 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.12 -5.02 15.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -94.25 177.8 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.1 p -128.96 142.79 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.76 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 19' ' ' THR . 3.4 p -137.32 155.2 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -125.63 125.36 42.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.53 146.51 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.367 0.603 . . . . 0.0 110.786 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -117.36 132.68 56.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.814 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.82 116.48 26.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -111.31 134.22 53.06 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 61.2 mtp180 -91.34 138.16 31.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.603 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.81 3.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.57 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -96.7 -12.87 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.21 -173.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 -1.87 39.4 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.266 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -124.24 124.73 43.08 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.215 0.206 . . . . 0.0 110.82 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -128.86 -55.33 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.691 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.34 -1.16 2.2 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 12.0 p -86.59 -32.24 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 111.698 -2.501 . . . . 0.0 111.075 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.445 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 1.8 m120 -122.46 159.23 28.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.15 123.39 25.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.975 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 ' H ' ' HB3' ' A' ' 52' ' ' ASP . 96.2 t -103.76 146.89 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.355 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 36' ' ' TRP . 5.4 tt0 -133.32 158.83 41.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 12.7 m95 -129.45 124.14 33.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.929 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CD2' ' OE1' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -110.73 149.55 30.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.17 142.21 49.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -140.36 117.1 10.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.429 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 2.5 mpt_? . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.491 1.332 0 N-CA-C 111.687 -0.159 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 m -148.7 97.95 2.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.921 0.391 . . . . 0.0 110.117 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 28.8 m -64.25 120.18 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 63' ' ' PHE . 24.8 t -100.16 -28.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.956 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -144.95 142.19 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -136.07 148.67 48.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.595 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 53' ' ' ASN . 14.2 tp10 58.96 22.49 10.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.942 1.353 . . . . 0.0 110.243 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER 42.73 17.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.813 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.44 -47.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.294 0.569 . . . . 0.0 111.409 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.25 140.63 29.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.329 -165.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.6 144.98 32.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.99 150.89 75.83 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.314 1.343 . . . . 0.0 111.275 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.2 p -71.05 -22.35 62.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.6 96.41 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.94 140.79 43.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -51.78 119.63 5.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.084 1.19 . . . . 0.0 110.581 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.74 1.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.009 -0.432 . . . . 0.0 111.037 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 60' ' ' PRO . 46.4 mtm180 -53.18 -22.34 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.62 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 6.8 m-85 -75.27 129.09 36.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.978 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 5.0 t -110.17 121.59 45.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.067 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.16 126.15 8.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.528 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.7 p -164.37 166.85 20.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.329 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.2 160.9 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -93.07 163.31 13.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.093 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 m -68.45 30.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -123.12 -46.33 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 79.0 25.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.787 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -98.33 -19.04 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.601 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' ILE . 30.9 p -158.32 169.94 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.838 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.88 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 8.0 m -99.02 110.99 23.51 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.988 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -101.15 140.45 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.471 ' O ' ' CB ' ' A' ' 64' ' ' SER . 94.9 m -112.56 124.38 52.39 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 163.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.2 mt -102.46 109.11 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 O-C-N 119.966 -1.709 . . . . 0.0 110.446 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -99.34 142.42 30.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.392 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.03 44.83 8.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 110' ' ' VAL . 2.7 tt -74.75 129.91 38.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.217 0.532 . . . . 0.0 110.559 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' GLU . 15.9 tttt -138.77 172.6 12.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.83 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 83' ' ' THR . 29.7 p -45.88 -19.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.544 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 27.6 tt0 -73.79 -38.45 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.335 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -68.89 -4.38 16.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 74.4 tt0 -60.43 129.16 40.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.425 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.76 173.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -91.02 143.58 26.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.782 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 11.5 m-85 -109.75 150.72 27.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.223 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 49.3 m-85 -146.81 153.77 40.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.369 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 94.3 m -120.73 141.08 50.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 33.6 mt-30 -126.71 137.47 53.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.727 0.694 . . . . 0.0 110.497 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NH2' ' A' ' 24' ' ' ARG . 3.0 t -128.71 143.21 50.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.276 0.56 . . . . 0.0 110.92 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.6 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.25 -157.24 16.96 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.15 53.9 38.91 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.27 107.1 3.36 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.436 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 37.9 m -124.54 129.96 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.027 0.441 . . . . 0.0 110.71 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.21 115.62 25.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.276 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -102.9 122.74 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 111' ' ' LEU . 93.0 m -119.68 114.99 23.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.406 0.622 . . . . 0.0 110.075 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 110' ' ' VAL . 57.9 t -76.83 30.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.822 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 109' ' ' THR . 77.3 mt . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.567 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.46 0.031 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.463 HD22 ' NE2' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -127.26 103.09 7.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -95.46 120.19 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.514 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 167.93 12.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -53.33 144.91 47.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -75.88 -51.6 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.82 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -159.27 151.16 20.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 110.809 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 11' ' ' SER . 5.4 p -161.37 155.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.468 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 10' ' ' VAL . 78.6 p -137.37 152.89 50.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -142.03 162.18 36.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.221 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.531 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -92.37 151.08 41.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.907 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.87 117.77 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.781 1.654 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.16 9.74 31.27 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 13' ' ' SER . 72.3 mttt -98.96 -178.7 4.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 110.619 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.6 p -122.54 128.07 50.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.212 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.6 139.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.741 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 76' ' ' LEU . 99.9 m -125.6 133.26 52.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.532 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 1.3 mt -113.06 142.02 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.198 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -117.08 131.72 56.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.556 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.3 m -119.59 124.07 45.47 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.1 m -120.53 142.11 49.63 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.954 -1.091 . . . . 0.0 108.24 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 26' ' ' SER . 28.2 ttm180 -99.74 144.6 28.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.294 168.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 p -60.75 3.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.837 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.585 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.32 -17.78 14.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 -175.143 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 71.3 23.68 77.79 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 t -119.86 105.27 10.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.646 0.26 . . . . 0.0 111.158 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.18 -64.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -3.79 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.7 m -97.85 -22.68 16.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.668 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -126.55 155.08 42.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -73.02 125.53 27.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.059 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.05 148.04 23.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.537 0.685 . . . . 0.0 110.779 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -141.45 169.97 16.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.182 -178.199 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 70.1 m95 -131.25 146.36 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.5 m-85 -132.9 149.04 52.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -127.5 135.55 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 7.1 tm0? -130.26 143.48 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.489 0.661 . . . . 0.0 109.66 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.061 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 110.319 -0.685 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -125.35 125.35 43.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 110.666 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -65.39 119.97 11.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.383 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.92 -25.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.007 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.0 mt -144.34 135.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 64.7 t80 -125.77 164.36 20.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.761 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.6 tt0 45.91 22.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.357 -170.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 43.55 17.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.926 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.573 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -128.87 -46.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 110.647 170.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.13 154.48 17.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.27 -1.786 . . . . 0.0 107.82 -165.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.81 ' H ' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -143.73 146.72 36.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.257 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.44 145.48 88.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.389 1.392 . . . . 0.0 110.929 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 m -62.07 -22.09 65.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.132 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.14 97.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.2 142.18 24.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.369 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.15 143.18 98.63 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.479 1.453 . . . . 0.0 111.702 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.4 p30 -62.61 -2.83 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.622 ' NH1' ' CE1' ' A' ' 63' ' ' PHE . 28.8 ptt85 -47.01 -40.21 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.371 0.605 . . . . 0.0 110.576 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' CE1' ' NH1' ' A' ' 62' ' ' ARG . 97.9 m-85 -62.98 129.18 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.422 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 6.1 t -113.79 119.44 37.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.414 0.626 . . . . 0.0 110.909 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.2 112.47 3.59 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.134 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 75' ' ' SER . 7.3 p -149.61 167.48 26.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.51 0.671 . . . . 0.0 110.208 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -143.49 163.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.976 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 70' ' ' SER . 75.8 m-20 -98.77 152.75 19.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.518 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -68.35 31.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.687 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 68' ' ' ASP . 30.1 m -104.12 -46.31 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.578 0.228 . . . . 0.0 110.565 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 85.43 25.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.473 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.05 -37.34 9.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.066 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.641 ' C ' HD13 ' A' ' 29' ' ' ILE . 52.9 p -160.12 166.67 29.37 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.535 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.25 127.01 54.76 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.741 -1.224 . . . . 0.0 109.513 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -121.72 116.07 23.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.39 -172.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 19' ' ' THR . 0.6 OUTLIER -99.02 140.27 33.42 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 118.344 -2.722 . . . . 0.0 117.329 168.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 64' ' ' SER . 61.8 m -106.06 126.28 52.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 163.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.471 ' CD1' HD21 ' A' ' 76' ' ' LEU . 3.1 mt -97.51 112.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 119.798 -1.813 . . . . 0.0 110.918 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.642 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -96.11 137.69 34.81 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.834 -0.541 . . . . 0.0 111.462 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 58.75 3.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.07 135.0 36.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.211 0.529 . . . . 0.0 110.478 177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -134.36 176.44 8.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.714 174.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 p -47.65 -19.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' N ' ' C ' ' A' ' 82' ' ' LYS . 9.4 tp10 -70.53 -39.36 74.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.821 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.602 ' CB ' HH22 ' A' ' 62' ' ' ARG . 27.6 t0 -67.18 -7.09 20.99 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.399 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -62.41 130.62 46.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.89 175.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -85.03 144.77 28.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.474 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 8.9 m-85 -108.91 154.21 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -150.49 145.48 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 59.4 m -120.28 141.01 50.38 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 5.7 mt-30 -124.45 145.39 49.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 24' ' ' ARG . 53.5 p -135.09 123.73 23.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 110.353 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.3 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 177.819 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.3 -139.24 10.91 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 45.12 29.67 2.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.13 158.11 5.61 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.9 m -126.06 130.09 50.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.517 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -80.59 110.34 15.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.2 tp -99.39 124.81 44.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.19 124.37 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.092 0.472 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' LEU . 61.2 t -87.63 94.43 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 110' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.234 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.575 ' N ' ' HG ' ' A' ' 25' ' ' SER . 16.8 mmm . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.899 0.38 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 3' ' ' MET . 7.7 mp -123.63 107.98 12.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -78.19 113.51 16.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 104' ' ' GLY . 14.6 mt-30 -140.37 158.21 66.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.18 140.99 71.12 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.93 1.753 . . . . 0.0 110.38 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -49.25 70.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.18 129.0 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.065 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 11' ' ' SER . 7.4 p -139.28 161.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.155 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.562 ' N ' HG22 ' A' ' 10' ' ' VAL . 94.1 p -143.43 155.53 44.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.624 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -140.31 153.17 46.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.074 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.26 141.98 74.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.195 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 115.28 2.16 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.715 1.61 . . . . 0.0 111.246 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.37 1.03 33.13 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -98.06 161.51 13.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.8 p -93.0 134.35 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.9 137.46 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -118.64 134.18 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.322 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mt -99.81 137.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.426 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 m -111.62 116.68 31.2 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -118.92 113.04 20.41 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 m -114.79 140.78 48.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 26' ' ' SER . 31.8 ttp180 -92.56 136.83 32.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.999 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 3' ' ' MET . 1.4 p -59.05 3.74 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.645 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.79 -18.06 14.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.678 -174.41 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.85 20.05 76.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -123.07 109.62 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.979 0.39 . . . . 0.0 110.773 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.17 -62.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 -176.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.22 0.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.642 ' H ' ' C ' ' A' ' 29' ' ' ILE . 91.5 p -109.82 -3.13 16.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.566 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -135.9 158.5 44.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.124 0.487 . . . . 0.0 110.874 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.43 129.18 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' HE21 ' A' ' 35' ' ' GLN . 81.9 t -123.14 148.06 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 110.728 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.99 153.93 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.151 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -110.3 135.13 51.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 11.4 m-85 -129.17 147.54 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.324 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.421 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -134.38 133.07 40.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.128 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -112.48 116.14 29.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 N-CA-C 111.431 -0.257 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -146.93 105.4 3.8 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.757 -0.59 . . . . 0.0 111.003 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 25.8 m -63.38 120.23 11.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.878 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.62 -28.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.735 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.4 149.95 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' ASP . 6.2 t80 -134.76 164.04 28.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.793 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.37 23.87 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.569 1.176 . . . . 0.0 110.754 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.7 p30 44.35 19.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.587 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -127.85 -45.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -53.54 134.89 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.279 -170.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -137.39 108.65 8.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -70.06 152.8 67.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.853 1.702 . . . . 0.0 112.013 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -70.78 -33.12 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.375 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.23 -47.7 79.97 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 59' ' ' VAL . 3.8 m -90.68 132.52 34.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.1 Cg_exo -59.3 142.07 98.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.462 1.441 . . . . 0.0 111.117 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' PHE . 49.9 p-10 -61.21 1.65 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.566 HH22 ' CG ' ' A' ' 85' ' ' ASP . 8.4 ptm180 -49.69 -2.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' ASP . 17.3 m-85 -107.98 146.44 32.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.3 t -130.39 121.03 25.17 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.893 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.79 123.16 7.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.345 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.6 p -158.81 164.51 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.426 -0.455 . . . . 0.0 110.2 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.652 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -135.08 159.92 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.589 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 70' ' ' SER . 30.7 m-20 -96.66 144.18 26.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 p -70.13 27.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.008 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 68' ' ' ASP . 21.2 m -102.23 -36.76 8.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.015 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 82.21 22.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.234 -177.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -95.8 -43.71 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.754 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' ILE . 95.0 p -162.1 174.86 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.009 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.9 126.78 55.07 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.331 -1.48 . . . . 0.0 110.573 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.9 m -118.23 112.31 19.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.569 -171.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -97.02 140.75 31.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 168.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.4 m -110.52 128.25 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 163.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.424 HG13 HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.0 109.95 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 119.812 -1.805 . . . . 0.0 110.666 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -98.65 141.25 31.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.555 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.82 32.99 35.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 110' ' ' VAL . 2.3 tt -55.8 145.79 23.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.987 0.422 . . . . 0.0 110.318 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' ASP . 6.6 tttp -160.66 177.87 10.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.355 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 t -46.01 -19.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 82' ' ' LYS . 77.4 mt-10 -71.85 -40.02 69.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.367 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.566 ' CG ' HH22 ' A' ' 62' ' ' ARG . 18.9 t70 -70.32 -13.12 62.02 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.173 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 32.9 tt0 -58.23 123.14 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.6 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.0 178.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 109.942 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.07 146.38 25.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.2 m-85 -121.88 146.27 47.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 111.083 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.1 m-85 -141.72 149.18 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.17 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.492 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.3 p -124.85 140.87 52.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.5 mt-30 -116.83 140.06 49.88 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.174 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.9 p -135.07 119.69 18.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 109.896 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.123 175.896 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.2 p90 . . . . . 0 N--CA 1.458 -0.065 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 144.93 -129.8 3.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.606 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . 84.92 62.57 1.67 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.11 110.14 2.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -117.16 118.89 33.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -78.44 116.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.986 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.8 tp -110.71 126.53 54.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 m -118.97 133.67 55.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.391 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.72 ' O ' HG12 ' A' ' 110' ' ' VAL . 79.2 t -86.03 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.228 0.537 . . . . 0.0 110.587 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.698 -1.144 . . . . 0.0 110.874 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.843 ' N ' ' HG ' ' A' ' 25' ' ' SER . 74.8 mmm . . . . . 0 N--CA 1.461 0.094 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.555 HD21 HH21 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -130.87 102.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -91.43 138.41 31.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.69 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 104' ' ' GLY . 15.1 mt-30 -143.87 160.12 51.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.31 128.53 23.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.925 1.75 . . . . 0.0 111.023 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.625 ' CD2' ' H ' ' A' ' 9' ' ' SER . 3.7 p-80 -45.21 -59.24 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.0 110.413 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.625 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 83.2 p -164.67 162.71 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.588 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 11' ' ' SER . 3.0 p -162.42 161.27 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.029 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 10' ' ' VAL . 84.1 p -143.2 149.74 38.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.616 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.1 153.15 45.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 147.89 82.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.566 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.76 119.7 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.628 1.552 . . . . 0.0 111.368 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.6 -3.25 26.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -98.27 -170.26 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.541 0.21 . . . . 0.0 110.967 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.5 p -127.26 150.47 49.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.732 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.56 147.82 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.886 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -121.69 134.23 54.96 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.1 mt -108.83 140.08 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -108.38 142.64 38.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.507 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.13 111.63 12.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 m -119.64 140.5 50.52 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.562 -1.336 . . . . 0.0 108.099 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.66 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -107.27 145.0 33.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.238 171.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.843 ' HG ' ' N ' ' A' ' 3' ' ' MET . 90.2 p -57.86 4.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.546 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.66 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.03 -18.18 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 -175.281 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 78.67 -32.16 1.91 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 14.7 m -68.4 110.05 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.548 0.213 . . . . 0.0 111.298 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.17 -62.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.754 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.77 -0.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 29' ' ' ILE . 10.7 p -98.91 -25.29 14.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.804 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 28' ' ' SER . 29.1 p30 -121.26 147.3 45.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -71.39 144.45 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.624 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.48 137.79 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.242 0.544 . . . . 0.0 110.198 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.405 ' OE1' ' OE1' ' A' ' 92' ' ' GLN . 4.1 pt20 -120.9 152.18 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 46.4 m95 -122.28 133.07 54.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.146 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.9 m-85 -130.1 149.08 51.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.826 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.589 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -117.96 135.69 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.276 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HE ' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 N-CA-C 111.022 -0.414 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.8 p -121.66 120.51 34.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.646 0.26 . . . . 0.0 110.381 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.52 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 10.4 m -62.01 117.72 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.831 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.73 -28.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.64 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.22 136.63 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 51' ' ' GLU . 11.0 t80 -125.01 166.23 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.706 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tt0 44.81 22.45 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.145 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.6 p-10 42.9 18.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.167 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -129.48 -47.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.183 0.516 . . . . 0.0 111.129 168.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.06 150.77 20.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.242 -1.799 . . . . 0.0 108.594 -167.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 148.32 65.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.14 147.6 95.21 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.723 1.616 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 m -67.76 -14.91 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -46.28 70.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.67 141.08 23.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -60.01 139.32 87.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.259 1.306 . . . . 0.0 111.631 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -61.17 0.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.601 HH12 ' CB ' ' A' ' 85' ' ' ASP . 8.8 ptm180 -47.16 -24.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.149 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CE1' ' CG ' ' A' ' 62' ' ' ARG . 23.5 m-85 -88.6 142.95 27.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -128.03 124.22 36.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.084 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.42 7.16 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.679 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.3 p -154.97 166.07 34.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.529 . . . . 0.0 111.355 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.6 pp -146.38 153.76 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.85 157.19 16.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.111 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.7 p -70.3 -8.44 50.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.0 m -60.38 -40.82 92.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER 79.0 25.76 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.284 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -97.48 -42.15 7.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.598 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.661 ' HA ' HG21 ' A' ' 29' ' ' ILE . 73.1 p -165.33 171.32 13.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.054 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.52 127.13 55.04 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.936 -1.103 . . . . 0.0 110.442 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 28.9 m -119.42 117.98 29.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.954 -169.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -97.54 140.59 31.74 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 118.651 -2.53 . . . . 0.0 117.217 168.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' SER . 75.8 m -111.49 127.72 55.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 162.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.507 HG23 HH21 ' A' ' 62' ' ' ARG . 3.0 mt -99.9 112.35 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 120.048 -1.657 . . . . 0.0 109.951 174.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 t -96.85 135.59 38.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.479 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.01 49.22 6.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.66 137.86 48.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 0.0 110.633 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' C ' ' N ' ' A' ' 84' ' ' GLU . 21.2 tttt -144.7 176.93 9.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.905 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 1.5 p -46.84 -20.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.662 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 82' ' ' LYS . 26.2 tt0 -72.7 -39.05 67.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.008 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.601 ' CB ' HH12 ' A' ' 62' ' ' ARG . 6.4 t70 -67.63 -6.9 22.53 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.691 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.8 tt0 -63.35 124.65 21.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.28 -178.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 0.0 110.552 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -87.14 136.72 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.675 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.589 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 27.8 m-85 -116.32 135.75 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.742 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.2 p90 -149.26 149.06 30.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.04 151.49 41.89 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.962 0.505 . . . . 0.0 110.924 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.405 ' OE1' ' OE1' ' A' ' 35' ' ' GLN . 6.9 mt-30 -123.56 147.69 47.05 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 122.213 -0.304 . . . . 0.0 111.338 168.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' NE ' ' A' ' 24' ' ' ARG . 13.7 t -135.25 159.99 39.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.681 0.276 . . . . 0.0 111.587 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.669 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.05 -161.89 34.74 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.069 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.476 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 96.04 34.3 5.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.8 95.01 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -111.27 114.58 27.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 0.0 109.798 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -80.25 108.66 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.422 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.8 tp -102.36 126.0 49.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.552 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -120.72 124.86 46.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.319 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.723 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.9 t -89.57 34.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.44 179.288 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 4' ' ' LEU . 17.5 mtp . . . . . 0 CA--C 1.524 -0.052 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 3' ' ' MET . 7.2 mp -132.77 104.78 6.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -78.93 126.06 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.177 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.616 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 6.8 mt-30 -145.42 164.46 26.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.83 127.21 25.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.135 1.89 . . . . 0.0 110.737 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 5.8 p80 -57.74 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.2 p -165.12 135.39 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.083 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.58 154.96 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.317 . . . . 0.0 110.398 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.7 p -138.45 137.58 37.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 31.3 mp0 -128.38 162.49 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.024 0.44 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -78.52 146.31 69.43 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.607 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.88 125.93 19.04 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.117 1.211 . . . . 0.0 111.57 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.85 -4.2 28.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -95.34 171.69 8.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.967 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 7.1 p -115.31 130.88 57.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.413 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -127.79 134.66 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -110.02 128.42 55.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.291 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 mm -98.44 145.06 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.083 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -117.59 116.68 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.318 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HB2' HE21 ' A' ' 6' ' ' GLN . 42.0 t -118.84 112.28 19.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -116.02 137.6 51.97 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.078 -1.014 . . . . 0.0 108.28 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.68 142.77 27.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.607 170.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -57.88 2.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.68 -16.94 14.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.538 -174.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.99 -50.39 4.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.479 ' HG ' ' NH2' ' A' ' 24' ' ' ARG . 75.0 p -54.28 113.88 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.312 . . . . 0.0 111.166 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.79 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.34 -61.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.181 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.79 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.5 -0.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 5.9 m -107.01 -18.99 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.623 -1.626 . . . . 0.0 111.798 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -116.87 147.82 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -78.88 132.41 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.489 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.73 146.32 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.11 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 8.5 pt20 -123.64 163.1 21.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 30.3 m95 -131.51 131.92 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 7.6 m-85 -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.9 139.98 53.46 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -141.83 141.26 33.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.252 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 110.805 -0.498 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -132.77 137.7 46.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.48 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.6 m -73.27 120.25 18.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.528 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.85 -28.0 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.141 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -145.28 149.27 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' O ' ' N ' ' A' ' 52' ' ' ASP . 37.5 t80 -133.94 163.62 29.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.182 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.2 tt0 45.37 23.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.686 0.755 . . . . 0.0 110.827 -173.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' TYR . 10.6 t70 44.73 19.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.594 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.1 t-20 -127.83 -46.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.861 170.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.72 134.11 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.498 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.731 ' NH1' ' H ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -123.59 108.8 30.93 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -65.66 136.81 47.47 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.618 1.546 . . . . 0.0 111.756 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 m -63.93 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.14 -57.81 12.25 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.08 150.36 58.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.8 Cg_endo -61.55 135.45 57.05 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.067 1.178 . . . . 0.0 111.219 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.79 -0.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.488 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 52.0 mtm180 -48.37 -38.44 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -71.72 134.84 46.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.9 t -124.12 122.71 38.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.731 ' H ' ' NH1' ' A' ' 55' ' ' ARG . . . -107.74 118.9 5.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.627 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.6 p -155.41 164.03 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.935 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.687 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -146.0 157.63 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -103.03 153.17 20.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.378 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -68.4 1.87 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.042 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.2 m -65.95 -43.97 86.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.62 27.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.543 -177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.38 -41.09 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.943 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.723 ' O ' HD13 ' A' ' 29' ' ' ILE . 94.4 p -166.7 175.34 7.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.767 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.78 125.51 50.91 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.812 -1.18 . . . . 0.0 109.881 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 m -115.84 112.73 22.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.744 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -98.3 140.53 32.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 170.19 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' SER . 89.3 m -107.72 126.7 52.93 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 163.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.472 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.7 mt -105.8 105.33 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 O-C-N 120.398 -1.439 . . . . 0.0 110.737 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 29.6 t -95.45 154.38 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.008 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 32.37 76.78 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -54.21 128.01 29.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 109.667 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 84' ' ' GLU . 18.9 mttp -139.48 171.1 14.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.055 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -45.94 -18.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.648 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 82' ' ' LYS . 39.9 mt-10 -69.31 -38.56 78.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.529 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 2.2 m-20 -73.26 -11.34 60.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.241 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -52.92 120.75 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.543 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.94 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -86.91 144.87 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -113.18 153.07 28.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -149.95 147.84 28.37 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 8.6 p -132.94 142.8 49.07 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.023 0.529 . . . . 0.0 109.972 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.89 147.31 50.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.422 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 9.0 t -135.24 160.84 37.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.1 0.476 . . . . 0.0 111.226 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD2' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.56 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.008 0.432 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.86 7.78 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.61 56.52 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.55 110.08 3.27 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.5 m -137.13 127.83 27.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.692 0.282 . . . . 0.0 110.286 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -88.42 99.36 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.404 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -91.08 123.67 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -120.77 122.36 40.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.371 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.698 ' O ' HG12 ' A' ' 110' ' ' VAL . 80.6 t -82.11 40.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.069 178.721 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.68 ' N ' ' HG ' ' A' ' 25' ' ' SER . 9.1 mtt . . . . . 0 N--CA 1.46 0.073 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -133.22 102.95 5.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.5 p -86.4 135.6 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.537 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 30.7 mt-30 -146.19 163.14 31.91 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.715 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.51 140.38 74.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.534 1.49 . . . . 0.0 111.021 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -69.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.257 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 p -161.27 155.2 22.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.792 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 11' ' ' SER . 4.7 p -162.11 161.01 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.787 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 p -128.65 151.47 49.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.419 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -135.21 143.83 46.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.401 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 138.05 86.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.88 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.48 113.24 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.377 1.385 . . . . 0.0 111.297 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.02 -8.23 16.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -93.05 -177.31 4.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 111.262 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 79' ' ' SER . 4.1 p -111.18 140.75 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.131 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.41 138.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.547 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 76' ' ' LEU . 3.5 m -119.44 129.86 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.92 134.0 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.469 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -100.53 166.3 10.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.298 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.33 111.85 4.19 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.972 HG23 HH21 ' A' ' 24' ' ' ARG . 19.7 m -115.89 136.22 53.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.903 -1.123 . . . . 0.0 108.065 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.972 HH21 HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER -104.02 143.1 33.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.154 171.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.68 ' HG ' ' N ' ' A' ' 3' ' ' MET . 88.9 p -58.63 5.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.467 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.37 -18.15 14.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.06 -173.317 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 68.63 29.06 72.78 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 24' ' ' ARG . 54.0 m -128.94 98.9 5.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.419 0.609 . . . . 0.0 111.864 -175.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -126.28 -62.27 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 122.584 0.354 . . . . 0.0 111.009 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.15 1.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 35.6 t -114.11 -28.02 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.027 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -112.99 139.85 48.31 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.9 130.67 42.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.87 141.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.552 0.691 . . . . 0.0 110.667 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -128.26 150.46 50.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.619 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -106.22 121.0 43.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.407 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 2.2 m-85 -112.38 148.63 33.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 133.44 41.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -125.45 135.03 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.355 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.49 1.303 0 N-CA-C 111.513 -0.226 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -137.59 121.27 17.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.349 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.407 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 3.4 m -62.29 121.42 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.965 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.676 ' HA ' HG21 ' A' ' 59' ' ' VAL . 2.5 t -101.16 -28.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.318 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -145.86 140.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' ASP . 5.9 t80 -127.3 164.14 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 44.59 22.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.389 -170.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 43.04 18.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.545 -179.122 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.564 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -129.23 -46.91 1.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 0.0 111.52 172.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.06 131.37 35.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.712 -165.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -108.57 111.68 61.11 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.465 -174.435 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.04 145.52 96.57 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.633 1.556 . . . . 0.0 112.176 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -69.41 -20.35 63.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.772 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.83 -31.32 67.68 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' A' ' 48' ' ' VAL . 16.7 m -124.2 141.82 38.33 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.8 Cg_exo -60.41 140.33 91.06 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.268 1.312 . . . . 0.0 111.412 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.3 p-10 -61.04 0.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.607 HH22 ' CB ' ' A' ' 85' ' ' ASP . 41.7 ptt85 -47.42 -24.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.331 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 90.8 m-85 -78.47 150.26 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.83 122.88 33.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.435 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.45 121.54 5.52 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.546 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.3 p -158.98 158.25 32.88 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.663 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -138.7 160.32 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.449 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 97.8 m-20 -103.63 152.9 21.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.769 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 m -72.61 27.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.5 m -97.98 -40.64 8.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.226 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.97 27.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.604 ' O ' ' NH2' ' A' ' 24' ' ' ARG . 39.8 t30 -99.32 -33.67 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.561 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' HD13 ' A' ' 29' ' ' ILE . 24.8 p -176.9 170.8 2.26 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.013 0.821 . . . . 0.0 110.185 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.4 133.78 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.153 -0.967 . . . . 0.0 109.857 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -127.37 112.56 15.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.088 -0.958 . . . . 0.0 113.192 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.13 140.59 31.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 168.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.5 m -107.83 131.25 54.68 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.219 -0.926 . . . . 0.0 113.401 163.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.87 110.65 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.163 -1.586 . . . . 0.0 110.37 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.573 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.2 t -97.51 139.38 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.06 45.86 8.01 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 143.65 51.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.09 0.471 . . . . 0.0 110.525 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' ASP . 10.4 mtpt -153.14 173.18 15.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.686 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 t -45.88 -20.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.579 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LYS . 48.7 mt-10 -69.38 -40.1 77.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.978 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.607 ' CB ' HH22 ' A' ' 62' ' ' ARG . 4.3 t0 -70.38 -10.44 59.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.211 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 56.4 tt0 -61.13 122.83 16.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.082 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.92 179.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.856 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 148.02 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.911 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.438 ' OH ' ' CG ' ' A' ' 85' ' ' ASP . 17.7 m-85 -115.52 145.79 42.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 12.5 m-85 -144.19 150.35 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.002 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -118.93 142.45 47.76 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.181 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -126.54 121.77 33.23 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.81 -0.556 . . . . 0.0 110.937 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -135.15 -176.82 4.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.723 0.297 . . . . 0.0 110.619 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 93' ' ' SER . 1.6 m-85 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.61 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 121.131 0.491 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.86 169.37 21.43 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 123.08 18.11 3.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.29 85.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.4 m -112.24 130.36 55.96 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.672 -0.31 . . . . 0.0 110.242 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -90.08 110.83 21.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -104.9 124.75 50.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.099 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.3 m -116.8 123.54 47.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.71 99.98 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.231 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.121 179.005 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 C--O 1.23 0.045 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 105.97 6.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m -89.58 131.61 35.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.115 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.693 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 2.7 mt-30 -146.07 169.87 8.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -65.78 136.55 45.99 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.433 1.422 . . . . 0.0 111.367 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.506 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -48.21 -76.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.765 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -155.38 149.16 25.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.993 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -159.46 160.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.166 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 10' ' ' VAL . 88.5 p -129.77 146.84 51.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.335 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 11' ' ' SER . 2.1 mp0 -130.53 162.93 28.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.45 140.86 22.55 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.42 117.48 4.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.418 1.412 . . . . 0.0 111.231 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.2 -11.41 14.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.01 159.97 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.701 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.4 p -98.13 148.63 23.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.69 141.2 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.618 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 76' ' ' LEU . 55.5 m -119.92 129.72 54.48 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.04 134.93 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.17 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -111.11 126.48 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.057 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.28 113.35 21.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.8 m -109.44 135.34 50.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 26' ' ' SER . 19.3 ttp85 -97.49 141.15 30.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.223 171.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -57.23 3.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.06 -11.9 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.765 -173.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.48 5.89 25.26 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -125.3 111.87 15.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.366 0.267 . . . . 0.0 110.434 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.8 pp -124.31 -57.09 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -2.58 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 14.5 m -89.14 -35.0 16.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 111.603 -2.544 . . . . 0.0 111.479 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 29' ' ' ILE . 3.4 m120 -116.83 152.94 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -75.16 140.93 43.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.037 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 67.9 t -126.13 148.02 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.958 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -129.38 147.15 51.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.903 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.484 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 23.0 m95 -111.1 122.63 48.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.296 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' N ' ' A' ' 47' ' ' THR . 2.4 m-85 -123.91 144.96 49.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.587 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -147.19 143.9 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.279 177.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 2.9 tp-100 -107.07 142.52 36.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.91 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.523 0.135 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -148.9 135.3 19.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.551 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -64.93 129.29 39.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.45 -25.23 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.99 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.473 HD11 ' CB ' ' A' ' 63' ' ' PHE . 19.7 mt -145.01 133.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' GLN . 4.0 t80 -122.25 167.33 13.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.447 174.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 53' ' ' ASN . 1.4 tp10 44.77 22.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.712 0.768 . . . . 0.0 111.419 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 43.16 18.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.05 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -129.22 -47.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.847 170.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -96.79 159.07 15.12 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.258 -167.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -140.41 149.88 59.07 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 157.63 22.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.584 1.523 . . . . 0.0 111.226 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.8 p -73.98 -7.19 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.456 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.58 -28.18 48.49 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 59' ' ' VAL . 29.5 m -113.02 131.34 22.86 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.9 Cg_endo -61.62 140.1 84.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 120.982 1.121 . . . . 0.0 111.021 -175.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD2' ' NE ' ' A' ' 55' ' ' ARG . 2.8 m-20 -61.25 1.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.637 HH22 ' CB ' ' A' ' 85' ' ' ASP . 22.7 ptt85 -42.1 -25.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.3 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CB ' HD11 ' A' ' 49' ' ' ILE . 53.4 m-85 -75.4 144.46 42.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.87 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -118.07 122.6 43.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.491 0.663 . . . . 0.0 110.949 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.46 125.06 8.38 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.447 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' SER . 6.5 p -157.76 158.72 35.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.106 0.479 . . . . 0.0 110.849 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.94 161.15 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.25 163.32 13.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.379 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 p -67.92 -7.45 28.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.355 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 71' ' ' SER . 14.4 m -82.38 -48.26 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.28 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 70' ' ' SER . 3.0 p 79.03 22.12 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.661 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.34 -18.92 27.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.566 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 54.9 p -163.24 166.5 23.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.249 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.79 115.5 30.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.1 m -104.41 110.76 23.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -102.68 140.42 36.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.725 -1.58 . . . . 0.0 115.252 169.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 98.3 m -104.76 128.11 52.77 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 162.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 76' ' ' LEU . 2.8 mt -103.16 113.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 120.115 -1.616 . . . . 0.0 110.043 173.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 t -104.62 146.69 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.791 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.83 30.46 57.72 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.99 138.42 49.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 110.518 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 28.3 mttt -150.57 177.74 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 83' ' ' THR . 1.2 p -46.78 -17.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.387 174.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 15.6 pt-20 -69.2 -40.55 77.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.351 177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.637 ' CB ' HH22 ' A' ' 62' ' ' ARG . 6.4 t70 -70.99 -8.6 54.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.458 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 57.5 tt0 -63.7 121.4 13.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.348 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.71 -175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.22 137.35 32.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.643 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 17.1 m-85 -119.54 134.07 55.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.669 0.271 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 90' ' ' TYR . 1.5 p90 -150.89 138.12 19.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.33 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.3 p -118.79 140.43 49.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -114.5 148.64 37.58 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.824 -0.547 . . . . 0.0 109.714 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 p -135.23 152.17 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.914 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.302 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.677 0.275 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.82 -149.96 6.74 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 75.28 24.29 71.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.57 98.27 0.27 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -129.77 118.16 21.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.325 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.73 120.11 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.1 tp -109.29 123.26 48.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.208 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 114.89 25.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 110' ' ' VAL . 89.0 t -85.23 40.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 110' ' ' VAL . 10.2 mt . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.665 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 C--O 1.231 0.095 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.1 mp -124.81 104.25 8.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 p -88.84 118.73 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.134 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.488 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.66 165.42 21.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 4.4 Cg_exo -52.6 146.7 33.19 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.184 1.923 . . . . 0.0 111.36 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.9 p80 -79.29 -55.91 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 p -154.84 142.79 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.635 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.89 146.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -126.55 146.39 50.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.737 0.303 . . . . 0.0 110.464 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -132.77 150.2 52.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.231 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.13 139.19 72.39 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.99 124.44 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.144 1.229 . . . . 0.0 110.94 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.43 -11.66 16.4 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -100.33 -171.57 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.774 0.321 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.7 p -125.39 159.56 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.349 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.11 153.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -129.2 132.02 47.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 HD22 ' A' ' 76' ' ' LEU . 10.7 mt -98.86 149.43 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.075 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -124.96 117.32 23.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.943 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 4' ' ' LEU . 4.0 t -119.72 120.58 37.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -119.49 142.04 48.64 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.017 -1.677 . . . . 0.0 108.752 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.615 ' HG3' HH11 ' A' ' 24' ' ' ARG . 7.3 mtm-85 -87.26 139.78 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.847 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.38 1.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.43 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -103.24 -17.86 15.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.627 -175.768 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.92 -41.9 3.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 77.9 p -63.82 113.22 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.59 0.233 . . . . 0.0 110.824 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.6 pp -135.11 -60.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.524 -176.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.779 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.8 -0.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.638 ' H ' ' C ' ' A' ' 29' ' ' ILE . 53.5 m -109.29 -2.5 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.777 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 31' ' ' SER . 3.1 m120 -133.22 149.96 51.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -81.86 135.26 35.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.437 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG2' HH22 ' A' ' 24' ' ' ARG . 17.5 t -127.61 139.03 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' TRP . 7.2 pt20 -116.96 164.29 14.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.186 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 8.8 m95 -134.96 125.13 26.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 0.0 110.53 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 28.0 m-85 -111.23 149.36 31.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -129.06 124.67 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.6 134.47 47.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.167 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.206 179.088 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.263 -0.322 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -138.16 133.56 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 36.4 m -60.94 120.78 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -96.13 -25.38 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.718 -178.209 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 19.9 mt -145.08 146.13 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASP . 10.4 t80 -132.12 167.26 20.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 44.62 22.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.687 0.756 . . . . 0.0 110.933 -171.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.1 p30 43.13 17.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.03 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 t-20 -129.4 -46.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 111.121 172.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.657 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -87.93 147.62 24.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.713 -165.248 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.736 ' N ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -111.23 131.93 21.99 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.68 146.59 84.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.563 1.509 . . . . 0.0 111.183 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -73.38 5.24 3.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.348 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 -26.55 11.39 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.67 151.68 45.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.302 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.93 143.78 95.84 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.662 1.575 . . . . 0.0 111.653 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.29 -2.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.722 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.4 mtp-105 -42.13 -38.65 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.068 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.7 m-85 -76.29 137.5 39.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.193 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -129.29 123.07 30.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.314 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.06 129.71 9.96 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.3 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.8 p -158.54 158.45 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.301 0.572 . . . . 0.0 111.198 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.39 160.85 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.641 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.84 153.31 23.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.664 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -4.49 13.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.909 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 71' ' ' SER . 50.2 m -65.44 -46.19 80.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.77 24.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.506 -178.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -100.06 -37.68 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.709 ' C ' HD13 ' A' ' 29' ' ' ILE . 82.1 p -166.07 174.55 9.25 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.8 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.44 123.51 49.49 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.796 -1.19 . . . . 0.0 109.84 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.1 m -112.23 116.59 30.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.722 -170.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -97.96 140.36 32.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 118.103 -2.873 . . . . 0.0 116.627 171.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' SER . 7.0 m -112.37 127.54 56.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 164.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.1 mt -96.66 116.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 120.029 -1.669 . . . . 0.0 110.459 171.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.54 132.27 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.449 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 75.74 61.08 3.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.52 130.82 36.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 0.0 111.063 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -154.06 176.4 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.113 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -19.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.315 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 82' ' ' LYS . 45.8 mt-10 -71.83 -38.0 70.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.205 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' LYS . 9.9 t70 -74.75 -13.06 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 84.2 tt0 -56.97 123.22 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.74 178.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.733 0.646 . . . . 0.0 109.791 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 85.4 m-20 -91.84 144.49 25.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 24.6 m-85 -110.8 151.17 28.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.986 0.422 . . . . 0.0 110.569 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 31.8 m-85 -149.44 138.35 21.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.653 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.488 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -120.95 140.7 51.5 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.597 0.635 . . . . 0.0 110.28 178.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -125.6 138.28 53.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.165 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.57 ' CB ' ' NH1' ' A' ' 24' ' ' ARG . 17.7 p -135.26 171.04 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 8.4 p90 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.05 -158.7 14.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.034 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 78.97 48.62 6.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.38 91.84 1.16 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 4.2 m -106.88 141.46 38.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -102.98 99.91 9.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.49 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.3 tp -90.24 125.46 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.532 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.95 130.16 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 110.162 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 82' ' ' LYS . 65.0 t -97.47 99.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.966 0.412 . . . . 0.0 110.527 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.407 179.708 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.841 ' N ' ' HG ' ' A' ' 25' ' ' SER . 16.4 mmm . . . . . 0 C--O 1.23 0.067 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.08 105.98 9.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.081 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.3 115.1 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.723 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.7 mm-40 -142.34 158.21 61.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.438 0.461 . . . . 0.0 110.584 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.95 142.47 93.57 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.662 1.575 . . . . 0.0 110.426 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' N ' ' A' ' 9' ' ' SER . 39.7 p-80 -65.86 -53.94 33.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.179 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 9.7 p -161.87 157.26 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.386 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 11' ' ' SER . 7.6 p -164.77 154.64 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.116 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 10' ' ' VAL . 9.6 p -122.5 135.63 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.796 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -122.08 143.59 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.483 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.43 153.06 94.01 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.18 118.41 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.193 1.262 . . . . 0.0 112.103 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.55 -13.57 20.64 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -88.67 161.46 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.559 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.9 p -98.62 138.41 35.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.32 141.66 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.383 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 76' ' ' LEU . 35.0 m -123.59 130.92 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.58 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.05 134.33 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.386 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 11.0 m -108.77 126.44 53.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.68 111.52 17.29 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.4 m -115.13 141.03 48.56 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.473 -1.392 . . . . 0.0 107.351 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.5 mmm-85 -93.7 139.87 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.264 170.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.841 ' HG ' ' N ' ' A' ' 3' ' ' MET . 78.8 p -60.53 1.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.371 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.49 -18.37 14.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.58 -173.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.73 -25.18 11.97 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 m -80.35 117.01 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.741 0.305 . . . . 0.0 111.312 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 73' ' ' SER . 1.3 pp -135.34 -64.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -67.27 -1.08 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' ILE . 4.3 t -97.56 -22.13 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.04 -1.891 . . . . 0.0 111.917 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' CB ' HH12 ' A' ' 24' ' ' ARG . 12.8 m120 -118.51 148.51 42.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -175.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.47 137.72 42.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.989 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.44 141.1 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.9 pt20 -119.7 153.26 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -117.76 128.79 55.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 110.34 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.2 m-85 -132.6 149.88 52.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.68 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.43 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -121.09 128.79 52.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -108.46 129.74 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.274 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.306 0 N-CA-C 110.55 -0.596 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -121.79 138.76 54.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.451 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.423 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -77.4 120.18 22.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.704 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 63' ' ' PHE . 3.7 t -101.02 -28.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.832 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.18 152.25 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 80.6 t80 -133.5 163.77 28.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.403 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.1 tt0 45.22 23.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.202 1.001 . . . . 0.0 110.44 -172.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.4 p30 44.59 19.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.668 -1.606 . . . . 0.0 109.964 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -127.89 -41.38 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.37 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -57.55 131.85 51.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.56 -1.654 . . . . 0.0 109.254 -167.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.772 HH21 ' H ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -117.31 108.89 42.96 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.99 145.29 49.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.707 1.605 . . . . 0.0 111.418 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 m -73.59 -24.46 60.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.56 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -29.54 72.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.09 148.16 36.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -59.22 128.48 27.73 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.621 1.547 . . . . 0.0 110.655 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.99 -0.85 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.271 . . . . 0.0 111.708 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' A' ' 85' ' ' ASP . 33.1 mtp180 -43.94 -23.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CD2' HG11 ' A' ' 48' ' ' VAL . 14.9 m-85 -79.49 140.79 37.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -127.32 122.84 34.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.772 ' H ' HH21 ' A' ' 55' ' ' ARG . . . -100.1 124.81 8.36 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 113.558 -1.655 . . . . 0.0 110.124 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.1 p -159.67 165.65 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.211 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -151.49 167.4 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.538 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 67.2 m-20 -104.1 153.03 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.815 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 m -69.89 13.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.103 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -87.86 -41.5 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.453 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m 79.15 27.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.077 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -98.46 -33.98 10.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.154 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.759 ' C ' HD13 ' A' ' 29' ' ' ILE . 90.9 p -165.36 168.62 16.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.753 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.05 130.83 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.832 -1.168 . . . . 0.0 109.641 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 66' ' ' SER . 16.2 m -128.34 112.81 14.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.72 140.52 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 118.564 -2.585 . . . . 0.0 116.711 168.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 64' ' ' SER . 85.4 m -99.85 127.55 46.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 162.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.563 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -107.9 106.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.107 -1.62 . . . . 0.0 109.701 172.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 p -102.29 154.95 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.644 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 79.93 25.62 57.55 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.16 138.32 56.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.12 0.486 . . . . 0.0 110.706 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.9 tttm -149.82 176.9 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.528 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 t -46.38 -21.33 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.45 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.6 mt-10 -72.01 -38.51 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.549 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.3 OUTLIER -70.63 -12.97 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.067 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 79.8 tt0 -52.76 122.72 9.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.364 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 164.42 -178.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.505 0.503 . . . . 0.0 109.874 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.95 132.39 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.72 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 16.2 m-85 -113.15 133.5 55.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -150.96 144.89 25.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.704 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.723 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.53 143.25 46.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.061 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -117.06 149.11 40.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 171.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 23.2 t -135.19 163.96 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 111.6 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.207 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.695 0.283 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.49 -160.88 11.48 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 80.73 18.94 69.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.55 85.11 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.5 m -133.84 124.19 26.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -89.93 127.31 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.0 tp -111.65 126.11 54.68 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.46 0.475 . . . . 0.0 110.365 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.7 m -120.99 128.82 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.607 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' OXT' ' A' ' 111' ' ' LEU . 64.0 t -93.7 104.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.428 . . . . 0.0 110.242 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 9.5 mt . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.75 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpp . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.52 103.04 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -78.82 127.44 32.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.581 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.703 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 16.3 mt-30 -143.47 159.76 53.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.72 125.46 18.7 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.498 1.465 . . . . 0.0 110.64 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -60.56 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 p -156.74 153.22 28.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.62 154.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.693 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -130.4 145.77 51.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -135.37 162.51 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -91.5 148.68 37.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.577 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -60.55 118.34 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.438 1.425 . . . . 0.0 111.296 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.37 3.54 29.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -95.01 -173.41 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.1 p -122.65 142.5 50.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.145 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.73 145.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 76' ' ' LEU . 87.9 m -127.48 122.59 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.023 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 135.99 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.913 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -106.19 135.61 47.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.335 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 4.1 m -118.72 115.63 24.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.0 m -118.92 140.0 50.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.631 ' C ' ' H ' ' A' ' 26' ' ' SER . 45.5 mtp180 -93.21 139.74 30.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.137 169.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -58.75 1.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.393 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.631 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -103.67 -18.07 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.789 -175.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 77.92 21.76 70.49 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -125.47 113.91 18.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.517 0.198 . . . . 0.0 110.731 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.1 pp -135.14 -63.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.902 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.88 -3.22 2.3 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 38.6 m -92.98 -21.86 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.372 -2.194 . . . . 0.0 111.226 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.6 ' ND2' HH12 ' A' ' 24' ' ' ARG . 2.2 m120 -132.61 156.64 46.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.0 110.065 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 23.3 m-85 -82.04 145.11 30.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.91 146.76 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.219 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.641 ' HG3' ' H ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -117.1 163.06 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 27.5 m95 -132.98 126.46 32.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.936 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 35' ' ' GLN . 4.6 m-85 -124.86 149.4 47.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.913 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 1.5 mm100 -124.64 131.02 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.26 137.9 52.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.49 1.27 0 N-CA-C 110.777 -0.509 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.7 m -125.31 116.56 22.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 110.559 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -62.13 122.29 15.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.78 -28.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.548 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -145.02 148.91 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -138.3 143.49 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' A' ' 53' ' ' ASN . 8.5 tt0 57.68 23.57 9.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.454 1.121 . . . . 0.0 110.17 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.4 t0 44.14 18.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.025 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.6 -46.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.231 165.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.4 tm0? -54.54 141.89 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.123 -168.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.455 ' CZ ' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -125.62 108.86 25.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 119.169 -0.444 . . . . 0.0 109.849 178.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.18 144.31 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.725 1.617 . . . . 0.0 111.575 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -70.64 -26.85 63.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -33.21 86.64 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.03 144.34 28.91 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 62' ' ' ARG . 3.3 Cg_exo -60.37 139.95 89.26 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.459 1.439 . . . . 0.0 110.771 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -60.97 0.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.658 HH22 ' CB ' ' A' ' 85' ' ' ASP . 35.7 ptt85 -50.55 -29.09 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.986 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 63.0 m-85 -78.61 131.8 36.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 t -112.19 123.66 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.36 122.24 5.31 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 5.9 p -154.97 156.49 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.181 0.515 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.58 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -132.96 159.06 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.13 148.63 25.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.413 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -67.96 -6.43 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 m -64.33 -42.64 96.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.916 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' GLY . 11.0 p 79.0 31.48 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.649 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -97.3 -43.64 7.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.403 -177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.605 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.1 p -167.11 168.35 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.325 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.71 122.79 47.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.8 m -114.52 112.89 23.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.684 -170.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.24 140.64 31.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 118.66 -2.525 . . . . 0.0 117.207 168.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.5 m -110.69 127.1 55.17 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.695 ' CD1' HD21 ' A' ' 76' ' ' LEU . 26.4 mm -93.84 113.09 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 120.057 -1.652 . . . . 0.0 110.887 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.76 129.22 45.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.523 0.201 . . . . 0.0 110.728 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.39 58.39 3.13 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD21 HG13 ' A' ' 110' ' ' VAL . 3.8 tt -75.16 138.61 42.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.502 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 84' ' ' GLU . 16.5 mttt -144.74 175.66 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.802 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 83' ' ' THR . 1.1 p -45.99 -18.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 82' ' ' LYS . 68.1 mm-40 -69.85 -38.36 76.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.461 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.658 ' CB ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -67.43 -6.91 21.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.529 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 21.9 tt0 -67.21 121.21 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.394 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.85 178.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.185 0.516 . . . . 0.0 110.176 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -87.4 134.15 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 10.9 m-85 -113.56 132.79 55.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.9 p90 -151.25 151.87 32.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 103' ' ' GLY . 28.3 p -132.62 143.4 49.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.159 -173.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.641 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 mt-30 -115.3 147.29 40.6 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.7 p -135.21 118.93 17.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.939 0.399 . . . . 0.0 110.844 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.7 p90 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.102 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.4 p90 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.461 0.172 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 141.09 -123.43 2.31 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.39 42.21 9.46 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.13 118.61 11.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -135.91 118.87 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.873 0.368 . . . . 0.0 110.478 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -88.06 115.89 25.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.615 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.56 124.34 50.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.086 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 111' ' ' LEU . 55.4 m -117.42 113.7 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 110' ' ' VAL . 90.0 t -78.57 38.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 110.36 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.512 ' H ' HG22 ' A' ' 109' ' ' THR . 6.3 mt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.152 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.461 ' C ' ' HE ' ' A' ' 24' ' ' ARG . 5.0 ptt? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.698 HD12 ' NH1' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -114.66 102.83 10.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.26 127.77 35.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.349 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.603 HE21 ' CB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -143.0 161.6 47.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.147 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 2.2 Cg_endo -47.73 136.43 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.477 2.118 . . . . 0.0 111.676 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -70.36 -45.35 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.845 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -157.56 157.15 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.375 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.06 125.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.5 p -108.0 130.37 55.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.45 164.92 15.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 m -96.6 143.44 26.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.448 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.09 115.07 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.44 1.427 . . . . 0.0 111.039 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.75 -10.77 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -91.85 -171.64 2.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -126.41 153.71 44.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.895 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.33 147.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.099 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 1.2 m -122.25 134.4 54.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -98.88 128.64 50.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -102.38 120.53 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.7 111.84 19.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -178.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 142.17 48.11 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.932 -1.105 . . . . 0.0 108.609 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' NH1' HD12 ' A' ' 4' ' ' LEU . 1.5 mmp_? -89.45 140.18 29.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.782 169.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -2.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.124 175.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.79 -18.18 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.072 -175.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 -36.26 3.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -66.78 110.73 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.13 -60.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.761 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.92 1.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 29' ' ' ILE . 85.1 p -109.02 -26.61 10.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.744 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -103.34 144.17 31.72 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.8 119.11 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.561 HG22 ' OG ' ' A' ' 93' ' ' SER . 93.3 t -121.47 143.25 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.782 0.801 . . . . 0.0 110.8 -175.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.539 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.6 pm0 -139.09 169.6 17.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.895 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.6 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 64.5 m95 -125.74 128.26 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.207 0.527 . . . . 0.0 110.474 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -113.99 149.43 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.754 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.39 129.86 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -124.1 142.41 51.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.529 178.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.159 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.943 -0.445 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -140.84 132.45 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.957 0.408 . . . . 0.0 110.873 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.5 m -62.08 123.54 18.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.917 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.24 -27.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.524 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.4 152.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' ASP . 31.2 t80 -132.87 163.26 29.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.2 tt0 45.94 24.18 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.953 -173.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.3 OUTLIER 44.16 19.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.962 -177.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.1 t-20 -128.04 -46.1 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.934 169.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 135.62 48.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.728 -168.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -130.48 108.66 16.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.261 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.17 143.23 64.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.873 1.715 . . . . 0.0 111.58 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.0 m -74.14 -18.54 60.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.66 -51.18 54.17 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -85.24 149.97 53.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -59.29 135.76 67.67 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.655 0.903 . . . . 0.0 110.171 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' PHE . 47.9 p30 -59.99 0.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.147 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.782 HH12 ' N ' ' A' ' 85' ' ' ASP . 30.8 mtm105 -54.39 4.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.891 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASP . 4.2 m-85 -118.47 143.38 46.75 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.21 -0.306 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -135.28 123.57 23.16 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.073 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.49 119.53 6.29 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.582 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' SER . 12.7 p -153.98 160.46 42.07 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.064 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 163.89 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.119 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 70' ' ' SER . 62.4 m-20 -108.72 146.35 33.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.507 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -67.98 2.73 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.796 174.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' SER . 28.5 m -71.27 -42.38 68.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 80.83 27.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.566 -178.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.19 -43.6 7.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.671 ' C ' HD13 ' A' ' 29' ' ' ILE . 93.7 p -164.63 168.44 18.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.403 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 125.17 52.18 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.114 -0.991 . . . . 0.0 109.604 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' SER . 5.5 m -123.38 115.57 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.074 -169.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -95.02 140.58 29.78 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.806 -1.809 . . . . 0.0 115.758 169.765 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -103.56 128.34 50.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 112.185 166.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.1 mt -108.36 108.24 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 120.758 -1.213 . . . . 0.0 110.116 172.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -102.96 173.04 6.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.839 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.09 18.8 35.75 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.16 143.38 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.9 tttm -163.49 176.9 9.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.059 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -45.96 -20.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.586 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' LYS . 97.2 mt-10 -71.85 -38.71 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.559 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.782 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.5 OUTLIER -73.09 -9.29 58.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.251 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.2 tt0 -58.41 122.26 12.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.851 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.7 -175.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.176 0.513 . . . . 0.0 110.668 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.28 136.13 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.949 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 22.3 m-85 -119.93 132.83 55.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.023 0.439 . . . . 0.0 110.809 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 6.1 p90 -151.21 154.98 37.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.6 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 4.6 m -117.9 141.59 48.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.41 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 55.7 tt0 -117.44 121.52 41.28 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.857 -0.527 . . . . 0.0 109.669 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -135.09 -177.19 4.53 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 -178.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.396 0.617 . . . . 0.0 110.629 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 11.8 p90 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.529 0.204 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.55 -147.37 15.36 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.302 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 62.15 52.49 49.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.42 102.96 1.54 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.603 ' CB ' HE21 ' A' ' 6' ' ' GLN . 42.1 m -106.84 126.34 52.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.22 98.36 11.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.172 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.0 tp -82.28 122.86 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.155 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 m -120.73 117.33 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 111' ' ' LEU . 95.2 t -81.85 93.53 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.148 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 110' ' ' VAL . 12.2 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.599 -1.191 . . . . 0.0 111.898 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.823 ' N ' ' HG ' ' A' ' 25' ' ' SER . 50.0 mtt . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.06 118.75 15.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.587 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -71.86 134.43 46.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.629 -172.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' A' ' 91' ' ' CYS . 2.8 mm-40 -146.08 157.65 49.65 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.277 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.08 168.67 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.946 . . . . 0.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.528 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -82.89 -66.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.163 179.667 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 9.6 m -165.04 162.85 20.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.5 150.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.6 p -130.2 128.32 41.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.137 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.98 162.57 18.31 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.487 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 3.8 m -96.88 147.02 32.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.75 120.0 7.61 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.481 1.454 . . . . 0.0 111.106 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.84 4.96 27.71 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' ' 13' ' ' SER . 61.8 mttm -101.66 -172.94 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.209 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -126.58 145.11 50.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.29 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.02 141.74 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.707 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -123.11 130.27 52.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 135.49 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 2.7 m -106.37 128.59 54.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.986 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.06 121.64 40.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' THR . 91.9 m -125.96 131.1 52.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.986 HH12 ' ND2' ' A' ' 32' ' ' ASN . 13.7 ttp180 -81.47 134.21 35.5 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.531 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.823 ' HG ' ' N ' ' A' ' 3' ' ' MET . 91.6 p -55.48 1.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.488 174.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.71 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.03 -18.05 14.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.19 -172.045 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.05 21.05 68.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.769 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.54 111.24 14.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.2 0.5 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.34 -63.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.67 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -64.04 0.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 34.6 m -109.27 -29.6 8.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.158 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.986 ' ND2' HH12 ' A' ' 24' ' ' ARG . 2.4 m-20 -116.81 155.05 29.64 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.15 125.52 27.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.926 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 t -121.03 148.15 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.626 ' NE2' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -142.0 160.41 40.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.339 -172.498 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -119.68 126.59 51.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.317 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.2 m-85 -108.01 149.11 28.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.866 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.637 ' NE2' ' CD1' ' A' ' 89' ' ' TYR . 4.3 tp60 -138.1 132.2 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.787 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -133.53 146.61 51.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.753 177.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.461 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.341 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -149.08 143.17 25.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.442 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -71.88 126.27 29.32 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.946 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 63' ' ' PHE . 2.5 t -95.11 -26.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.26 140.76 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' GLN . 50.2 t80 -127.66 152.96 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 53' ' ' ASN . 11.9 tt0 54.69 23.45 4.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.127 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 43.74 18.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.817 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.44 -46.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.698 . . . . 0.0 109.5 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 50' ' ' TYR . 6.8 tm0? -62.69 114.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.758 -167.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HE ' ' CB ' ' A' ' 61' ' ' ASP . 25.4 ttp-105 -118.67 108.75 40.77 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -68.21 148.03 73.82 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.97 1.78 . . . . 0.0 111.57 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -74.12 -19.37 60.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.89 92.61 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.5 148.72 44.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 62' ' ' ARG . 4.8 Cg_exo -51.65 121.85 9.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.799 1.666 . . . . 0.0 111.675 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' PHE . 38.6 p-10 -60.91 1.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.418 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.578 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.5 mtp-105 -64.53 16.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.446 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASP . 14.4 m-85 -116.9 144.02 45.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -131.66 123.28 27.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.37 126.41 8.72 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.46 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -158.62 164.28 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.257 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.9 161.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.969 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -99.07 178.96 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.658 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 p -91.25 9.14 32.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.023 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' SER . 18.5 m -83.12 -44.41 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.71 28.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.463 -176.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -100.07 -38.63 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.805 -176.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.642 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.4 p -161.3 167.05 26.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.735 -177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.88 124.74 50.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.013 -1.054 . . . . 0.0 109.576 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 6.3 m -115.21 112.64 22.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.702 -171.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.72 140.59 31.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 119.345 -2.097 . . . . 0.0 116.515 170.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 78.3 m -108.0 130.21 55.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.905 0.859 . . . . 0.0 113.153 163.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -108.13 113.55 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 t -99.24 168.0 10.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.085 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 38.38 93.1 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD21 HG13 ' A' ' 110' ' ' VAL . 3.5 tt -65.37 134.53 53.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.032 0.444 . . . . 0.0 110.97 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' C ' HG11 ' A' ' 110' ' ' VAL . 9.2 tttt -151.94 176.26 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 83' ' ' THR . 0.0 OUTLIER -45.91 -19.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.791 174.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.452 ' N ' ' C ' ' A' ' 82' ' ' LYS . 65.0 tt0 -74.55 -38.61 62.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.179 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.578 ' CG ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -72.64 -11.41 60.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.9 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 76.7 tt0 -57.42 125.75 24.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.869 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.39 176.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.88 142.46 27.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.897 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.637 ' CD1' ' NE2' ' A' ' 38' ' ' GLN . 13.4 m-85 -113.99 147.62 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.569 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -146.48 154.13 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.631 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.421 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 42.2 t -127.66 140.66 51.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.562 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 2.8 tp-100 -128.26 131.99 48.74 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.499 ' N ' ' OE1' ' A' ' 92' ' ' GLN . 35.4 p -134.99 145.19 47.87 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.054 -0.404 . . . . 0.0 111.172 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.149 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.418 ' HB3' ' NE2' ' A' ' 92' ' ' GLN . 9.6 p90 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 110.698 -0.112 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.49 ' H ' HD11 ' A' ' 4' ' ' LEU . . . 178.25 -166.84 37.12 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.238 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.22 48.57 4.01 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.26 96.38 0.06 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -105.27 116.33 31.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.45 123.94 30.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.027 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.1 tp -110.86 122.91 49.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.797 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -116.23 120.28 38.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.803 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.4 t -91.65 34.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.408 179.282 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.5 mmm . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.78 103.05 7.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.68 121.75 25.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.577 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.9 mt-30 -143.78 -177.68 0.69 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.8 Cg_exo -74.38 151.83 43.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.188 1.925 . . . . 0.0 111.658 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.62 ' CG ' ' N ' ' A' ' 9' ' ' SER . 19.0 p-80 -82.44 -57.01 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.625 0.25 . . . . 0.0 111.182 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.62 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 30.6 p -152.6 149.04 28.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.582 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.38 153.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.288 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.1 p -132.15 141.85 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.423 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -131.81 158.1 42.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -76.74 148.9 80.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -63.46 120.23 7.58 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.572 1.515 . . . . 0.0 112.044 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.14 -6.3 17.32 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -96.45 164.94 12.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.162 0.506 . . . . 0.0 111.147 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -95.52 132.3 40.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.065 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.51 135.16 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.079 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.2 m -120.13 134.88 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.465 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.06 134.29 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.125 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -110.23 125.93 53.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 30.7 m -118.75 125.27 49.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 m -116.88 131.73 56.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 26' ' ' SER . 41.7 ttt180 -83.86 136.54 34.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.301 171.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.5 m -58.6 2.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.554 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -104.9 -18.04 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -174.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.17 -32.29 4.14 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -72.47 110.24 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -134.59 -60.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.778 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.89 0.3 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.4 p -110.13 -26.98 9.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.358 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -104.26 151.3 23.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -81.55 114.76 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.97 148.0 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -135.84 156.61 48.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.26 135.36 54.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.427 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -139.06 137.07 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.63 ' CD ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -132.0 148.08 52.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.185 0.517 . . . . 0.0 110.098 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.73 140.01 47.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.219 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.491 1.379 0 CA-C-O 120.588 0.162 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.402 ' C ' ' CE1' ' A' ' 37' ' ' TYR . 81.2 p -140.4 126.56 19.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.629 176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.491 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 64.6 m -61.14 121.14 11.75 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.726 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.63 HG21 ' CD ' ' A' ' 38' ' ' GLN . 40.4 t -101.36 -28.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.928 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.3 mt -145.63 146.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.8 t80 -132.99 159.16 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 50.98 24.03 1.69 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.2 1.0 . . . . 0.0 110.361 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 38.5 t0 44.35 19.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.361 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -127.87 -46.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 170.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -55.29 140.46 39.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.909 -168.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -142.34 108.68 5.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.295 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -68.37 143.94 59.95 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.407 1.405 . . . . 0.0 111.992 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -69.64 -35.79 75.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.685 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.96 -50.58 26.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -91.54 139.51 25.12 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -57.83 137.18 79.77 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.137 1.225 . . . . 0.0 110.54 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' N ' ' A' ' 63' ' ' PHE . 4.0 p-10 -62.75 -0.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.61 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.552 HH22 ' CG ' ' A' ' 85' ' ' ASP . 17.9 mtp-105 -38.33 -24.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.495 -175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.2 m-85 -89.77 141.01 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.5 t -126.38 124.36 40.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.951 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.39 117.52 5.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.509 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 75' ' ' SER . 8.1 p -153.93 167.05 31.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.125 0.462 . . . . 0.0 110.722 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -149.14 160.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -101.15 153.75 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.605 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.0 p -68.09 -7.46 29.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.248 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.7 m -61.96 -42.8 99.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 80.84 27.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.481 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.07 -38.25 8.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.786 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.698 ' C ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -166.28 171.41 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.042 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.04 135.41 48.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.784 -1.198 . . . . 0.0 109.467 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -130.42 115.69 17.21 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.794 -1.098 . . . . 0.0 112.825 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -96.99 140.73 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 118.927 -2.358 . . . . 0.0 116.284 169.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.4 m -102.48 126.13 49.42 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.473 -0.767 . . . . 0.0 112.969 162.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.523 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.5 mt -105.25 103.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 120.79 -1.194 . . . . 0.0 109.788 172.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -98.98 154.31 18.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.21 17.25 78.43 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.91 131.91 22.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.318 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' C ' ' N ' ' A' ' 84' ' ' GLU . 26.6 mttt -148.99 176.09 10.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.818 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -18.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.627 174.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.0 mt-10 -75.67 -37.0 59.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.552 ' CG ' HH22 ' A' ' 62' ' ' ARG . 6.9 t70 -74.3 -10.7 59.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 38.8 tt0 -57.59 123.94 17.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.14 -175.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.922 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -89.11 150.01 22.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.563 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 19.1 m-85 -122.26 151.76 40.75 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.543 0.337 . . . . 0.0 110.526 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 37' ' ' TYR . 56.0 m-85 -150.45 137.37 19.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.577 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 16.2 p -118.9 140.66 49.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.951 0.341 . . . . 0.0 111.368 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -118.08 134.71 54.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -135.12 146.99 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.612 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.9 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.63 0.253 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.37 -131.43 6.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.75 24.13 3.94 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.09 164.71 4.79 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.8 m -131.81 130.57 41.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.87 112.89 15.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.9 tp -105.83 124.45 49.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.116 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.2 m -117.62 124.76 49.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.119 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.07 99.21 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.204 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.887 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.405 ' N ' ' HG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.3 mp -133.78 103.87 6.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -90.41 135.35 33.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.825 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.662 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 30.5 mt-30 -136.55 163.42 49.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.829 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.49 135.46 66.26 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.899 1.733 . . . . 0.0 110.817 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -41.49 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -161.28 157.46 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -163.62 162.88 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.447 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 t -137.07 156.88 47.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.064 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.68 151.78 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.436 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.73 142.32 85.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.528 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.88 113.9 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.459 1.439 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.82 1.34 22.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -94.9 -174.16 3.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.004 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -113.44 127.81 56.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.138 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 144.06 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -130.58 131.45 45.0 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.97 140.17 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.303 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -113.88 120.08 39.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB2' HE21 ' A' ' 6' ' ' GLN . 31.9 t -120.75 123.6 43.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.6 m -119.69 142.09 48.8 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.019 -1.05 . . . . 0.0 108.278 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.605 ' C ' ' H ' ' A' ' 26' ' ' SER . 75.3 mtp85 -92.94 141.1 28.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.685 170.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HG ' ' N ' ' A' ' 3' ' ' MET . 7.0 p -59.74 2.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.246 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.09 -18.15 14.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.132 -175.417 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 74.3 8.93 80.68 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 6.7 t -110.85 105.46 14.29 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.786 -0.244 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -129.61 -63.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.53 -0.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -98.91 -27.05 14.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.719 -178.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -131.71 152.22 51.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -71.07 149.09 46.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.676 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 17.1 t -125.5 148.21 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.597 HE21 HG23 ' A' ' 47' ' ' THR . 29.5 tt0 -120.24 155.41 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.97 131.04 54.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.054 0.454 . . . . 0.0 110.425 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.511 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.2 OUTLIER -127.91 146.19 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.84 136.66 48.87 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -120.49 121.75 39.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.348 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 40' ' ' ARG . 16.2 mtt180 . . . . . 0 C--N 1.33 -0.258 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.491 1.324 0 CA-C-O 119.602 -0.249 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -139.92 97.94 3.36 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 121.914 -0.491 . . . . 0.0 110.202 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.597 HG23 HE21 ' A' ' 35' ' ' GLN . 33.9 m -64.83 118.89 9.66 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.94 -28.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.199 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.44 151.47 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . 5.7 t80 -134.13 161.01 36.07 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.0 tt0 48.6 23.86 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.351 0.596 . . . . 0.0 111.217 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 34' ' ' VAL . 35.0 t0 44.48 19.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.119 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -127.93 -46.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.502 . . . . 0.0 109.825 170.483 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -54.52 132.33 44.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.951 -168.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -134.64 108.63 10.97 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.08 149.09 64.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.964 1.776 . . . . 0.0 111.62 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -71.55 -36.75 71.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.698 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.76 42.48 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 59' ' ' VAL . 3.7 m -86.6 138.09 33.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.5 Cg_endo -59.89 131.37 39.2 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 CA-C-N 119.88 0.993 . . . . 0.0 110.665 -177.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 63' ' ' PHE . 25.6 p-10 -60.95 1.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 13.6 mtm105 -46.65 -5.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.165 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 m-85 -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.4 t -119.06 124.36 46.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.72 122.46 6.98 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 37.8 p -159.15 163.35 36.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.051 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -134.91 158.82 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.858 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 70' ' ' SER . 73.5 m-20 -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.864 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.22 30.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 68' ' ' ASP . 6.7 m -107.19 -40.46 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.537 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 83.79 25.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.391 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -42.17 7.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.678 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.611 ' O ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -164.69 170.73 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.63 133.94 51.35 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 120.61 -1.306 . . . . 0.0 110.177 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 12.5 m -125.47 113.56 17.65 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.055 -0.974 . . . . 0.0 113.092 -171.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.44 140.6 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 118.591 -2.568 . . . . 0.0 116.994 170.015 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' SER . 19.5 m -105.1 125.53 51.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 163.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.644 ' CD1' HD21 ' A' ' 76' ' ' LEU . 38.4 mm -89.79 103.62 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.565 -1.334 . . . . 0.0 110.724 172.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 m -99.32 141.56 31.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.371 . . . . 0.0 111.486 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.94 15.42 79.1 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.03 135.66 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.57 . . . . 0.0 110.461 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -144.04 176.06 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.302 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 83' ' ' THR . 0.7 OUTLIER -49.73 -19.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.432 175.559 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE1' ' NH2' ' A' ' 62' ' ' ARG . 3.2 tt0 -70.97 -42.02 70.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.352 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 4.6 m-20 -66.86 -7.07 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.22 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.0 tt0 -58.99 121.03 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.977 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.5 -175.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -93.0 147.36 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.21 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -116.73 145.33 43.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 14.0 m-85 -145.93 152.62 39.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.859 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.662 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -125.08 140.89 52.49 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -118.98 139.81 51.05 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.487 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 2.4 m -135.09 158.29 44.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 110.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.435 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.9 p90 . . . . . 0 C--O 1.232 0.14 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.83 -150.13 8.66 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' TYR . . . 86.1 35.91 10.58 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.36 110.08 2.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -142.13 137.79 31.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.769 0.319 . . . . 0.0 110.371 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.31 112.72 25.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.565 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.11 125.93 50.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.085 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.88 125.19 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -96.21 103.21 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.209 179.069 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -103.71 170.41 7.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.425 ' H ' ' HB3' ' A' ' 25' ' ' SER . 1.1 ttt -132.4 170.01 15.71 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.1 102.77 6.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -92.1 121.08 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.008 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.632 HE21 ' CB ' ' A' ' 106' ' ' THR . 0.0 OUTLIER -144.55 164.86 25.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.15 134.42 36.91 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.246 1.964 . . . . 0.0 111.612 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.485 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 9.7 t-80 -67.0 -68.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.2 m -148.43 146.04 28.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 11' ' ' SER . 7.9 p -162.52 156.14 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.525 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' HG22 ' A' ' 10' ' ' VAL . 86.0 p -133.86 145.55 49.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.384 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -133.82 156.68 47.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.093 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -77.06 136.76 65.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.166 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.56 125.19 17.07 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.583 1.522 . . . . 0.0 111.093 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 -6.68 25.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -94.08 173.52 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.778 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.6 p -100.56 136.62 40.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.225 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.5 137.43 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -125.14 127.59 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.59 139.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.42 127.71 53.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.379 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -118.62 126.36 51.79 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.8 m -118.93 141.64 48.47 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 26' ' ' SER . 33.1 mtp85 -94.74 141.11 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.185 170.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 3' ' ' MET . 32.5 t -58.2 0.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.544 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.635 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.25 -18.1 14.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.794 -173.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 75.47 21.87 76.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' OD1' ' A' ' 32' ' ' ASN . 10.5 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.32 -63.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.439 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.96 1.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 29' ' ' ILE . 54.7 m -104.97 -27.08 11.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.378 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 28' ' ' SER . 4.0 p-10 -122.2 163.58 19.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.152 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -81.92 142.88 32.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.67 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.02 148.26 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.571 HE22 ' HG3' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -133.24 144.52 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -110.43 135.03 51.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 110.878 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.515 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -128.29 149.11 50.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.03 140.55 52.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.415 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 6.6 tm0? -148.24 144.65 27.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -163.31 153.35 13.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.449 178.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.29 145.15 94.5 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.27 1.313 . . . . 0.0 111.181 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 9.66 82.73 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -151.31 -167.7 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.407 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 p -135.59 155.65 78.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.1 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.27 137.92 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.09 1.86 . . . . 0.0 111.836 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 m -138.78 110.31 7.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.515 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -60.87 121.15 11.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.45 -27.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.408 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mt -145.11 146.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 8.5 t80 -130.96 159.08 38.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.251 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 3.7 tt0 49.3 24.31 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.653 0.74 . . . . 0.0 110.682 -175.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.2 p-10 44.5 19.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.61 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.1 t-20 -128.0 -46.35 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.378 0.609 . . . . 0.0 109.811 171.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.55 124.79 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.033 -167.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.56 108.8 40.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.462 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.56 144.54 55.44 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.475 1.45 . . . . 0.0 111.662 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -67.26 -32.38 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.711 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.99 -58.65 13.44 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.45 137.87 48.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.2 Cg_exo -59.01 137.92 82.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.966 1.111 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 63' ' ' PHE . 12.0 p-10 -61.5 1.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.445 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.559 HH22 ' CG ' ' A' ' 85' ' ' ASP . 9.1 ptm180 -49.79 -2.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.93 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.56 ' H ' ' C ' ' A' ' 61' ' ' ASP . 47.2 m-85 -104.45 143.65 32.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.31 122.55 34.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.893 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.07 125.29 8.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.497 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.3 p -157.57 161.88 38.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.194 0.521 . . . . 0.0 111.124 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.623 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.7 pp -141.89 158.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.8 m-20 -102.65 145.96 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.8 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.91 -3.72 10.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.442 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.3 m -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.068 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 28.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.593 -177.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -98.77 -40.55 8.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.52 ' O ' HD13 ' A' ' 29' ' ' ILE . 80.3 p -168.17 169.83 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.088 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.32 135.54 49.46 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 120.613 -1.304 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -128.48 115.6 18.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.137 -171.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.03 140.72 31.94 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 118.622 -2.549 . . . . 0.0 116.91 168.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.0 m -104.63 129.22 52.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 162.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.584 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.0 mt -109.65 105.94 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 120.179 -1.576 . . . . 0.0 110.193 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 t -88.86 153.13 21.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 61.34 4.06 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.21 137.92 34.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.163 0.506 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 84' ' ' GLU . 22.3 mttt -151.45 173.73 14.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.694 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.33 -19.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.497 173.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 82' ' ' LYS . 91.2 mt-10 -68.81 -41.0 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.392 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.559 ' CG ' HH22 ' A' ' 62' ' ' ARG . 16.7 t70 -72.68 -9.9 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.242 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 82.3 tt0 -56.4 120.97 8.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.812 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.88 176.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -88.73 152.86 21.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.668 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 17.6 m-85 -117.67 143.26 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.997 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.3 m-85 -144.58 142.51 30.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.727 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.1 p -134.96 140.86 46.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.829 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.571 ' HG3' HE22 ' A' ' 35' ' ' GLN . 56.6 mt-30 -121.16 148.55 44.07 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.76 -0.587 . . . . 0.0 110.482 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 p -135.15 153.37 52.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 110.68 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.67 133.94 9.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.98 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.24 -156.93 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.634 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -77.91 -31.78 51.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -84.96 39.79 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 53.39 -118.42 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.624 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 48.0 81.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 110.07 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.57 135.85 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.8 156.22 41.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.095 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -136.08 147.56 47.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.99 -141.99 4.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.619 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . 62.68 53.86 38.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.06 103.5 2.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.632 ' CB ' HE21 ' A' ' 6' ' ' GLN . 34.4 m -126.27 141.7 51.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 110.642 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -104.93 101.15 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.69 124.97 36.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.379 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 m -120.74 124.91 46.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.55 100.94 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.113 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.836 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -68.24 143.72 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.345 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.492 ' H ' ' HB2' ' A' ' 25' ' ' SER . 4.4 ptm -155.33 170.02 22.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.38 104.49 9.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -80.17 129.68 34.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.321 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 3.0 mt-30 -145.34 166.68 16.8 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -63.84 133.32 38.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.475 1.45 . . . . 0.0 111.319 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.674 ' CG ' ' H ' ' A' ' 9' ' ' SER . 6.1 p80 -44.19 -60.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.674 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 35.2 p -164.08 160.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -162.95 147.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 p -130.71 132.2 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.849 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.92 158.23 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 m -80.93 140.03 50.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.57 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.38 116.13 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.751 1.634 . . . . 0.0 111.043 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.32 -0.6 18.82 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -107.56 -163.05 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.9 p -136.63 153.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.16 147.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.051 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 131.74 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.85 134.27 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.292 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.8 m -104.92 123.56 47.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.877 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.99 111.91 18.92 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.7 m -116.59 141.97 47.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.9 mtm180 -99.55 143.27 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.071 170.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.492 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -58.24 1.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 176.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -101.45 -14.05 17.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.784 -174.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.33 27.14 70.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.8 p -124.5 109.53 13.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 110.571 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.17 -64.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.995 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.72 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -66.59 -2.41 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.6 t -100.93 -29.18 12.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.57 -2.104 . . . . 0.0 111.339 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -121.09 148.53 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.0 112.84 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.372 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 22.0 t -102.3 146.3 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.598 HE21 ' CB ' ' A' ' 92' ' ' GLN . 7.1 tt0 -127.97 165.09 20.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 28.2 m95 -130.04 127.43 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.936 0.398 . . . . 0.0 110.914 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 2.1 m-85 -121.19 148.99 43.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.374 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -126.74 134.79 50.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.31 117.54 32.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -113.97 126.94 27.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.687 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.74 144.71 99.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 120.904 1.069 . . . . 0.0 110.673 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.17 87.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 p -155.09 158.96 39.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.655 0.264 . . . . 0.0 110.322 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 p -86.5 158.02 54.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.296 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.9 155.32 18.56 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.794 1.663 . . . . 0.0 110.812 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 126.82 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.436 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.492 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -74.94 120.96 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.099 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.691 ' HA ' HG21 ' A' ' 59' ' ' VAL . 23.8 t -103.17 -28.4 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.491 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -145.42 151.66 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.801 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 3.5 t80 -140.82 164.86 29.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' ASN . 2.7 tt0 44.84 21.9 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 110.887 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 43.09 18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.614 -177.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.79 -46.97 1.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 173.752 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.801 ' OE1' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.01 153.28 40.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.993 -164.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.534 ' CZ ' ' O ' ' A' ' 63' ' ' PHE . 3.3 ttt85 -132.0 108.67 14.01 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 120.322 -1.486 . . . . 0.0 109.939 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -69.7 143.0 49.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.446 1.43 . . . . 0.0 111.449 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -73.99 -18.86 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.062 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.46 -38.33 96.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 48' ' ' VAL . 17.2 m -103.08 149.95 37.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 122.291 -0.535 . . . . 0.0 109.626 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 2.4 Cg_endo -53.65 125.98 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.795 1.663 . . . . 0.0 111.342 -173.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' CA ' HH21 ' A' ' 55' ' ' ARG . 97.8 m-20 -61.05 2.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.443 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 19.6 mtm105 -69.25 21.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -173.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' O ' ' CZ ' ' A' ' 55' ' ' ARG . 16.9 m-85 -131.32 143.6 50.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.151 0.432 . . . . 0.0 110.626 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 77' ' ' THR . 2.1 t -126.64 123.14 36.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.139 -0.457 . . . . 0.0 111.269 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.21 136.54 13.66 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.374 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.4 p -163.83 159.92 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD13 ' CB ' ' A' ' 30' ' ' ALA . 2.5 pp -141.03 154.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.669 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 70' ' ' SER . 15.9 m-20 -102.98 154.21 19.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.948 176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.4 p -69.7 7.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 68' ' ' ASP . 24.4 m -74.19 -43.11 58.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.596 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 70' ' ' SER . 12.7 p 79.5 30.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.657 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.05 -38.14 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.767 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.591 ' O ' HD13 ' A' ' 29' ' ' ILE . 67.4 p -169.5 172.39 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.775 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.76 123.81 49.6 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 120.864 -1.147 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' SER . 13.7 m -114.02 112.8 23.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.519 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.92 140.48 31.4 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 119.3 -2.125 . . . . 0.0 116.019 169.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.481 ' O ' ' CB ' ' A' ' 64' ' ' SER . 5.6 m -112.64 126.23 55.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 164.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.698 ' CD1' HD21 ' A' ' 76' ' ' LEU . 28.5 mm -86.29 114.25 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 120.21 -1.556 . . . . 0.0 110.919 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.9 t -103.76 131.71 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.85 52.92 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.96 133.82 10.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.252 0.548 . . . . 0.0 110.106 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.0 ttmt -144.17 171.98 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.198 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.03 -19.03 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.831 173.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 5.6 mp0 -70.86 -39.38 72.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -69.76 -9.05 53.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.276 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.0 tt0 -60.37 122.91 15.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 157.38 -179.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 90' ' ' TYR . 9.8 t0 -87.62 149.89 24.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.9 m-85 -115.28 145.39 42.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 88' ' ' ASP . 67.7 m-85 -143.5 154.1 43.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.215 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.84 141.0 49.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.598 ' CB ' HE21 ' A' ' 35' ' ' GLN . 1.5 mm-40 -125.48 120.74 31.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.615 0.643 . . . . 0.0 109.386 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.7 p -128.54 152.5 48.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.966 0.412 . . . . 0.0 110.649 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.01 147.37 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 96' ' ' SER . 19.0 t0 -72.17 -145.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.545 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.6 m -108.34 -35.54 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.07 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 98' ' ' ASN . 82.7 p -88.8 -10.01 49.71 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.277 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 97' ' ' SER . 9.9 p30 148.59 -110.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 O-C-N 123.995 0.809 . . . . 0.0 109.977 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.424 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 24.0 t-80 50.14 71.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 100' ' ' VAL . 13.5 m -85.92 126.14 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.8 m -149.46 148.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.626 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -135.94 140.41 43.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.23 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.82 -132.47 1.39 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 48.37 47.01 28.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.33 108.78 2.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -133.16 134.57 44.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.841 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.83 124.31 36.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -113.81 131.32 56.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.934 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 111' ' ' LEU . 88.3 m -124.29 128.97 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 110' ' ' VAL . 58.2 t -87.56 34.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' H ' HG22 ' A' ' 109' ' ' THR . 13.7 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.952 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.1 p30 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -112.97 131.47 55.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.984 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.445 ' H ' ' HB2' ' A' ' 25' ' ' SER . 30.1 mtm -153.94 170.11 21.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.32 103.24 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.48 113.93 11.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.588 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 14.0 tt0 -144.87 141.82 17.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 118.977 -0.535 . . . . 0.0 109.58 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 106' ' ' THR . 6.0 Cg_exo -51.4 137.16 48.08 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 CA-C-N 120.563 1.237 . . . . 0.0 110.954 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 9' ' ' SER . 42.2 p-80 -58.85 -49.43 77.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.629 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' ' CD2' ' A' ' 8' ' ' HIS . 2.4 m -158.7 151.68 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.45 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 11' ' ' SER . 6.6 p -160.29 154.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 10' ' ' VAL . 1.8 t -131.9 149.0 52.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.312 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -141.37 162.19 36.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.459 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -85.93 156.8 57.87 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.325 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.71 128.36 19.84 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.69 1.593 . . . . 0.0 112.283 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.77 -5.27 39.94 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -89.4 167.94 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.672 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p -102.75 125.41 49.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.782 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.44 138.95 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 76' ' ' LEU . 32.5 m -128.59 119.78 25.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.931 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.06 132.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -109.07 124.93 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.0 m -118.86 115.4 24.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.4 m -116.96 137.66 52.07 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.659 ' C ' ' H ' ' A' ' 26' ' ' SER . 12.7 ttp85 -92.81 139.18 30.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.498 170.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' A' ' 3' ' ' MET . 16.6 m -58.41 2.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.627 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.06 -18.13 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.89 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.68 22.98 76.32 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.428 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 30.1 t -120.82 110.02 15.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.507 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.47 -63.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.799 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.35 0.35 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.0 p -103.87 -11.63 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.837 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.2 OUTLIER -132.33 152.07 51.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 109.982 -177.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.98 127.96 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.092 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.5 t -119.81 146.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.228 0.537 . . . . 0.0 110.719 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.463 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -138.56 156.99 47.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.341 -177.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.538 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 98.0 m95 -113.93 136.69 52.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.445 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 10.2 m-85 -126.17 149.15 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.42 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -146.13 133.53 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.575 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 1.7 pp0? -130.07 160.21 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.533 177.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -146.7 157.4 47.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.08 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.65 139.07 67.6 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.802 1.668 . . . . 0.0 110.633 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.37 5.51 84.99 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -157.03 176.26 12.99 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.96 176.27 1.56 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.061 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -68.15 148.96 76.03 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.432 2.088 . . . . 0.0 111.924 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 p -132.72 143.31 49.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.424 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 5.5 m -71.7 120.89 17.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.455 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -102.84 -28.66 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.299 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mt -145.61 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.2 t80 -127.79 166.04 18.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.7 tt0 44.77 22.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.083 0.944 . . . . 0.0 110.6 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.2 p30 43.48 17.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.763 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -129.09 -47.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 170.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.9 126.12 30.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.936 -166.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -121.22 119.29 29.67 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.276 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.26 141.37 97.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.8 1.321 . . . . 0.0 111.64 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -67.3 -5.35 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.54 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.99 59.03 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.24 148.5 35.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 122.587 -0.361 . . . . 0.0 110.845 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -59.35 139.41 89.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.813 1.675 . . . . 0.0 111.568 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -61.05 -0.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 63' ' ' PHE . 42.6 ptt85 -56.12 -31.87 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 0.0 111.313 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 60.3 m-85 -72.25 140.89 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.6 t -128.36 122.61 31.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.89 123.94 7.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.41 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -154.56 158.23 39.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.631 . . . . 0.0 111.29 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -143.46 157.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.635 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 m-20 -105.16 143.63 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.813 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -0.05 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.955 0.407 . . . . 0.0 110.327 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.4 m -70.58 -40.77 73.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.02 29.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.397 -177.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -98.93 -39.7 8.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.579 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' ILE . 92.5 p -167.78 169.55 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.889 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.36 130.29 55.21 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.544 -1.348 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' SER . 9.1 m -129.94 114.78 16.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.143 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -97.95 140.53 32.16 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 118.645 -2.534 . . . . 0.0 116.166 167.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 64' ' ' SER . 86.2 m -100.12 128.03 46.27 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 162.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -105.44 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 120.684 -1.26 . . . . 0.0 110.072 174.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.78 170.94 10.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.032 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.36 56.63 4.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 110' ' ' VAL . 1.8 tt -79.38 136.47 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.536 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.467 ' C ' ' N ' ' A' ' 84' ' ' GLU . 14.0 mttp -145.66 -176.6 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.399 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -47.3 -18.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.509 171.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 82' ' ' LYS . 77.9 tt0 -69.97 -41.63 74.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.233 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 14.5 t70 -74.3 -3.65 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.6 tt0 -69.16 124.14 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.76 -175.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.817 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -88.55 135.38 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.239 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 85' ' ' ASP . 13.5 m-85 -114.27 139.95 49.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.028 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.4 m-85 -129.52 154.15 47.31 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.538 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -118.53 140.68 49.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.81 116.47 23.02 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 p -135.41 141.68 45.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' CB ' ' N ' ' A' ' 100' ' ' VAL . 9.7 p90 -159.51 144.97 15.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.703 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' H ' ' HB2' ' A' ' 98' ' ' ASN . 3.4 t70 -110.8 -148.25 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.093 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 t -72.46 -41.58 65.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.988 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 -6.64 58.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 110.715 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.447 ' O ' ' CB ' ' A' ' 99' ' ' HIS . 1.3 m120 -101.54 -69.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.381 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.857 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.5 t-80 78.8 -10.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.883 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER 170.66 114.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.82 148.3 26.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -129.32 137.96 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.486 0.184 . . . . 0.0 110.593 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.24 -154.41 11.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.76 40.17 97.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.67 96.96 0.87 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 7' ' ' PRO . 63.3 m -120.48 131.39 54.72 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.89 117.43 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 29.8 tp -100.32 125.22 46.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.74 109.64 17.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 61.6 t -84.37 44.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.615 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.236 178.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.67 122.15 11.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 3.8 ttt -161.33 170.1 20.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.206 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.3 OUTLIER -129.41 103.15 6.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -83.38 119.71 24.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.875 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.5 tt0 -144.98 145.54 27.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.649 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -49.94 136.59 36.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.257 1.128 . . . . 0.0 111.209 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.537 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 5.1 m -156.41 160.18 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.683 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.84 146.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.912 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p -141.08 145.87 36.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.589 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -142.95 154.24 43.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -78.04 140.67 62.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.635 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.06 123.98 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.737 1.624 . . . . 0.0 111.021 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.79 22.41 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -97.88 -171.73 2.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.662 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p -119.89 142.42 48.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.47 142.41 44.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.079 0.466 . . . . 0.0 110.611 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -128.62 134.45 48.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.434 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mm -105.8 146.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.179 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -124.06 122.8 38.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.5 117.91 30.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 m -117.01 142.11 47.38 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.683 ' HE ' ' CB ' ' A' ' 93' ' ' SER . 50.9 mtt85 -98.59 140.53 32.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.315 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -58.54 3.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.33 -17.11 15.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.603 -174.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.48 -41.3 2.49 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -65.42 111.0 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.054 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.12 -59.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.505 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.758 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.66 1.09 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 29' ' ' ILE . 7.8 t -107.92 -30.23 8.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.901 -1.5 . . . . 0.0 111.568 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.516 ' ND2' ' OD2' ' A' ' 95' ' ' ASP . 16.0 m120 -111.86 143.11 43.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.4 m-85 -73.95 134.31 43.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.888 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' CG2' ' NH2' ' A' ' 24' ' ' ARG . 1.5 t -121.0 145.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.354 0.597 . . . . 0.0 109.944 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.7 153.23 45.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.463 -176.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 29.3 m95 -129.99 132.34 46.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 110.519 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 32.3 m-85 -119.29 149.39 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.633 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.548 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -131.37 129.27 41.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 43' ' ' SER . 52.7 tp60 -113.56 124.83 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.749 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.14 148.95 59.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 139.28 89.8 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.418 1.412 . . . . 0.0 110.559 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.62 10.03 82.66 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 7.6 m -148.71 143.0 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 110.589 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 175.95 4.01 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.123 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.84 142.25 42.75 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.19 1.927 . . . . 0.0 111.458 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.5 p -139.25 134.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.507 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 4.4 m -70.29 118.79 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.162 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.88 -21.82 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.338 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.4 mt -144.56 143.16 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 52' ' ' ASP . 76.8 t80 -133.12 167.22 20.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.314 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 53' ' ' ASN . 10.0 tp10 44.67 23.51 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.043 0.925 . . . . 0.0 110.241 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.2 t70 44.22 19.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.255 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.04 -45.18 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.783 168.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -53.31 143.89 17.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.36 -170.115 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -146.82 108.57 4.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 118.989 -0.529 . . . . 0.0 109.866 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.21 148.89 56.76 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.534 1.489 . . . . 0.0 111.95 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -74.13 -30.2 62.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.38 -47.12 63.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.51 145.31 31.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.1 Cg_endo -53.01 117.99 4.33 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.915 1.744 . . . . 0.0 111.293 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' PHE . 18.5 p-10 -60.78 0.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.697 HH12 ' N ' ' A' ' 85' ' ' ASP . 47.2 mtm105 -46.12 -11.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.996 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 3.4 m-85 -105.4 143.08 34.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.6 t -124.75 122.86 38.66 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.81 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.19 121.77 7.0 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.47 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.1 p -157.29 163.75 38.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -139.1 155.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.522 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -100.18 152.06 20.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.836 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.7 m -67.94 -8.56 38.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' SER . 58.0 m -61.34 -41.17 96.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER 79.6 27.29 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.347 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -98.55 -41.75 7.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.648 ' C ' HD13 ' A' ' 29' ' ' ILE . 62.7 p -164.43 174.85 10.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.67 47.78 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.614 -1.303 . . . . 0.0 110.011 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 66' ' ' SER . 69.1 m -116.77 116.67 27.93 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.839 -169.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.82 140.58 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 118.474 -2.642 . . . . 0.0 117.386 170.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 64' ' ' SER . 4.5 m -107.85 127.39 53.68 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 163.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -104.18 109.92 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 120.08 -1.638 . . . . 0.0 110.21 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.99 155.75 16.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.332 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.06 42.22 96.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.21 136.86 57.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -151.83 177.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.262 177.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.93 -21.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.521 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.8 mt-10 -70.22 -40.69 74.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.261 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.9 OUTLIER -70.82 -9.03 56.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.145 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 39.5 tt0 -64.18 125.22 23.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.183 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 163.1 -175.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.039 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.085 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.548 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 16.2 m-85 -115.25 146.82 41.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.459 . . . . 0.0 111.08 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.6 m-85 -144.79 149.01 34.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.077 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.402 ' N ' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -140.7 140.18 34.86 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.432 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 mt-30 -133.16 149.02 52.09 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.683 ' CB ' ' HE ' ' A' ' 24' ' ' ARG . 15.1 m -135.19 126.76 28.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.389 . . . . 0.0 110.938 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 35' ' ' GLN . 12.3 p90 -159.14 130.98 6.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.849 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD2' ' ND2' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -98.87 -153.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.488 178.111 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -16.37 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -87.66 39.44 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 49.89 -128.41 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.698 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 49.69 82.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.348 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 100' ' ' VAL . 9.3 p -85.91 116.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.11 125.84 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.839 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -116.28 140.34 49.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.225 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.52 -145.0 4.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 91' ' ' CYS . . . 76.38 12.78 83.98 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.15 99.33 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.4 m -142.42 141.76 32.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.005 0.431 . . . . 0.0 110.26 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -106.19 119.16 38.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 tp -104.04 122.61 45.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -117.29 111.66 19.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 110' ' ' VAL . 47.6 t -82.76 31.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.779 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.984 -179.18 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.4 p-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -73.47 103.77 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.145 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtm -137.52 169.89 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.508 HD13 ' HA2' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -126.79 118.82 25.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -85.88 120.47 27.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.783 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.58 ' NE2' ' O ' ' A' ' 103' ' ' GLY . 7.5 tt0 -145.48 141.94 17.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.45 160.76 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.247 1.298 . . . . 0.0 111.773 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.29 -56.56 3.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -156.31 150.55 25.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.48 149.62 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 p -120.26 137.62 54.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -117.01 155.38 29.29 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 m -82.99 131.99 52.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.978 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.4 116.77 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.665 1.577 . . . . 0.0 111.018 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.53 -1.97 20.25 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -101.93 -171.74 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.242 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 p -125.85 146.77 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.205 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.83 150.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -126.26 137.31 53.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.6 mm -94.54 150.45 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -125.83 114.93 19.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.812 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 50.5 m -118.69 113.76 21.68 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' HD23 ' A' ' 4' ' ' LEU . 57.2 m -113.31 141.22 47.28 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.02 -1.05 . . . . 0.0 108.272 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 26' ' ' SER . 40.5 mtp85 -89.53 137.24 32.5 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.32 -0.862 . . . . 0.0 110.377 170.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -60.97 2.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.48 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.613 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -102.75 -16.93 15.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.499 -175.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.03 22.84 70.44 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 m -125.89 111.06 14.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.496 0.189 . . . . 0.0 110.829 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.31 -61.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.14 -0.35 . . . . 0.0 111.584 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.76 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.0 1.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 29' ' ' ILE . 94.0 p -109.77 -9.83 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.483 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 28' ' ' SER . 2.7 m120 -124.69 145.7 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.27 134.84 45.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.0 t -130.06 147.93 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.509 0.671 . . . . 0.0 111.164 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.1 OUTLIER -137.88 153.39 49.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.108 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -117.58 120.75 39.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HE1' HG23 ' A' ' 47' ' ' THR . 9.0 m-85 -121.48 149.31 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.229 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.34 137.21 47.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.17 135.48 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.76 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -123.81 125.76 25.84 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.983 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.6 141.65 95.38 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.225 1.283 . . . . 0.0 110.843 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.99 -8.57 79.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -154.88 162.49 41.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.33 176.45 3.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.0 148.74 51.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.307 2.004 . . . . 0.0 111.703 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 m -120.63 121.72 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.139 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.413 HG23 ' HE1' ' A' ' 37' ' ' TYR . 29.9 m -62.13 120.59 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.793 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.568 HG13 HG21 ' A' ' 59' ' ' VAL . 2.4 t -101.14 -28.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.007 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -145.23 149.35 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 52' ' ' ASP . 62.7 t80 -134.3 160.85 36.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.033 172.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 6.6 tt0 47.19 24.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.326 0.584 . . . . 0.0 111.136 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.6 p30 44.42 19.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.602 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -127.76 -46.19 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.432 0.634 . . . . 0.0 109.56 170.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -53.65 135.52 40.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.599 -167.55 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 108.79 18.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -63.36 148.71 92.59 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.96 1.774 . . . . 0.0 111.771 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 t -64.15 -29.54 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.86 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.34 -49.57 71.69 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.568 HG21 HG13 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -96.03 129.63 33.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.5 Cg_endo -62.91 164.34 19.4 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.641 1.561 . . . . 0.0 111.901 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -59.54 1.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.081 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.631 ' NE ' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -39.59 -37.08 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 44.3 m-85 -89.53 143.75 26.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.5 t -136.93 122.97 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.221 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.12 125.93 7.09 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.562 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 68.8 p -159.43 161.35 35.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.069 0.462 . . . . 0.0 111.023 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -137.02 161.31 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.646 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 70' ' ' SER . 86.6 m-20 -102.39 154.9 18.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.717 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -68.87 10.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 68' ' ' ASP . 26.1 m -80.49 -42.94 21.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.88 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.0 28.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.444 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -99.69 -38.12 8.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.607 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' HD13 ' A' ' 29' ' ' ILE . 88.9 p -167.95 166.26 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.97 134.18 51.24 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.063 -1.023 . . . . 0.0 109.655 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 7.4 m -134.07 120.07 19.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.79 140.35 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.296 -1.503 . . . . 0.0 114.101 167.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 57.6 m -106.6 128.84 54.46 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 164.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 78' ' ' ILE . 2.0 mt -104.82 116.56 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 120.82 -1.175 . . . . 0.0 109.672 171.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 t -98.82 127.98 44.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.704 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 69.65 1.38 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.7 tt -85.4 127.84 34.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.383 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' C ' ' N ' ' A' ' 84' ' ' GLU . 8.3 mtmt -137.05 -177.0 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.8 0.334 . . . . 0.0 110.636 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -19.36 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.316 171.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' C ' ' A' ' 82' ' ' LYS . 52.7 tp10 -67.2 -41.18 86.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.849 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 1.3 m-20 -68.99 -19.05 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.082 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 68.3 tt0 -51.16 120.83 5.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.669 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.87 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.317 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.76 143.7 26.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.18 139.64 50.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.158 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -137.8 142.49 40.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.764 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.477 ' SG ' ' HA3' ' A' ' 103' ' ' GLY . 5.7 p -121.84 140.46 52.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.551 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 40.1 mt-30 -124.25 128.75 49.63 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.214 -0.304 . . . . 0.0 110.478 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.833 ' O ' HG22 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -135.16 155.61 50.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.682 -177.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.425 ' CE2' ' NE2' ' A' ' 35' ' ' GLN . 2.8 p90 -159.34 130.79 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.175 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' N ' ' HB2' ' A' ' 98' ' ' ASN . 16.0 m-20 -89.92 -149.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -42.18 79.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.667 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.411 ' C ' HD22 ' A' ' 98' ' ' ASN . 74.9 m -107.3 38.15 2.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.766 0.317 . . . . 0.0 110.845 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 100' ' ' VAL . 1.5 m-80 -125.11 -58.61 1.45 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.169 0.509 . . . . 0.0 111.348 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.881 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER 61.69 -10.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.929 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER 172.48 122.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 118.153 0.433 . . . . 0.0 110.214 177.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 93' ' ' SER . 1.1 m -141.5 173.07 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.09 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.1 p90 -113.0 143.97 43.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.6 . . . . 0.0 109.97 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.58 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . -103.49 27.7 18.74 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.469 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.523 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . 54.55 63.27 5.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.233 -0.985 . . . . 0.0 110.74 174.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.55 149.46 8.23 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.598 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.8 m -111.04 141.47 44.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -81.55 123.94 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.504 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 tp -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.565 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.5 m -123.73 121.46 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.406 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 82' ' ' LYS . 39.0 t -83.76 96.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 110' ' ' VAL . 7.0 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.725 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' A' ' 2' ' ' PHE . 18.5 t-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.416 ' N ' ' OD1' ' A' ' 1' ' ' ASN . 14.7 m-85 -126.69 116.66 21.31 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.0 ttp -150.72 169.96 20.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 103' ' ' GLY . 0.5 OUTLIER -119.4 103.02 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 130.89 35.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.493 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.834 HE22 ' H ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -146.34 164.41 24.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.023 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.85 145.29 51.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.398 2.066 . . . . 0.0 110.869 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.587 ' CD2' ' C ' ' A' ' 8' ' ' HIS . 1.9 t-80 -59.25 -73.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.503 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.432 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 49.0 m -161.47 159.35 27.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.605 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.24 155.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.467 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' HD21 ' A' ' 111' ' ' LEU . 5.0 p -125.6 137.3 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.373 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.12 161.93 18.64 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -89.94 142.29 28.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.312 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.3 114.9 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.576 1.517 . . . . 0.0 111.452 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.43 -20.3 16.03 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.56 -169.42 1.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.5 p -129.61 153.89 47.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.42 152.23 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -124.27 134.05 53.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.948 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.2 mt -101.85 143.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.584 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -119.59 127.96 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.737 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -118.46 112.52 20.06 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.9 m -113.22 140.58 47.83 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.707 -1.246 . . . . 0.0 108.02 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 20.2 mtp85 -94.1 139.35 31.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.011 170.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -59.13 1.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.542 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.94 -18.2 14.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.546 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 86.57 -19.16 29.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.409 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 1.1 t -87.12 116.78 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.978 -0.719 . . . . 0.0 110.543 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.42 -61.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.34 -0.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.8 t -97.23 -26.66 14.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.268 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 28' ' ' SER . 2.4 p30 -114.85 141.46 47.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.25 144.38 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.46 140.71 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.446 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 13.6 pt20 -121.44 152.54 38.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.363 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.18 142.31 46.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.486 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.8 m-85 -139.14 149.24 44.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.89 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.409 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -131.18 141.54 50.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -125.75 135.35 51.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.358 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -123.93 149.71 60.6 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -55.67 134.05 61.7 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.537 1.492 . . . . 0.0 110.814 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.12 2.86 84.1 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -138.83 146.6 41.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.05 0.452 . . . . 0.0 110.307 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.435 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -80.8 178.29 2.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -178.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -69.41 150.44 70.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.352 2.035 . . . . 0.0 111.865 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 m -132.83 126.69 32.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.351 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.0 m -64.14 119.02 9.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.176 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 t -101.29 -29.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.048 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 mt -145.35 150.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.3 t80 -136.22 163.9 29.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.888 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp10 44.68 24.27 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.834 0.826 . . . . 0.0 110.682 -172.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' TYR . 33.7 t0 43.97 20.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.015 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -128.06 -46.13 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 169.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.97 131.06 26.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.124 -168.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.766 ' NH2' ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -116.43 108.82 44.8 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 48' ' ' VAL . 5.7 Cg_exo -65.91 147.24 84.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.965 1.777 . . . . 0.0 111.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 p -70.81 -36.58 73.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.67 -43.12 86.31 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.0 m -98.1 127.74 35.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.4 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.7 Cg_exo -62.78 161.93 27.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.322 1.348 . . . . 0.0 111.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.606 ' C ' HH21 ' A' ' 55' ' ' ARG . 47.3 t0 -60.12 3.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.412 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -48.02 -27.59 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.633 -175.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.766 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 31.8 m-85 -92.07 136.55 33.08 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.215 -0.303 . . . . 0.0 110.663 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.4 t -125.12 123.85 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.933 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.67 131.74 10.65 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.128 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.7 p -161.63 172.43 16.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.304 0.574 . . . . 0.0 111.224 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 30' ' ' ALA . 3.6 pt -149.56 163.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.229 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.85 152.76 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.698 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 p -68.02 -8.32 36.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.42 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.3 m -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.886 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.03 27.73 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 -178.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -99.13 -37.07 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.224 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.755 ' C ' HD13 ' A' ' 29' ' ' ILE . 85.5 p -165.96 166.76 17.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.406 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.01 130.04 55.47 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.084 -1.01 . . . . 0.0 109.709 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.5 m -132.9 122.45 24.37 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.458 -169.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.25 141.05 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.8 -1.813 . . . . 0.0 114.834 169.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 64' ' ' SER . 9.9 m -106.31 125.71 51.34 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 165.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.702 ' CD1' HD21 ' A' ' 76' ' ' LEU . 30.9 mm -86.86 123.51 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 120.195 -1.566 . . . . 0.0 110.543 171.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 t -112.95 127.71 56.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.577 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.42 43.77 10.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HA ' HH22 ' A' ' 62' ' ' ARG . 2.1 tt -64.82 132.21 48.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.429 . . . . 0.0 110.453 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.458 ' C ' ' N ' ' A' ' 84' ' ' GLU . 11.9 tttp -143.65 174.72 10.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.128 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -46.16 -21.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.542 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' A' ' 82' ' ' LYS . 66.8 mm-40 -69.27 -42.77 75.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.132 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 19.8 m-20 -68.81 -5.64 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.433 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.6 tt0 -62.08 121.06 12.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.2 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.22 -179.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.528 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.87 151.61 23.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.162 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -121.72 146.17 47.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 111.068 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.8 m-85 -144.38 148.75 35.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.469 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 103' ' ' GLY . 0.7 OUTLIER -134.43 140.17 46.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.38 136.32 51.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.333 0.587 . . . . 0.0 110.019 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -134.97 -176.39 4.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.546 ' CD1' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -149.02 135.05 19.06 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 123.64 0.588 . . . . 0.0 110.479 174.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 96' ' ' SER . 31.5 t0 -134.85 -145.99 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.992 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.541 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 4.7 t -46.62 -14.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.524 0.202 . . . . 0.0 110.694 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 95' ' ' ASP . 11.0 p -81.41 -7.12 59.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.931 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 63.76 111.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.341 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.42 ' O ' HG23 ' A' ' 100' ' ' VAL . 37.1 m-70 42.21 31.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 99' ' ' HIS . 70.0 t -152.64 111.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 118.565 0.62 . . . . 0.0 111.84 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -167.78 136.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 166.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 2.9 p90 -119.24 148.98 42.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.001 0.429 . . . . 0.0 111.133 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 4' ' ' LEU . . . -172.2 -146.53 5.38 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.834 ' H ' HE22 ' A' ' 6' ' ' GLN . . . 65.66 -7.03 1.12 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.187 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . -51.96 84.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' GLY . 20.5 m -150.09 125.67 10.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.23 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -83.58 132.37 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.159 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.2 tp -119.74 127.04 52.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.629 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.8 125.75 50.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.264 0.554 . . . . 0.0 110.038 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 110' ' ' VAL . 65.5 t -88.91 36.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.381 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.548 HD21 ' OG ' ' A' ' 11' ' ' SER . 83.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.746 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 2' ' ' PHE . 17.8 p30 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.415 ' N ' ' OD1' ' A' ' 1' ' ' ASN . 16.7 m-85 -150.65 124.85 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.765 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.1 mtm -128.73 169.99 13.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 3' ' ' MET . 8.2 mp -132.6 108.84 9.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -92.12 117.53 29.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.621 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -145.79 165.66 20.17 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.13 151.26 12.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.546 2.164 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.563 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -75.83 -65.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.03 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -158.82 146.03 17.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.229 0.537 . . . . 0.0 110.373 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.28 146.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.057 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 p -117.07 143.64 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.491 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.32 163.08 26.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.334 0.587 . . . . 0.0 110.475 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -94.67 142.57 24.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.27 113.99 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.416 1.411 . . . . 0.0 111.152 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.12 -5.02 15.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -94.25 177.8 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.1 p -128.96 142.79 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.76 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 19' ' ' THR . 3.4 p -137.32 155.2 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -125.63 125.36 42.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.53 146.51 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.367 0.603 . . . . 0.0 110.786 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -117.36 132.68 56.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.814 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.82 116.48 26.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -111.31 134.22 53.06 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 61.2 mtp180 -91.34 138.16 31.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.603 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.639 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -57.81 3.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.57 176.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -96.7 -12.87 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.21 -173.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 -1.87 39.4 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.266 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -124.24 124.73 43.08 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.215 0.206 . . . . 0.0 110.82 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -128.86 -55.33 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.691 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.34 -1.16 2.2 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 12.0 p -86.59 -32.24 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 111.698 -2.501 . . . . 0.0 111.075 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.445 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 1.8 m120 -122.46 159.23 28.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.15 123.39 25.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.975 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 ' H ' ' HB3' ' A' ' 52' ' ' ASP . 96.2 t -103.76 146.89 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.355 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 36' ' ' TRP . 5.4 tt0 -133.32 158.83 41.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 12.7 m95 -129.45 124.14 33.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.929 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CD2' ' OE1' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -110.73 149.55 30.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.17 142.21 49.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.545 ' OE1' ' N ' ' A' ' 44' ' ' SER . 0.5 OUTLIER -140.36 117.1 10.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.429 ' O ' ' OE1' ' A' ' 39' ' ' GLN . 2.5 mpt_? -84.53 175.87 4.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.84 126.24 20.66 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 CA-C-O 121.963 0.735 . . . . 0.0 111.107 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 -35.65 0.26 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 113.654 -1.612 . . . . 0.0 114.824 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.414 ' C ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -158.91 115.91 2.75 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.938 1.869 . . . . 0.0 112.688 170.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.545 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -170.75 92.7 0.46 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 119.05 0.841 . . . . 0.0 111.763 169.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.24 121.13 4.27 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.46 1.44 . . . . 0.0 111.687 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 m -148.7 97.95 2.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.921 0.391 . . . . 0.0 110.117 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 28.8 m -64.25 120.18 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 63' ' ' PHE . 24.8 t -100.16 -28.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.956 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -144.95 142.19 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -136.07 148.67 48.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.595 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 53' ' ' ASN . 14.2 tp10 58.96 22.49 10.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.942 1.353 . . . . 0.0 110.243 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER 42.73 17.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.813 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.44 -47.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.294 0.569 . . . . 0.0 111.409 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.25 140.63 29.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.329 -165.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.6 144.98 32.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.99 150.89 75.83 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.314 1.343 . . . . 0.0 111.275 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.2 p -71.05 -22.35 62.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.6 96.41 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.94 140.79 43.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -51.78 119.63 5.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.084 1.19 . . . . 0.0 110.581 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.74 1.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.009 -0.432 . . . . 0.0 111.037 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 60' ' ' PRO . 46.4 mtm180 -53.18 -22.34 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.62 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 6.8 m-85 -75.27 129.09 36.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.978 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 5.0 t -110.17 121.59 45.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.067 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.16 126.15 8.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.528 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.7 p -164.37 166.85 20.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.329 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.2 160.9 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -93.07 163.31 13.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.093 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 m -68.45 30.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -123.12 -46.33 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 79.0 25.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.787 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -98.33 -19.04 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.601 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' ILE . 30.9 p -158.32 169.94 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.838 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.88 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 8.0 m -99.02 110.99 23.51 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.988 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -101.15 140.45 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.471 ' O ' ' CB ' ' A' ' 64' ' ' SER . 94.9 m -112.56 124.38 52.39 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 163.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.2 mt -102.46 109.11 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 O-C-N 119.966 -1.709 . . . . 0.0 110.446 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -99.34 142.42 30.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.392 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.03 44.83 8.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 110' ' ' VAL . 2.7 tt -74.75 129.91 38.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.217 0.532 . . . . 0.0 110.559 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' GLU . 15.9 tttt -138.77 172.6 12.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.83 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 83' ' ' THR . 29.7 p -45.88 -19.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.544 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 27.6 tt0 -73.79 -38.45 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.335 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -68.89 -4.38 16.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 74.4 tt0 -60.43 129.16 40.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.425 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.76 173.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -91.02 143.58 26.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.782 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 11.5 m-85 -109.75 150.72 27.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.223 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 49.3 m-85 -146.81 153.77 40.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.369 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 94.3 m -120.73 141.08 50.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 33.6 mt-30 -126.71 137.47 53.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.727 0.694 . . . . 0.0 110.497 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NH2' ' A' ' 24' ' ' ARG . 3.0 t -128.71 143.21 50.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.276 0.56 . . . . 0.0 110.92 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.67 135.64 9.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.3 m-20 -105.02 -175.89 2.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.831 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -54.01 -32.13 53.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.628 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.491 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 7.2 t -80.34 38.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.891 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 46.61 -113.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 97' ' ' SER . 27.4 m170 44.85 81.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.857 0.361 . . . . 0.0 110.587 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 m -86.13 129.46 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.92 158.54 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.918 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -136.36 144.62 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.134 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.25 -157.24 16.96 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.15 53.9 38.91 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.27 107.1 3.36 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.436 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 37.9 m -124.54 129.96 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.027 0.441 . . . . 0.0 110.71 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.21 115.62 25.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.276 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -102.9 122.74 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 111' ' ' LEU . 93.0 m -119.68 114.99 23.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.406 0.622 . . . . 0.0 110.075 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 110' ' ' VAL . 57.9 t -76.83 30.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.822 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 109' ' ' THR . 77.3 mt . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.567 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.85 130.23 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.574 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 ttt -140.62 170.23 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.463 HD22 ' NE2' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -127.26 103.09 7.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -95.46 120.19 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.514 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 167.93 12.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -53.33 144.91 47.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -75.88 -51.6 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.82 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -159.27 151.16 20.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 110.809 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 11' ' ' SER . 5.4 p -161.37 155.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.468 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 10' ' ' VAL . 78.6 p -137.37 152.89 50.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -142.03 162.18 36.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.221 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.531 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -92.37 151.08 41.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.907 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.87 117.77 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.781 1.654 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.16 9.74 31.27 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 13' ' ' SER . 72.3 mttt -98.96 -178.7 4.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 110.619 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.6 p -122.54 128.07 50.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.212 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.6 139.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.741 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 76' ' ' LEU . 99.9 m -125.6 133.26 52.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.532 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 1.3 mt -113.06 142.02 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.198 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -117.08 131.72 56.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.556 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.514 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.3 m -119.59 124.07 45.47 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.1 m -120.53 142.11 49.63 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.954 -1.091 . . . . 0.0 108.24 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 26' ' ' SER . 28.2 ttm180 -99.74 144.6 28.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.294 168.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 p -60.75 3.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.837 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.585 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.32 -17.78 14.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 -175.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 71.3 23.68 77.79 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 t -119.86 105.27 10.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.646 0.26 . . . . 0.0 111.158 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.18 -64.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -3.79 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.7 m -97.85 -22.68 16.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.668 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -126.55 155.08 42.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -73.02 125.53 27.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.059 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.05 148.04 23.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.537 0.685 . . . . 0.0 110.779 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -141.45 169.97 16.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.182 -178.199 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 70.1 m95 -131.25 146.36 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.5 m-85 -132.9 149.04 52.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -127.5 135.55 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 7.1 tm0? -130.26 143.48 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.489 0.661 . . . . 0.0 109.66 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 1.0 OUTLIER -144.55 158.24 54.21 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.061 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -52.08 130.84 36.69 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.817 1.678 . . . . 0.0 110.677 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -32.84 1.63 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 41' ' ' PRO . 28.3 t -76.57 171.66 14.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -121.82 156.18 59.44 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.318 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.87 124.05 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.313 2.009 . . . . 0.0 110.319 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -125.35 125.35 43.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 110.666 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -65.39 119.97 11.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.383 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.92 -25.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.007 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.0 mt -144.34 135.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 64.7 t80 -125.77 164.36 20.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.761 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.6 tt0 45.91 22.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.357 -170.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 43.55 17.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.926 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.573 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -128.87 -46.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 110.647 170.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.13 154.48 17.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.27 -1.786 . . . . 0.0 107.82 -165.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.81 ' H ' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -143.73 146.72 36.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.257 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.44 145.48 88.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.389 1.392 . . . . 0.0 110.929 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 m -62.07 -22.09 65.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.132 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.14 97.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.2 142.18 24.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.369 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.15 143.18 98.63 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.479 1.453 . . . . 0.0 111.702 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.4 p30 -62.61 -2.83 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.622 ' NH1' ' CE1' ' A' ' 63' ' ' PHE . 28.8 ptt85 -47.01 -40.21 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.371 0.605 . . . . 0.0 110.576 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' CE1' ' NH1' ' A' ' 62' ' ' ARG . 97.9 m-85 -62.98 129.18 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.422 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 6.1 t -113.79 119.44 37.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.414 0.626 . . . . 0.0 110.909 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.2 112.47 3.59 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.134 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 75' ' ' SER . 7.3 p -149.61 167.48 26.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.51 0.671 . . . . 0.0 110.208 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -143.49 163.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.976 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 70' ' ' SER . 75.8 m-20 -98.77 152.75 19.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.518 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -68.35 31.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.687 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 68' ' ' ASP . 30.1 m -104.12 -46.31 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.578 0.228 . . . . 0.0 110.565 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 85.43 25.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.473 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.05 -37.34 9.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.066 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.641 ' C ' HD13 ' A' ' 29' ' ' ILE . 52.9 p -160.12 166.67 29.37 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.535 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.25 127.01 54.76 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.741 -1.224 . . . . 0.0 109.513 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -121.72 116.07 23.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.39 -172.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 19' ' ' THR . 0.6 OUTLIER -99.02 140.27 33.42 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 118.344 -2.722 . . . . 0.0 117.329 168.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 64' ' ' SER . 61.8 m -106.06 126.28 52.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 163.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.471 ' CD1' HD21 ' A' ' 76' ' ' LEU . 3.1 mt -97.51 112.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 119.798 -1.813 . . . . 0.0 110.918 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.642 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -96.11 137.69 34.81 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.834 -0.541 . . . . 0.0 111.462 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 58.75 3.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.07 135.0 36.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.211 0.529 . . . . 0.0 110.478 177.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -134.36 176.44 8.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.714 174.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 p -47.65 -19.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' N ' ' C ' ' A' ' 82' ' ' LYS . 9.4 tp10 -70.53 -39.36 74.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.821 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.602 ' CB ' HH22 ' A' ' 62' ' ' ARG . 27.6 t0 -67.18 -7.09 20.99 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.399 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -62.41 130.62 46.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.89 175.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -85.03 144.77 28.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.474 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 8.9 m-85 -108.91 154.21 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -150.49 145.48 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 59.4 m -120.28 141.01 50.38 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 5.7 mt-30 -124.45 145.39 49.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 24' ' ' ARG . 53.5 p -135.09 123.73 23.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 110.353 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.25 131.67 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -99.22 -148.46 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.871 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 m -84.2 -26.52 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.615 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.43 35.85 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.334 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.9 m120 51.44 -136.48 1.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.503 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.0 m170 48.71 82.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.4 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.16 138.34 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.199 0.523 . . . . 0.0 110.852 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.73 131.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.126 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.29 166.83 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.736 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.3 -139.24 10.91 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 45.12 29.67 2.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.13 158.11 5.61 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.9 m -126.06 130.09 50.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.517 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -80.59 110.34 15.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.2 tp -99.39 124.81 44.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.19 124.37 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.092 0.472 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' LEU . 61.2 t -87.63 94.43 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 110' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.234 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -84.41 133.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.451 ' C ' HD12 ' A' ' 4' ' ' LEU . 16.8 mmm -146.96 168.45 21.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 110.308 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 3' ' ' MET . 7.7 mp -123.63 107.98 12.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -78.19 113.51 16.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 104' ' ' GLY . 14.6 mt-30 -140.37 158.21 66.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.18 140.99 71.12 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.93 1.753 . . . . 0.0 110.38 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -49.25 70.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.18 129.0 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.065 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 11' ' ' SER . 7.4 p -139.28 161.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.155 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.562 ' N ' HG22 ' A' ' 10' ' ' VAL . 94.1 p -143.43 155.53 44.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.624 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -140.31 153.17 46.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.074 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.26 141.98 74.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.195 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 115.28 2.16 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.715 1.61 . . . . 0.0 111.246 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.37 1.03 33.13 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -98.06 161.51 13.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.8 p -93.0 134.35 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.9 137.46 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -118.64 134.18 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.322 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mt -99.81 137.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.426 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 m -111.62 116.68 31.2 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.5 t -118.92 113.04 20.41 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 m -114.79 140.78 48.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 26' ' ' SER . 31.8 ttp180 -92.56 136.83 32.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.999 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -59.05 3.74 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.645 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.79 -18.06 14.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.678 -174.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.85 20.05 76.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -123.07 109.62 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.979 0.39 . . . . 0.0 110.773 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.17 -62.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 -176.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.22 0.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.642 ' H ' ' C ' ' A' ' 29' ' ' ILE . 91.5 p -109.82 -3.13 16.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.566 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -135.9 158.5 44.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.124 0.487 . . . . 0.0 110.874 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.43 129.18 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' HE21 ' A' ' 35' ' ' GLN . 81.9 t -123.14 148.06 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 110.728 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.99 153.93 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.151 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -110.3 135.13 51.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 11.4 m-85 -129.17 147.54 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.324 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.421 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -134.38 133.07 40.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.128 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -112.48 116.14 29.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -173.83 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -69.72 125.62 12.38 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 CA-C-N 120.449 1.196 . . . . 0.0 110.094 -172.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.25 -36.12 0.25 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 112.876 -1.965 . . . . 0.0 114.927 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 m -159.38 92.15 1.05 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.155 1.977 . . . . 0.0 114.477 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -170.77 91.89 0.47 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 118.07 -1.452 . . . . 0.0 111.727 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -76.75 135.39 15.9 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.84 2.36 . . . . 0.0 111.431 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -146.93 105.4 3.8 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.757 -0.59 . . . . 0.0 111.003 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 25.8 m -63.38 120.23 11.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.878 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.62 -28.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.735 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.4 149.95 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' ASP . 6.2 t80 -134.76 164.04 28.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.793 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.37 23.87 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.569 1.176 . . . . 0.0 110.754 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.7 p30 44.35 19.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.587 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -127.85 -45.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.405 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.6 OUTLIER -53.54 134.89 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.279 -170.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -137.39 108.65 8.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -70.06 152.8 67.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.853 1.702 . . . . 0.0 112.013 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -70.78 -33.12 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.375 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.23 -47.7 79.97 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 59' ' ' VAL . 3.8 m -90.68 132.52 34.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.1 Cg_exo -59.3 142.07 98.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.462 1.441 . . . . 0.0 111.117 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' PHE . 49.9 p-10 -61.21 1.65 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.566 HH22 ' CG ' ' A' ' 85' ' ' ASP . 8.4 ptm180 -49.69 -2.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' ASP . 17.3 m-85 -107.98 146.44 32.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.3 t -130.39 121.03 25.17 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.893 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.79 123.16 7.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.345 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.6 p -158.81 164.51 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.426 -0.455 . . . . 0.0 110.2 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.652 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -135.08 159.92 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.589 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 70' ' ' SER . 30.7 m-20 -96.66 144.18 26.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 p -70.13 27.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.008 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 68' ' ' ASP . 21.2 m -102.23 -36.76 8.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.015 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 82.21 22.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.234 -177.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -95.8 -43.71 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.754 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' ILE . 95.0 p -162.1 174.86 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.009 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.9 126.78 55.07 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.331 -1.48 . . . . 0.0 110.573 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.9 m -118.23 112.31 19.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.569 -171.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -97.02 140.75 31.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 168.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.4 m -110.52 128.25 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 163.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.424 HG13 HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.0 109.95 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 119.812 -1.805 . . . . 0.0 110.666 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -98.65 141.25 31.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.555 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.82 32.99 35.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 110' ' ' VAL . 2.3 tt -55.8 145.79 23.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.987 0.422 . . . . 0.0 110.318 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' ASP . 6.6 tttp -160.66 177.87 10.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.355 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 t -46.01 -19.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 82' ' ' LYS . 77.4 mt-10 -71.85 -40.02 69.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.367 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.566 ' CG ' HH22 ' A' ' 62' ' ' ARG . 18.9 t70 -70.32 -13.12 62.02 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.173 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 32.9 tt0 -58.23 123.14 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.6 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.0 178.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 109.942 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.07 146.38 25.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.2 m-85 -121.88 146.27 47.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 111.083 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.1 m-85 -141.72 149.18 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.17 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.492 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.3 p -124.85 140.87 52.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.5 mt-30 -116.83 140.06 49.88 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.174 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 101' ' ' VAL . 60.9 p -135.07 119.69 18.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' HA ' HG11 ' A' ' 100' ' ' VAL . 32.2 p90 -158.96 153.91 25.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.123 175.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -128.62 -146.54 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.655 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -22.74 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.288 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.9 p -82.63 14.07 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 99' ' ' HIS . 1.1 m120 44.69 -136.17 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.35 -176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 98' ' ' ASN . 75.6 m80 37.2 70.12 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.229 0.538 . . . . 0.0 110.825 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.674 HG22 ' H ' ' A' ' 101' ' ' VAL . 1.8 p -160.3 -171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.253 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.674 ' H ' HG22 ' A' ' 100' ' ' VAL . 1.3 m -155.37 -179.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.663 0.744 . . . . 0.0 111.619 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -157.22 151.63 25.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.235 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 144.93 -129.8 3.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.606 ' O ' ' NE2' ' A' ' 6' ' ' GLN . . . 84.92 62.57 1.67 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.11 110.14 2.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -117.16 118.89 33.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -78.44 116.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.986 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.8 tp -110.71 126.53 54.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 m -118.97 133.67 55.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.391 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.72 ' O ' HG12 ' A' ' 110' ' ' VAL . 79.2 t -86.03 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.228 0.537 . . . . 0.0 110.587 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.698 -1.144 . . . . 0.0 110.874 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -118.08 127.85 54.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.023 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.8 mmm -128.73 170.03 13.8 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.555 HD21 HH21 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -130.87 102.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -91.43 138.41 31.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.69 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 104' ' ' GLY . 15.1 mt-30 -143.87 160.12 51.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.31 128.53 23.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.925 1.75 . . . . 0.0 111.023 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' CD2' ' H ' ' A' ' 9' ' ' SER . 3.7 p-80 -45.21 -59.24 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.0 110.413 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.625 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 83.2 p -164.67 162.71 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.588 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 11' ' ' SER . 3.0 p -162.42 161.27 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.029 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 10' ' ' VAL . 84.1 p -143.2 149.74 38.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.616 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.1 153.15 45.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 147.89 82.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.566 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.76 119.7 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.628 1.552 . . . . 0.0 111.368 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.6 -3.25 26.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -98.27 -170.26 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.541 0.21 . . . . 0.0 110.967 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.5 p -127.26 150.47 49.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.732 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.56 147.82 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.886 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -121.69 134.23 54.96 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.1 mt -108.83 140.08 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -108.38 142.64 38.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.507 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.13 111.63 12.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 m -119.64 140.5 50.52 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.562 -1.336 . . . . 0.0 108.099 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.66 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -107.27 145.0 33.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.238 171.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -57.86 4.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.66 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.03 -18.18 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 -175.281 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 78.67 -32.16 1.91 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 14.7 m -68.4 110.05 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.548 0.213 . . . . 0.0 111.298 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.17 -62.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.754 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.77 -0.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 29' ' ' ILE . 10.7 p -98.91 -25.29 14.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.804 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 28' ' ' SER . 29.1 p30 -121.26 147.3 45.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -71.39 144.45 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.624 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.48 137.79 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.242 0.544 . . . . 0.0 110.198 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.405 ' OE1' ' OE1' ' A' ' 92' ' ' GLN . 4.1 pt20 -120.9 152.18 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 46.4 m95 -122.28 133.07 54.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.146 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.9 m-85 -130.1 149.08 51.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.826 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.589 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -117.96 135.69 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.276 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HE ' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -147.28 156.21 46.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -55.49 129.4 34.92 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.808 1.672 . . . . 0.0 111.129 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.33 -7.21 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 m -113.18 126.11 55.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.268 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.62 164.72 54.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.41 131.07 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.289 1.993 . . . . 0.0 111.022 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.8 p -121.66 120.51 34.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.646 0.26 . . . . 0.0 110.381 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.52 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 10.4 m -62.01 117.72 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.831 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.73 -28.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.64 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.22 136.63 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 51' ' ' GLU . 11.0 t80 -125.01 166.23 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.706 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tt0 44.81 22.45 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.145 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.6 p-10 42.9 18.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.167 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -129.48 -47.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.183 0.516 . . . . 0.0 111.129 168.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.06 150.77 20.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.242 -1.799 . . . . 0.0 108.594 -167.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 148.32 65.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.14 147.6 95.21 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.723 1.616 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 m -67.76 -14.91 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -46.28 70.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.67 141.08 23.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -60.01 139.32 87.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.259 1.306 . . . . 0.0 111.631 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -61.17 0.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.601 HH12 ' CB ' ' A' ' 85' ' ' ASP . 8.8 ptm180 -47.16 -24.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.149 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CE1' ' CG ' ' A' ' 62' ' ' ARG . 23.5 m-85 -88.6 142.95 27.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -128.03 124.22 36.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.084 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.42 7.16 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.679 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.3 p -154.97 166.07 34.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.529 . . . . 0.0 111.355 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.6 pp -146.38 153.76 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.85 157.19 16.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.111 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.7 p -70.3 -8.44 50.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.0 m -60.38 -40.82 92.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER 79.0 25.76 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.284 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -97.48 -42.15 7.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.598 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.661 ' HA ' HG21 ' A' ' 29' ' ' ILE . 73.1 p -165.33 171.32 13.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.054 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.52 127.13 55.04 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.936 -1.103 . . . . 0.0 110.442 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 28.9 m -119.42 117.98 29.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.954 -169.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -97.54 140.59 31.74 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 118.651 -2.53 . . . . 0.0 117.217 168.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' SER . 75.8 m -111.49 127.72 55.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 162.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.507 HG23 HH21 ' A' ' 62' ' ' ARG . 3.0 mt -99.9 112.35 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 120.048 -1.657 . . . . 0.0 109.951 174.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 t -96.85 135.59 38.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.479 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.01 49.22 6.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.66 137.86 48.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 0.0 110.633 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' C ' ' N ' ' A' ' 84' ' ' GLU . 21.2 tttt -144.7 176.93 9.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.905 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 1.5 p -46.84 -20.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.662 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 82' ' ' LYS . 26.2 tt0 -72.7 -39.05 67.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.008 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.601 ' CB ' HH12 ' A' ' 62' ' ' ARG . 6.4 t70 -67.63 -6.9 22.53 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.691 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.8 tt0 -63.35 124.65 21.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.28 -178.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 0.0 110.552 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -87.14 136.72 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.675 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.589 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 27.8 m-85 -116.32 135.75 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.742 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.2 p90 -149.26 149.06 30.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.04 151.49 41.89 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.962 0.505 . . . . 0.0 110.924 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.405 ' OE1' ' OE1' ' A' ' 35' ' ' GLN . 6.9 mt-30 -123.56 147.69 47.05 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 122.213 -0.304 . . . . 0.0 111.338 168.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' NE ' ' A' ' 24' ' ' ARG . 13.7 t -135.25 159.99 39.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.681 0.276 . . . . 0.0 111.587 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.73 132.62 8.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.669 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.84 174.99 6.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.27 -37.44 23.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.905 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.9 m -79.28 39.9 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.365 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 58.57 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.442 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 40.02 78.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.04 0.448 . . . . 0.0 111.131 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 100' ' ' VAL . 1.3 m -87.15 117.48 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 0.0 109.978 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 m -134.14 145.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.147 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -136.31 144.56 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.05 -161.89 34.74 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.069 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 96.04 34.3 5.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.8 95.01 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -111.27 114.58 27.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 0.0 109.798 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -80.25 108.66 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.422 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.8 tp -102.36 126.0 49.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.552 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -120.72 124.86 46.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.319 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.723 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.9 t -89.57 34.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.44 179.288 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -83.55 161.52 21.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 4' ' ' LEU . 17.5 mtp -138.89 169.61 17.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 3' ' ' MET . 7.2 mp -132.77 104.78 6.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -78.93 126.06 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.177 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.616 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 6.8 mt-30 -145.42 164.46 26.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.83 127.21 25.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.135 1.89 . . . . 0.0 110.737 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 5.8 p80 -57.74 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.2 p -165.12 135.39 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.083 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.58 154.96 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.317 . . . . 0.0 110.398 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.7 p -138.45 137.58 37.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 31.3 mp0 -128.38 162.49 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.024 0.44 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -78.52 146.31 69.43 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.607 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.88 125.93 19.04 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.117 1.211 . . . . 0.0 111.57 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.85 -4.2 28.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -95.34 171.69 8.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.967 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 7.1 p -115.31 130.88 57.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.413 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -127.79 134.66 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -110.02 128.42 55.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.291 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 mm -98.44 145.06 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.083 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -117.59 116.68 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.318 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HB2' HE21 ' A' ' 6' ' ' GLN . 42.0 t -118.84 112.28 19.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -116.02 137.6 51.97 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.078 -1.014 . . . . 0.0 108.28 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.68 142.77 27.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.607 170.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -57.88 2.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.68 -16.94 14.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.538 -174.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.99 -50.39 4.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.479 ' HG ' ' NH2' ' A' ' 24' ' ' ARG . 75.0 p -54.28 113.88 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.312 . . . . 0.0 111.166 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.79 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.34 -61.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.181 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.79 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.5 -0.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 5.9 m -107.01 -18.99 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.623 -1.626 . . . . 0.0 111.798 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -116.87 147.82 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -78.88 132.41 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.489 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.73 146.32 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.11 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 8.5 pt20 -123.64 163.1 21.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 30.3 m95 -131.51 131.92 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 7.6 m-85 -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.9 139.98 53.46 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.26 33.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.29 156.19 9.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.48 135.39 67.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.633 1.555 . . . . 0.0 110.916 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.0 -2.0 75.06 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 m -151.26 138.8 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.734 0.302 . . . . 0.0 110.521 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.53 165.47 41.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.074 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.06 135.46 66.52 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.003 1.802 . . . . 0.0 110.805 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -132.77 137.7 46.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.48 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.6 m -73.27 120.25 18.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.528 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.85 -28.0 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.141 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -145.28 149.27 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' O ' ' N ' ' A' ' 52' ' ' ASP . 37.5 t80 -133.94 163.62 29.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.182 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.2 tt0 45.37 23.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.686 0.755 . . . . 0.0 110.827 -173.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' TYR . 10.6 t70 44.73 19.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.594 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.1 t-20 -127.83 -46.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.861 170.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -52.72 134.11 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.498 -167.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.731 ' NH1' ' H ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -123.59 108.8 30.93 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -65.66 136.81 47.47 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.618 1.546 . . . . 0.0 111.756 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 m -63.93 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.14 -57.81 12.25 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.08 150.36 58.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.8 Cg_endo -61.55 135.45 57.05 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.067 1.178 . . . . 0.0 111.219 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.79 -0.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.488 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 52.0 mtm180 -48.37 -38.44 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -71.72 134.84 46.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.9 t -124.12 122.71 38.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.731 ' H ' ' NH1' ' A' ' 55' ' ' ARG . . . -107.74 118.9 5.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.627 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.6 p -155.41 164.03 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.935 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.687 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -146.0 157.63 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -103.03 153.17 20.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.378 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -68.4 1.87 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.042 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.2 m -65.95 -43.97 86.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.62 27.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.543 -177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.38 -41.09 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.943 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.723 ' O ' HD13 ' A' ' 29' ' ' ILE . 94.4 p -166.7 175.34 7.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.767 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.78 125.51 50.91 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.812 -1.18 . . . . 0.0 109.881 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 m -115.84 112.73 22.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.744 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -98.3 140.53 32.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 170.19 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' SER . 89.3 m -107.72 126.7 52.93 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 163.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.472 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.7 mt -105.8 105.33 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 O-C-N 120.398 -1.439 . . . . 0.0 110.737 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 29.6 t -95.45 154.38 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.008 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 32.37 76.78 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 176.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -54.21 128.01 29.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 109.667 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 84' ' ' GLU . 18.9 mttp -139.48 171.1 14.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.055 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -45.94 -18.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.648 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 82' ' ' LYS . 39.9 mt-10 -69.31 -38.56 78.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.529 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 2.2 m-20 -73.26 -11.34 60.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.241 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -52.92 120.75 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.543 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.94 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -86.91 144.87 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -113.18 153.07 28.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -149.95 147.84 28.37 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 8.6 p -132.94 142.8 49.07 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.023 0.529 . . . . 0.0 109.972 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.89 147.31 50.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.422 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 9.0 t -135.24 160.84 37.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.1 0.476 . . . . 0.0 111.226 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD2' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -158.42 136.61 10.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.56 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 13.6 m-20 -97.73 177.34 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.985 0.421 . . . . 0.0 110.982 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 98' ' ' ASN . 4.7 t -60.56 -38.67 85.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.8 m -76.17 32.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.578 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 96' ' ' SER . 9.2 m-20 67.34 -124.86 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.478 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 48.5 m80 56.74 76.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -89.19 122.3 40.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.122 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.15 156.21 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.283 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -134.08 160.67 37.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.007 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.86 7.78 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.61 56.52 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.55 110.08 3.27 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.5 m -137.13 127.83 27.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.692 0.282 . . . . 0.0 110.286 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -88.42 99.36 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.404 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -91.08 123.67 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -120.77 122.36 40.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.371 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.698 ' O ' HG12 ' A' ' 110' ' ' VAL . 80.6 t -82.11 40.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.069 178.721 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -114.07 160.31 19.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.202 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.1 mtt -129.4 169.98 14.24 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -133.22 102.95 5.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.5 p -86.4 135.6 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 30.7 mt-30 -146.19 163.14 31.91 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.715 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.51 140.38 74.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.534 1.49 . . . . 0.0 111.021 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -69.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.257 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 p -161.27 155.2 22.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.792 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 11' ' ' SER . 4.7 p -162.11 161.01 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.787 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 p -128.65 151.47 49.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.419 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -135.21 143.83 46.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.401 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 138.05 86.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.88 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.48 113.24 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.377 1.385 . . . . 0.0 111.297 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.02 -8.23 16.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -93.05 -177.31 4.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 111.262 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 79' ' ' SER . 4.1 p -111.18 140.75 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.131 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.41 138.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.547 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 76' ' ' LEU . 3.5 m -119.44 129.86 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.92 134.0 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.469 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -100.53 166.3 10.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.298 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.33 111.85 4.19 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.972 HG23 HH21 ' A' ' 24' ' ' ARG . 19.7 m -115.89 136.22 53.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.903 -1.123 . . . . 0.0 108.065 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.972 HH21 HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER -104.02 143.1 33.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.154 171.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -58.63 5.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.467 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.37 -18.15 14.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.06 -173.317 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 68.63 29.06 72.78 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 24' ' ' ARG . 54.0 m -128.94 98.9 5.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.419 0.609 . . . . 0.0 111.864 -175.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -126.28 -62.27 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 122.584 0.354 . . . . 0.0 111.009 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.15 1.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 35.6 t -114.11 -28.02 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.027 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -112.99 139.85 48.31 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.9 130.67 42.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.87 141.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.552 0.691 . . . . 0.0 110.667 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -128.26 150.46 50.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.619 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -106.22 121.0 43.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.407 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 2.2 m-85 -112.38 148.63 33.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 133.44 41.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -125.45 135.03 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.355 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -133.68 135.04 24.2 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.3 Cg_exo -55.47 137.44 77.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.184 1.256 . . . . 0.0 110.776 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.51 -16.26 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -144.23 161.74 38.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.608 0.242 . . . . 0.0 110.381 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.401 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -81.97 178.09 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.095 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.8 Cg_exo -72.68 156.35 53.46 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.559 2.173 . . . . 0.0 111.513 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -137.59 121.27 17.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.349 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.407 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 3.4 m -62.29 121.42 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.965 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.676 ' HA ' HG21 ' A' ' 59' ' ' VAL . 2.5 t -101.16 -28.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.318 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -145.86 140.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' ASP . 5.9 t80 -127.3 164.14 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 44.59 22.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.389 -170.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 43.04 18.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.545 -179.122 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.564 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -129.23 -46.91 1.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 0.0 111.52 172.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.06 131.37 35.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.712 -165.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -108.57 111.68 61.11 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.465 -174.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.04 145.52 96.57 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.633 1.556 . . . . 0.0 112.176 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -69.41 -20.35 63.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.772 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.83 -31.32 67.68 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' A' ' 48' ' ' VAL . 16.7 m -124.2 141.82 38.33 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.8 Cg_exo -60.41 140.33 91.06 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.268 1.312 . . . . 0.0 111.412 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.3 p-10 -61.04 0.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.607 HH22 ' CB ' ' A' ' 85' ' ' ASP . 41.7 ptt85 -47.42 -24.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.331 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 90.8 m-85 -78.47 150.26 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.83 122.88 33.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.435 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.45 121.54 5.52 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.546 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.3 p -158.98 158.25 32.88 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.663 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -138.7 160.32 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.449 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 97.8 m-20 -103.63 152.9 21.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.769 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 m -72.61 27.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.5 m -97.98 -40.64 8.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.226 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.97 27.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.604 ' O ' ' NH2' ' A' ' 24' ' ' ARG . 39.8 t30 -99.32 -33.67 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.561 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' HD13 ' A' ' 29' ' ' ILE . 24.8 p -176.9 170.8 2.26 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.013 0.821 . . . . 0.0 110.185 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.4 133.78 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.153 -0.967 . . . . 0.0 109.857 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -127.37 112.56 15.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.088 -0.958 . . . . 0.0 113.192 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.13 140.59 31.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 168.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.5 m -107.83 131.25 54.68 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.219 -0.926 . . . . 0.0 113.401 163.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.87 110.65 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.163 -1.586 . . . . 0.0 110.37 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.573 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.2 t -97.51 139.38 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.06 45.86 8.01 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 143.65 51.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.09 0.471 . . . . 0.0 110.525 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' ASP . 10.4 mtpt -153.14 173.18 15.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.686 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 t -45.88 -20.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.579 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LYS . 48.7 mt-10 -69.38 -40.1 77.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.978 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.607 ' CB ' HH22 ' A' ' 62' ' ' ARG . 4.3 t0 -70.38 -10.44 59.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.211 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 56.4 tt0 -61.13 122.83 16.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.082 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.92 179.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.856 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 148.02 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.911 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.438 ' OH ' ' CG ' ' A' ' 85' ' ' ASP . 17.7 m-85 -115.52 145.79 42.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 12.5 m-85 -144.19 150.35 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.002 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -118.93 142.45 47.76 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -126.54 121.77 33.23 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.81 -0.556 . . . . 0.0 110.937 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -135.15 -176.82 4.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.723 0.297 . . . . 0.0 110.619 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 93' ' ' SER . 1.6 m-85 -142.85 130.9 21.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.61 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 96' ' ' SER . 37.5 t0 -126.4 -145.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.985 176.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.526 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -49.46 -13.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.635 -177.443 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ASP . 10.3 t -83.45 5.25 24.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.569 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER 46.1 102.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.082 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 100' ' ' VAL . 11.7 m-70 62.92 31.01 16.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.198 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 99' ' ' HIS . 54.5 t -150.89 111.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 O-C-N 121.681 -0.637 . . . . 0.0 112.382 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 93' ' ' SER . 1.2 t -177.55 139.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 166.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -159.33 151.13 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.118 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.86 169.37 21.43 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 123.08 18.11 3.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.29 85.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.4 m -112.24 130.36 55.96 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.672 -0.31 . . . . 0.0 110.242 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -90.08 110.83 21.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -104.9 124.75 50.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.099 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.3 m -116.8 123.54 47.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.71 99.98 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.231 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.121 179.005 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 25.3 t30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.8 p90 -160.44 96.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.865 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.0 mtt -151.95 170.11 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 105.97 6.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m -89.58 131.61 35.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.115 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.693 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 2.7 mt-30 -146.07 169.87 8.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -65.78 136.55 45.99 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.433 1.422 . . . . 0.0 111.367 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.506 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -48.21 -76.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.765 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -155.38 149.16 25.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.993 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -159.46 160.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.166 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 10' ' ' VAL . 88.5 p -129.77 146.84 51.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.335 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 11' ' ' SER . 2.1 mp0 -130.53 162.93 28.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.45 140.86 22.55 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.42 117.48 4.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.418 1.412 . . . . 0.0 111.231 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.2 -11.41 14.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.01 159.97 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.701 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.4 p -98.13 148.63 23.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.69 141.2 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.618 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 76' ' ' LEU . 55.5 m -119.92 129.72 54.48 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.04 134.93 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.17 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -111.11 126.48 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.057 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.28 113.35 21.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.8 m -109.44 135.34 50.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 26' ' ' SER . 19.3 ttp85 -97.49 141.15 30.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.223 171.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -57.23 3.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.06 -11.9 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.765 -173.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.48 5.89 25.26 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.0 m -125.3 111.87 15.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.366 0.267 . . . . 0.0 110.434 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.8 pp -124.31 -57.09 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -2.58 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 14.5 m -89.14 -35.0 16.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 111.603 -2.544 . . . . 0.0 111.479 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.517 ' ND2' ' OD1' ' A' ' 95' ' ' ASP . 3.4 m120 -116.83 152.94 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -75.16 140.93 43.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.037 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 67.9 t -126.13 148.02 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.958 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -129.38 147.15 51.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.903 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 23.0 m95 -111.1 122.63 48.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.296 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' N ' ' A' ' 47' ' ' THR . 2.4 m-85 -123.91 144.96 49.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.587 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -147.19 143.9 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.279 177.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 2.9 tp-100 -107.07 142.52 36.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -135.78 146.57 57.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.91 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.24 152.52 65.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.574 1.516 . . . . 0.0 111.31 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.7 58.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.86 157.01 34.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.421 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HA ' HE22 ' A' ' 39' ' ' GLN . 0.1 OUTLIER -82.74 179.84 1.77 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.245 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.65 150.41 56.72 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.522 2.148 . . . . 0.0 112.026 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -148.9 135.3 19.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.551 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -64.93 129.29 39.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.45 -25.23 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.99 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.473 HD11 ' CB ' ' A' ' 63' ' ' PHE . 19.7 mt -145.01 133.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' GLN . 4.0 t80 -122.25 167.33 13.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.447 174.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 53' ' ' ASN . 1.4 tp10 44.77 22.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.712 0.768 . . . . 0.0 111.419 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 43.16 18.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.05 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -129.22 -47.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.847 170.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -96.79 159.07 15.12 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.258 -167.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -140.41 149.88 59.07 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 157.63 22.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.584 1.523 . . . . 0.0 111.226 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.8 p -73.98 -7.19 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.456 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.58 -28.18 48.49 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 59' ' ' VAL . 29.5 m -113.02 131.34 22.86 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.9 Cg_endo -61.62 140.1 84.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 120.982 1.121 . . . . 0.0 111.021 -175.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD2' ' NE ' ' A' ' 55' ' ' ARG . 2.8 m-20 -61.25 1.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.637 HH22 ' CB ' ' A' ' 85' ' ' ASP . 22.7 ptt85 -42.1 -25.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.3 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CB ' HD11 ' A' ' 49' ' ' ILE . 53.4 m-85 -75.4 144.46 42.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.87 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -118.07 122.6 43.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.491 0.663 . . . . 0.0 110.949 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.46 125.06 8.38 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.447 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' SER . 6.5 p -157.76 158.72 35.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.106 0.479 . . . . 0.0 110.849 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.94 161.15 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.25 163.32 13.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.379 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 p -67.92 -7.45 28.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.355 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 71' ' ' SER . 14.4 m -82.38 -48.26 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.28 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 70' ' ' SER . 3.0 p 79.03 22.12 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.661 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.34 -18.92 27.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.566 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 54.9 p -163.24 166.5 23.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.249 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.79 115.5 30.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.1 m -104.41 110.76 23.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -102.68 140.42 36.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.725 -1.58 . . . . 0.0 115.252 169.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 98.3 m -104.76 128.11 52.77 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 162.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 76' ' ' LEU . 2.8 mt -103.16 113.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 120.115 -1.616 . . . . 0.0 110.043 173.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 t -104.62 146.69 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.791 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.83 30.46 57.72 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.99 138.42 49.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 110.518 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 28.3 mttt -150.57 177.74 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 83' ' ' THR . 1.2 p -46.78 -17.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.387 174.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 15.6 pt-20 -69.2 -40.55 77.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.351 177.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.637 ' CB ' HH22 ' A' ' 62' ' ' ARG . 6.4 t70 -70.99 -8.6 54.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.458 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 57.5 tt0 -63.7 121.4 13.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.348 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.71 -175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.22 137.35 32.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.643 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 17.1 m-85 -119.54 134.07 55.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.669 0.271 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 90' ' ' TYR . 1.5 p90 -150.89 138.12 19.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.33 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.3 p -118.79 140.43 49.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -114.5 148.64 37.58 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.824 -0.547 . . . . 0.0 109.714 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 p -135.23 152.17 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.914 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.04 138.98 11.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' OD1' ' ND2' ' A' ' 32' ' ' ASN . 13.5 m-20 -99.05 178.24 4.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -20.67 64.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.651 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.3 p -90.81 32.33 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.431 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 57.27 -159.1 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.2 t60 75.55 69.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.27 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 m -86.93 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.599 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.93 151.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -118.07 144.04 45.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.401 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.82 -149.96 6.74 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 75.28 24.29 71.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.57 98.27 0.27 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -129.77 118.16 21.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.325 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.73 120.11 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.1 tp -109.29 123.26 48.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.208 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 114.89 25.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 110' ' ' VAL . 89.0 t -85.23 40.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 110' ' ' VAL . 10.2 mt . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.665 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 21.8 p90 -139.63 86.61 2.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.508 ' H ' ' HB2' ' A' ' 25' ' ' SER . 77.4 mtm -147.66 166.46 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.1 mp -124.81 104.25 8.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 p -88.84 118.73 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.134 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.488 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.66 165.42 21.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 4.4 Cg_exo -52.6 146.7 33.19 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.184 1.923 . . . . 0.0 111.36 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.9 p80 -79.29 -55.91 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 p -154.84 142.79 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.635 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.89 146.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -126.55 146.39 50.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.737 0.303 . . . . 0.0 110.464 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -132.77 150.2 52.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.231 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.13 139.19 72.39 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.99 124.44 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.144 1.229 . . . . 0.0 110.94 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.43 -11.66 16.4 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -100.33 -171.57 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.774 0.321 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.7 p -125.39 159.56 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.349 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.11 153.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -129.2 132.02 47.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 HD22 ' A' ' 76' ' ' LEU . 10.7 mt -98.86 149.43 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.075 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -124.96 117.32 23.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.943 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 4' ' ' LEU . 4.0 t -119.72 120.58 37.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -119.49 142.04 48.64 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.017 -1.677 . . . . 0.0 108.752 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.615 ' HG3' HH11 ' A' ' 24' ' ' ARG . 7.3 mtm-85 -87.26 139.78 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.847 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.7 OUTLIER -60.38 1.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.43 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -103.24 -17.86 15.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.627 -175.768 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.92 -41.9 3.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 77.9 p -63.82 113.22 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.59 0.233 . . . . 0.0 110.824 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.6 pp -135.11 -60.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.524 -176.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.779 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.8 -0.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.638 ' H ' ' C ' ' A' ' 29' ' ' ILE . 53.5 m -109.29 -2.5 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.777 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 31' ' ' SER . 3.1 m120 -133.22 149.96 51.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -81.86 135.26 35.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.437 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG2' HH22 ' A' ' 24' ' ' ARG . 17.5 t -127.61 139.03 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' TRP . 7.2 pt20 -116.96 164.29 14.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.186 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 8.8 m95 -134.96 125.13 26.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 0.0 110.53 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 28.0 m-85 -111.23 149.36 31.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -129.06 124.67 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.454 HE22 ' HD3' ' A' ' 45' ' ' PRO . 11.3 tp60 -104.6 134.47 47.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.167 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -125.73 149.55 65.82 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.206 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.51 130.54 40.6 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.482 1.455 . . . . 0.0 110.713 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.01 10.0 85.24 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 m -133.38 173.86 11.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.6 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.94 165.37 12.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.454 ' HD3' HE22 ' A' ' 39' ' ' GLN . 1.5 Cg_endo -60.31 144.27 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.671 1.581 . . . . 0.0 111.263 178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -138.16 133.56 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 36.4 m -60.94 120.78 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -96.13 -25.38 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.718 -178.209 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 19.9 mt -145.08 146.13 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' O ' ' N ' ' A' ' 52' ' ' ASP . 10.4 t80 -132.12 167.26 20.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 44.62 22.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.687 0.756 . . . . 0.0 110.933 -171.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.1 p30 43.13 17.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.03 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.2 t-20 -129.4 -46.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 111.121 172.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.657 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -87.93 147.62 24.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.713 -165.248 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.736 ' N ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -111.23 131.93 21.99 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.68 146.59 84.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.563 1.509 . . . . 0.0 111.183 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -73.38 5.24 3.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.348 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 -26.55 11.39 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.67 151.68 45.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.302 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.93 143.78 95.84 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.662 1.575 . . . . 0.0 111.653 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.29 -2.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.722 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.4 mtp-105 -42.13 -38.65 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.068 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.7 m-85 -76.29 137.5 39.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.193 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -129.29 123.07 30.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.314 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.06 129.71 9.96 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.3 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.8 p -158.54 158.45 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.301 0.572 . . . . 0.0 111.198 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.39 160.85 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.641 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.84 153.31 23.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.664 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -4.49 13.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.909 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 71' ' ' SER . 50.2 m -65.44 -46.19 80.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.77 24.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.506 -178.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -100.06 -37.68 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.709 ' C ' HD13 ' A' ' 29' ' ' ILE . 82.1 p -166.07 174.55 9.25 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.8 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.44 123.51 49.49 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.796 -1.19 . . . . 0.0 109.84 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.1 m -112.23 116.59 30.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.722 -170.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -97.96 140.36 32.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 118.103 -2.873 . . . . 0.0 116.627 171.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' SER . 7.0 m -112.37 127.54 56.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 164.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.1 mt -96.66 116.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 120.029 -1.669 . . . . 0.0 110.459 171.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.54 132.27 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.449 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 75.74 61.08 3.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.52 130.82 36.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 0.0 111.063 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -154.06 176.4 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.113 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -19.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.315 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 82' ' ' LYS . 45.8 mt-10 -71.83 -38.0 70.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.205 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' LYS . 9.9 t70 -74.75 -13.06 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 84.2 tt0 -56.97 123.22 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.74 178.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.733 0.646 . . . . 0.0 109.791 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 85.4 m-20 -91.84 144.49 25.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 24.6 m-85 -110.8 151.17 28.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.986 0.422 . . . . 0.0 110.569 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 31.8 m-85 -149.44 138.35 21.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.653 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.488 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -120.95 140.7 51.5 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.597 0.635 . . . . 0.0 110.28 178.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -125.6 138.28 53.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.165 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.57 ' CB ' ' NH1' ' A' ' 24' ' ' ARG . 17.7 p -135.26 171.04 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -158.51 132.29 7.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.95 -179.63 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.039 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -59.68 -38.43 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -81.99 39.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 62.84 -107.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.66 80.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.696 0.284 . . . . 0.0 110.362 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.51 123.27 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 m -136.55 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 8.4 p90 -112.95 137.2 51.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.05 -158.7 14.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.034 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 78.97 48.62 6.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.38 91.84 1.16 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 4.2 m -106.88 141.46 38.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -102.98 99.91 9.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.49 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.3 tp -90.24 125.46 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.532 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.95 130.16 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 110.162 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 82' ' ' LYS . 65.0 t -97.47 99.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.966 0.412 . . . . 0.0 110.527 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.407 179.708 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.54 106.86 8.47 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.4 mmm -137.84 168.93 18.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.08 105.98 9.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.081 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.3 115.1 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.723 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.7 mm-40 -142.34 158.21 61.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.438 0.461 . . . . 0.0 110.584 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.95 142.47 93.57 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.662 1.575 . . . . 0.0 110.426 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' N ' ' A' ' 9' ' ' SER . 39.7 p-80 -65.86 -53.94 33.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.179 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 9.7 p -161.87 157.26 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.386 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 11' ' ' SER . 7.6 p -164.77 154.64 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.116 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 10' ' ' VAL . 9.6 p -122.5 135.63 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.796 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -122.08 143.59 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.483 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.43 153.06 94.01 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.18 118.41 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.193 1.262 . . . . 0.0 112.103 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.55 -13.57 20.64 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -88.67 161.46 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.559 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.9 p -98.62 138.41 35.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.32 141.66 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.383 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 76' ' ' LEU . 35.0 m -123.59 130.92 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.58 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.05 134.33 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.386 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 11.0 m -108.77 126.44 53.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.68 111.52 17.29 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.4 m -115.13 141.03 48.56 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.473 -1.392 . . . . 0.0 107.351 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.5 mmm-85 -93.7 139.87 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.264 170.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.8 p -60.53 1.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.371 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.49 -18.37 14.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.58 -173.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.73 -25.18 11.97 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 m -80.35 117.01 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.741 0.305 . . . . 0.0 111.312 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 73' ' ' SER . 1.3 pp -135.34 -64.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -67.27 -1.08 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' ILE . 4.3 t -97.56 -22.13 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.04 -1.891 . . . . 0.0 111.917 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' CB ' HH12 ' A' ' 24' ' ' ARG . 12.8 m120 -118.51 148.51 42.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -175.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.47 137.72 42.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.989 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.44 141.1 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.9 pt20 -119.7 153.26 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -117.76 128.79 55.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 110.34 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.2 m-85 -132.6 149.88 52.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.68 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.43 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -121.09 128.79 52.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -108.46 129.74 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.274 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 142.7 19.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.607 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.82 147.36 95.49 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.117 1.878 . . . . 0.0 110.96 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 8.88 82.82 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -156.71 140.21 15.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.48 . . . . 0.0 110.506 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 156.36 81.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.465 -178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.14 142.7 65.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.281 1.987 . . . . 0.0 110.55 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -121.79 138.76 54.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.451 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.423 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -77.4 120.18 22.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.704 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 63' ' ' PHE . 3.7 t -101.02 -28.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.832 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.18 152.25 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 80.6 t80 -133.5 163.77 28.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.403 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.1 tt0 45.22 23.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.202 1.001 . . . . 0.0 110.44 -172.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.4 p30 44.59 19.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.668 -1.606 . . . . 0.0 109.964 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -127.89 -41.38 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.37 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.446 ' OE1' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -57.55 131.85 51.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.56 -1.654 . . . . 0.0 109.254 -167.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.772 HH21 ' H ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -117.31 108.89 42.96 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.99 145.29 49.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.707 1.605 . . . . 0.0 111.418 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 m -73.59 -24.46 60.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.56 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -29.54 72.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.09 148.16 36.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -59.22 128.48 27.73 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.621 1.547 . . . . 0.0 110.655 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.99 -0.85 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.271 . . . . 0.0 111.708 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' A' ' 85' ' ' ASP . 33.1 mtp180 -43.94 -23.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CD2' HG11 ' A' ' 48' ' ' VAL . 14.9 m-85 -79.49 140.79 37.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -127.32 122.84 34.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.772 ' H ' HH21 ' A' ' 55' ' ' ARG . . . -100.1 124.81 8.36 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 113.558 -1.655 . . . . 0.0 110.124 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.1 p -159.67 165.65 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.211 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -151.49 167.4 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.538 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 67.2 m-20 -104.1 153.03 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.815 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 m -69.89 13.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.103 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -87.86 -41.5 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.453 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m 79.15 27.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.077 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -98.46 -33.98 10.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.154 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.759 ' C ' HD13 ' A' ' 29' ' ' ILE . 90.9 p -165.36 168.62 16.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.753 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.05 130.83 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.832 -1.168 . . . . 0.0 109.641 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 66' ' ' SER . 16.2 m -128.34 112.81 14.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.72 140.52 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 118.564 -2.585 . . . . 0.0 116.711 168.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 64' ' ' SER . 85.4 m -99.85 127.55 46.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 162.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.563 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -107.9 106.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.107 -1.62 . . . . 0.0 109.701 172.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 p -102.29 154.95 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.644 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 79.93 25.62 57.55 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.16 138.32 56.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.12 0.486 . . . . 0.0 110.706 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.9 tttm -149.82 176.9 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.528 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 t -46.38 -21.33 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.45 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.6 mt-10 -72.01 -38.51 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.549 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.3 OUTLIER -70.63 -12.97 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.067 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 79.8 tt0 -52.76 122.72 9.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.364 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 164.42 -178.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.505 0.503 . . . . 0.0 109.874 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.95 132.39 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.72 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 16.2 m-85 -113.15 133.5 55.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -150.96 144.89 25.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.704 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.723 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.53 143.25 46.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.061 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -117.06 149.11 40.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 171.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 23.2 t -135.19 163.96 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 111.6 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -158.75 135.05 9.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.207 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 24' ' ' ARG . 96.5 m-20 -85.05 172.83 10.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 176.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -60.66 -35.24 75.75 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.126 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -80.11 34.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.447 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 67.05 -135.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.7 m170 60.54 81.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.268 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 m -87.17 135.42 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 p -142.28 153.66 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -113.73 147.63 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.839 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.49 -160.88 11.48 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 80.73 18.94 69.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.55 85.11 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.5 m -133.84 124.19 26.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -89.93 127.31 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.0 tp -111.65 126.11 54.68 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.46 0.475 . . . . 0.0 110.365 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.7 m -120.99 128.82 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.607 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' OXT' ' A' ' 111' ' ' LEU . 64.0 t -93.7 104.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.428 . . . . 0.0 110.242 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 9.5 mt . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.75 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -144.6 83.34 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.648 0.261 . . . . 0.0 110.305 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpp -156.6 169.99 23.41 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.52 103.04 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -78.82 127.44 32.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.581 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.703 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 16.3 mt-30 -143.47 159.76 53.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.72 125.46 18.7 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.498 1.465 . . . . 0.0 110.64 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -60.56 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 p -156.74 153.22 28.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.62 154.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.693 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -130.4 145.77 51.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -135.37 162.51 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -91.5 148.68 37.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.577 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -60.55 118.34 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.438 1.425 . . . . 0.0 111.296 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.37 3.54 29.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -95.01 -173.41 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.1 p -122.65 142.5 50.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.145 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.73 145.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 76' ' ' LEU . 87.9 m -127.48 122.59 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.023 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 135.99 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.913 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -106.19 135.61 47.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.335 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 4.1 m -118.72 115.63 24.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.0 m -118.92 140.0 50.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.631 ' C ' ' H ' ' A' ' 26' ' ' SER . 45.5 mtp180 -93.21 139.74 30.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.137 169.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -58.75 1.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.393 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.631 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -103.67 -18.07 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.789 -175.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 77.92 21.76 70.49 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -125.47 113.91 18.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.517 0.198 . . . . 0.0 110.731 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.1 pp -135.14 -63.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.902 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.88 -3.22 2.3 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 38.6 m -92.98 -21.86 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.372 -2.194 . . . . 0.0 111.226 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.6 ' ND2' HH12 ' A' ' 24' ' ' ARG . 2.2 m120 -132.61 156.64 46.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.0 110.065 -178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 23.3 m-85 -82.04 145.11 30.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.91 146.76 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.219 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.641 ' HG3' ' H ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -117.1 163.06 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.487 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 27.5 m95 -132.98 126.46 32.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.936 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 35' ' ' GLN . 4.6 m-85 -124.86 149.4 47.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.913 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 1.5 mm100 -124.64 131.02 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.26 137.9 52.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.83 149.82 21.72 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.49 140.22 93.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.564 1.509 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.05 86.25 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -147.04 163.84 34.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.49 160.79 28.08 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.01 129.49 33.51 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.198 1.932 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.7 m -125.31 116.56 22.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 110.559 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.514 HG23 ' NE2' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -62.13 122.29 15.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.78 -28.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.548 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -145.02 148.91 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -138.3 143.49 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' A' ' 53' ' ' ASN . 8.5 tt0 57.68 23.57 9.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.454 1.121 . . . . 0.0 110.17 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.4 t0 44.14 18.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.025 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.6 -46.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.231 165.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.465 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.4 tm0? -54.54 141.89 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.123 -168.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.455 ' CZ ' ' O ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -125.62 108.86 25.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 119.169 -0.444 . . . . 0.0 109.849 178.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -60.18 144.31 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.725 1.617 . . . . 0.0 111.575 176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -70.64 -26.85 63.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -33.21 86.64 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.03 144.34 28.91 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 62' ' ' ARG . 3.3 Cg_exo -60.37 139.95 89.26 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.459 1.439 . . . . 0.0 110.771 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -60.97 0.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.658 HH22 ' CB ' ' A' ' 85' ' ' ASP . 35.7 ptt85 -50.55 -29.09 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.986 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 63.0 m-85 -78.61 131.8 36.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 t -112.19 123.66 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.36 122.24 5.31 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 5.9 p -154.97 156.49 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.181 0.515 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.58 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -132.96 159.06 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.13 148.63 25.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.413 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -67.96 -6.43 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 m -64.33 -42.64 96.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.916 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' GLY . 11.0 p 79.0 31.48 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.649 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -97.3 -43.64 7.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.403 -177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.605 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.1 p -167.11 168.35 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.325 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.71 122.79 47.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.8 m -114.52 112.89 23.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.684 -170.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.24 140.64 31.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 118.66 -2.525 . . . . 0.0 117.207 168.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.5 m -110.69 127.1 55.17 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.695 ' CD1' HD21 ' A' ' 76' ' ' LEU . 26.4 mm -93.84 113.09 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 120.057 -1.652 . . . . 0.0 110.887 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.76 129.22 45.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.523 0.201 . . . . 0.0 110.728 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.39 58.39 3.13 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD21 HG13 ' A' ' 110' ' ' VAL . 3.8 tt -75.16 138.61 42.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.502 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 84' ' ' GLU . 16.5 mttt -144.74 175.66 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.802 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 83' ' ' THR . 1.1 p -45.99 -18.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 82' ' ' LYS . 68.1 mm-40 -69.85 -38.36 76.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.461 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.658 ' CB ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -67.43 -6.91 21.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.529 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 21.9 tt0 -67.21 121.21 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.394 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.85 178.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.185 0.516 . . . . 0.0 110.176 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -87.4 134.15 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 10.9 m-85 -113.56 132.79 55.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.9 p90 -151.25 151.87 32.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 103' ' ' GLY . 28.3 p -132.62 143.4 49.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.159 -173.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.641 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 mt-30 -115.3 147.29 40.6 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.7 p -135.21 118.93 17.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.939 0.399 . . . . 0.0 110.844 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.7 p90 -159.28 131.08 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.102 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' H ' HG21 ' A' ' 100' ' ' VAL . 0.8 OUTLIER -112.64 -159.98 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.986 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -12.7 46.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.038 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 m -90.02 0.31 57.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 53.44 -165.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.712 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.32 29.96 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 178.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -113.92 -171.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.722 -178.6 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 93' ' ' SER . 27.4 m -148.42 -178.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.437 . . . . 0.0 111.354 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -151.27 163.43 38.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 141.09 -123.43 2.31 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.39 42.21 9.46 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.13 118.61 11.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -135.91 118.87 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.873 0.368 . . . . 0.0 110.478 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -88.06 115.89 25.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.615 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.56 124.34 50.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.086 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 111' ' ' LEU . 55.4 m -117.42 113.7 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 110' ' ' VAL . 90.0 t -78.57 38.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 110.36 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.512 ' H ' HG22 ' A' ' 109' ' ' THR . 6.3 mt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.152 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 19.7 p30 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -130.67 146.23 52.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.541 ' H ' ' HB2' ' A' ' 25' ' ' SER . 5.0 ptt? -157.03 169.64 24.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.031 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.698 HD12 ' NH1' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -114.66 102.83 10.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.26 127.77 35.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.349 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.603 HE21 ' CB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -143.0 161.6 47.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.147 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 2.2 Cg_endo -47.73 136.43 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.477 2.118 . . . . 0.0 111.676 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -70.36 -45.35 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.845 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -157.56 157.15 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.375 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.06 125.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.5 p -108.0 130.37 55.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.45 164.92 15.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 m -96.6 143.44 26.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.448 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.09 115.07 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.44 1.427 . . . . 0.0 111.039 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.75 -10.77 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -91.85 -171.64 2.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -126.41 153.71 44.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.895 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.33 147.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.099 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 1.2 m -122.25 134.4 54.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -98.88 128.64 50.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -102.38 120.53 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.7 111.84 19.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -178.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 142.17 48.11 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.932 -1.105 . . . . 0.0 108.609 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' NH1' HD12 ' A' ' 4' ' ' LEU . 1.5 mmp_? -89.45 140.18 29.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.782 169.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.541 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.1 OUTLIER -59.05 -2.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.124 175.207 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.79 -18.18 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.072 -175.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 -36.26 3.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -66.78 110.73 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.13 -60.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.761 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.92 1.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 29' ' ' ILE . 85.1 p -109.02 -26.61 10.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.744 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -103.34 144.17 31.72 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.8 119.11 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG22 ' OG ' ' A' ' 93' ' ' SER . 93.3 t -121.47 143.25 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.782 0.801 . . . . 0.0 110.8 -175.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.539 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.6 pm0 -139.09 169.6 17.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.895 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.6 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 64.5 m95 -125.74 128.26 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.207 0.527 . . . . 0.0 110.474 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -113.99 149.43 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.754 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.39 129.86 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -124.1 142.41 51.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.529 178.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -167.75 147.04 4.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.159 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.43 148.89 69.28 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.222 1.281 . . . . 0.0 110.765 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 -17.26 48.38 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 44' ' ' SER . 39.8 t -153.44 -168.95 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 43' ' ' SER . 0.2 OUTLIER -111.16 161.27 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.1 143.52 73.75 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.807 1.671 . . . . 0.0 110.943 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -140.84 132.45 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.957 0.408 . . . . 0.0 110.873 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.5 m -62.08 123.54 18.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.917 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.24 -27.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.524 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.4 152.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' ASP . 31.2 t80 -132.87 163.26 29.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.2 tt0 45.94 24.18 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.953 -173.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.3 OUTLIER 44.16 19.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.962 -177.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.1 t-20 -128.04 -46.1 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.934 169.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 135.62 48.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.728 -168.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -130.48 108.66 16.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.261 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.17 143.23 64.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.873 1.715 . . . . 0.0 111.58 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.0 m -74.14 -18.54 60.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.66 -51.18 54.17 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -85.24 149.97 53.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -59.29 135.76 67.67 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.655 0.903 . . . . 0.0 110.171 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' PHE . 47.9 p30 -59.99 0.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.147 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.782 HH12 ' N ' ' A' ' 85' ' ' ASP . 30.8 mtm105 -54.39 4.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.891 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASP . 4.2 m-85 -118.47 143.38 46.75 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.21 -0.306 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -135.28 123.57 23.16 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.073 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.49 119.53 6.29 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.582 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' SER . 12.7 p -153.98 160.46 42.07 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.064 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 163.89 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.119 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 70' ' ' SER . 62.4 m-20 -108.72 146.35 33.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.507 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -67.98 2.73 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.796 174.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' SER . 28.5 m -71.27 -42.38 68.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 80.83 27.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.566 -178.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.19 -43.6 7.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.671 ' C ' HD13 ' A' ' 29' ' ' ILE . 93.7 p -164.63 168.44 18.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.403 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 125.17 52.18 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.114 -0.991 . . . . 0.0 109.604 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' SER . 5.5 m -123.38 115.57 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.074 -169.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -95.02 140.58 29.78 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.806 -1.809 . . . . 0.0 115.758 169.765 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -103.56 128.34 50.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 112.185 166.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.1 mt -108.36 108.24 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 120.758 -1.213 . . . . 0.0 110.116 172.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -102.96 173.04 6.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.839 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.09 18.8 35.75 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.16 143.38 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.9 tttm -163.49 176.9 9.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.059 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -45.96 -20.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.586 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' LYS . 97.2 mt-10 -71.85 -38.71 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.559 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.782 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.5 OUTLIER -73.09 -9.29 58.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.251 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.2 tt0 -58.41 122.26 12.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.851 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.7 -175.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.176 0.513 . . . . 0.0 110.668 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.28 136.13 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.949 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 22.3 m-85 -119.93 132.83 55.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.023 0.439 . . . . 0.0 110.809 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 6.1 p90 -151.21 154.98 37.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.6 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 4.6 m -117.9 141.59 48.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.41 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 55.7 tt0 -117.44 121.52 41.28 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.857 -0.527 . . . . 0.0 109.669 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -135.09 -177.19 4.53 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 -178.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -147.69 130.86 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.396 0.617 . . . . 0.0 110.629 175.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 97' ' ' SER . 34.2 t0 -131.67 -145.58 0.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.134 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.5 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -45.36 -12.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.019 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 95' ' ' ASP . 32.2 m -81.01 -6.36 58.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.768 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER 61.76 109.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.005 177.277 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 37.97 40.28 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.668 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.7 p -164.77 112.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' CG1' HH12 ' A' ' 24' ' ' ARG . 0.9 OUTLIER -176.87 140.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 11.8 p90 -165.29 161.12 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.159 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.55 -147.37 15.36 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.302 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 62.15 52.49 49.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.42 102.96 1.54 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.603 ' CB ' HE21 ' A' ' 6' ' ' GLN . 42.1 m -106.84 126.34 52.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.22 98.36 11.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.172 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.0 tp -82.28 122.86 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.155 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 m -120.73 117.33 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 111' ' ' LEU . 95.2 t -81.85 93.53 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.148 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 110' ' ' VAL . 12.2 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.599 -1.191 . . . . 0.0 111.898 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.496 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 35.2 t-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.6 ' CG ' ' NE2' ' A' ' 99' ' ' HIS . 1.1 m-85 -146.97 141.0 26.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.318 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.585 ' O ' ' N ' ' A' ' 25' ' ' SER . 50.0 mtt -151.24 170.52 19.27 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.06 118.75 15.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.587 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -71.86 134.43 46.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.629 -172.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' A' ' 91' ' ' CYS . 2.8 mm-40 -146.08 157.65 49.65 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.277 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.08 168.67 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.946 . . . . 0.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.528 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -82.89 -66.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.163 179.667 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 9.6 m -165.04 162.85 20.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.5 150.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.6 p -130.2 128.32 41.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.137 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.98 162.57 18.31 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.487 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 3.8 m -96.88 147.02 32.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.75 120.0 7.61 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.481 1.454 . . . . 0.0 111.106 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.84 4.96 27.71 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' ' 13' ' ' SER . 61.8 mttm -101.66 -172.94 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.209 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -126.58 145.11 50.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.29 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.02 141.74 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.707 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -123.11 130.27 52.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 135.49 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 2.7 m -106.37 128.59 54.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.986 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.06 121.64 40.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' THR . 91.9 m -125.96 131.1 52.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 26' ' ' SER . 13.7 ttp180 -81.47 134.21 35.5 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.531 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 3' ' ' MET . 91.6 p -55.48 1.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.488 174.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.71 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.03 -18.05 14.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.19 -172.045 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.05 21.05 68.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.769 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.54 111.24 14.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.2 0.5 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.34 -63.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.67 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -64.04 0.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 34.6 m -109.27 -29.6 8.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.158 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.7 OUTLIER -116.81 155.05 29.64 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.15 125.52 27.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.926 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 t -121.03 148.15 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.626 ' NE2' ' CE1' ' A' ' 94' ' ' TYR . 0.2 OUTLIER -142.0 160.41 40.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.339 -172.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -119.68 126.59 51.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.317 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.2 m-85 -108.01 149.11 28.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.866 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.637 ' NE2' ' CD1' ' A' ' 89' ' ' TYR . 4.3 tp60 -138.1 132.2 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.787 -178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -133.53 146.61 51.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.753 177.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -152.28 174.84 3.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.27 141.33 42.89 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.934 1.756 . . . . 0.0 111.61 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.36 0.75 82.14 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 p -154.02 176.32 12.35 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.2 163.09 24.75 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.486 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -55.26 138.77 80.28 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.558 2.172 . . . . 0.0 111.48 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -149.08 143.17 25.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.442 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -71.88 126.27 29.32 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.946 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 63' ' ' PHE . 2.5 t -95.11 -26.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.26 140.76 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' GLN . 50.2 t80 -127.66 152.96 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 53' ' ' ASN . 11.9 tt0 54.69 23.45 4.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.127 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 43.74 18.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.817 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.44 -46.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.698 . . . . 0.0 109.5 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 50' ' ' TYR . 6.8 tm0? -62.69 114.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.758 -167.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HE ' ' CB ' ' A' ' 61' ' ' ASP . 25.4 ttp-105 -118.67 108.75 40.77 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -68.21 148.03 73.82 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.97 1.78 . . . . 0.0 111.57 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -74.12 -19.37 60.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.89 92.61 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.5 148.72 44.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 62' ' ' ARG . 4.8 Cg_exo -51.65 121.85 9.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.799 1.666 . . . . 0.0 111.675 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' PHE . 38.6 p-10 -60.91 1.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.418 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.578 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.5 mtp-105 -64.53 16.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.446 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASP . 14.4 m-85 -116.9 144.02 45.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -131.66 123.28 27.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.37 126.41 8.72 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.46 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -158.62 164.28 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.257 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.9 161.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.969 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -99.07 178.96 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.658 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 p -91.25 9.14 32.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.023 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' SER . 18.5 m -83.12 -44.41 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.71 28.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.463 -176.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -100.07 -38.63 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.805 -176.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.642 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.4 p -161.3 167.05 26.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.735 -177.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.88 124.74 50.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.013 -1.054 . . . . 0.0 109.576 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 6.3 m -115.21 112.64 22.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.702 -171.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.72 140.59 31.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 119.345 -2.097 . . . . 0.0 116.515 170.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 78.3 m -108.0 130.21 55.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.905 0.859 . . . . 0.0 113.153 163.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -108.13 113.55 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 t -99.24 168.0 10.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.085 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 38.38 93.1 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD21 HG13 ' A' ' 110' ' ' VAL . 3.5 tt -65.37 134.53 53.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.032 0.444 . . . . 0.0 110.97 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' C ' HG11 ' A' ' 110' ' ' VAL . 9.2 tttt -151.94 176.26 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 83' ' ' THR . 0.0 OUTLIER -45.91 -19.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.791 174.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' N ' ' C ' ' A' ' 82' ' ' LYS . 65.0 tt0 -74.55 -38.61 62.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.179 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.578 ' CG ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -72.64 -11.41 60.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.9 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 76.7 tt0 -57.42 125.75 24.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.869 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.39 176.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.88 142.46 27.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.897 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.637 ' CD1' ' NE2' ' A' ' 38' ' ' GLN . 13.4 m-85 -113.99 147.62 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.569 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -146.48 154.13 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.631 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.421 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 42.2 t -127.66 140.66 51.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.562 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 2.8 tp-100 -128.26 131.99 48.74 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.499 ' N ' ' OE1' ' A' ' 92' ' ' GLN . 35.4 p -134.99 145.19 47.87 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.054 -0.404 . . . . 0.0 111.172 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.626 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -154.79 150.65 27.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.149 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -109.94 -165.66 1.03 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.937 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 98' ' ' ASN . 6.0 m -72.37 -40.54 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.373 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -76.28 38.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.432 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 96' ' ' SER . 84.9 m-20 56.2 -114.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.567 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.6 ' NE2' ' CG ' ' A' ' 2' ' ' PHE . 7.3 t-160 43.97 75.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.477 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 94' ' ' TYR . 11.1 m -102.99 129.9 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.829 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.51 155.4 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.438 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.418 ' HB3' ' NE2' ' A' ' 92' ' ' GLN . 9.6 p90 -146.25 152.65 39.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.49 ' H ' HD11 ' A' ' 4' ' ' LEU . . . 178.25 -166.84 37.12 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.238 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.22 48.57 4.01 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.26 96.38 0.06 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -105.27 116.33 31.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.45 123.94 30.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.027 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.1 tp -110.86 122.91 49.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.797 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -116.23 120.28 38.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.803 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.4 t -91.65 34.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.408 179.282 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.407 ' OD1' ' N ' ' A' ' 2' ' ' PHE . 12.9 t-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.407 ' N ' ' OD1' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -142.35 106.88 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.5 mmm -148.12 169.29 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.78 103.05 7.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.68 121.75 25.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.577 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.9 mt-30 -143.78 -177.68 0.69 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.8 Cg_exo -74.38 151.83 43.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.188 1.925 . . . . 0.0 111.658 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.62 ' CG ' ' N ' ' A' ' 9' ' ' SER . 19.0 p-80 -82.44 -57.01 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.625 0.25 . . . . 0.0 111.182 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.62 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 30.6 p -152.6 149.04 28.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.582 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.38 153.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.288 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.1 p -132.15 141.85 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.423 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -131.81 158.1 42.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -76.74 148.9 80.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -63.46 120.23 7.58 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.572 1.515 . . . . 0.0 112.044 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.14 -6.3 17.32 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -96.45 164.94 12.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.162 0.506 . . . . 0.0 111.147 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -95.52 132.3 40.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.065 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.51 135.16 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.079 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.2 m -120.13 134.88 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.465 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.06 134.29 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.125 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -110.23 125.93 53.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 30.7 m -118.75 125.27 49.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 m -116.88 131.73 56.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 26' ' ' SER . 41.7 ttt180 -83.86 136.54 34.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.301 171.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.5 m -58.6 2.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.554 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -104.9 -18.04 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -174.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.17 -32.29 4.14 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -72.47 110.24 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -134.59 -60.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.778 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.89 0.3 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.4 p -110.13 -26.98 9.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.358 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' ND2' HH11 ' A' ' 24' ' ' ARG . 98.3 m-20 -104.26 151.3 23.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -81.55 114.76 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.97 148.0 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -135.84 156.61 48.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.26 135.36 54.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.427 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -139.06 137.07 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.63 ' CD ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -132.0 148.08 52.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.185 0.517 . . . . 0.0 110.098 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -112.73 140.01 47.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.219 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.98 148.27 40.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.8 Cg_exo -57.81 135.21 67.67 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.817 1.678 . . . . 0.0 111.261 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.83 -12.98 4.49 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 41' ' ' PRO . 1.8 t -120.67 150.8 40.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.038 0.447 . . . . 0.0 110.579 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -78.3 179.8 1.59 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.826 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.3 Cg_exo -72.43 156.24 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.557 2.171 . . . . 0.0 112.039 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.402 ' C ' ' CE1' ' A' ' 37' ' ' TYR . 81.2 p -140.4 126.56 19.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.629 176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.491 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 64.6 m -61.14 121.14 11.75 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.726 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.63 HG21 ' CD ' ' A' ' 38' ' ' GLN . 40.4 t -101.36 -28.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.928 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.3 mt -145.63 146.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 172.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.8 t80 -132.99 159.16 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 50.98 24.03 1.69 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.2 1.0 . . . . 0.0 110.361 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 38.5 t0 44.35 19.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.361 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -127.87 -46.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 170.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -55.29 140.46 39.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.909 -168.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -142.34 108.68 5.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.295 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -68.37 143.94 59.95 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.407 1.405 . . . . 0.0 111.992 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -69.64 -35.79 75.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.685 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.96 -50.58 26.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -91.54 139.51 25.12 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -57.83 137.18 79.77 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.137 1.225 . . . . 0.0 110.54 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' N ' ' A' ' 63' ' ' PHE . 4.0 p-10 -62.75 -0.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.61 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.552 HH22 ' CG ' ' A' ' 85' ' ' ASP . 17.9 mtp-105 -38.33 -24.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.495 -175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.2 m-85 -89.77 141.01 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.5 t -126.38 124.36 40.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.951 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.39 117.52 5.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.509 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 75' ' ' SER . 8.1 p -153.93 167.05 31.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.125 0.462 . . . . 0.0 110.722 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -149.14 160.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -101.15 153.75 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.605 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.0 p -68.09 -7.46 29.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.248 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.7 m -61.96 -42.8 99.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 80.84 27.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.481 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.07 -38.25 8.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.786 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.698 ' C ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -166.28 171.41 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.042 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.04 135.41 48.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.784 -1.198 . . . . 0.0 109.467 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -130.42 115.69 17.21 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.794 -1.098 . . . . 0.0 112.825 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -96.99 140.73 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 118.927 -2.358 . . . . 0.0 116.284 169.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.4 m -102.48 126.13 49.42 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.473 -0.767 . . . . 0.0 112.969 162.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.523 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.5 mt -105.25 103.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 120.79 -1.194 . . . . 0.0 109.788 172.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -98.98 154.31 18.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.21 17.25 78.43 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.91 131.91 22.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.318 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' C ' ' N ' ' A' ' 84' ' ' GLU . 26.6 mttt -148.99 176.09 10.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.818 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -18.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.627 174.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.0 mt-10 -75.67 -37.0 59.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.552 ' CG ' HH22 ' A' ' 62' ' ' ARG . 6.9 t70 -74.3 -10.7 59.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 38.8 tt0 -57.59 123.94 17.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.14 -175.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.922 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -89.11 150.01 22.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.563 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 19.1 m-85 -122.26 151.76 40.75 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.543 0.337 . . . . 0.0 110.526 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 37' ' ' TYR . 56.0 m-85 -150.45 137.37 19.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.577 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 16.2 p -118.9 140.66 49.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.951 0.341 . . . . 0.0 111.368 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -118.08 134.71 54.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -135.12 146.99 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.612 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.91 133.96 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -87.3 -175.87 5.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.193 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.8 m -65.26 -41.98 93.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.959 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 m -77.72 37.89 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.492 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 96' ' ' SER . 2.3 m-20 70.21 -127.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.544 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 64.59 78.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.599 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 100' ' ' VAL . 2.6 m -89.15 119.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.37 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.49 141.22 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.233 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -154.1 161.39 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.359 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.37 -131.43 6.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.75 24.13 3.94 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.09 164.71 4.79 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.8 m -131.81 130.57 41.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.87 112.89 15.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.9 tp -105.83 124.45 49.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.116 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.2 m -117.62 124.76 49.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.119 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.07 99.21 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.204 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.887 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.38 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.32 168.17 21.75 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.3 mp -133.78 103.87 6.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -90.41 135.35 33.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.825 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.662 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 30.5 mt-30 -136.55 163.42 49.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.829 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.49 135.46 66.26 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.899 1.733 . . . . 0.0 110.817 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -41.49 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -161.28 157.46 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -163.62 162.88 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.447 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 t -137.07 156.88 47.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.064 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.68 151.78 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.436 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.73 142.32 85.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.528 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.88 113.9 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.459 1.439 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.82 1.34 22.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -94.9 -174.16 3.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.004 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -113.44 127.81 56.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.138 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 144.06 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -130.58 131.45 45.0 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.97 140.17 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.303 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -113.88 120.08 39.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB2' HE21 ' A' ' 6' ' ' GLN . 31.9 t -120.75 123.6 43.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.6 m -119.69 142.09 48.8 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.019 -1.05 . . . . 0.0 108.278 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.605 ' C ' ' H ' ' A' ' 26' ' ' SER . 75.3 mtp85 -92.94 141.1 28.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.685 170.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 p -59.74 2.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.246 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.09 -18.15 14.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.132 -175.417 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 74.3 8.93 80.68 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 6.7 t -110.85 105.46 14.29 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.786 -0.244 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -129.61 -63.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.53 -0.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -98.91 -27.05 14.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.719 -178.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -131.71 152.22 51.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -71.07 149.09 46.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.676 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 17.1 t -125.5 148.21 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.597 HE21 HG23 ' A' ' 47' ' ' THR . 29.5 tt0 -120.24 155.41 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.97 131.04 54.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.054 0.454 . . . . 0.0 110.425 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.511 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.2 OUTLIER -127.91 146.19 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.84 136.66 48.87 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.796 ' NE2' ' H ' ' A' ' 44' ' ' SER . 7.2 tp-100 -120.49 121.75 39.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.348 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 44' ' ' SER . 16.2 mtt180 -79.83 -168.67 0.19 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 40' ' ' ARG . 5.6 Cg_exo -68.89 125.75 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 CA-C-N 121.419 1.542 . . . . 0.0 110.779 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.12 -36.14 0.25 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 113.225 -1.807 . . . . 0.0 114.529 164.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 p -159.38 103.21 1.59 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.336 1.568 . . . . 0.0 112.762 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.796 ' H ' ' NE2' ' A' ' 39' ' ' GLN . 26.0 t -170.7 92.35 0.47 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 119.462 1.028 . . . . 0.0 112.162 171.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.09 127.92 7.95 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.224 1.949 . . . . 0.0 111.456 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -139.92 97.94 3.36 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 121.914 -0.491 . . . . 0.0 110.202 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.597 HG23 HE21 ' A' ' 35' ' ' GLN . 33.9 m -64.83 118.89 9.66 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.94 -28.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.199 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.44 151.47 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . 5.7 t80 -134.13 161.01 36.07 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.0 tt0 48.6 23.86 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.351 0.596 . . . . 0.0 111.217 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 34' ' ' VAL . 35.0 t0 44.48 19.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.119 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -127.93 -46.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.502 . . . . 0.0 109.825 170.483 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' OE1' ' ND2' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -54.52 132.33 44.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.951 -168.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -134.64 108.63 10.97 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.08 149.09 64.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.964 1.776 . . . . 0.0 111.62 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -71.55 -36.75 71.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.698 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.76 42.48 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 59' ' ' VAL . 3.7 m -86.6 138.09 33.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.5 Cg_endo -59.89 131.37 39.2 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 CA-C-N 119.88 0.993 . . . . 0.0 110.665 -177.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 63' ' ' PHE . 25.6 p-10 -60.95 1.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 13.6 mtm105 -46.65 -5.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.165 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 m-85 -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.4 t -119.06 124.36 46.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.72 122.46 6.98 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 37.8 p -159.15 163.35 36.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.051 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -134.91 158.82 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.858 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 70' ' ' SER . 73.5 m-20 -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.864 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.22 30.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 68' ' ' ASP . 6.7 m -107.19 -40.46 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.537 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 83.79 25.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.391 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -42.17 7.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.678 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.611 ' O ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -164.69 170.73 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.63 133.94 51.35 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 120.61 -1.306 . . . . 0.0 110.177 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 12.5 m -125.47 113.56 17.65 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.055 -0.974 . . . . 0.0 113.092 -171.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.44 140.6 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 118.591 -2.568 . . . . 0.0 116.994 170.015 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' SER . 19.5 m -105.1 125.53 51.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 163.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.644 ' CD1' HD21 ' A' ' 76' ' ' LEU . 38.4 mm -89.79 103.62 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.565 -1.334 . . . . 0.0 110.724 172.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 m -99.32 141.56 31.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.371 . . . . 0.0 111.486 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.94 15.42 79.1 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.03 135.66 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.57 . . . . 0.0 110.461 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -144.04 176.06 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.302 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 83' ' ' THR . 0.7 OUTLIER -49.73 -19.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.432 175.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE1' ' NH2' ' A' ' 62' ' ' ARG . 3.2 tt0 -70.97 -42.02 70.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.352 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 4.6 m-20 -66.86 -7.07 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.22 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.0 tt0 -58.99 121.03 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.977 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.5 -175.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -93.0 147.36 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.21 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -116.73 145.33 43.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 14.0 m-85 -145.93 152.62 39.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.859 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.662 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -125.08 140.89 52.49 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -118.98 139.81 51.05 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.487 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 2.4 m -135.09 158.29 44.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 110.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -157.25 138.21 13.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.435 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.18 -170.99 1.81 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.67 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.9 m -62.17 -42.03 98.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.237 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.6 40.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.278 0.561 . . . . 0.0 110.146 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 96' ' ' SER . 3.7 m-20 54.64 -101.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.008 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 43.06 70.84 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.25 121.51 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.116 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.66 157.64 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.425 . . . . 0.0 110.619 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.9 p90 -134.23 142.7 47.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.074 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.83 -150.13 8.66 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' TYR . . . 86.1 35.91 10.58 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.36 110.08 2.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -142.13 137.79 31.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.769 0.319 . . . . 0.0 110.371 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.31 112.72 25.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.565 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.11 125.93 50.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.085 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.88 125.19 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -96.21 103.21 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.209 179.069 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 C--O 1.228 -0.057 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.1 102.77 6.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -92.1 121.08 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.008 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.549 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.55 164.86 25.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.15 134.42 36.91 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.246 1.964 . . . . 0.0 111.612 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.485 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 9.7 t-80 -67.0 -68.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.2 m -148.43 146.04 28.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 11' ' ' SER . 7.9 p -162.52 156.14 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.525 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' HG22 ' A' ' 10' ' ' VAL . 86.0 p -133.86 145.55 49.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.384 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -133.82 156.68 47.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.093 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -77.06 136.76 65.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.166 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.56 125.19 17.07 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.583 1.522 . . . . 0.0 111.093 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 -6.68 25.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -94.08 173.52 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.778 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.6 p -100.56 136.62 40.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.225 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.5 137.43 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -125.14 127.59 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.59 139.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.42 127.71 53.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.379 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 11.2 m -118.62 126.36 51.79 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.8 m -118.93 141.64 48.47 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 26' ' ' SER . 33.1 mtp85 -94.74 141.11 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.185 170.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.5 t -58.2 0.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.544 175.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.635 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.25 -18.1 14.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.794 -173.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 75.47 21.87 76.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' OD1' ' A' ' 32' ' ' ASN . 10.5 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.32 -63.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.439 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.96 1.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 29' ' ' ILE . 54.7 m -104.97 -27.08 11.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.378 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 28' ' ' SER . 4.0 p-10 -122.2 163.58 19.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.152 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -81.92 142.88 32.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.67 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.02 148.26 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.481 HE21 ' C ' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -133.24 144.52 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' C ' HE21 ' A' ' 35' ' ' GLN . 97.9 m95 -110.43 135.03 51.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 110.878 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.515 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -128.29 149.11 50.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.03 140.55 52.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.415 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 6.6 tm0? -148.24 144.65 27.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.449 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 CA-C-O 120.663 0.193 . . . . 0.0 111.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 m -138.78 110.31 7.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.515 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -60.87 121.15 11.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.45 -27.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.408 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mt -145.11 146.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 8.5 t80 -130.96 159.08 38.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.251 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 3.7 tt0 49.3 24.31 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.653 0.74 . . . . 0.0 110.682 -175.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.2 p-10 44.5 19.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.61 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.637 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.0 -46.35 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.378 0.609 . . . . 0.0 109.811 171.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.637 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.55 124.79 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.033 -167.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.56 108.8 40.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.462 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.56 144.54 55.44 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.475 1.45 . . . . 0.0 111.662 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -67.26 -32.38 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.711 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.99 -58.65 13.44 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.45 137.87 48.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.2 Cg_exo -59.01 137.92 82.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.966 1.111 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 63' ' ' PHE . 12.0 p-10 -61.5 1.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.445 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.559 HH22 ' CG ' ' A' ' 85' ' ' ASP . 9.1 ptm180 -49.79 -2.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.93 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.56 ' H ' ' C ' ' A' ' 61' ' ' ASP . 47.2 m-85 -104.45 143.65 32.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.31 122.55 34.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.893 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.07 125.29 8.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.497 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.3 p -157.57 161.88 38.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.194 0.521 . . . . 0.0 111.124 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.623 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.7 pp -141.89 158.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.8 m-20 -102.65 145.96 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.8 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.91 -3.72 10.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.442 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.3 m -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.068 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 28.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.593 -177.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -98.77 -40.55 8.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.52 ' O ' HD13 ' A' ' 29' ' ' ILE . 80.3 p -168.17 169.83 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.088 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.32 135.54 49.46 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 120.613 -1.304 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -128.48 115.6 18.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.137 -171.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.03 140.72 31.94 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 118.622 -2.549 . . . . 0.0 116.91 168.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.0 m -104.63 129.22 52.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 162.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.584 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.0 mt -109.65 105.94 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 120.179 -1.576 . . . . 0.0 110.193 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 t -88.86 153.13 21.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 61.34 4.06 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.21 137.92 34.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.163 0.506 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 84' ' ' GLU . 22.3 mttt -151.45 173.73 14.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.694 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.33 -19.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.497 173.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 82' ' ' LYS . 91.2 mt-10 -68.81 -41.0 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.392 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.559 ' CG ' HH22 ' A' ' 62' ' ' ARG . 16.7 t70 -72.68 -9.9 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.242 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 82.3 tt0 -56.4 120.97 8.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.812 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.88 176.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -88.73 152.86 21.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.668 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 17.6 m-85 -117.67 143.26 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.997 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.3 m-85 -144.58 142.51 30.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.727 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.1 p -134.96 140.86 46.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.829 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -121.16 148.55 44.07 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.76 -0.587 . . . . 0.0 110.482 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 p -135.15 153.37 52.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 110.68 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.98 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.2 p90 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.694 0.283 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.99 -141.99 4.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.68 53.86 38.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.06 103.5 2.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 34.4 m -126.27 141.7 51.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 110.642 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -104.93 101.15 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.69 124.97 36.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.379 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 m -120.74 124.91 46.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.55 100.94 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.113 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.836 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.4 ptm . . . . . 0 C--O 1.231 0.105 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.38 104.49 9.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -80.17 129.68 34.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.321 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.568 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 3.0 mt-30 -145.34 166.68 16.8 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -63.84 133.32 38.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.475 1.45 . . . . 0.0 111.319 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.674 ' CG ' ' H ' ' A' ' 9' ' ' SER . 6.1 p80 -44.19 -60.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.674 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 35.2 p -164.08 160.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -162.95 147.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 p -130.71 132.2 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.849 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.92 158.23 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 m -80.93 140.03 50.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.57 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.38 116.13 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.751 1.634 . . . . 0.0 111.043 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.32 -0.6 18.82 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -107.56 -163.05 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.9 p -136.63 153.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.16 147.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.051 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 131.74 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.85 134.27 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.292 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.8 m -104.92 123.56 47.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.877 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.568 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.99 111.91 18.92 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.7 m -116.59 141.97 47.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.9 mtm180 -99.55 143.27 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.071 170.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.24 1.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -101.45 -14.05 17.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.784 -174.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.33 27.14 70.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.8 p -124.5 109.53 13.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 110.571 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.17 -64.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.995 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.72 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -66.59 -2.41 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.6 t -100.93 -29.18 12.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.57 -2.104 . . . . 0.0 111.339 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -121.09 148.53 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.0 112.84 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.372 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 22.0 t -102.3 146.3 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.598 HE21 ' CB ' ' A' ' 92' ' ' GLN . 7.1 tt0 -127.97 165.09 20.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 28.2 m95 -130.04 127.43 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.936 0.398 . . . . 0.0 110.914 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.492 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 2.1 m-85 -121.19 148.99 43.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.374 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -126.74 134.79 50.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -112.31 117.54 32.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.687 -179.567 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.49 1.278 0 N-CA-C 110.812 -0.495 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 126.82 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.436 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.492 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -74.94 120.96 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.099 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.691 ' HA ' HG21 ' A' ' 59' ' ' VAL . 23.8 t -103.17 -28.4 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.491 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -145.42 151.66 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.801 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 3.5 t80 -140.82 164.86 29.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' ASN . 2.7 tt0 44.84 21.9 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 110.887 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 43.09 18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.614 -177.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.79 -46.97 1.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 173.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.801 ' OE1' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.01 153.28 40.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.993 -164.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.534 ' CZ ' ' O ' ' A' ' 63' ' ' PHE . 3.3 ttt85 -132.0 108.67 14.01 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 120.322 -1.486 . . . . 0.0 109.939 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -69.7 143.0 49.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.446 1.43 . . . . 0.0 111.449 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -73.99 -18.86 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.062 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.46 -38.33 96.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 48' ' ' VAL . 17.2 m -103.08 149.95 37.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 122.291 -0.535 . . . . 0.0 109.626 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.534 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 2.4 Cg_endo -53.65 125.98 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.795 1.663 . . . . 0.0 111.342 -173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' CA ' HH21 ' A' ' 55' ' ' ARG . 97.8 m-20 -61.05 2.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.443 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 19.6 mtm105 -69.25 21.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -173.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.534 ' O ' ' CZ ' ' A' ' 55' ' ' ARG . 16.9 m-85 -131.32 143.6 50.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.151 0.432 . . . . 0.0 110.626 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 77' ' ' THR . 2.1 t -126.64 123.14 36.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.139 -0.457 . . . . 0.0 111.269 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.21 136.54 13.66 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.374 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.4 p -163.83 159.92 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.526 HD13 ' CB ' ' A' ' 30' ' ' ALA . 2.5 pp -141.03 154.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.669 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 70' ' ' SER . 15.9 m-20 -102.98 154.21 19.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.948 176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.4 p -69.7 7.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 68' ' ' ASP . 24.4 m -74.19 -43.11 58.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.596 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 70' ' ' SER . 12.7 p 79.5 30.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.657 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.05 -38.14 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.767 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.591 ' O ' HD13 ' A' ' 29' ' ' ILE . 67.4 p -169.5 172.39 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.775 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.76 123.81 49.6 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 120.864 -1.147 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' SER . 13.7 m -114.02 112.8 23.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.519 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.92 140.48 31.4 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 119.3 -2.125 . . . . 0.0 116.019 169.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.481 ' O ' ' CB ' ' A' ' 64' ' ' SER . 5.6 m -112.64 126.23 55.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 164.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.698 ' CD1' HD21 ' A' ' 76' ' ' LEU . 28.5 mm -86.29 114.25 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 120.21 -1.556 . . . . 0.0 110.919 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.9 t -103.76 131.71 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.85 52.92 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.96 133.82 10.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.252 0.548 . . . . 0.0 110.106 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.0 ttmt -144.17 171.98 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.198 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.03 -19.03 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.831 173.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 5.6 mp0 -70.86 -39.38 72.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -69.76 -9.05 53.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.276 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.0 tt0 -60.37 122.91 15.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 157.38 -179.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 90' ' ' TYR . 9.8 t0 -87.62 149.89 24.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.9 m-85 -115.28 145.39 42.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 88' ' ' ASP . 67.7 m-85 -143.5 154.1 43.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.215 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.84 141.0 49.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.598 ' CB ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.48 120.74 31.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.615 0.643 . . . . 0.0 109.386 174.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.7 p -128.54 152.5 48.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.966 0.412 . . . . 0.0 110.649 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.73 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.746 0.308 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.82 -132.47 1.39 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 48.37 47.01 28.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.33 108.78 2.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -133.16 134.57 44.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.841 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.83 124.31 36.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -113.81 131.32 56.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.934 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 111' ' ' LEU . 88.3 m -124.29 128.97 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 110' ' ' VAL . 58.2 t -87.56 34.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' H ' HG22 ' A' ' 109' ' ' THR . 13.7 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.952 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 30.1 mtm . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.32 103.24 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.48 113.93 11.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.588 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 14.0 tt0 -144.87 141.82 17.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 118.977 -0.535 . . . . 0.0 109.58 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 106' ' ' THR . 6.0 Cg_exo -51.4 137.16 48.08 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 CA-C-N 120.563 1.237 . . . . 0.0 110.954 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 9' ' ' SER . 42.2 p-80 -58.85 -49.43 77.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.629 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' ' CD2' ' A' ' 8' ' ' HIS . 2.4 m -158.7 151.68 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.45 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 11' ' ' SER . 6.6 p -160.29 154.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 10' ' ' VAL . 1.8 t -131.9 149.0 52.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.312 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -141.37 162.19 36.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.459 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -85.93 156.8 57.87 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.325 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.71 128.36 19.84 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.69 1.593 . . . . 0.0 112.283 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.77 -5.27 39.94 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -89.4 167.94 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.672 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p -102.75 125.41 49.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.782 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.44 138.95 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 76' ' ' LEU . 32.5 m -128.59 119.78 25.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.931 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.06 132.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -109.07 124.93 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.0 m -118.86 115.4 24.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.4 m -116.96 137.66 52.07 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.659 ' C ' ' H ' ' A' ' 26' ' ' SER . 12.7 ttp85 -92.81 139.18 30.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.498 170.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.41 2.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.627 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.06 -18.13 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.89 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.68 22.98 76.32 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.613 ' C ' HD21 ' A' ' 32' ' ' ASN . 30.1 t -120.82 110.02 15.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.507 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.47 -63.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.799 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.35 0.35 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.0 p -103.87 -11.63 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.837 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.613 HD21 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -132.33 152.07 51.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 109.982 -177.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.98 127.96 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.092 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.516 ' HA ' HE21 ' A' ' 35' ' ' GLN . 20.5 t -119.81 146.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.228 0.537 . . . . 0.0 110.719 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.56 156.99 47.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.341 -177.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.538 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 98.0 m95 -113.93 136.69 52.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.445 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.424 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 10.2 m-85 -126.17 149.15 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.42 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -146.13 133.53 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.575 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -130.07 160.21 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.533 177.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.08 178.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.491 1.333 0 CA-C-O 120.587 0.161 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 p -132.72 143.31 49.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.424 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 5.5 m -71.7 120.89 17.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.455 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -102.84 -28.66 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.299 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mt -145.61 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.2 t80 -127.79 166.04 18.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.7 tt0 44.77 22.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.083 0.944 . . . . 0.0 110.6 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.2 p30 43.48 17.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.763 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.09 -47.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 170.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 1.1 pp0? -80.9 126.12 30.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.936 -166.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -121.22 119.29 29.67 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.276 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.26 141.37 97.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.8 1.321 . . . . 0.0 111.64 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -67.3 -5.35 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.54 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.99 59.03 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.24 148.5 35.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 122.587 -0.361 . . . . 0.0 110.845 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -59.35 139.41 89.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.813 1.675 . . . . 0.0 111.568 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -61.05 -0.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 63' ' ' PHE . 42.6 ptt85 -56.12 -31.87 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 0.0 111.313 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 60.3 m-85 -72.25 140.89 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.6 t -128.36 122.61 31.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.89 123.94 7.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.41 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -154.56 158.23 39.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.631 . . . . 0.0 111.29 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -143.46 157.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.635 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 m-20 -105.16 143.63 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.813 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -0.05 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.955 0.407 . . . . 0.0 110.327 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.4 m -70.58 -40.77 73.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.02 29.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.397 -177.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -98.93 -39.7 8.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.579 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' ILE . 92.5 p -167.78 169.55 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.889 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.36 130.29 55.21 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.544 -1.348 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' SER . 9.1 m -129.94 114.78 16.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.143 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -97.95 140.53 32.16 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 118.645 -2.534 . . . . 0.0 116.166 167.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 64' ' ' SER . 86.2 m -100.12 128.03 46.27 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 162.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -105.44 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 120.684 -1.26 . . . . 0.0 110.072 174.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.78 170.94 10.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.032 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.36 56.63 4.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 110' ' ' VAL . 1.8 tt -79.38 136.47 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.536 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.467 ' C ' ' N ' ' A' ' 84' ' ' GLU . 14.0 mttp -145.66 -176.6 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.399 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -47.3 -18.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.509 171.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 82' ' ' LYS . 77.9 tt0 -69.97 -41.63 74.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.233 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 14.5 t70 -74.3 -3.65 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.6 tt0 -69.16 124.14 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.76 -175.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.817 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -88.55 135.38 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.239 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 85' ' ' ASP . 13.5 m-85 -114.27 139.95 49.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.028 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.4 m-85 -129.52 154.15 47.31 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.538 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -118.53 140.68 49.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -123.81 116.47 23.02 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 p -135.41 141.68 45.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 C--N 1.328 -0.367 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.703 178.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HA ' HE21 ' A' ' 92' ' ' GLN . 31.6 p90 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.486 0.184 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.24 -154.41 11.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.76 40.17 97.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.67 96.96 0.87 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 7' ' ' PRO . 63.3 m -120.48 131.39 54.72 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.89 117.43 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 29.8 tp -100.32 125.22 46.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.74 109.64 17.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 61.6 t -84.37 44.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.615 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.236 178.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 3.8 ttt . . . . . 0 C--O 1.231 0.081 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.413 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.3 OUTLIER -129.41 103.15 6.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -83.38 119.71 24.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.875 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.5 tt0 -144.98 145.54 27.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.649 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -49.94 136.59 36.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.257 1.128 . . . . 0.0 111.209 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.537 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 5.1 m -156.41 160.18 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.683 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.84 146.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.912 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p -141.08 145.87 36.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.589 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -142.95 154.24 43.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -78.04 140.67 62.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.635 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.06 123.98 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.737 1.624 . . . . 0.0 111.021 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.79 22.41 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -97.88 -171.73 2.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.662 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p -119.89 142.42 48.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.47 142.41 44.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.079 0.466 . . . . 0.0 110.611 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -128.62 134.45 48.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.434 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mm -105.8 146.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.179 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -124.06 122.8 38.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.5 117.91 30.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 m -117.01 142.11 47.38 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.683 ' HE ' ' CB ' ' A' ' 93' ' ' SER . 50.9 mtt85 -98.59 140.53 32.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.315 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -58.54 3.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.33 -17.11 15.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.603 -174.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.48 -41.3 2.49 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -65.42 111.0 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.054 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.12 -59.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.505 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.758 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.66 1.09 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 29' ' ' ILE . 7.8 t -107.92 -30.23 8.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.901 -1.5 . . . . 0.0 111.568 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -111.86 143.11 43.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.4 m-85 -73.95 134.31 43.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.888 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' CG2' ' NH2' ' A' ' 24' ' ' ARG . 1.5 t -121.0 145.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.354 0.597 . . . . 0.0 109.944 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.7 153.23 45.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.463 -176.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 29.3 m95 -129.99 132.34 46.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 110.519 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 32.3 m-85 -119.29 149.39 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.633 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.548 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -131.37 129.27 41.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -113.56 124.83 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.491 1.332 0 N-CA-C 111.458 -0.247 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.5 p -139.25 134.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.507 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 4.4 m -70.29 118.79 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.162 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.88 -21.82 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.338 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.4 mt -144.56 143.16 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 52' ' ' ASP . 76.8 t80 -133.12 167.22 20.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.314 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 53' ' ' ASN . 10.0 tp10 44.67 23.51 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.043 0.925 . . . . 0.0 110.241 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.2 t70 44.22 19.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.255 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' ND2' ' NE2' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -128.04 -45.18 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.783 168.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.629 ' NE2' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.31 143.89 17.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.36 -170.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -146.82 108.57 4.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 118.989 -0.529 . . . . 0.0 109.866 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.21 148.89 56.76 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.534 1.489 . . . . 0.0 111.95 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -74.13 -30.2 62.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.38 -47.12 63.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.51 145.31 31.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.1 Cg_endo -53.01 117.99 4.33 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.915 1.744 . . . . 0.0 111.293 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' PHE . 18.5 p-10 -60.78 0.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.697 HH12 ' N ' ' A' ' 85' ' ' ASP . 47.2 mtm105 -46.12 -11.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.996 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 3.4 m-85 -105.4 143.08 34.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.6 t -124.75 122.86 38.66 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.81 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.19 121.77 7.0 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.47 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.1 p -157.29 163.75 38.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -139.1 155.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.522 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -100.18 152.06 20.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.836 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.7 m -67.94 -8.56 38.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' SER . 58.0 m -61.34 -41.17 96.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER 79.6 27.29 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.347 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -98.55 -41.75 7.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.648 ' C ' HD13 ' A' ' 29' ' ' ILE . 62.7 p -164.43 174.85 10.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.67 47.78 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.614 -1.303 . . . . 0.0 110.011 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 66' ' ' SER . 69.1 m -116.77 116.67 27.93 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.839 -169.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.82 140.58 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 118.474 -2.642 . . . . 0.0 117.386 170.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 64' ' ' SER . 4.5 m -107.85 127.39 53.68 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 163.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -104.18 109.92 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 120.08 -1.638 . . . . 0.0 110.21 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.99 155.75 16.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.332 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.06 42.22 96.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.21 136.86 57.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.45 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -151.83 177.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.262 177.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.93 -21.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.521 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.8 mt-10 -70.22 -40.69 74.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.261 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.9 OUTLIER -70.82 -9.03 56.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.145 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 39.5 tt0 -64.18 125.22 23.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.183 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 163.1 -175.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.039 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.085 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.548 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 16.2 m-85 -115.25 146.82 41.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.459 . . . . 0.0 111.08 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.6 m-85 -144.79 149.01 34.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.077 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.402 ' N ' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -140.7 140.18 34.86 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.432 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 mt-30 -133.16 149.02 52.09 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.683 ' CB ' ' HE ' ' A' ' 24' ' ' ARG . 15.1 m -135.19 126.76 28.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.389 . . . . 0.0 110.938 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 35' ' ' GLN . 12.3 p90 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.849 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.723 0.297 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.52 -145.0 4.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 91' ' ' CYS . . . 76.38 12.78 83.98 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.15 99.33 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.4 m -142.42 141.76 32.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.005 0.431 . . . . 0.0 110.26 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -106.19 119.16 38.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 tp -104.04 122.61 45.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -117.29 111.66 19.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 110' ' ' VAL . 47.6 t -82.76 31.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.779 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.984 -179.18 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 CA--C 1.522 -0.111 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.508 HD13 ' HA2' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -126.79 118.82 25.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -85.88 120.47 27.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.783 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.698 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.6 tt0 -145.48 141.94 17.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.45 160.76 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.247 1.298 . . . . 0.0 111.773 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.29 -56.56 3.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -156.31 150.55 25.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.48 149.62 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 p -120.26 137.62 54.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -117.01 155.38 29.29 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 m -82.99 131.99 52.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.978 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.4 116.77 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.665 1.577 . . . . 0.0 111.018 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.53 -1.97 20.25 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -101.93 -171.74 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.242 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 p -125.85 146.77 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.205 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.83 150.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -126.26 137.31 53.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG2' HE21 ' A' ' 6' ' ' GLN . 43.6 mm -94.54 150.45 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -125.83 114.93 19.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.812 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.698 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 50.5 m -118.69 113.76 21.68 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' HD23 ' A' ' 4' ' ' LEU . 57.2 m -113.31 141.22 47.28 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.02 -1.05 . . . . 0.0 108.272 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 26' ' ' SER . 40.5 mtp85 -89.53 137.24 32.5 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.32 -0.862 . . . . 0.0 110.377 170.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -60.97 2.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.48 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.613 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -102.75 -16.93 15.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.499 -175.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.03 22.84 70.44 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 m -125.89 111.06 14.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.496 0.189 . . . . 0.0 110.829 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.31 -61.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.14 -0.35 . . . . 0.0 111.584 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.76 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.0 1.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 29' ' ' ILE . 94.0 p -109.77 -9.83 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.483 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 28' ' ' SER . 2.7 m120 -124.69 145.7 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.27 134.84 45.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.0 t -130.06 147.93 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.509 0.671 . . . . 0.0 111.164 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -137.88 153.39 49.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.108 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -117.58 120.75 39.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HE1' HG23 ' A' ' 47' ' ' THR . 9.0 m-85 -121.48 149.31 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.229 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.34 137.21 47.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 135.48 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.76 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.983 179.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo . . . . . 0 N--CA 1.49 1.323 0 CA-C-O 120.704 0.21 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 m -120.63 121.72 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.139 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.413 HG23 ' HE1' ' A' ' 37' ' ' TYR . 29.9 m -62.13 120.59 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.793 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.568 HG13 HG21 ' A' ' 59' ' ' VAL . 2.4 t -101.14 -28.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.007 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -145.23 149.35 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 52' ' ' ASP . 62.7 t80 -134.3 160.85 36.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.033 172.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 6.6 tt0 47.19 24.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.326 0.584 . . . . 0.0 111.136 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.6 p30 44.42 19.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.602 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.772 HD22 HE22 ' A' ' 54' ' ' GLN . 0.4 OUTLIER -127.76 -46.19 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.432 0.634 . . . . 0.0 109.56 170.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.772 HE22 HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.65 135.52 40.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.599 -167.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 108.79 18.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -63.36 148.71 92.59 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.96 1.774 . . . . 0.0 111.771 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 t -64.15 -29.54 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.86 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.34 -49.57 71.69 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.568 HG21 HG13 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -96.03 129.63 33.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.5 Cg_endo -62.91 164.34 19.4 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.641 1.561 . . . . 0.0 111.901 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -59.54 1.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.081 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.631 ' NE ' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -39.59 -37.08 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 44.3 m-85 -89.53 143.75 26.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.5 t -136.93 122.97 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.221 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.12 125.93 7.09 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.562 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 68.8 p -159.43 161.35 35.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.069 0.462 . . . . 0.0 111.023 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -137.02 161.31 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.646 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 70' ' ' SER . 86.6 m-20 -102.39 154.9 18.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.717 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -68.87 10.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 68' ' ' ASP . 26.1 m -80.49 -42.94 21.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.88 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.0 28.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.444 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -99.69 -38.12 8.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.607 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' HD13 ' A' ' 29' ' ' ILE . 88.9 p -167.95 166.26 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.97 134.18 51.24 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.063 -1.023 . . . . 0.0 109.655 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 7.4 m -134.07 120.07 19.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.79 140.35 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.296 -1.503 . . . . 0.0 114.101 167.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 57.6 m -106.6 128.84 54.46 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 164.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 78' ' ' ILE . 2.0 mt -104.82 116.56 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 120.82 -1.175 . . . . 0.0 109.672 171.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 t -98.82 127.98 44.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.704 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 69.65 1.38 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.7 tt -85.4 127.84 34.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.383 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' C ' ' N ' ' A' ' 84' ' ' GLU . 8.3 mtmt -137.05 -177.0 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.8 0.334 . . . . 0.0 110.636 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -19.36 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.316 171.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' C ' ' A' ' 82' ' ' LYS . 52.7 tp10 -67.2 -41.18 86.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.849 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 1.3 m-20 -68.99 -19.05 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.082 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 68.3 tt0 -51.16 120.83 5.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.669 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.87 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.317 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.76 143.7 26.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.18 139.64 50.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.158 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -137.8 142.49 40.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.764 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.477 ' SG ' ' HA3' ' A' ' 103' ' ' GLY . 5.7 p -121.84 140.46 52.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 40.1 mt-30 -124.25 128.75 49.63 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.214 -0.304 . . . . 0.0 110.478 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 155.61 50.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.682 -177.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.175 175.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.1 p90 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.359 0.6 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.508 ' HA2' HD13 ' A' ' 4' ' ' LEU . . . -103.49 27.7 18.74 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.469 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.55 63.27 5.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.233 -0.985 . . . . 0.0 110.74 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.55 149.46 8.23 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.598 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.8 m -111.04 141.47 44.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -81.55 123.94 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.504 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 tp -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.565 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.5 m -123.73 121.46 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.406 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 82' ' ' LYS . 39.0 t -83.76 96.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 110' ' ' VAL . 7.0 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.725 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.0 ttp . . . . . 0 C--O 1.231 0.092 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 103' ' ' GLY . 0.5 OUTLIER -119.4 103.02 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 130.89 35.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.493 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.834 HE22 ' H ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -146.34 164.41 24.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.023 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.85 145.29 51.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.398 2.066 . . . . 0.0 110.869 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.25 -73.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.503 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 49.0 m -161.47 159.35 27.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.605 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.24 155.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.467 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' HD21 ' A' ' 111' ' ' LEU . 5.0 p -125.6 137.3 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.373 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.12 161.93 18.64 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -89.94 142.29 28.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.312 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.3 114.9 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.576 1.517 . . . . 0.0 111.452 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.43 -20.3 16.03 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.56 -169.42 1.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.5 p -129.61 153.89 47.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.42 152.23 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -124.27 134.05 53.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.948 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.2 mt -101.85 143.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.584 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -119.59 127.96 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.737 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -118.46 112.52 20.06 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.9 m -113.22 140.58 47.83 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.707 -1.246 . . . . 0.0 108.02 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 20.2 mtp85 -94.1 139.35 31.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.011 170.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -59.13 1.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.542 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.94 -18.2 14.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.546 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 86.57 -19.16 29.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.409 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 1.1 t -87.12 116.78 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.978 -0.719 . . . . 0.0 110.543 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.42 -61.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.34 -0.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.8 t -97.23 -26.66 14.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.268 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 28' ' ' SER . 2.4 p30 -114.85 141.46 47.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.25 144.38 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.46 140.71 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.446 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 13.6 pt20 -121.44 152.54 38.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.363 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.18 142.31 46.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.486 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.8 m-85 -139.14 149.24 44.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.89 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.409 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -131.18 141.54 50.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.462 HE21 ' N ' ' A' ' 45' ' ' PRO . 1.4 tt0 -125.75 135.35 51.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.358 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.225 -179.77 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.462 ' N ' HE21 ' A' ' 39' ' ' GLN . 5.9 Cg_exo . . . . . 0 N--CA 1.491 1.336 0 CA-C-O 120.421 0.092 . . . . 0.0 111.865 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 m -132.83 126.69 32.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.351 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.0 m -64.14 119.02 9.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.176 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 t -101.29 -29.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.048 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 mt -145.35 150.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.3 t80 -136.22 163.9 29.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.888 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp10 44.68 24.27 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.834 0.826 . . . . 0.0 110.682 -172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' TYR . 33.7 t0 43.97 20.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.015 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.747 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -128.06 -46.13 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 169.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.747 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.97 131.06 26.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.124 -168.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.766 ' NH2' ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -116.43 108.82 44.8 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 48' ' ' VAL . 5.7 Cg_exo -65.91 147.24 84.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.965 1.777 . . . . 0.0 111.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 p -70.81 -36.58 73.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.67 -43.12 86.31 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.0 m -98.1 127.74 35.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.4 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.7 Cg_exo -62.78 161.93 27.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.322 1.348 . . . . 0.0 111.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.606 ' C ' HH21 ' A' ' 55' ' ' ARG . 47.3 t0 -60.12 3.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.412 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -48.02 -27.59 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.633 -175.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.766 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 31.8 m-85 -92.07 136.55 33.08 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.215 -0.303 . . . . 0.0 110.663 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.4 t -125.12 123.85 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.933 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.67 131.74 10.65 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.128 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.7 p -161.63 172.43 16.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.304 0.574 . . . . 0.0 111.224 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 30' ' ' ALA . 3.6 pt -149.56 163.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.229 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.85 152.76 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.698 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 p -68.02 -8.32 36.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.42 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.3 m -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.886 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.03 27.73 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 -178.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -99.13 -37.07 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.224 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.755 ' C ' HD13 ' A' ' 29' ' ' ILE . 85.5 p -165.96 166.76 17.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.406 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.01 130.04 55.47 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.084 -1.01 . . . . 0.0 109.709 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.5 m -132.9 122.45 24.37 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.458 -169.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.25 141.05 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.8 -1.813 . . . . 0.0 114.834 169.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 64' ' ' SER . 9.9 m -106.31 125.71 51.34 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 165.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.702 ' CD1' HD21 ' A' ' 76' ' ' LEU . 30.9 mm -86.86 123.51 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 120.195 -1.566 . . . . 0.0 110.543 171.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 t -112.95 127.71 56.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.577 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.42 43.77 10.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HA ' HH22 ' A' ' 62' ' ' ARG . 2.1 tt -64.82 132.21 48.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.429 . . . . 0.0 110.453 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.458 ' C ' ' N ' ' A' ' 84' ' ' GLU . 11.9 tttp -143.65 174.72 10.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.128 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -46.16 -21.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.542 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' A' ' 82' ' ' LYS . 66.8 mm-40 -69.27 -42.77 75.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.132 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 19.8 m-20 -68.81 -5.64 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.433 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.6 tt0 -62.08 121.06 12.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.2 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.22 -179.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.528 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.87 151.61 23.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.162 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -121.72 146.17 47.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 111.068 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.8 m-85 -144.38 148.75 35.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.469 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 103' ' ' GLY . 0.7 OUTLIER -134.43 140.17 46.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.38 136.32 51.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.333 0.587 . . . . 0.0 110.019 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -134.97 -176.39 4.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.546 ' CD1' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.37 0 O-C-N 123.64 0.588 . . . . 0.0 110.479 174.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 2.9 p90 . . . . . 0 C--O 1.232 0.162 0 CA-C-O 121.001 0.429 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 4' ' ' LEU . . . -172.2 -146.53 5.38 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.834 ' H ' HE22 ' A' ' 6' ' ' GLN . . . 65.66 -7.03 1.12 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.187 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . -51.96 84.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' GLY . 20.5 m -150.09 125.67 10.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.23 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -83.58 132.37 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.159 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.2 tp -119.74 127.04 52.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.629 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.8 125.75 50.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.264 0.554 . . . . 0.0 110.038 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 110' ' ' VAL . 65.5 t -88.91 36.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.381 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.548 HD21 ' OG ' ' A' ' 11' ' ' SER . 83.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.746 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.765 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.1 mtm . . . . . 0 C--O 1.231 0.087 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 3' ' ' MET . 8.2 mp -132.6 108.84 9.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -92.12 117.53 29.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.621 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -145.79 165.66 20.17 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.13 151.26 12.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.546 2.164 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.563 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -75.83 -65.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.03 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -158.82 146.03 17.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.229 0.537 . . . . 0.0 110.373 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.28 146.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.057 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 p -117.07 143.64 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.491 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.32 163.08 26.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.334 0.587 . . . . 0.0 110.475 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -94.67 142.57 24.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.27 113.99 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.416 1.411 . . . . 0.0 111.152 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.12 -5.02 15.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -94.25 177.8 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.1 p -128.96 142.79 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.76 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 19' ' ' THR . 3.4 p -137.32 155.2 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -125.63 125.36 42.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.53 146.51 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.367 0.603 . . . . 0.0 110.786 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -117.36 132.68 56.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.814 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.82 116.48 26.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -111.31 134.22 53.06 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 61.2 mtp180 -91.34 138.16 31.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.603 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.81 3.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.57 176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -96.7 -12.87 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.21 -173.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 -1.87 39.4 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.266 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -124.24 124.73 43.08 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.215 0.206 . . . . 0.0 110.82 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -128.86 -55.33 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.691 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.34 -1.16 2.2 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 12.0 p -86.59 -32.24 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 111.698 -2.501 . . . . 0.0 111.075 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.445 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 1.8 m120 -122.46 159.23 28.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.15 123.39 25.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.975 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 ' H ' ' HB3' ' A' ' 52' ' ' ASP . 96.2 t -103.76 146.89 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.355 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 36' ' ' TRP . 5.4 tt0 -133.32 158.83 41.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 12.7 m95 -129.45 124.14 33.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.929 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CD2' ' OE1' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -110.73 149.55 30.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.17 142.21 49.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.586 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -140.36 117.1 10.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.586 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 2.5 mpt_? . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.491 1.332 0 N-CA-C 111.687 -0.159 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 m -148.7 97.95 2.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.921 0.391 . . . . 0.0 110.117 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 28.8 m -64.25 120.18 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 63' ' ' PHE . 24.8 t -100.16 -28.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.956 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -144.95 142.19 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -136.07 148.67 48.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.595 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 53' ' ' ASN . 14.2 tp10 58.96 22.49 10.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.942 1.353 . . . . 0.0 110.243 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER 42.73 17.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.813 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -129.44 -47.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.294 0.569 . . . . 0.0 111.409 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.472 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -92.25 140.63 29.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.329 -165.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.6 144.98 32.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.99 150.89 75.83 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.314 1.343 . . . . 0.0 111.275 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.2 p -71.05 -22.35 62.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.6 96.41 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.94 140.79 43.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -51.78 119.63 5.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.084 1.19 . . . . 0.0 110.581 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.74 1.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.009 -0.432 . . . . 0.0 111.037 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 60' ' ' PRO . 46.4 mtm180 -53.18 -22.34 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.62 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 6.8 m-85 -75.27 129.09 36.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.978 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 5.0 t -110.17 121.59 45.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.067 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.16 126.15 8.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.528 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.7 p -164.37 166.85 20.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.329 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.2 160.9 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -93.07 163.31 13.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.093 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 m -68.45 30.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -123.12 -46.33 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 79.0 25.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.787 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -98.33 -19.04 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.601 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' ILE . 30.9 p -158.32 169.94 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.838 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.88 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 8.0 m -99.02 110.99 23.51 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.988 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -101.15 140.45 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.471 ' O ' ' CB ' ' A' ' 64' ' ' SER . 94.9 m -112.56 124.38 52.39 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 163.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.2 mt -102.46 109.11 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 O-C-N 119.966 -1.709 . . . . 0.0 110.446 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -99.34 142.42 30.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.392 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.03 44.83 8.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 110' ' ' VAL . 2.7 tt -74.75 129.91 38.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.217 0.532 . . . . 0.0 110.559 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' GLU . 15.9 tttt -138.77 172.6 12.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.83 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 83' ' ' THR . 29.7 p -45.88 -19.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.544 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 27.6 tt0 -73.79 -38.45 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.335 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -68.89 -4.38 16.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 74.4 tt0 -60.43 129.16 40.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.425 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.76 173.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -91.02 143.58 26.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.782 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.522 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 11.5 m-85 -109.75 150.72 27.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.223 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 49.3 m-85 -146.81 153.77 40.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.369 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 94.3 m -120.73 141.08 50.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.519 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 33.6 mt-30 -126.71 137.47 53.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.727 0.694 . . . . 0.0 110.497 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NH2' ' A' ' 24' ' ' ARG . 3.0 t -128.71 143.21 50.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.276 0.56 . . . . 0.0 110.92 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.6 p90 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.925 0.393 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.25 -157.24 16.96 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.15 53.9 38.91 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.27 107.1 3.36 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.436 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 37.9 m -124.54 129.96 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.027 0.441 . . . . 0.0 110.71 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.21 115.62 25.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.276 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -102.9 122.74 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 111' ' ' LEU . 93.0 m -119.68 114.99 23.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.406 0.622 . . . . 0.0 110.075 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 110' ' ' VAL . 57.9 t -76.83 30.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.822 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 109' ' ' THR . 77.3 mt . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.567 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 ttt . . . . . 0 N--CA 1.46 0.031 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.26 103.09 7.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -95.46 120.19 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.12 167.93 12.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -53.33 144.91 47.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.711 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.4 p80 -75.88 -51.6 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.82 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -159.27 151.16 20.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 110.809 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 11' ' ' SER . 5.4 p -161.37 155.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.468 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 10' ' ' VAL . 78.6 p -137.37 152.89 50.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -142.03 162.18 36.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.221 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.531 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -92.37 151.08 41.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.907 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.87 117.77 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.781 1.654 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.16 9.74 31.27 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 13' ' ' SER . 72.3 mttt -98.96 -178.7 4.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 110.619 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.6 p -122.54 128.07 50.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.212 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.6 139.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.741 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 76' ' ' LEU . 99.9 m -125.6 133.26 52.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.532 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 1.3 mt -113.06 142.02 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.198 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -117.08 131.72 56.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.556 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -119.59 124.07 45.47 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.1 m -120.53 142.11 49.63 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.954 -1.091 . . . . 0.0 108.24 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 26' ' ' SER . 28.2 ttm180 -99.74 144.6 28.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.294 168.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 p -60.75 3.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.837 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.585 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.32 -17.78 14.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 -175.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 71.3 23.68 77.79 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 t -119.86 105.27 10.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.646 0.26 . . . . 0.0 111.158 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.18 -64.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -3.79 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.7 m -97.85 -22.68 16.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.668 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -126.55 155.08 42.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -73.02 125.53 27.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.059 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.05 148.04 23.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.537 0.685 . . . . 0.0 110.779 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -141.45 169.97 16.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.182 -178.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 70.1 m95 -131.25 146.36 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.5 m-85 -132.9 149.04 52.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -127.5 135.55 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 7.1 tm0? -130.26 143.48 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.489 0.661 . . . . 0.0 109.66 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.526 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.061 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 110.319 -0.685 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -125.35 125.35 43.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 110.666 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -65.39 119.97 11.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.383 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.92 -25.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.007 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.0 mt -144.34 135.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 64.7 t80 -125.77 164.36 20.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.761 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.6 tt0 45.91 22.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.357 -170.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 43.55 17.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.926 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.573 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -128.87 -46.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 110.647 170.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.444 HE21 ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.13 154.48 17.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.27 -1.786 . . . . 0.0 107.82 -165.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.81 ' H ' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -143.73 146.72 36.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.257 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.44 145.48 88.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.389 1.392 . . . . 0.0 110.929 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 m -62.07 -22.09 65.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.132 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.14 97.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.2 142.18 24.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.369 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.15 143.18 98.63 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.479 1.453 . . . . 0.0 111.702 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.4 p30 -62.61 -2.83 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.622 ' NH1' ' CE1' ' A' ' 63' ' ' PHE . 28.8 ptt85 -47.01 -40.21 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.371 0.605 . . . . 0.0 110.576 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' CE1' ' NH1' ' A' ' 62' ' ' ARG . 97.9 m-85 -62.98 129.18 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.422 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 6.1 t -113.79 119.44 37.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.414 0.626 . . . . 0.0 110.909 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.2 112.47 3.59 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.134 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 75' ' ' SER . 7.3 p -149.61 167.48 26.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.51 0.671 . . . . 0.0 110.208 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -143.49 163.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.976 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 70' ' ' SER . 75.8 m-20 -98.77 152.75 19.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.518 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -68.35 31.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.687 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 68' ' ' ASP . 30.1 m -104.12 -46.31 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.578 0.228 . . . . 0.0 110.565 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 85.43 25.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.473 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.05 -37.34 9.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.066 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.641 ' C ' HD13 ' A' ' 29' ' ' ILE . 52.9 p -160.12 166.67 29.37 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.535 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.25 127.01 54.76 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.741 -1.224 . . . . 0.0 109.513 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -121.72 116.07 23.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.39 -172.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 19' ' ' THR . 0.6 OUTLIER -99.02 140.27 33.42 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 118.344 -2.722 . . . . 0.0 117.329 168.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 64' ' ' SER . 61.8 m -106.06 126.28 52.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 163.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.471 ' CD1' HD21 ' A' ' 76' ' ' LEU . 3.1 mt -97.51 112.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 119.798 -1.813 . . . . 0.0 110.918 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.642 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -96.11 137.69 34.81 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.834 -0.541 . . . . 0.0 111.462 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 58.75 3.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.07 135.0 36.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.211 0.529 . . . . 0.0 110.478 177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -134.36 176.44 8.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.714 174.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 p -47.65 -19.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' N ' ' C ' ' A' ' 82' ' ' LYS . 9.4 tp10 -70.53 -39.36 74.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.821 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.602 ' CB ' HH22 ' A' ' 62' ' ' ARG . 27.6 t0 -67.18 -7.09 20.99 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.399 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -62.41 130.62 46.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.89 175.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -85.03 144.77 28.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.474 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 8.9 m-85 -108.91 154.21 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -150.49 145.48 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 59.4 m -120.28 141.01 50.38 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 5.7 mt-30 -124.45 145.39 49.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 24' ' ' ARG . 53.5 p -135.09 123.73 23.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 110.353 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.3 p90 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 177.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.388 0.137 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.3 -139.24 10.91 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 45.12 29.67 2.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.13 158.11 5.61 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.9 m -126.06 130.09 50.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.517 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -80.59 110.34 15.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.2 tp -99.39 124.81 44.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.19 124.37 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.092 0.472 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' LEU . 61.2 t -87.63 94.43 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 110' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.234 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.575 ' N ' ' HG ' ' A' ' 25' ' ' SER . 16.8 mmm . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.899 0.38 . . . . 0.0 110.308 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 3' ' ' MET . 7.7 mp -123.63 107.98 12.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -78.19 113.51 16.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.635 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 52.4 mt-30 -140.37 158.21 66.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.18 140.99 71.12 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.93 1.753 . . . . 0.0 110.38 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -49.25 70.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.18 129.0 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.065 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 11' ' ' SER . 7.4 p -139.28 161.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.155 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.562 ' N ' HG22 ' A' ' 10' ' ' VAL . 94.1 p -143.43 155.53 44.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.624 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -140.31 153.17 46.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.074 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.26 141.98 74.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.195 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 115.28 2.16 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.715 1.61 . . . . 0.0 111.246 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.37 1.03 33.13 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -98.06 161.51 13.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.8 p -93.0 134.35 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.9 137.46 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -118.64 134.18 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.322 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mt -99.81 137.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.426 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 m -111.62 116.68 31.2 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HB2' HE21 ' A' ' 6' ' ' GLN . 17.5 t -118.92 113.04 20.41 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 m -114.79 140.78 48.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 26' ' ' SER . 31.8 ttp180 -92.56 136.83 32.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.999 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.575 ' HG ' ' N ' ' A' ' 3' ' ' MET . 1.4 p -59.05 3.74 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.645 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.79 -18.06 14.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.678 -174.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.85 20.05 76.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -123.07 109.62 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.979 0.39 . . . . 0.0 110.773 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.17 -62.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 -176.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.22 0.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.642 ' H ' ' C ' ' A' ' 29' ' ' ILE . 91.5 p -109.82 -3.13 16.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.566 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -135.9 158.5 44.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.124 0.487 . . . . 0.0 110.874 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.43 129.18 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' HE21 ' A' ' 35' ' ' GLN . 81.9 t -123.14 148.06 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 110.728 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.99 153.93 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.151 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -110.3 135.13 51.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 11.4 m-85 -129.17 147.54 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.324 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.421 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -134.38 133.07 40.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.128 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -112.48 116.14 29.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 N-CA-C 111.431 -0.257 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -146.93 105.4 3.8 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.757 -0.59 . . . . 0.0 111.003 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 25.8 m -63.38 120.23 11.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.878 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.62 -28.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.735 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.4 149.95 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' ASP . 6.2 t80 -134.76 164.04 28.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.793 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.37 23.87 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.569 1.176 . . . . 0.0 110.754 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.7 p30 44.35 19.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.587 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.551 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -127.85 -45.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.673 ' N ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -53.54 134.89 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.279 -170.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -137.39 108.65 8.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -70.06 152.8 67.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.853 1.702 . . . . 0.0 112.013 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -70.78 -33.12 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.375 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.23 -47.7 79.97 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 59' ' ' VAL . 3.8 m -90.68 132.52 34.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.1 Cg_exo -59.3 142.07 98.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.462 1.441 . . . . 0.0 111.117 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' PHE . 49.9 p-10 -61.21 1.65 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.566 HH22 ' CG ' ' A' ' 85' ' ' ASP . 8.4 ptm180 -49.69 -2.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' ASP . 17.3 m-85 -107.98 146.44 32.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.3 t -130.39 121.03 25.17 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.893 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.79 123.16 7.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.345 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.6 p -158.81 164.51 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.426 -0.455 . . . . 0.0 110.2 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.652 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -135.08 159.92 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.589 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 70' ' ' SER . 30.7 m-20 -96.66 144.18 26.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 p -70.13 27.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.008 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 68' ' ' ASP . 21.2 m -102.23 -36.76 8.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.015 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 82.21 22.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.234 -177.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -95.8 -43.71 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.754 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' ILE . 95.0 p -162.1 174.86 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.009 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.9 126.78 55.07 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.331 -1.48 . . . . 0.0 110.573 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.9 m -118.23 112.31 19.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.569 -171.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -97.02 140.75 31.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 168.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.4 m -110.52 128.25 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 163.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.424 HG13 HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.0 109.95 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 119.812 -1.805 . . . . 0.0 110.666 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -98.65 141.25 31.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.555 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.82 32.99 35.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 110' ' ' VAL . 2.3 tt -55.8 145.79 23.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.987 0.422 . . . . 0.0 110.318 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' ASP . 6.6 tttp -160.66 177.87 10.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.355 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 t -46.01 -19.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 82' ' ' LYS . 77.4 mt-10 -71.85 -40.02 69.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.367 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.566 ' CG ' HH22 ' A' ' 62' ' ' ARG . 18.9 t70 -70.32 -13.12 62.02 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.173 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 32.9 tt0 -58.23 123.14 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.6 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.0 178.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 109.942 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.07 146.38 25.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.2 m-85 -121.88 146.27 47.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 111.083 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.1 m-85 -141.72 149.18 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.17 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.635 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 p -124.85 140.87 52.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.5 mt-30 -116.83 140.06 49.88 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.174 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.9 p -135.07 119.69 18.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 109.896 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.123 175.896 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.2 p90 . . . . . 0 N--CA 1.458 -0.065 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 144.93 -129.8 3.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 84.92 62.57 1.67 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.11 110.14 2.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -117.16 118.89 33.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -78.44 116.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.986 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.8 tp -110.71 126.53 54.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 m -118.97 133.67 55.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.391 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.72 ' O ' HG12 ' A' ' 110' ' ' VAL . 79.2 t -86.03 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.228 0.537 . . . . 0.0 110.587 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.698 -1.144 . . . . 0.0 110.874 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.843 ' N ' ' HG ' ' A' ' 25' ' ' SER . 74.8 mmm . . . . . 0 N--CA 1.461 0.094 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.555 HD21 HH21 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -130.87 102.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -91.43 138.41 31.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.69 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 104' ' ' GLY . 15.1 mt-30 -143.87 160.12 51.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.31 128.53 23.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.925 1.75 . . . . 0.0 111.023 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.625 ' CD2' ' H ' ' A' ' 9' ' ' SER . 3.7 p-80 -45.21 -59.24 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.0 110.413 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.625 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 83.2 p -164.67 162.71 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.588 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 11' ' ' SER . 3.0 p -162.42 161.27 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.029 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 10' ' ' VAL . 84.1 p -143.2 149.74 38.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.616 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.1 153.15 45.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 147.89 82.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.566 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.76 119.7 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.628 1.552 . . . . 0.0 111.368 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.6 -3.25 26.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -98.27 -170.26 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.541 0.21 . . . . 0.0 110.967 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.5 p -127.26 150.47 49.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.732 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.56 147.82 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.886 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -121.69 134.23 54.96 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.1 mt -108.83 140.08 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -108.38 142.64 38.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.507 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.13 111.63 12.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 m -119.64 140.5 50.52 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.562 -1.336 . . . . 0.0 108.099 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.66 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -107.27 145.0 33.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.238 171.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.843 ' HG ' ' N ' ' A' ' 3' ' ' MET . 90.2 p -57.86 4.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.546 176.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.66 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.03 -18.18 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 -175.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 78.67 -32.16 1.91 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 14.7 m -68.4 110.05 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.548 0.213 . . . . 0.0 111.298 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.17 -62.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.754 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.77 -0.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 29' ' ' ILE . 10.7 p -98.91 -25.29 14.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.804 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 28' ' ' SER . 29.1 p30 -121.26 147.3 45.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -71.39 144.45 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.624 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.48 137.79 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.242 0.544 . . . . 0.0 110.198 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.555 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 4.1 pt20 -120.9 152.18 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 46.4 m95 -122.28 133.07 54.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.146 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.9 m-85 -130.1 149.08 51.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.826 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.589 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -117.96 135.69 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.276 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HE ' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 N-CA-C 111.022 -0.414 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.8 p -121.66 120.51 34.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.646 0.26 . . . . 0.0 110.381 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.52 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 10.4 m -62.01 117.72 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.831 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.73 -28.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.64 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.22 136.63 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 51' ' ' GLU . 11.0 t80 -125.01 166.23 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.706 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tt0 44.81 22.45 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.145 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.6 p-10 42.9 18.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.167 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.48 -47.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.183 0.516 . . . . 0.0 111.129 168.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.605 HE21 ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.06 150.77 20.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.242 -1.799 . . . . 0.0 108.594 -167.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 148.32 65.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.14 147.6 95.21 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.723 1.616 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 m -67.76 -14.91 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -46.28 70.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.67 141.08 23.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -60.01 139.32 87.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.259 1.306 . . . . 0.0 111.631 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -61.17 0.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.601 HH12 ' CB ' ' A' ' 85' ' ' ASP . 8.8 ptm180 -47.16 -24.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.149 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CE1' ' CG ' ' A' ' 62' ' ' ARG . 23.5 m-85 -88.6 142.95 27.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -128.03 124.22 36.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.084 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.42 7.16 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.679 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.3 p -154.97 166.07 34.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.529 . . . . 0.0 111.355 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.6 pp -146.38 153.76 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.85 157.19 16.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.111 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.7 p -70.3 -8.44 50.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.0 m -60.38 -40.82 92.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER 79.0 25.76 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.284 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -97.48 -42.15 7.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.598 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.661 ' HA ' HG21 ' A' ' 29' ' ' ILE . 73.1 p -165.33 171.32 13.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.054 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.52 127.13 55.04 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.936 -1.103 . . . . 0.0 110.442 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 28.9 m -119.42 117.98 29.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.954 -169.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -97.54 140.59 31.74 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 118.651 -2.53 . . . . 0.0 117.217 168.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' SER . 75.8 m -111.49 127.72 55.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 162.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.507 HG23 HH21 ' A' ' 62' ' ' ARG . 3.0 mt -99.9 112.35 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 120.048 -1.657 . . . . 0.0 109.951 174.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 t -96.85 135.59 38.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.479 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.01 49.22 6.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.66 137.86 48.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 0.0 110.633 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.454 ' C ' ' N ' ' A' ' 84' ' ' GLU . 21.2 tttt -144.7 176.93 9.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.905 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 1.5 p -46.84 -20.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.662 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 82' ' ' LYS . 26.2 tt0 -72.7 -39.05 67.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.008 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.601 ' CB ' HH12 ' A' ' 62' ' ' ARG . 6.4 t70 -67.63 -6.9 22.53 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.691 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.8 tt0 -63.35 124.65 21.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.28 -178.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 0.0 110.552 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -87.14 136.72 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.675 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.589 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 27.8 m-85 -116.32 135.75 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.742 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.2 p90 -149.26 149.06 30.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.04 151.49 41.89 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.962 0.505 . . . . 0.0 110.924 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 18.7 mt-30 -123.56 147.69 47.05 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 122.213 -0.304 . . . . 0.0 111.338 168.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' NE ' ' A' ' 24' ' ' ARG . 13.7 t -135.25 159.99 39.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.681 0.276 . . . . 0.0 111.587 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.669 176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.05 -161.89 34.74 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.069 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.476 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 96.04 34.3 5.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.8 95.01 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -111.27 114.58 27.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 0.0 109.798 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -80.25 108.66 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.422 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.8 tp -102.36 126.0 49.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.552 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -120.72 124.86 46.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.319 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.723 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.9 t -89.57 34.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.44 179.288 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 4' ' ' LEU . 17.5 mtp . . . . . 0 CA--C 1.524 -0.052 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 3' ' ' MET . 7.2 mp -132.77 104.78 6.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -78.93 126.06 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.177 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.616 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 6.8 mt-30 -145.42 164.46 26.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.83 127.21 25.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.135 1.89 . . . . 0.0 110.737 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 5.8 p80 -57.74 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.2 p -165.12 135.39 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.083 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.58 154.96 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.317 . . . . 0.0 110.398 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.7 p -138.45 137.58 37.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 31.3 mp0 -128.38 162.49 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.024 0.44 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -78.52 146.31 69.43 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.607 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.88 125.93 19.04 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.117 1.211 . . . . 0.0 111.57 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.85 -4.2 28.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -95.34 171.69 8.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.967 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 7.1 p -115.31 130.88 57.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.413 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -127.79 134.66 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -110.02 128.42 55.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.291 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 mm -98.44 145.06 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.083 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -117.59 116.68 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.318 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HB2' HE21 ' A' ' 6' ' ' GLN . 42.0 t -118.84 112.28 19.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -116.02 137.6 51.97 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.078 -1.014 . . . . 0.0 108.28 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.68 142.77 27.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.607 170.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -57.88 2.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.68 -16.94 14.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.538 -174.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.99 -50.39 4.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 75.0 p -54.28 113.88 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.312 . . . . 0.0 111.166 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.79 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.34 -61.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.181 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.79 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.5 -0.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 5.9 m -107.01 -18.99 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.623 -1.626 . . . . 0.0 111.798 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.506 ' ND2' ' NH2' ' A' ' 24' ' ' ARG . 38.5 m-20 -116.87 147.82 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -78.88 132.41 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.489 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.73 146.32 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.11 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 8.5 pt20 -123.64 163.1 21.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 30.3 m95 -131.51 131.92 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 7.6 m-85 -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.9 139.98 53.46 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -141.83 141.26 33.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.252 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 110.805 -0.498 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -132.77 137.7 46.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.48 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.6 m -73.27 120.25 18.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.528 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.85 -28.0 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.141 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -145.28 149.27 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' O ' ' N ' ' A' ' 52' ' ' ASP . 37.5 t80 -133.94 163.62 29.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.182 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.2 tt0 45.37 23.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.686 0.755 . . . . 0.0 110.827 -173.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' TYR . 10.6 t70 44.73 19.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.594 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.534 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.83 -46.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.861 170.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.599 ' N ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -52.72 134.11 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.498 -167.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.731 ' NH1' ' H ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -123.59 108.8 30.93 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -65.66 136.81 47.47 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.618 1.546 . . . . 0.0 111.756 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 m -63.93 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.14 -57.81 12.25 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.08 150.36 58.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.8 Cg_endo -61.55 135.45 57.05 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.067 1.178 . . . . 0.0 111.219 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.79 -0.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.488 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 52.0 mtm180 -48.37 -38.44 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -71.72 134.84 46.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.9 t -124.12 122.71 38.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.731 ' H ' ' NH1' ' A' ' 55' ' ' ARG . . . -107.74 118.9 5.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.627 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.6 p -155.41 164.03 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.935 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.687 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -146.0 157.63 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -103.03 153.17 20.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.378 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -68.4 1.87 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.042 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.2 m -65.95 -43.97 86.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.62 27.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.543 -177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.38 -41.09 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.943 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.723 ' O ' HD13 ' A' ' 29' ' ' ILE . 94.4 p -166.7 175.34 7.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.767 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.78 125.51 50.91 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.812 -1.18 . . . . 0.0 109.881 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 m -115.84 112.73 22.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.744 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -98.3 140.53 32.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 170.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' SER . 89.3 m -107.72 126.7 52.93 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 163.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.472 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.7 mt -105.8 105.33 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 O-C-N 120.398 -1.439 . . . . 0.0 110.737 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 29.6 t -95.45 154.38 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.008 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 32.37 76.78 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -54.21 128.01 29.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 109.667 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 84' ' ' GLU . 18.9 mttp -139.48 171.1 14.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.055 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -45.94 -18.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.648 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 82' ' ' LYS . 39.9 mt-10 -69.31 -38.56 78.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.529 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 2.2 m-20 -73.26 -11.34 60.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.241 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -52.92 120.75 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.543 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.94 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -86.91 144.87 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -113.18 153.07 28.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -149.95 147.84 28.37 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 8.6 p -132.94 142.8 49.07 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.023 0.529 . . . . 0.0 109.972 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.89 147.31 50.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.422 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 9.0 t -135.24 160.84 37.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.1 0.476 . . . . 0.0 111.226 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD2' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.56 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 121.008 0.432 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.86 7.78 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.61 56.52 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.55 110.08 3.27 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.5 m -137.13 127.83 27.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.692 0.282 . . . . 0.0 110.286 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -88.42 99.36 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.404 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -91.08 123.67 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -120.77 122.36 40.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.371 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.698 ' O ' HG12 ' A' ' 110' ' ' VAL . 80.6 t -82.11 40.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.069 178.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.68 ' N ' ' HG ' ' A' ' 25' ' ' SER . 9.1 mtt . . . . . 0 N--CA 1.46 0.073 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -133.22 102.95 5.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.5 p -86.4 135.6 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.537 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 30.7 mt-30 -146.19 163.14 31.91 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.715 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.51 140.38 74.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.534 1.49 . . . . 0.0 111.021 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -69.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.257 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 p -161.27 155.2 22.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.792 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 11' ' ' SER . 4.7 p -162.11 161.01 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.787 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 p -128.65 151.47 49.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.419 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -135.21 143.83 46.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.401 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 138.05 86.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.88 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.48 113.24 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.377 1.385 . . . . 0.0 111.297 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.02 -8.23 16.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -93.05 -177.31 4.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 111.262 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 79' ' ' SER . 4.1 p -111.18 140.75 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.131 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.41 138.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.547 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 76' ' ' LEU . 3.5 m -119.44 129.86 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.92 134.0 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.469 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -100.53 166.3 10.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.298 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.33 111.85 4.19 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.972 HG23 HH21 ' A' ' 24' ' ' ARG . 19.7 m -115.89 136.22 53.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.903 -1.123 . . . . 0.0 108.065 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.972 HH21 HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER -104.02 143.1 33.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.154 171.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.68 ' HG ' ' N ' ' A' ' 3' ' ' MET . 88.9 p -58.63 5.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.467 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.37 -18.15 14.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.06 -173.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 68.63 29.06 72.78 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 24' ' ' ARG . 54.0 m -128.94 98.9 5.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.419 0.609 . . . . 0.0 111.864 -175.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -126.28 -62.27 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 122.584 0.354 . . . . 0.0 111.009 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.15 1.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 35.6 t -114.11 -28.02 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.027 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -112.99 139.85 48.31 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.9 130.67 42.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.87 141.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.552 0.691 . . . . 0.0 110.667 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -128.26 150.46 50.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.619 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -106.22 121.0 43.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.407 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 2.2 m-85 -112.38 148.63 33.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 133.44 41.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -125.45 135.03 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.355 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 N--CA 1.49 1.303 0 N-CA-C 111.513 -0.226 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -137.59 121.27 17.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.349 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.407 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 3.4 m -62.29 121.42 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.965 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.676 ' HA ' HG21 ' A' ' 59' ' ' VAL . 2.5 t -101.16 -28.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.318 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -145.86 140.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' ASP . 5.9 t80 -127.3 164.14 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 44.59 22.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.389 -170.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 43.04 18.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.545 -179.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.564 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.23 -46.91 1.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 0.0 111.52 172.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -80.06 131.37 35.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.712 -165.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -108.57 111.68 61.11 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.465 -174.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.04 145.52 96.57 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.633 1.556 . . . . 0.0 112.176 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -69.41 -20.35 63.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.772 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.83 -31.32 67.68 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' A' ' 48' ' ' VAL . 16.7 m -124.2 141.82 38.33 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.8 Cg_exo -60.41 140.33 91.06 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.268 1.312 . . . . 0.0 111.412 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.3 p-10 -61.04 0.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.607 HH22 ' CB ' ' A' ' 85' ' ' ASP . 41.7 ptt85 -47.42 -24.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.331 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 90.8 m-85 -78.47 150.26 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.83 122.88 33.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.435 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.45 121.54 5.52 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.546 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.3 p -158.98 158.25 32.88 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.663 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -138.7 160.32 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.449 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 97.8 m-20 -103.63 152.9 21.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.769 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 m -72.61 27.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.5 m -97.98 -40.64 8.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.226 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.97 27.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.604 ' O ' ' NH2' ' A' ' 24' ' ' ARG . 39.8 t30 -99.32 -33.67 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.561 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' HD13 ' A' ' 29' ' ' ILE . 24.8 p -176.9 170.8 2.26 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.013 0.821 . . . . 0.0 110.185 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.4 133.78 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.153 -0.967 . . . . 0.0 109.857 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -127.37 112.56 15.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.088 -0.958 . . . . 0.0 113.192 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.13 140.59 31.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 168.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.5 m -107.83 131.25 54.68 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.219 -0.926 . . . . 0.0 113.401 163.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.87 110.65 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.163 -1.586 . . . . 0.0 110.37 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.573 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.2 t -97.51 139.38 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.06 45.86 8.01 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 143.65 51.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.09 0.471 . . . . 0.0 110.525 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' ASP . 10.4 mtpt -153.14 173.18 15.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.686 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 t -45.88 -20.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.579 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LYS . 48.7 mt-10 -69.38 -40.1 77.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.978 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.607 ' CB ' HH22 ' A' ' 62' ' ' ARG . 4.3 t0 -70.38 -10.44 59.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.211 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 56.4 tt0 -61.13 122.83 16.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.082 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.92 179.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.856 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 148.02 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.911 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.438 ' OH ' ' CG ' ' A' ' 85' ' ' ASP . 17.7 m-85 -115.52 145.79 42.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 12.5 m-85 -144.19 150.35 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.002 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -118.93 142.45 47.76 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 51.9 tt0 -126.54 121.77 33.23 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.81 -0.556 . . . . 0.0 110.937 172.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -135.15 -176.82 4.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.723 0.297 . . . . 0.0 110.619 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 93' ' ' SER . 1.6 m-85 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.61 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 121.131 0.491 . . . . 0.0 112.118 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.86 169.37 21.43 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 123.08 18.11 3.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.29 85.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.4 m -112.24 130.36 55.96 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.672 -0.31 . . . . 0.0 110.242 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -90.08 110.83 21.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -104.9 124.75 50.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.099 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.3 m -116.8 123.54 47.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.71 99.98 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.231 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.121 179.005 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 C--O 1.23 0.045 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 105.97 6.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m -89.58 131.61 35.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.115 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.693 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 2.7 mt-30 -146.07 169.87 8.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -65.78 136.55 45.99 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.433 1.422 . . . . 0.0 111.367 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.506 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -48.21 -76.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.765 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -155.38 149.16 25.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.993 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -159.46 160.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.166 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 10' ' ' VAL . 88.5 p -129.77 146.84 51.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.335 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 11' ' ' SER . 2.1 mp0 -130.53 162.93 28.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.45 140.86 22.55 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.42 117.48 4.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.418 1.412 . . . . 0.0 111.231 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.2 -11.41 14.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.01 159.97 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.701 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.4 p -98.13 148.63 23.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.69 141.2 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.618 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 76' ' ' LEU . 55.5 m -119.92 129.72 54.48 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.04 134.93 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.17 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -111.11 126.48 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.057 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.28 113.35 21.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.8 m -109.44 135.34 50.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 26' ' ' SER . 19.3 ttp85 -97.49 141.15 30.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.223 171.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -57.23 3.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.06 -11.9 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.765 -173.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.48 5.89 25.26 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 m -125.3 111.87 15.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.366 0.267 . . . . 0.0 110.434 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.8 pp -124.31 -57.09 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -2.58 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 14.5 m -89.14 -35.0 16.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 111.603 -2.544 . . . . 0.0 111.479 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.578 ' ND2' HH21 ' A' ' 24' ' ' ARG . 4.0 m-80 -116.83 152.94 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -75.16 140.93 43.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.037 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 67.9 t -126.13 148.02 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.958 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -129.38 147.15 51.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.903 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.484 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 23.0 m95 -111.1 122.63 48.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.296 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' N ' ' A' ' 47' ' ' THR . 2.4 m-85 -123.91 144.96 49.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.587 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -147.19 143.9 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.279 177.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 2.9 tp-100 -107.07 142.52 36.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.91 177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.523 0.135 . . . . 0.0 112.026 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -148.9 135.3 19.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.551 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -64.93 129.29 39.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.45 -25.23 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.99 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.473 HD11 ' CB ' ' A' ' 63' ' ' PHE . 19.7 mt -145.01 133.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' GLN . 4.0 t80 -122.25 167.33 13.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.447 174.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 53' ' ' ASN . 1.4 tp10 44.77 22.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.712 0.768 . . . . 0.0 111.419 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 43.16 18.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.05 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.584 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.22 -47.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.847 170.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -96.79 159.07 15.12 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.258 -167.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.432 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -140.41 149.88 59.07 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 157.63 22.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.584 1.523 . . . . 0.0 111.226 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.8 p -73.98 -7.19 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.456 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.58 -28.18 48.49 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 59' ' ' VAL . 29.5 m -113.02 131.34 22.86 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.9 Cg_endo -61.62 140.1 84.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 120.982 1.121 . . . . 0.0 111.021 -175.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD2' ' NE ' ' A' ' 55' ' ' ARG . 2.8 m-20 -61.25 1.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.637 HH22 ' CB ' ' A' ' 85' ' ' ASP . 22.7 ptt85 -42.1 -25.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.3 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CB ' HD11 ' A' ' 49' ' ' ILE . 53.4 m-85 -75.4 144.46 42.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.87 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -118.07 122.6 43.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.491 0.663 . . . . 0.0 110.949 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.46 125.06 8.38 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.447 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' SER . 6.5 p -157.76 158.72 35.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.106 0.479 . . . . 0.0 110.849 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.94 161.15 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.25 163.32 13.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.379 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 p -67.92 -7.45 28.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.355 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 71' ' ' SER . 14.4 m -82.38 -48.26 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.28 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 70' ' ' SER . 3.0 p 79.03 22.12 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.661 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.34 -18.92 27.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.566 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 54.9 p -163.24 166.5 23.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.249 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.79 115.5 30.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.1 m -104.41 110.76 23.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -102.68 140.42 36.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.725 -1.58 . . . . 0.0 115.252 169.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 98.3 m -104.76 128.11 52.77 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 162.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 76' ' ' LEU . 2.8 mt -103.16 113.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 120.115 -1.616 . . . . 0.0 110.043 173.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 t -104.62 146.69 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.791 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.83 30.46 57.72 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.99 138.42 49.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 110.518 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 28.3 mttt -150.57 177.74 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 83' ' ' THR . 1.2 p -46.78 -17.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.387 174.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 15.6 pt-20 -69.2 -40.55 77.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.351 177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.637 ' CB ' HH22 ' A' ' 62' ' ' ARG . 6.4 t70 -70.99 -8.6 54.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.458 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 57.5 tt0 -63.7 121.4 13.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.348 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.71 -175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.22 137.35 32.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.643 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 17.1 m-85 -119.54 134.07 55.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.669 0.271 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 90' ' ' TYR . 1.5 p90 -150.89 138.12 19.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.33 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.3 p -118.79 140.43 49.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -114.5 148.64 37.58 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.824 -0.547 . . . . 0.0 109.714 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 p -135.23 152.17 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.914 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.302 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.677 0.275 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.82 -149.96 6.74 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 75.28 24.29 71.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.57 98.27 0.27 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -129.77 118.16 21.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.325 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.73 120.11 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.1 tp -109.29 123.26 48.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.208 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 114.89 25.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 110' ' ' VAL . 89.0 t -85.23 40.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 110' ' ' VAL . 10.2 mt . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.665 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 C--O 1.231 0.095 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.1 mp -124.81 104.25 8.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 p -88.84 118.73 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.134 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.488 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.66 165.42 21.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 4.4 Cg_exo -52.6 146.7 33.19 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.184 1.923 . . . . 0.0 111.36 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.9 p80 -79.29 -55.91 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 p -154.84 142.79 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.635 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.89 146.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -126.55 146.39 50.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.737 0.303 . . . . 0.0 110.464 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -132.77 150.2 52.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.231 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.13 139.19 72.39 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.99 124.44 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.144 1.229 . . . . 0.0 110.94 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.43 -11.66 16.4 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -100.33 -171.57 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.774 0.321 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.7 p -125.39 159.56 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.349 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.11 153.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -129.2 132.02 47.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 HD22 ' A' ' 76' ' ' LEU . 10.7 mt -98.86 149.43 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.075 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -124.96 117.32 23.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.943 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 4' ' ' LEU . 4.0 t -119.72 120.58 37.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -119.49 142.04 48.64 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.017 -1.677 . . . . 0.0 108.752 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.615 ' HG3' HH11 ' A' ' 24' ' ' ARG . 7.3 mtm-85 -87.26 139.78 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.847 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.38 1.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.43 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -103.24 -17.86 15.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.627 -175.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.92 -41.9 3.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 77.9 p -63.82 113.22 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.59 0.233 . . . . 0.0 110.824 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.6 pp -135.11 -60.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.524 -176.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.779 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.8 -0.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.638 ' H ' ' C ' ' A' ' 29' ' ' ILE . 53.5 m -109.29 -2.5 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.777 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 31' ' ' SER . 3.1 m120 -133.22 149.96 51.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -81.86 135.26 35.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.437 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG2' HH22 ' A' ' 24' ' ' ARG . 17.5 t -127.61 139.03 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' TRP . 7.2 pt20 -116.96 164.29 14.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.186 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 8.8 m95 -134.96 125.13 26.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 0.0 110.53 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.484 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 28.0 m-85 -111.23 149.36 31.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -129.06 124.67 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.6 134.47 47.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.167 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.206 179.088 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 N--CA 1.489 1.225 0 N-CA-C 111.263 -0.322 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -138.16 133.56 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 36.4 m -60.94 120.78 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -96.13 -25.38 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.718 -178.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 19.9 mt -145.08 146.13 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' H ' HE21 ' A' ' 54' ' ' GLN . 10.4 t80 -132.12 167.26 20.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 44.62 22.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.687 0.756 . . . . 0.0 110.933 -171.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.1 p30 43.13 17.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.03 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.4 -46.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 111.121 172.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.657 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 1.7 pp0? -87.93 147.62 24.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.713 -165.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.736 ' N ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -111.23 131.93 21.99 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.68 146.59 84.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.563 1.509 . . . . 0.0 111.183 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -73.38 5.24 3.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.348 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 -26.55 11.39 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.67 151.68 45.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.302 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.93 143.78 95.84 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.662 1.575 . . . . 0.0 111.653 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.29 -2.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.722 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.4 mtp-105 -42.13 -38.65 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.068 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.7 m-85 -76.29 137.5 39.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.193 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -129.29 123.07 30.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.314 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.06 129.71 9.96 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.3 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.8 p -158.54 158.45 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.301 0.572 . . . . 0.0 111.198 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.39 160.85 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.641 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.84 153.31 23.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.664 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -4.49 13.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.909 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 71' ' ' SER . 50.2 m -65.44 -46.19 80.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.77 24.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.506 -178.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -100.06 -37.68 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.709 ' C ' HD13 ' A' ' 29' ' ' ILE . 82.1 p -166.07 174.55 9.25 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.8 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.44 123.51 49.49 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.796 -1.19 . . . . 0.0 109.84 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.1 m -112.23 116.59 30.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.722 -170.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -97.96 140.36 32.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 118.103 -2.873 . . . . 0.0 116.627 171.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' SER . 7.0 m -112.37 127.54 56.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 164.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.1 mt -96.66 116.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 120.029 -1.669 . . . . 0.0 110.459 171.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.54 132.27 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.449 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 75.74 61.08 3.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.52 130.82 36.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 0.0 111.063 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -154.06 176.4 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.113 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -19.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.315 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 82' ' ' LYS . 45.8 mt-10 -71.83 -38.0 70.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.205 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' LYS . 9.9 t70 -74.75 -13.06 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 84.2 tt0 -56.97 123.22 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.74 178.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.733 0.646 . . . . 0.0 109.791 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 85.4 m-20 -91.84 144.49 25.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 24.6 m-85 -110.8 151.17 28.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.986 0.422 . . . . 0.0 110.569 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 31.8 m-85 -149.44 138.35 21.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.653 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.488 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -120.95 140.7 51.5 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.597 0.635 . . . . 0.0 110.28 178.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -125.6 138.28 53.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.165 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.57 ' CB ' ' NH1' ' A' ' 24' ' ' ARG . 17.7 p -135.26 171.04 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 8.4 p90 . . . . . 0 C--O 1.231 0.119 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.05 -158.7 14.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.034 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 78.97 48.62 6.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.38 91.84 1.16 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 4.2 m -106.88 141.46 38.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -102.98 99.91 9.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.49 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.3 tp -90.24 125.46 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.532 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.95 130.16 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 110.162 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 82' ' ' LYS . 65.0 t -97.47 99.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.966 0.412 . . . . 0.0 110.527 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.407 179.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.841 ' N ' ' HG ' ' A' ' 25' ' ' SER . 16.4 mmm . . . . . 0 C--O 1.23 0.067 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.08 105.98 9.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.081 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.3 115.1 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.723 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.7 mm-40 -142.34 158.21 61.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.438 0.461 . . . . 0.0 110.584 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.95 142.47 93.57 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.662 1.575 . . . . 0.0 110.426 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' N ' ' A' ' 9' ' ' SER . 9.5 p80 -65.86 -53.94 33.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.179 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 9.7 p -161.87 157.26 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.386 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 11' ' ' SER . 7.6 p -164.77 154.64 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.116 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 10' ' ' VAL . 9.6 p -122.5 135.63 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.796 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -122.08 143.59 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.483 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.43 153.06 94.01 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.18 118.41 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.193 1.262 . . . . 0.0 112.103 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.55 -13.57 20.64 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -88.67 161.46 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.559 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.9 p -98.62 138.41 35.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.32 141.66 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.383 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 76' ' ' LEU . 35.0 m -123.59 130.92 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.58 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.05 134.33 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.386 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 11.0 m -108.77 126.44 53.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.68 111.52 17.29 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.4 m -115.13 141.03 48.56 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.473 -1.392 . . . . 0.0 107.351 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.5 mmm-85 -93.7 139.87 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.264 170.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.841 ' HG ' ' N ' ' A' ' 3' ' ' MET . 78.8 p -60.53 1.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.371 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.49 -18.37 14.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.58 -173.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.73 -25.18 11.97 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 m -80.35 117.01 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.741 0.305 . . . . 0.0 111.312 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 73' ' ' SER . 1.3 pp -135.34 -64.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -67.27 -1.08 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' ILE . 4.3 t -97.56 -22.13 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.04 -1.891 . . . . 0.0 111.917 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' CB ' HH12 ' A' ' 24' ' ' ARG . 12.8 m120 -118.51 148.51 42.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -175.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.47 137.72 42.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.989 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.44 141.1 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.538 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.9 pt20 -119.7 153.26 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -117.76 128.79 55.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 110.34 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.423 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.2 m-85 -132.6 149.88 52.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.68 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.43 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -121.09 128.79 52.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -108.46 129.74 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.274 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.49 1.306 0 N-CA-C 110.55 -0.596 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -121.79 138.76 54.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.451 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.423 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -77.4 120.18 22.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.704 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 63' ' ' PHE . 3.7 t -101.02 -28.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.832 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.18 152.25 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 80.6 t80 -133.5 163.77 28.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.403 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.1 tt0 45.22 23.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.202 1.001 . . . . 0.0 110.44 -172.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.4 p30 44.59 19.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.668 -1.606 . . . . 0.0 109.964 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.6 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.89 -41.38 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.647 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.55 131.85 51.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.56 -1.654 . . . . 0.0 109.254 -167.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.772 HH21 ' H ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -117.31 108.89 42.96 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.99 145.29 49.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.707 1.605 . . . . 0.0 111.418 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 m -73.59 -24.46 60.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.56 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -29.54 72.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.09 148.16 36.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -59.22 128.48 27.73 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.621 1.547 . . . . 0.0 110.655 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.99 -0.85 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.271 . . . . 0.0 111.708 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' A' ' 85' ' ' ASP . 33.1 mtp180 -43.94 -23.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CD2' HG11 ' A' ' 48' ' ' VAL . 14.9 m-85 -79.49 140.79 37.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -127.32 122.84 34.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.772 ' H ' HH21 ' A' ' 55' ' ' ARG . . . -100.1 124.81 8.36 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 113.558 -1.655 . . . . 0.0 110.124 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.1 p -159.67 165.65 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.211 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -151.49 167.4 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.538 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 67.2 m-20 -104.1 153.03 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.815 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 m -69.89 13.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.103 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -87.86 -41.5 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.453 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m 79.15 27.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.077 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -98.46 -33.98 10.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.154 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.759 ' C ' HD13 ' A' ' 29' ' ' ILE . 90.9 p -165.36 168.62 16.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.753 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.05 130.83 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.832 -1.168 . . . . 0.0 109.641 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 66' ' ' SER . 16.2 m -128.34 112.81 14.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.72 140.52 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 118.564 -2.585 . . . . 0.0 116.711 168.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 64' ' ' SER . 85.4 m -99.85 127.55 46.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 162.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.563 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -107.9 106.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.107 -1.62 . . . . 0.0 109.701 172.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 p -102.29 154.95 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.644 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 79.93 25.62 57.55 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.16 138.32 56.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.12 0.486 . . . . 0.0 110.706 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.9 tttm -149.82 176.9 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.528 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 t -46.38 -21.33 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.45 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.6 mt-10 -72.01 -38.51 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.549 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.3 OUTLIER -70.63 -12.97 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 79.8 tt0 -52.76 122.72 9.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.364 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 164.42 -178.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.505 0.503 . . . . 0.0 109.874 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.95 132.39 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.72 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 16.2 m-85 -113.15 133.5 55.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -150.96 144.89 25.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.704 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.723 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.53 143.25 46.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -117.06 149.11 40.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 171.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 23.2 t -135.19 163.96 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 111.6 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.207 -178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.695 0.283 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.49 -160.88 11.48 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 80.73 18.94 69.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.55 85.11 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.5 m -133.84 124.19 26.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -89.93 127.31 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.0 tp -111.65 126.11 54.68 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.46 0.475 . . . . 0.0 110.365 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.7 m -120.99 128.82 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.607 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' OXT' ' A' ' 111' ' ' LEU . 64.0 t -93.7 104.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.428 . . . . 0.0 110.242 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.412 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 9.5 mt . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.75 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpp . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.52 103.04 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -78.82 127.44 32.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.581 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.703 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 16.3 mt-30 -143.47 159.76 53.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.72 125.46 18.7 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.498 1.465 . . . . 0.0 110.64 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -60.56 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 p -156.74 153.22 28.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.62 154.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.693 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -130.4 145.77 51.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -135.37 162.51 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -91.5 148.68 37.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.577 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -60.55 118.34 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.438 1.425 . . . . 0.0 111.296 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.37 3.54 29.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -95.01 -173.41 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.1 p -122.65 142.5 50.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.145 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.73 145.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 76' ' ' LEU . 87.9 m -127.48 122.59 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.023 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 135.99 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.913 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -106.19 135.61 47.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.335 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 4.1 m -118.72 115.63 24.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.0 m -118.92 140.0 50.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.631 ' C ' ' H ' ' A' ' 26' ' ' SER . 45.5 mtp180 -93.21 139.74 30.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.137 169.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -58.75 1.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.393 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.631 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -103.67 -18.07 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.789 -175.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 77.92 21.76 70.49 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -125.47 113.91 18.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.517 0.198 . . . . 0.0 110.731 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.1 pp -135.14 -63.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.902 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.88 -3.22 2.3 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 38.6 m -92.98 -21.86 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.372 -2.194 . . . . 0.0 111.226 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -132.61 156.64 46.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.0 110.065 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 23.3 m-85 -82.04 145.11 30.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.91 146.76 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.219 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.756 HE22 ' N ' ' A' ' 37' ' ' TYR . 1.9 pp0? -117.1 163.06 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 27.5 m95 -132.98 126.46 32.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.936 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.756 ' N ' HE22 ' A' ' 35' ' ' GLN . 4.6 m-85 -124.86 149.4 47.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.913 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 1.5 mm100 -124.64 131.02 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.26 137.9 52.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.49 1.27 0 N-CA-C 110.777 -0.509 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.7 m -125.31 116.56 22.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 110.559 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.444 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -62.13 122.29 15.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.78 -28.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.548 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -145.02 148.91 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -138.3 143.49 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' A' ' 53' ' ' ASN . 8.5 tt0 57.68 23.57 9.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.454 1.121 . . . . 0.0 110.17 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.4 t0 44.14 18.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.025 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.6 -46.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.231 165.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -54.54 141.89 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.123 -168.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.52 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -125.62 108.86 25.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 119.169 -0.444 . . . . 0.0 109.849 178.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.498 ' N ' HE22 ' A' ' 54' ' ' GLN . 2.8 Cg_exo -60.18 144.31 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.725 1.617 . . . . 0.0 111.575 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -70.64 -26.85 63.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -33.21 86.64 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.03 144.34 28.91 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 62' ' ' ARG . 3.3 Cg_exo -60.37 139.95 89.26 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.459 1.439 . . . . 0.0 110.771 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -60.97 0.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.658 HH22 ' CB ' ' A' ' 85' ' ' ASP . 35.7 ptt85 -50.55 -29.09 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.986 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 63.0 m-85 -78.61 131.8 36.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 t -112.19 123.66 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.36 122.24 5.31 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 5.9 p -154.97 156.49 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.181 0.515 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.58 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -132.96 159.06 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.13 148.63 25.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.413 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -67.96 -6.43 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 m -64.33 -42.64 96.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.916 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' GLY . 11.0 p 79.0 31.48 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.649 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -97.3 -43.64 7.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.403 -177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.605 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.1 p -167.11 168.35 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.325 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.71 122.79 47.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.8 m -114.52 112.89 23.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.684 -170.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.24 140.64 31.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 118.66 -2.525 . . . . 0.0 117.207 168.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.5 m -110.69 127.1 55.17 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.695 ' CD1' HD21 ' A' ' 76' ' ' LEU . 26.4 mm -93.84 113.09 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 120.057 -1.652 . . . . 0.0 110.887 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.76 129.22 45.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.523 0.201 . . . . 0.0 110.728 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.39 58.39 3.13 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.59 HD21 HG13 ' A' ' 110' ' ' VAL . 3.8 tt -75.16 138.61 42.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.502 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 84' ' ' GLU . 16.5 mttt -144.74 175.66 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.802 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 83' ' ' THR . 1.1 p -45.99 -18.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 82' ' ' LYS . 68.1 mm-40 -69.85 -38.36 76.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.461 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.658 ' CB ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -67.43 -6.91 21.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.529 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 21.9 tt0 -67.21 121.21 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.394 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.85 178.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.185 0.516 . . . . 0.0 110.176 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -87.4 134.15 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 10.9 m-85 -113.56 132.79 55.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.9 p90 -151.25 151.87 32.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 103' ' ' GLY . 28.3 p -132.62 143.4 49.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.159 -173.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.641 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 mt-30 -115.3 147.29 40.6 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 78.7 p -135.21 118.93 17.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.939 0.399 . . . . 0.0 110.844 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.7 p90 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.102 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.4 p90 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.461 0.172 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 141.09 -123.43 2.31 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.39 42.21 9.46 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.13 118.61 11.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -135.91 118.87 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.873 0.368 . . . . 0.0 110.478 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -88.06 115.89 25.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.615 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.56 124.34 50.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.086 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 111' ' ' LEU . 55.4 m -117.42 113.7 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 110' ' ' VAL . 90.0 t -78.57 38.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 110.36 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.512 ' H ' HG22 ' A' ' 109' ' ' THR . 6.3 mt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.152 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.461 ' C ' ' HE ' ' A' ' 24' ' ' ARG . 5.0 ptt? . . . . . 0 C--O 1.232 0.15 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.698 HD12 ' NH1' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -114.66 102.83 10.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.26 127.77 35.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.349 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.6 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.0 161.6 47.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 2.2 Cg_endo -47.73 136.43 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.477 2.118 . . . . 0.0 111.676 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -70.36 -45.35 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.845 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -157.56 157.15 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.375 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.06 125.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.5 p -108.0 130.37 55.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.45 164.92 15.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 m -96.6 143.44 26.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.448 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.09 115.07 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.44 1.427 . . . . 0.0 111.039 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.75 -10.77 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -91.85 -171.64 2.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -126.41 153.71 44.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.895 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.33 147.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.099 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 1.2 m -122.25 134.4 54.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -98.88 128.64 50.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -102.38 120.53 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.7 111.84 19.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -178.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 142.17 48.11 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.932 -1.105 . . . . 0.0 108.609 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' NH1' HD12 ' A' ' 4' ' ' LEU . 1.5 mmp_? -89.45 140.18 29.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.782 169.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.05 -2.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.124 175.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.79 -18.18 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.072 -175.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 -36.26 3.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -66.78 110.73 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.13 -60.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.761 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.92 1.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 29' ' ' ILE . 85.1 p -109.02 -26.61 10.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.744 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -103.34 144.17 31.72 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.8 119.11 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.561 HG22 ' OG ' ' A' ' 93' ' ' SER . 93.3 t -121.47 143.25 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.782 0.801 . . . . 0.0 110.8 -175.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.539 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.6 pm0 -139.09 169.6 17.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.895 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.6 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 64.5 m95 -125.74 128.26 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.207 0.527 . . . . 0.0 110.474 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -113.99 149.43 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.754 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.39 129.86 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 5.7 tm0? -124.1 142.41 51.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.529 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.159 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.489 1.242 0 N-CA-C 110.943 -0.445 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -140.84 132.45 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.957 0.408 . . . . 0.0 110.873 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.5 m -62.08 123.54 18.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.917 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.24 -27.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.524 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.4 152.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' ASP . 31.2 t80 -132.87 163.26 29.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.2 tt0 45.94 24.18 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.953 -173.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.3 OUTLIER 44.16 19.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.962 -177.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.564 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.04 -46.1 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.934 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.564 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.94 135.62 48.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.728 -168.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -130.48 108.66 16.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.261 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.17 143.23 64.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.873 1.715 . . . . 0.0 111.58 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.0 m -74.14 -18.54 60.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.66 -51.18 54.17 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -85.24 149.97 53.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -59.29 135.76 67.67 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.655 0.903 . . . . 0.0 110.171 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' PHE . 47.9 p30 -59.99 0.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.147 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.782 HH12 ' N ' ' A' ' 85' ' ' ASP . 30.8 mtm105 -54.39 4.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.891 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASP . 4.2 m-85 -118.47 143.38 46.75 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.21 -0.306 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -135.28 123.57 23.16 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.073 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.49 119.53 6.29 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.582 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' SER . 12.7 p -153.98 160.46 42.07 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.064 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 163.89 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.119 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 70' ' ' SER . 62.4 m-20 -108.72 146.35 33.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.507 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -67.98 2.73 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.796 174.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' SER . 28.5 m -71.27 -42.38 68.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 80.83 27.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.566 -178.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.19 -43.6 7.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.671 ' C ' HD13 ' A' ' 29' ' ' ILE . 93.7 p -164.63 168.44 18.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.403 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 125.17 52.18 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.114 -0.991 . . . . 0.0 109.604 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' SER . 5.5 m -123.38 115.57 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.074 -169.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -95.02 140.58 29.78 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.806 -1.809 . . . . 0.0 115.758 169.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -103.56 128.34 50.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 112.185 166.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.1 mt -108.36 108.24 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 120.758 -1.213 . . . . 0.0 110.116 172.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -102.96 173.04 6.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.839 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.09 18.8 35.75 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.16 143.38 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.9 tttm -163.49 176.9 9.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.059 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -45.96 -20.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.586 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' LYS . 97.2 mt-10 -71.85 -38.71 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.559 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.782 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.5 OUTLIER -73.09 -9.29 58.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.251 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.2 tt0 -58.41 122.26 12.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.851 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.7 -175.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.176 0.513 . . . . 0.0 110.668 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.28 136.13 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.949 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.63 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 22.3 m-85 -119.93 132.83 55.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.023 0.439 . . . . 0.0 110.809 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 6.1 p90 -151.21 154.98 37.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.6 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 4.6 m -117.9 141.59 48.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.41 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 55.7 tt0 -117.44 121.52 41.28 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.857 -0.527 . . . . 0.0 109.669 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -135.09 -177.19 4.53 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 -178.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.396 0.617 . . . . 0.0 110.629 175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 11.8 p90 . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.529 0.204 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.55 -147.37 15.36 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.302 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 62.15 52.49 49.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.42 102.96 1.54 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.1 m -106.84 126.34 52.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.22 98.36 11.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.172 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.0 tp -82.28 122.86 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.155 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 m -120.73 117.33 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 111' ' ' LEU . 95.2 t -81.85 93.53 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.148 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 110' ' ' VAL . 12.2 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.599 -1.191 . . . . 0.0 111.898 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.823 ' N ' ' HG ' ' A' ' 25' ' ' SER . 50.0 mtt . . . . . 0 CA--C 1.52 -0.205 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.06 118.75 15.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.587 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -71.86 134.43 46.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.629 -172.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' A' ' 91' ' ' CYS . 2.8 mm-40 -146.08 157.65 49.65 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.277 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.08 168.67 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.946 . . . . 0.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.528 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -82.89 -66.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.163 179.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 9.6 m -165.04 162.85 20.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.5 150.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.6 p -130.2 128.32 41.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.137 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.98 162.57 18.31 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.487 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 3.8 m -96.88 147.02 32.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.75 120.0 7.61 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.481 1.454 . . . . 0.0 111.106 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.84 4.96 27.71 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' ' 13' ' ' SER . 61.8 mttm -101.66 -172.94 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.209 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -126.58 145.11 50.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.29 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.02 141.74 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.707 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -123.11 130.27 52.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 135.49 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 2.7 m -106.37 128.59 54.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.986 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.06 121.64 40.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' THR . 91.9 m -125.96 131.1 52.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 26' ' ' SER . 13.7 ttp180 -81.47 134.21 35.5 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.531 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.823 ' HG ' ' N ' ' A' ' 3' ' ' MET . 91.6 p -55.48 1.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.488 174.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.71 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.03 -18.05 14.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.19 -172.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.05 21.05 68.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.769 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.54 111.24 14.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.2 0.5 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.34 -63.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.67 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -64.04 0.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 34.6 m -109.27 -29.6 8.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.158 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.7 OUTLIER -116.81 155.05 29.64 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.15 125.52 27.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.926 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 t -121.03 148.15 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' OE1' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -142.0 160.41 40.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.339 -172.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -119.68 126.59 51.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.317 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.2 m-85 -108.01 149.11 28.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.866 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.478 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -138.1 132.2 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.787 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -133.53 146.61 51.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.753 177.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.611 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.341 0 N-CA-C 111.48 -0.238 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -149.08 143.17 25.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.442 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -71.88 126.27 29.32 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.946 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 63' ' ' PHE . 2.5 t -95.11 -26.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.26 140.76 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' GLN . 50.2 t80 -127.66 152.96 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 53' ' ' ASN . 11.9 tt0 54.69 23.45 4.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.127 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 43.74 18.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.817 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.44 -46.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.698 . . . . 0.0 109.5 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.504 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -62.69 114.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.758 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HE ' ' CB ' ' A' ' 61' ' ' ASP . 25.4 ttp-105 -118.67 108.75 40.77 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -68.21 148.03 73.82 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.97 1.78 . . . . 0.0 111.57 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -74.12 -19.37 60.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.89 92.61 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.5 148.72 44.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 62' ' ' ARG . 4.8 Cg_exo -51.65 121.85 9.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.799 1.666 . . . . 0.0 111.675 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' PHE . 38.6 p-10 -60.91 1.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.418 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.578 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.5 mtp-105 -64.53 16.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.446 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASP . 14.4 m-85 -116.9 144.02 45.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -131.66 123.28 27.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.37 126.41 8.72 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.46 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -158.62 164.28 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.257 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.9 161.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.969 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -99.07 178.96 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.658 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 p -91.25 9.14 32.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.023 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' SER . 18.5 m -83.12 -44.41 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.71 28.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.463 -176.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -100.07 -38.63 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.805 -176.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.642 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.4 p -161.3 167.05 26.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.735 -177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.88 124.74 50.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.013 -1.054 . . . . 0.0 109.576 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 6.3 m -115.21 112.64 22.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.702 -171.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.72 140.59 31.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 119.345 -2.097 . . . . 0.0 116.515 170.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 78.3 m -108.0 130.21 55.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.905 0.859 . . . . 0.0 113.153 163.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -108.13 113.55 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 t -99.24 168.0 10.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.085 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 38.38 93.1 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.494 HD21 HG13 ' A' ' 110' ' ' VAL . 3.5 tt -65.37 134.53 53.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.032 0.444 . . . . 0.0 110.97 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.567 ' C ' HG11 ' A' ' 110' ' ' VAL . 9.2 tttt -151.94 176.26 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 83' ' ' THR . 0.0 OUTLIER -45.91 -19.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.791 174.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.452 ' N ' ' C ' ' A' ' 82' ' ' LYS . 65.0 tt0 -74.55 -38.61 62.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.179 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.578 ' CG ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -72.64 -11.41 60.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.9 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 76.7 tt0 -57.42 125.75 24.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.869 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.39 176.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.88 142.46 27.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.897 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 13.4 m-85 -113.99 147.62 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.569 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -146.48 154.13 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.631 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.421 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 42.2 t -127.66 140.66 51.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 93' ' ' SER . 8.8 tp60 -128.26 131.99 48.74 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 92' ' ' GLN . 35.4 p -134.99 145.19 47.87 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.054 -0.404 . . . . 0.0 111.172 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.149 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.6 p90 . . . . . 0 C--O 1.231 0.114 0 N-CA-C 110.698 -0.112 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.49 ' H ' HD11 ' A' ' 4' ' ' LEU . . . 178.25 -166.84 37.12 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.238 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.22 48.57 4.01 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.26 96.38 0.06 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -105.27 116.33 31.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.45 123.94 30.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.027 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.1 tp -110.86 122.91 49.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.797 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -116.23 120.28 38.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.803 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.4 t -91.65 34.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.408 179.282 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.5 mmm . . . . . 0 C--O 1.231 0.099 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.78 103.05 7.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.68 121.75 25.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.597 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.78 -177.68 0.69 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.8 Cg_exo -74.38 151.83 43.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.188 1.925 . . . . 0.0 111.658 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.62 ' CG ' ' N ' ' A' ' 9' ' ' SER . 19.0 p-80 -82.44 -57.01 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.625 0.25 . . . . 0.0 111.182 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.62 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 30.6 p -152.6 149.04 28.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.582 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.38 153.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.288 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.1 p -132.15 141.85 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.423 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -131.81 158.1 42.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -76.74 148.9 80.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -63.46 120.23 7.58 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.572 1.515 . . . . 0.0 112.044 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.14 -6.3 17.32 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -96.45 164.94 12.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.162 0.506 . . . . 0.0 111.147 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -95.52 132.3 40.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.065 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.51 135.16 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.079 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.2 m -120.13 134.88 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.465 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.06 134.29 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.125 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -110.23 125.93 53.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 30.7 m -118.75 125.27 49.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 m -116.88 131.73 56.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 26' ' ' SER . 41.7 ttt180 -83.86 136.54 34.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.301 171.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.5 m -58.6 2.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.554 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -104.9 -18.04 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -174.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.17 -32.29 4.14 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -72.47 110.24 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -134.59 -60.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.778 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.89 0.3 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.4 p -110.13 -26.98 9.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.358 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.427 ' ND2' HH11 ' A' ' 24' ' ' ARG . 98.3 m-20 -104.26 151.3 23.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -81.55 114.76 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.97 148.0 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 47' ' ' THR . 18.7 tt0 -135.84 156.61 48.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.26 135.36 54.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.427 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -139.06 137.07 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.63 ' CD ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -132.0 148.08 52.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.185 0.517 . . . . 0.0 110.098 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.73 140.01 47.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.219 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.491 1.379 0 CA-C-O 120.588 0.162 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.402 ' C ' ' CE1' ' A' ' 37' ' ' TYR . 81.2 p -140.4 126.56 19.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.629 176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.491 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 64.6 m -61.14 121.14 11.75 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.726 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.63 HG21 ' CD ' ' A' ' 38' ' ' GLN . 40.4 t -101.36 -28.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.928 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.3 mt -145.63 146.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.8 t80 -132.99 159.16 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 50.98 24.03 1.69 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.2 1.0 . . . . 0.0 110.361 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 38.5 t0 44.35 19.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.361 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -127.87 -46.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 170.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.519 ' NE2' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -55.29 140.46 39.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.909 -168.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -142.34 108.68 5.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.295 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -68.37 143.94 59.95 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.407 1.405 . . . . 0.0 111.992 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -69.64 -35.79 75.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.685 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.96 -50.58 26.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -91.54 139.51 25.12 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -57.83 137.18 79.77 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.137 1.225 . . . . 0.0 110.54 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' N ' ' A' ' 63' ' ' PHE . 4.0 p-10 -62.75 -0.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.61 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.552 HH22 ' CG ' ' A' ' 85' ' ' ASP . 17.9 mtp-105 -38.33 -24.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.495 -175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.2 m-85 -89.77 141.01 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.5 t -126.38 124.36 40.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.951 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.39 117.52 5.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.509 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 75' ' ' SER . 8.1 p -153.93 167.05 31.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.125 0.462 . . . . 0.0 110.722 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.691 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -149.14 160.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -101.15 153.75 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.605 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.0 p -68.09 -7.46 29.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.248 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.7 m -61.96 -42.8 99.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 80.84 27.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.481 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.07 -38.25 8.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.786 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.698 ' C ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -166.28 171.41 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.042 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.04 135.41 48.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.784 -1.198 . . . . 0.0 109.467 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -130.42 115.69 17.21 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.794 -1.098 . . . . 0.0 112.825 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -96.99 140.73 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 118.927 -2.358 . . . . 0.0 116.284 169.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.4 m -102.48 126.13 49.42 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.473 -0.767 . . . . 0.0 112.969 162.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.523 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.5 mt -105.25 103.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 120.79 -1.194 . . . . 0.0 109.788 172.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -98.98 154.31 18.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.21 17.25 78.43 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.91 131.91 22.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.318 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.49 ' C ' ' N ' ' A' ' 84' ' ' GLU . 26.6 mttt -148.99 176.09 10.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.818 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -18.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.627 174.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.0 mt-10 -75.67 -37.0 59.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.552 ' CG ' HH22 ' A' ' 62' ' ' ARG . 6.9 t70 -74.3 -10.7 59.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 38.8 tt0 -57.59 123.94 17.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.14 -175.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.922 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -89.11 150.01 22.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.563 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 19.1 m-85 -122.26 151.76 40.75 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.543 0.337 . . . . 0.0 110.526 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 37' ' ' TYR . 56.0 m-85 -150.45 137.37 19.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.427 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 16.2 p -118.9 140.66 49.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.951 0.341 . . . . 0.0 111.368 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -118.08 134.71 54.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -135.12 146.99 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.612 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.9 p90 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.63 0.253 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.37 -131.43 6.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.75 24.13 3.94 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.09 164.71 4.79 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.8 m -131.81 130.57 41.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.87 112.89 15.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.9 tp -105.83 124.45 49.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.116 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.2 m -117.62 124.76 49.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.119 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.07 99.21 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.204 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.887 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.405 ' N ' ' HG ' ' A' ' 25' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.3 mp -133.78 103.87 6.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -90.41 135.35 33.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.825 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.662 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 30.5 mt-30 -136.55 163.42 49.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.829 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.49 135.46 66.26 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.899 1.733 . . . . 0.0 110.817 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -41.49 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -161.28 157.46 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -163.62 162.88 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.447 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 t -137.07 156.88 47.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.064 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.68 151.78 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.436 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.73 142.32 85.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.528 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.88 113.9 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.459 1.439 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.82 1.34 22.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -94.9 -174.16 3.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.004 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -113.44 127.81 56.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.138 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 144.06 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -130.58 131.45 45.0 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.97 140.17 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.303 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -113.88 120.08 39.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB2' HE21 ' A' ' 6' ' ' GLN . 31.9 t -120.75 123.6 43.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.6 m -119.69 142.09 48.8 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.019 -1.05 . . . . 0.0 108.278 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.605 ' C ' ' H ' ' A' ' 26' ' ' SER . 75.3 mtp85 -92.94 141.1 28.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.685 170.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.405 ' HG ' ' N ' ' A' ' 3' ' ' MET . 7.0 p -59.74 2.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.246 175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.09 -18.15 14.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.132 -175.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 74.3 8.93 80.68 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 6.7 t -110.85 105.46 14.29 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.786 -0.244 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -129.61 -63.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.53 -0.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -98.91 -27.05 14.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.719 -178.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -131.71 152.22 51.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -71.07 149.09 46.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.676 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 17.1 t -125.5 148.21 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.24 155.41 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.97 131.04 54.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.054 0.454 . . . . 0.0 110.425 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.511 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.2 OUTLIER -127.91 146.19 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.84 136.66 48.87 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -120.49 121.75 39.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.348 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.432 ' H ' ' HG3' ' A' ' 40' ' ' ARG . 16.2 mtt180 . . . . . 0 C--N 1.33 -0.258 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.491 1.324 0 CA-C-O 119.602 -0.249 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -139.92 97.94 3.36 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 121.914 -0.491 . . . . 0.0 110.202 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.511 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 33.9 m -64.83 118.89 9.66 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.94 -28.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.199 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.44 151.47 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . 5.7 t80 -134.13 161.01 36.07 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.0 tt0 48.6 23.86 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.351 0.596 . . . . 0.0 111.217 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 34' ' ' VAL . 35.0 t0 44.48 19.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.119 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.767 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -127.93 -46.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.502 . . . . 0.0 109.825 170.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.767 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.52 132.33 44.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.951 -168.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -134.64 108.63 10.97 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.08 149.09 64.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.964 1.776 . . . . 0.0 111.62 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -71.55 -36.75 71.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.698 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.76 42.48 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 59' ' ' VAL . 3.7 m -86.6 138.09 33.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.5 Cg_endo -59.89 131.37 39.2 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 CA-C-N 119.88 0.993 . . . . 0.0 110.665 -177.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 63' ' ' PHE . 25.6 p-10 -60.95 1.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 13.6 mtm105 -46.65 -5.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.165 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 m-85 -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.4 t -119.06 124.36 46.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.72 122.46 6.98 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 37.8 p -159.15 163.35 36.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.051 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -134.91 158.82 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.858 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 70' ' ' SER . 73.5 m-20 -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.864 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.22 30.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 68' ' ' ASP . 6.7 m -107.19 -40.46 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.537 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 83.79 25.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.391 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -42.17 7.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.678 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.611 ' O ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -164.69 170.73 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.63 133.94 51.35 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 120.61 -1.306 . . . . 0.0 110.177 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 12.5 m -125.47 113.56 17.65 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.055 -0.974 . . . . 0.0 113.092 -171.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.44 140.6 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 118.591 -2.568 . . . . 0.0 116.994 170.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' SER . 19.5 m -105.1 125.53 51.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 163.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.644 ' CD1' HD21 ' A' ' 76' ' ' LEU . 38.4 mm -89.79 103.62 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.565 -1.334 . . . . 0.0 110.724 172.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 m -99.32 141.56 31.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.371 . . . . 0.0 111.486 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.94 15.42 79.1 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.03 135.66 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.57 . . . . 0.0 110.461 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -144.04 176.06 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.302 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 83' ' ' THR . 0.7 OUTLIER -49.73 -19.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.432 175.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE1' ' NH2' ' A' ' 62' ' ' ARG . 3.2 tt0 -70.97 -42.02 70.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.352 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 4.6 m-20 -66.86 -7.07 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.22 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.0 tt0 -58.99 121.03 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.977 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.5 -175.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -93.0 147.36 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.21 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -116.73 145.33 43.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 14.0 m-85 -145.93 152.62 39.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.859 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.662 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -125.08 140.89 52.49 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -118.98 139.81 51.05 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.487 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 2.4 m -135.09 158.29 44.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 110.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.435 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.9 p90 . . . . . 0 C--O 1.232 0.14 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.83 -150.13 8.66 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' TYR . . . 86.1 35.91 10.58 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.36 110.08 2.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -142.13 137.79 31.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.769 0.319 . . . . 0.0 110.371 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.31 112.72 25.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.565 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.11 125.93 50.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.085 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.88 125.19 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -96.21 103.21 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.209 179.069 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 4.1 m-85 -103.71 170.41 7.95 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.425 ' H ' ' HB3' ' A' ' 25' ' ' SER . 1.1 ttt -132.4 170.01 15.71 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.1 102.77 6.16 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.5 p -92.1 121.08 33.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.008 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.549 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.55 164.86 25.85 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.15 134.42 36.91 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.246 1.964 . . . . 0.0 111.612 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.485 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 9.7 t-80 -67.0 -68.53 0.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.745 -0.382 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 53.2 m -148.43 146.04 28.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.876 0.37 . . . . 0.0 110.025 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 11' ' ' SER . 7.9 p -162.52 156.14 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.525 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' N ' HG22 ' A' ' 10' ' ' VAL . 86.0 p -133.86 145.55 49.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.384 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.5 tp10 -133.82 156.68 47.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.093 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -77.06 136.76 65.72 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 110.166 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -52.56 125.19 17.07 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 121.583 1.522 . . . . 0.0 111.093 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.78 -6.68 25.89 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -94.08 173.52 7.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.05 0.452 . . . . 0.0 110.778 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.6 p -100.56 136.62 40.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.225 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.5 137.43 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.241 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 m -125.14 127.59 47.1 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.7 mm -104.59 139.1 26.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.432 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -119.42 127.71 53.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.379 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 11.2 m -118.62 126.36 51.79 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 177.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.8 m -118.93 141.64 48.47 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 26' ' ' SER . 33.1 mtp85 -94.74 141.11 29.0 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.185 170.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 3' ' ' MET . 32.5 t -58.2 0.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.544 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.635 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.25 -18.1 14.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.794 -173.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 75.47 21.87 76.57 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.408 ' C ' ' OD1' ' A' ' 32' ' ' ASN . 10.5 t -117.47 110.9 18.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.976 0.417 . . . . 0.0 110.493 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.32 -63.12 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.439 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.96 1.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 29' ' ' ILE . 54.7 m -104.97 -27.08 11.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 113.474 -1.694 . . . . 0.0 111.378 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' OD1' ' C ' ' A' ' 28' ' ' SER . 4.0 p-10 -122.2 163.58 19.33 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.77 0.319 . . . . 0.0 110.152 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -81.92 142.88 32.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.67 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -121.02 148.26 24.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.328 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.481 HE21 ' C ' ' A' ' 36' ' ' TRP . 0.2 OUTLIER -133.24 144.52 49.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -177.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' C ' HE21 ' A' ' 35' ' ' GLN . 97.9 m95 -110.43 135.03 51.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.16 0.505 . . . . 0.0 110.878 177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.515 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.1 OUTLIER -128.29 149.11 50.63 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.03 140.55 52.22 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.415 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 6.6 tm0? -148.24 144.65 27.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -163.31 153.35 13.24 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.449 178.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -58.29 145.15 94.5 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 121.27 1.313 . . . . 0.0 111.181 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.67 9.66 82.73 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.2 p -151.31 -167.7 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 110.407 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 p -135.59 155.65 78.16 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.1 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -53.27 137.92 64.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.09 1.86 . . . . 0.0 111.836 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.4 m -138.78 110.31 7.04 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.715 0.293 . . . . 0.0 110.272 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.515 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -60.87 121.15 11.63 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -97.45 -27.03 3.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.408 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.9 mt -145.11 146.97 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 175.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' O ' ' N ' ' A' ' 52' ' ' ASP . 8.5 t80 -130.96 159.08 38.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.251 175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 3.7 tt0 49.3 24.31 1.0 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.653 0.74 . . . . 0.0 110.682 -175.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.2 p-10 44.5 19.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.61 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.637 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.0 -46.35 1.39 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.378 0.609 . . . . 0.0 109.811 171.235 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.637 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.55 124.79 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.998 -1.456 . . . . 0.0 109.033 -167.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.41 ' HG2' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.56 108.8 40.89 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.462 177.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.56 144.54 55.44 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 121.475 1.45 . . . . 0.0 111.662 178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p -67.26 -32.38 73.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.711 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.99 -58.65 13.44 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.044 -0.823 . . . . 0.0 111.044 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -81.45 137.87 48.25 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.51 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.2 Cg_exo -59.01 137.92 82.52 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 120.966 1.111 . . . . 0.0 110.703 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.56 ' C ' ' H ' ' A' ' 63' ' ' PHE . 12.0 p-10 -61.5 1.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.445 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.559 HH22 ' CG ' ' A' ' 85' ' ' ASP . 9.1 ptm180 -49.79 -2.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.93 -175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.56 ' H ' ' C ' ' A' ' 61' ' ' ASP . 47.2 m-85 -104.45 143.65 32.73 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.31 122.55 34.13 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.893 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.07 125.29 8.48 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-N 113.239 -1.8 . . . . 0.0 110.497 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.3 p -157.57 161.88 38.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.194 0.521 . . . . 0.0 111.124 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.623 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.7 pp -141.89 158.17 20.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.8 m-20 -102.65 145.96 28.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.8 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.9 m -67.91 -3.72 10.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.993 0.425 . . . . 0.0 110.442 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.3 m -64.25 -41.95 96.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.068 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 28.17 0.35 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.593 -177.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -98.77 -40.55 8.08 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.559 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.52 ' O ' HD13 ' A' ' 29' ' ' ILE . 80.3 p -168.17 169.83 10.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.088 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.32 135.54 49.46 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 120.613 -1.304 . . . . 0.0 110.027 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -128.48 115.6 18.41 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 117.908 -1.044 . . . . 0.0 113.137 -171.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.03 140.72 31.94 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 118.622 -2.549 . . . . 0.0 116.91 168.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.0 m -104.63 129.22 52.8 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 162.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.584 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.0 mt -109.65 105.94 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 O-C-N 120.179 -1.576 . . . . 0.0 110.193 173.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 21.5 t -88.86 153.13 21.31 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.98 61.34 4.06 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 tp -82.21 137.92 34.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.163 0.506 . . . . 0.0 111.251 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 84' ' ' GLU . 22.3 mttt -151.45 173.73 14.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.694 177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.434 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.33 -19.05 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.497 173.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 82' ' ' LYS . 91.2 mt-10 -68.81 -41.0 79.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.392 177.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.559 ' CG ' HH22 ' A' ' 62' ' ' ARG . 16.7 t70 -72.68 -9.9 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.242 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.633 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 82.3 tt0 -56.4 120.97 8.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.812 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.88 176.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -88.73 152.86 21.53 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.668 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 17.6 m-85 -117.67 143.26 46.34 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.805 0.336 . . . . 0.0 110.997 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 37' ' ' TYR . 5.3 m-85 -144.58 142.51 30.23 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.727 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 30.1 p -134.96 140.86 46.04 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 119.936 -0.078 . . . . 0.0 110.829 -175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -121.16 148.55 44.07 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.76 -0.587 . . . . 0.0 110.482 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.7 p -135.15 153.37 52.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.809 0.337 . . . . 0.0 110.68 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.67 133.94 9.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.98 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -88.24 -156.93 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.634 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 t -77.91 -31.78 51.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.605 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 65.6 m -84.96 39.79 0.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.585 -176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 10.2 m120 53.39 -118.42 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.624 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 48.0 81.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.866 0.365 . . . . 0.0 110.07 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 m -87.57 135.85 24.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.355 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.8 156.22 41.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.095 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -136.08 147.56 47.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.141 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -179.99 -141.99 4.91 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.68 53.86 38.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.06 103.5 2.69 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 34.4 m -126.27 141.7 51.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.836 0.35 . . . . 0.0 110.642 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -104.93 101.15 10.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.723 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.5 tp -91.69 124.97 36.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.379 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.2 m -120.74 124.91 46.28 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.55 100.94 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.966 0.412 . . . . 0.0 110.113 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 19.0 mt . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.836 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.498 HD22 ' N ' ' A' ' 2' ' ' PHE . 2.6 t30 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.498 ' N ' HD22 ' A' ' 1' ' ' ASN . 46.2 m-85 -68.24 143.72 55.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.345 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.492 ' H ' ' HB2' ' A' ' 25' ' ' SER . 4.4 ptm -155.33 170.02 22.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.4 mp -122.38 104.49 9.44 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -80.17 129.68 34.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.321 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.568 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 3.0 mt-30 -145.34 166.68 16.8 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -63.84 133.32 38.42 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.475 1.45 . . . . 0.0 111.319 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.674 ' CG ' ' H ' ' A' ' 9' ' ' SER . 6.1 p80 -44.19 -60.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.674 ' H ' ' CG ' ' A' ' 8' ' ' HIS . 35.2 p -164.08 160.87 22.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.31 177.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -162.95 147.64 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.337 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.4 p -130.71 132.2 45.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.849 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.92 158.23 24.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 12.7 m -80.93 140.03 50.06 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.57 -177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.38 116.13 3.03 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.751 1.634 . . . . 0.0 111.043 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.32 -0.6 18.82 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -107.56 -163.05 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 68.9 p -136.63 153.2 51.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.643 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 p -143.16 147.16 20.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.051 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 131.74 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.85 134.27 50.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.292 177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.8 m -104.92 123.56 47.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.877 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.99 111.91 18.92 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 93.7 m -116.59 141.97 47.5 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.9 mtm180 -99.55 143.27 29.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.071 170.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.492 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -58.24 1.64 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.38 176.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.628 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -101.45 -14.05 17.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.784 -174.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.33 27.14 70.24 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.8 p -124.5 109.53 13.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 110.571 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.17 -64.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.995 -178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.72 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -66.59 -2.41 4.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.572 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.6 t -100.93 -29.18 12.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 112.57 -2.104 . . . . 0.0 111.339 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 29' ' ' ILE . 1.4 m-20 -121.09 148.53 44.05 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -76.0 112.84 12.86 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.372 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 22.0 t -102.3 146.3 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.239 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.598 HE21 ' CB ' ' A' ' 92' ' ' GLN . 7.1 tt0 -127.97 165.09 20.92 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -175.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.469 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 28.2 m95 -130.04 127.43 39.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.936 0.398 . . . . 0.0 110.914 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.492 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 2.1 m-85 -121.19 148.99 43.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.374 176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -126.74 134.79 50.56 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -112.31 117.54 32.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.88 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -113.97 126.94 27.37 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.687 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.74 144.71 99.39 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 120.904 1.069 . . . . 0.0 110.673 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.97 9.17 87.36 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 p -155.09 158.96 39.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.655 0.264 . . . . 0.0 110.322 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 p -86.5 158.02 54.95 Favored Pre-proline 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.296 -177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.9 155.32 18.56 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.794 1.663 . . . . 0.0 110.812 -177.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.15 126.82 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.883 0.373 . . . . 0.0 110.436 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.492 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -74.94 120.96 21.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.099 178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.691 ' HA ' HG21 ' A' ' 59' ' ' VAL . 23.8 t -103.17 -28.4 3.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 119.987 -0.685 . . . . 0.0 111.491 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 39.5 mt -145.42 151.66 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 176.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.801 ' O ' ' OE1' ' A' ' 54' ' ' GLN . 3.5 t80 -140.82 164.86 29.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.507 176.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' ASN . 2.7 tt0 44.84 21.9 0.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 120.991 -1.068 . . . . 0.0 110.887 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.613 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.2 OUTLIER 43.09 18.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.614 -177.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.79 -46.97 1.26 Allowed 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 173.752 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.801 ' OE1' ' O ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -73.01 153.28 40.97 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.993 -164.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.534 ' CZ ' ' O ' ' A' ' 63' ' ' PHE . 3.3 ttt85 -132.0 108.67 14.01 Favored Pre-proline 0 C--N 1.327 -0.37 0 O-C-N 120.322 -1.486 . . . . 0.0 109.939 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -69.7 143.0 49.73 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.446 1.43 . . . . 0.0 111.449 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -73.99 -18.86 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.062 176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.46 -38.33 96.14 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 48' ' ' VAL . 17.2 m -103.08 149.95 37.38 Favored Pre-proline 0 C--N 1.33 -0.274 0 O-C-N 122.291 -0.535 . . . . 0.0 109.626 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.534 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 2.4 Cg_endo -53.65 125.98 20.36 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 121.795 1.663 . . . . 0.0 111.342 -173.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' CA ' HH21 ' A' ' 55' ' ' ARG . 97.8 m-20 -61.05 2.17 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.443 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 19.6 mtm105 -69.25 21.07 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -173.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.534 ' O ' ' CZ ' ' A' ' 55' ' ' ARG . 16.9 m-85 -131.32 143.6 50.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 118.151 0.432 . . . . 0.0 110.626 177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' A' ' 77' ' ' THR . 2.1 t -126.64 123.14 36.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 119.139 -0.457 . . . . 0.0 111.269 177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.21 136.54 13.66 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-N 112.963 -1.926 . . . . 0.0 110.374 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.4 p -163.83 159.92 21.7 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.404 -0.519 . . . . 0.0 110.567 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.526 HD13 ' CB ' ' A' ' 30' ' ' ALA . 2.5 pp -141.03 154.8 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.669 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 70' ' ' SER . 15.9 m-20 -102.98 154.21 19.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.948 176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.4 p -69.7 7.96 0.77 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.941 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 68' ' ' ASP . 24.4 m -74.19 -43.11 58.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.596 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 70' ' ' SER . 12.7 p 79.5 30.0 0.3 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.657 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -100.05 -38.14 8.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.767 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.591 ' O ' HD13 ' A' ' 29' ' ' ILE . 67.4 p -169.5 172.39 7.07 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.775 177.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.76 123.81 49.6 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 120.864 -1.147 . . . . 0.0 109.912 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 66' ' ' SER . 13.7 m -114.02 112.8 23.85 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.177 -0.916 . . . . 0.0 112.519 -172.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.92 140.48 31.4 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 119.3 -2.125 . . . . 0.0 116.019 169.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.481 ' O ' ' CB ' ' A' ' 64' ' ' SER . 5.6 m -112.64 126.23 55.15 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.321 0.859 . . . . 0.0 113.321 164.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.698 ' CD1' HD21 ' A' ' 76' ' ' LEU . 28.5 mm -86.29 114.25 25.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 O-C-N 120.21 -1.556 . . . . 0.0 110.919 171.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.9 t -103.76 131.71 50.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.217 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.53 31.85 52.92 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tt -46.96 133.82 10.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.252 0.548 . . . . 0.0 110.106 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.0 ttmt -144.17 171.98 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.198 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.44 HG22 ' H ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -46.03 -19.03 0.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.831 173.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 5.6 mp0 -70.86 -39.38 72.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.064 176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -69.76 -9.05 53.05 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.276 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.642 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.0 tt0 -60.37 122.91 15.73 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 157.38 -179.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.528 ' OD1' ' CE2' ' A' ' 90' ' ' TYR . 9.8 t0 -87.62 149.89 24.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.972 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.9 m-85 -115.28 145.39 42.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.628 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' CE2' ' OD1' ' A' ' 88' ' ' ASP . 67.7 m-85 -143.5 154.1 43.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.215 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.1 m -118.84 141.0 49.04 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.598 ' CB ' HE21 ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.48 120.74 31.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.615 0.643 . . . . 0.0 109.386 174.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.7 p -128.54 152.5 48.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.966 0.412 . . . . 0.0 110.649 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.01 147.37 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.73 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 96' ' ' SER . 19.0 t0 -72.17 -145.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.477 178.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.545 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 3.6 m -108.34 -35.54 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.07 -178.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 98' ' ' ASN . 82.7 p -88.8 -10.01 49.71 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.277 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.483 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.1 OUTLIER 148.59 -110.83 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 O-C-N 123.995 0.809 . . . . 0.0 109.977 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.424 ' H ' ' CG ' ' A' ' 98' ' ' ASN . 24.0 t-80 50.14 71.99 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.915 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 100' ' ' VAL . 13.5 m -85.92 126.14 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' O ' ' NE2' ' A' ' 92' ' ' GLN . 16.8 m -149.46 148.67 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.626 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -135.94 140.41 43.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.23 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -166.82 -132.47 1.39 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 48.37 47.01 28.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.33 108.78 2.76 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 92.8 m -133.16 134.57 44.31 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.845 0.355 . . . . 0.0 110.841 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -92.83 124.31 36.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.249 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -113.81 131.32 56.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.934 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 111' ' ' LEU . 88.3 m -124.29 128.97 49.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.687 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.664 ' O ' HG12 ' A' ' 110' ' ' VAL . 58.2 t -87.56 34.2 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.187 0.517 . . . . 0.0 110.511 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' H ' HG22 ' A' ' 109' ' ' THR . 13.7 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.952 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -112.97 131.47 55.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.984 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.445 ' H ' ' HB2' ' A' ' 25' ' ' SER . 30.1 mtm -153.94 170.11 21.84 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.32 103.24 9.06 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.48 113.93 11.13 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.588 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.643 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 14.0 tt0 -144.87 141.82 17.93 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 118.977 -0.535 . . . . 0.0 109.58 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 106' ' ' THR . 6.0 Cg_exo -51.4 137.16 48.08 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 CA-C-N 120.563 1.237 . . . . 0.0 110.954 -177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.487 ' CD2' ' N ' ' A' ' 9' ' ' SER . 42.2 p-80 -58.85 -49.43 77.76 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.629 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.487 ' N ' ' CD2' ' A' ' 8' ' ' HIS . 2.4 m -158.7 151.68 22.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.45 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 11' ' ' SER . 6.6 p -160.29 154.55 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.446 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' N ' HG22 ' A' ' 10' ' ' VAL . 1.8 t -131.9 149.0 52.57 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.312 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -141.37 162.19 36.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.459 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -85.93 156.8 57.87 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.325 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -65.71 128.36 19.84 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.69 1.593 . . . . 0.0 112.283 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.77 -5.27 39.94 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 43.6 mttp -89.4 167.94 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.1 0.476 . . . . 0.0 110.672 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.6 p -102.75 125.41 49.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.782 176.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -114.44 138.95 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 76' ' ' LEU . 32.5 m -128.59 119.78 25.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.931 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.06 132.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -109.07 124.93 51.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.812 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.643 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.0 m -118.86 115.4 24.33 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 94.4 m -116.96 137.66 52.07 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.659 ' C ' ' H ' ' A' ' 26' ' ' SER . 12.7 ttp85 -92.81 139.18 30.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.498 170.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' A' ' 3' ' ' MET . 16.6 m -58.41 2.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.627 177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.06 -18.13 14.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.89 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.68 22.98 76.32 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.613 ' C ' HD21 ' A' ' 32' ' ' ASN . 30.1 t -120.82 110.02 15.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.507 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.765 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.47 -63.91 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.799 -178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.765 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.35 0.35 0.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.0 p -103.87 -11.63 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 113.302 -1.772 . . . . 0.0 111.837 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.613 HD21 ' C ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -132.33 152.07 51.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.964 0.411 . . . . 0.0 109.982 -177.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -71.98 127.96 34.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.092 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.516 ' HA ' HE21 ' A' ' 35' ' ' GLN . 20.5 t -119.81 146.87 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.228 0.537 . . . . 0.0 110.719 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.519 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.56 156.99 47.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.341 -177.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.538 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 98.0 m95 -113.93 136.69 52.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.445 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.424 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 10.2 m-85 -126.17 149.15 49.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.12 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.42 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -146.13 133.53 20.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.575 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -130.07 160.21 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.533 177.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -146.7 157.4 47.71 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.08 178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -53.65 139.07 67.6 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.802 1.668 . . . . 0.0 110.633 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.37 5.51 84.99 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 m -157.03 176.26 12.99 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.96 176.27 1.56 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.061 -178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -68.15 148.96 76.03 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.432 2.088 . . . . 0.0 111.924 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 67.0 p -132.72 143.31 49.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.75 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.424 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 5.5 m -71.7 120.89 17.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.455 178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -102.84 -28.66 3.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.299 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.9 mt -145.61 141.47 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ASP . 1.2 t80 -127.79 166.04 18.96 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.7 tt0 44.77 22.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 122.083 0.944 . . . . 0.0 110.6 -172.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.2 p30 43.48 17.82 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.339 -1.755 . . . . 0.0 108.763 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.09 -47.01 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 111.08 170.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 1.1 pp0? -80.9 126.12 30.97 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.936 -166.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -121.22 119.29 29.67 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 118.774 -0.631 . . . . 0.0 110.276 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -59.26 141.37 97.74 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.8 1.321 . . . . 0.0 111.64 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -67.3 -5.35 13.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.54 176.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.99 59.03 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -93.24 148.5 35.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 O-C-N 122.587 -0.361 . . . . 0.0 110.845 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.456 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -59.35 139.41 89.66 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.813 1.675 . . . . 0.0 111.568 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -61.05 -0.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 63' ' ' PHE . 42.6 ptt85 -56.12 -31.87 63.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.835 0.35 . . . . 0.0 111.313 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 60.3 m-85 -72.25 140.89 48.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.6 t -128.36 122.61 31.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.721 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.89 123.94 7.91 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 113.64 -1.618 . . . . 0.0 110.41 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -154.56 158.23 39.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.426 0.631 . . . . 0.0 111.29 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.434 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -143.46 157.62 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.635 -176.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 4.6 m-20 -105.16 143.63 33.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.813 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -0.05 3.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.955 0.407 . . . . 0.0 110.327 175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.4 m -70.58 -40.77 73.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.59 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.02 29.71 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.397 -177.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -98.93 -39.7 8.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.579 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' ILE . 92.5 p -167.78 169.55 11.54 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.889 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.36 130.29 55.21 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.544 -1.348 . . . . 0.0 109.627 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' SER . 9.1 m -129.94 114.78 16.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.151 -0.928 . . . . 0.0 113.143 -171.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.679 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -97.95 140.53 32.16 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 118.645 -2.534 . . . . 0.0 116.166 167.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CB ' ' A' ' 64' ' ' SER . 86.2 m -100.12 128.03 46.27 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 162.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -105.44 107.24 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 O-C-N 120.684 -1.26 . . . . 0.0 110.072 174.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.78 170.94 10.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.032 178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 42.36 56.63 4.02 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 110' ' ' VAL . 1.8 tt -79.38 136.47 36.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 110.536 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.467 ' C ' ' N ' ' A' ' 84' ' ' GLU . 14.0 mttp -145.66 -176.6 5.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.399 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -47.3 -18.86 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.509 171.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' N ' ' C ' ' A' ' 82' ' ' LYS . 77.9 tt0 -69.97 -41.63 74.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.233 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 14.5 t70 -74.3 -3.65 31.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.938 0.399 . . . . 0.0 110.377 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.6 tt0 -69.16 124.14 23.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.771 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.76 -175.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.817 177.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -88.55 135.38 33.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.239 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 85' ' ' ASP . 13.5 m-85 -114.27 139.95 49.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.028 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.4 m-85 -129.52 154.15 47.31 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.538 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 0.7 OUTLIER -118.53 140.68 49.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 -175.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -123.81 116.47 23.02 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.5 p -135.41 141.68 45.51 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' CB ' ' N ' ' A' ' 100' ' ' VAL . 9.7 p90 -159.51 144.97 15.79 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.703 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.438 ' H ' ' HB2' ' A' ' 98' ' ' ASN . 3.4 t70 -110.8 -148.25 0.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.093 177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 t -72.46 -41.58 65.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.988 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.7 t -86.84 -6.64 58.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.372 . . . . 0.0 110.715 -176.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.619 ' H ' HD22 ' A' ' 98' ' ' ASN . 0.0 OUTLIER -101.54 -69.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.381 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.857 ' O ' HG13 ' A' ' 100' ' ' VAL . 3.5 t-80 78.8 -10.19 1.39 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.883 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER 170.66 114.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -136.82 148.3 26.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 172.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HA ' HE21 ' A' ' 92' ' ' GLN . 31.6 p90 -129.32 137.96 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.486 0.184 . . . . 0.0 110.593 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -175.24 -154.41 11.22 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 64.76 40.17 97.18 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.67 96.96 0.87 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 7' ' ' PRO . 63.3 m -120.48 131.39 54.72 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.89 117.43 28.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.404 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 29.8 tp -100.32 125.22 46.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.885 0.374 . . . . 0.0 110.266 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.74 109.64 17.41 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.658 ' O ' HG12 ' A' ' 110' ' ' VAL . 61.6 t -84.37 44.83 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.615 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 117.906 -1.045 . . . . 0.0 111.236 178.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.535 HD22 ' H3 ' ' A' ' 1' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.67 122.15 11.4 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.413 ' HG2' ' H ' ' A' ' 4' ' ' LEU . 3.8 ttt -161.33 170.1 20.79 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.206 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.413 ' H ' ' HG2' ' A' ' 3' ' ' MET . 0.3 OUTLIER -129.41 103.15 6.75 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -178.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -83.38 119.71 24.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.875 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.554 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.5 tt0 -144.98 145.54 27.74 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 118.982 -0.532 . . . . 0.0 109.649 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -49.94 136.59 36.4 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 CA-C-N 120.257 1.128 . . . . 0.0 111.209 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.59 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.537 -179.334 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' N ' ' ND1' ' A' ' 8' ' ' HIS . 5.1 m -156.41 160.18 39.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.822 0.344 . . . . 0.0 110.683 -178.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.84 146.58 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.912 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.7 p -141.08 145.87 36.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.589 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -142.95 154.24 43.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.626 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.3 m -78.04 140.67 62.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.635 -177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -57.06 123.98 15.13 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 121.737 1.624 . . . . 0.0 111.021 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.8 -5.79 22.41 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -97.88 -171.73 2.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.887 0.375 . . . . 0.0 110.662 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.0 p -119.89 142.42 48.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.32 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.2 t -129.47 142.41 44.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.079 0.466 . . . . 0.0 110.611 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -128.62 134.45 48.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.434 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.4 mm -105.8 146.19 12.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.179 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.3 m -124.06 122.8 38.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.776 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.554 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.5 117.91 30.28 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.9 m -117.01 142.11 47.38 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.683 ' HE ' ' CB ' ' A' ' 93' ' ' SER . 50.9 mtt85 -98.59 140.53 32.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.315 172.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 m -58.54 3.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.589 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.657 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.33 -17.11 15.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.603 -174.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.48 -41.3 2.49 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 p -65.42 111.0 2.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.054 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.758 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.12 -59.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.505 -176.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.758 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.66 1.09 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 29' ' ' ILE . 7.8 t -107.92 -30.23 8.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.901 -1.5 . . . . 0.0 111.568 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.404 ' OD1' ' OD2' ' A' ' 95' ' ' ASP . 42.5 m-80 -111.86 143.11 43.36 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 2.4 m-85 -73.95 134.31 43.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.888 -175.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' CG2' ' NH2' ' A' ' 24' ' ' ARG . 1.5 t -121.0 145.53 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.354 0.597 . . . . 0.0 109.944 -178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.551 ' NE2' ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.7 153.23 45.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.463 -176.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.463 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 29.3 m95 -129.99 132.34 46.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.127 0.489 . . . . 0.0 110.519 -178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 32.3 m-85 -119.29 149.39 41.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.633 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.548 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -131.37 129.27 41.13 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 43' ' ' SER . 52.7 tp60 -113.56 124.83 53.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.749 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.14 148.95 59.13 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.86 139.28 89.8 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 121.418 1.412 . . . . 0.0 110.559 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.62 10.03 82.66 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.527 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 7.6 m -148.71 143.0 26.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.775 0.321 . . . . 0.0 110.589 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.39 175.95 4.01 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.123 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -70.84 142.25 42.75 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.19 1.927 . . . . 0.0 111.458 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.5 p -139.25 134.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.507 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 4.4 m -70.29 118.79 13.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.162 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.0 t -98.88 -21.82 5.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.338 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.4 mt -144.56 143.16 23.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 175.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 52' ' ' ASP . 76.8 t80 -133.12 167.22 20.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.314 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 53' ' ' ASN . 10.0 tp10 44.67 23.51 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.043 0.925 . . . . 0.0 110.241 -173.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' TYR . 11.2 t70 44.22 19.37 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.255 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' ND2' ' NE2' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -128.04 -45.18 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.783 168.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.629 ' NE2' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.31 143.89 17.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.36 -170.115 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -146.82 108.57 4.04 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 118.989 -0.529 . . . . 0.0 109.866 176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -71.21 148.89 56.76 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 121.534 1.489 . . . . 0.0 111.95 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.7 m -74.13 -30.2 62.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.1 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.38 -47.12 63.18 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -177.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.51 145.31 31.06 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.1 Cg_endo -53.01 117.99 4.33 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.915 1.744 . . . . 0.0 111.293 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 63' ' ' PHE . 18.5 p-10 -60.78 0.13 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.697 HH12 ' N ' ' A' ' 85' ' ' ASP . 47.2 mtm105 -46.12 -11.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.996 -174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CZ ' ' NH2' ' A' ' 62' ' ' ARG . 3.4 m-85 -105.4 143.08 34.07 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.6 t -124.75 122.86 38.66 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.81 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.19 121.77 7.0 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.47 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.1 p -157.29 163.75 38.38 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.422 -0.511 . . . . 0.0 111.0 -178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.531 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -139.1 155.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.522 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -100.18 152.06 20.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.836 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 43.7 m -67.94 -8.56 38.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.865 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' SER . 58.0 m -61.34 -41.17 96.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.9 OUTLIER 79.6 27.29 0.36 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.347 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -98.55 -41.75 7.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.648 ' C ' HD13 ' A' ' 29' ' ' ILE . 62.7 p -164.43 174.85 10.53 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.12 122.67 47.78 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.614 -1.303 . . . . 0.0 110.011 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.465 ' O ' ' O ' ' A' ' 66' ' ' SER . 69.1 m -116.77 116.67 27.93 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.694 -1.146 . . . . 0.0 112.839 -169.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.82 140.58 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 118.474 -2.642 . . . . 0.0 117.386 170.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 64' ' ' SER . 4.5 m -107.85 127.39 53.68 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 163.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.562 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -104.18 109.92 28.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 120.08 -1.638 . . . . 0.0 110.21 172.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.99 155.75 16.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.332 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 65.06 42.22 96.77 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.21 136.86 57.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.98 0.419 . . . . 0.0 110.329 -179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.45 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -151.83 177.52 10.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.262 177.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.93 -21.12 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.521 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.45 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.8 mt-10 -70.22 -40.69 74.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.261 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.697 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.9 OUTLIER -70.82 -9.03 56.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.145 -179.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.635 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 39.5 tt0 -64.18 125.22 23.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.183 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 163.1 -175.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.039 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.085 178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.548 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 16.2 m-85 -115.25 146.82 41.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.459 . . . . 0.0 111.08 -178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.6 m-85 -144.79 149.01 34.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.077 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.402 ' N ' ' HA3' ' A' ' 104' ' ' GLY . 0.5 OUTLIER -140.7 140.18 34.86 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.432 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 24.9 mt-30 -133.16 149.02 52.09 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.683 ' CB ' ' HE ' ' A' ' 24' ' ' ARG . 15.1 m -135.19 126.76 28.83 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.918 0.389 . . . . 0.0 110.938 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.528 ' CE2' ' OE1' ' A' ' 35' ' ' GLN . 12.3 p90 -159.14 130.98 6.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.849 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 0.8 OUTLIER -98.87 -153.98 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.488 178.111 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.07 -16.37 53.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.612 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.7 m -87.66 39.44 0.88 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.806 -177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.6 m120 49.89 -128.41 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.698 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 49.69 82.2 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.72 0.295 . . . . 0.0 110.348 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 100' ' ' VAL . 9.3 p -85.91 116.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.06 0.457 . . . . 0.0 110.787 -178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.11 125.84 71.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.839 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -116.28 140.34 49.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.225 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.52 -145.0 4.56 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 91' ' ' CYS . . . 76.38 12.78 83.98 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -60.15 99.33 0.17 Allowed Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 16.4 m -142.42 141.76 32.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.005 0.431 . . . . 0.0 110.26 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.0 mttm -106.19 119.16 38.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.24 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.5 tp -104.04 122.61 45.63 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -117.29 111.66 19.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.867 -0.419 . . . . 0.0 109.867 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.655 ' O ' HG12 ' A' ' 110' ' ' VAL . 47.6 t -82.76 31.72 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 109.779 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.7 mt . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.984 -179.18 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.504 ' N ' HD22 ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -73.47 103.77 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.145 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.4 mtm -137.52 169.89 17.0 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.508 HD13 ' HA2' ' A' ' 103' ' ' GLY . 0.3 OUTLIER -126.79 118.82 25.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -85.88 120.47 27.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.783 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.698 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 43.6 tt0 -145.48 141.94 17.56 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 178.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -51.45 160.76 2.24 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.247 1.298 . . . . 0.0 111.773 -175.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -81.29 -56.56 3.98 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -156.31 150.55 25.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 110.261 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -160.48 149.62 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.309 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 p -120.26 137.62 54.13 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -117.01 155.38 29.29 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.1 m -82.99 131.99 52.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.978 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -56.4 116.77 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.665 1.577 . . . . 0.0 111.018 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.53 -1.97 20.25 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 mtpt -101.93 -171.74 2.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.114 0.483 . . . . 0.0 111.242 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 p -125.85 146.77 49.67 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.205 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -143.83 150.79 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 76' ' ' LEU . 0.7 OUTLIER -126.26 137.31 53.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG2' HE21 ' A' ' 6' ' ' GLN . 43.6 mm -94.54 150.45 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -125.83 114.93 19.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.812 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.698 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 50.5 m -118.69 113.76 21.68 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' HD23 ' A' ' 4' ' ' LEU . 57.2 m -113.31 141.22 47.28 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.02 -1.05 . . . . 0.0 108.272 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 26' ' ' SER . 40.5 mtp85 -89.53 137.24 32.5 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 121.32 -0.862 . . . . 0.0 110.377 170.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -60.97 2.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.48 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.613 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -102.75 -16.93 15.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.499 -175.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.03 22.84 70.44 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 m -125.89 111.06 14.37 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.496 0.189 . . . . 0.0 110.829 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.76 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.31 -61.18 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 O-C-N 122.14 -0.35 . . . . 0.0 111.584 -176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.76 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.0 1.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 29' ' ' ILE . 94.0 p -109.77 -9.83 14.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 113.856 -1.52 . . . . 0.0 111.483 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 28' ' ' SER . 2.7 m120 -124.69 145.7 49.53 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 -177.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -72.27 134.84 45.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.443 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 52' ' ' ASP . 2.0 t -130.06 147.93 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.509 0.671 . . . . 0.0 111.164 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -137.88 153.39 49.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.108 -177.332 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -117.58 120.75 39.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.349 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HE1' HG23 ' A' ' 47' ' ' THR . 9.0 m-85 -121.48 149.31 43.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.229 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.34 137.21 47.32 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.17 135.48 41.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.76 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -123.81 125.76 25.84 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.983 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.6 141.65 95.38 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.225 1.283 . . . . 0.0 110.843 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.99 -8.57 79.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 85.9 p -154.88 162.49 41.08 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.33 176.45 3.12 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.0 148.74 51.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.307 2.004 . . . . 0.0 111.703 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.4 m -120.63 121.72 38.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.139 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.413 HG23 ' HE1' ' A' ' 37' ' ' TYR . 29.9 m -62.13 120.59 11.18 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.793 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.568 HG13 HG21 ' A' ' 59' ' ' VAL . 2.4 t -101.14 -28.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.007 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.1 mt -145.23 149.35 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.412 ' O ' ' N ' ' A' ' 52' ' ' ASP . 62.7 t80 -134.3 160.85 36.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.033 172.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 6.6 tt0 47.19 24.01 0.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.326 0.584 . . . . 0.0 111.136 -174.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.6 p30 44.42 19.94 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.602 -176.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.772 HD22 HE22 ' A' ' 54' ' ' GLN . 0.4 OUTLIER -127.76 -46.19 1.43 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.432 0.634 . . . . 0.0 109.56 170.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.772 HE22 HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -53.65 135.52 40.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.599 -167.55 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.1 108.79 18.04 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -63.36 148.71 92.59 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.96 1.774 . . . . 0.0 111.771 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 t -64.15 -29.54 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.86 176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.34 -49.57 71.69 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.568 HG21 HG13 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -96.03 129.63 33.48 Favored Pre-proline 0 C--N 1.331 -0.238 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.5 Cg_endo -62.91 164.34 19.4 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 121.641 1.561 . . . . 0.0 111.901 175.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.4 p30 -59.54 1.29 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.081 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.631 ' NE ' ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -39.59 -37.08 0.46 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.631 ' CE1' ' NE ' ' A' ' 62' ' ' ARG . 44.3 m-85 -89.53 143.75 26.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.5 t -136.93 122.97 20.28 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.221 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.12 125.93 7.09 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 113.39 -1.732 . . . . 0.0 110.562 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 68.8 p -159.43 161.35 35.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.069 0.462 . . . . 0.0 111.023 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.679 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -137.02 161.31 35.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.646 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 70' ' ' SER . 86.6 m-20 -102.39 154.9 18.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.717 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.5 t -68.87 10.43 0.28 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.221 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 68' ' ' ASP . 26.1 m -80.49 -42.94 21.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.88 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.0 28.38 0.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.444 -178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -99.69 -38.12 8.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.607 -175.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.514 ' O ' HD13 ' A' ' 29' ' ' ILE . 88.9 p -167.95 166.26 13.38 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.545 177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.97 134.18 51.24 Favored 'General case' 0 C--N 1.331 -0.203 0 O-C-N 121.063 -1.023 . . . . 0.0 109.655 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 7.4 m -134.07 120.07 19.73 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -173.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' O ' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.79 140.35 29.88 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 120.296 -1.503 . . . . 0.0 114.101 167.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 57.6 m -106.6 128.84 54.46 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 164.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 78' ' ' ILE . 2.0 mt -104.82 116.56 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 120.82 -1.175 . . . . 0.0 109.672 171.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.5 t -98.82 127.98 44.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.704 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.18 69.65 1.38 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.615 -0.594 . . . . 0.0 111.615 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.7 tt -85.4 127.84 34.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.659 -0.27 . . . . 0.0 111.383 177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' C ' ' N ' ' A' ' 84' ' ' GLU . 8.3 mtmt -137.05 -177.0 4.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.8 0.334 . . . . 0.0 110.636 176.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -19.36 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.316 171.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' C ' ' A' ' 82' ' ' LYS . 52.7 tp10 -67.2 -41.18 86.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.849 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' OD1' ' NH2' ' A' ' 62' ' ' ARG . 1.3 m-20 -68.99 -19.05 64.13 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.082 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 68.3 tt0 -51.16 120.83 5.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.669 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.87 -174.29 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.317 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.76 143.7 26.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.22 176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -116.18 139.64 50.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.158 -178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -137.8 142.49 40.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.764 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.477 ' SG ' ' HA3' ' A' ' 103' ' ' GLY . 5.7 p -121.84 140.46 52.36 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 40.1 mt-30 -124.25 128.75 49.63 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 122.214 -0.304 . . . . 0.0 110.478 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.833 ' O ' HG22 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -135.16 155.61 50.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.682 -177.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.418 ' HB3' ' N ' ' A' ' 100' ' ' VAL . 2.8 p90 -159.34 130.79 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.175 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' N ' ' HB2' ' A' ' 98' ' ' ASN . 16.0 m-20 -89.92 -149.82 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 -42.18 79.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.667 -178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.411 ' C ' HD22 ' A' ' 98' ' ' ASN . 74.9 m -107.3 38.15 2.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.766 0.317 . . . . 0.0 110.845 -175.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 100' ' ' VAL . 1.5 m-80 -125.11 -58.61 1.45 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.169 0.509 . . . . 0.0 111.348 -177.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.881 ' O ' HG13 ' A' ' 100' ' ' VAL . 0.1 OUTLIER 61.69 -10.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.929 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 99' ' ' HIS . 0.0 OUTLIER 172.48 122.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 118.153 0.433 . . . . 0.0 110.214 177.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 93' ' ' SER . 1.1 m -141.5 173.07 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.09 173.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.1 p90 -113.0 143.97 43.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.359 0.6 . . . . 0.0 109.97 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.508 ' HA2' HD13 ' A' ' 4' ' ' LEU . . . -103.49 27.7 18.74 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.469 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 54.55 63.27 5.37 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.233 -0.985 . . . . 0.0 110.74 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -51.55 149.46 8.23 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.598 -172.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 73.8 m -111.04 141.47 44.49 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.3 mtmm -81.55 123.94 29.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.504 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 30.5 tp -113.95 129.71 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.565 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 78.5 m -123.73 121.46 35.53 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.406 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 82' ' ' LYS . 39.0 t -83.76 96.87 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 110' ' ' VAL . 7.0 mt . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.725 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.566 ' ND2' ' N ' ' A' ' 2' ' ' PHE . 2.1 t30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' N ' ' ND2' ' A' ' 1' ' ' ASN . 14.7 m-85 -126.69 116.66 21.31 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.0 ttp -150.72 169.96 20.36 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.688 HD13 ' HA3' ' A' ' 103' ' ' GLY . 0.5 OUTLIER -119.4 103.02 9.09 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.6 p -89.05 130.89 35.43 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.493 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.834 HE22 ' H ' ' A' ' 104' ' ' GLY . 0.0 OUTLIER -146.34 164.41 24.79 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.023 -177.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -53.85 145.29 51.48 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.398 2.066 . . . . 0.0 110.869 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 9' ' ' SER . 0.1 OUTLIER -59.25 -73.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.503 -178.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 49.0 m -161.47 159.35 27.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.605 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.434 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.24 155.7 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.467 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' HD21 ' A' ' 111' ' ' LEU . 5.0 p -125.6 137.3 53.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.373 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.12 161.93 18.64 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 m -89.94 142.29 28.79 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.312 -176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.3 114.9 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.576 1.517 . . . . 0.0 111.452 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.43 -20.3 16.03 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.789 -0.925 . . . . 0.0 110.789 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -78.56 -169.42 1.69 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 176.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.5 p -129.61 153.89 47.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.857 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.42 152.23 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.602 177.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.2 m -124.27 134.05 53.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.948 177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.2 mt -101.85 143.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.584 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 m -119.59 127.96 53.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 119.246 -0.407 . . . . 0.0 110.737 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.594 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -118.46 112.52 20.06 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 176.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 59.9 m -113.22 140.58 47.83 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.707 -1.246 . . . . 0.0 108.02 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 20.2 mtp85 -94.1 139.35 31.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.011 170.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.1 m -59.13 1.74 0.06 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.542 176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.94 -18.2 14.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.546 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 86.57 -19.16 29.93 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.409 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 1.1 t -87.12 116.78 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.978 -0.719 . . . . 0.0 110.543 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.763 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.42 -61.08 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.632 -176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -60.34 -0.3 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.8 t -97.23 -26.66 14.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.268 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.409 ' ND2' ' O ' ' A' ' 28' ' ' SER . 2.4 p30 -114.85 141.46 47.87 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.25 144.38 48.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.714 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.7 t -125.46 140.71 47.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.446 -178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.43 ' O ' ' HA ' ' A' ' 91' ' ' CYS . 13.6 pt20 -121.44 152.54 38.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.363 178.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.18 142.31 46.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.113 0.482 . . . . 0.0 110.354 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.486 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.8 m-85 -139.14 149.24 44.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.89 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.409 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -131.18 141.54 50.09 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.462 HE21 ' N ' ' A' ' 45' ' ' PRO . 1.4 tt0 -125.75 135.35 51.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.358 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.6 mtm-85 -123.93 149.71 60.6 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.225 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -55.67 134.05 61.7 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.537 1.492 . . . . 0.0 110.814 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.12 2.86 84.1 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.284 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.3 t -138.83 146.6 41.45 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.05 0.452 . . . . 0.0 110.307 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.435 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -80.8 178.29 2.49 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.98 -178.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.462 ' N ' HE21 ' A' ' 39' ' ' GLN . 5.9 Cg_exo -69.41 150.44 70.36 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.352 2.035 . . . . 0.0 111.865 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.6 m -132.83 126.69 32.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.351 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.0 m -64.14 119.02 9.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.176 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.484 ' O ' ' CD ' ' A' ' 56' ' ' PRO . 1.8 t -101.29 -29.03 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 119.062 -0.494 . . . . 0.0 111.048 -178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 mt -145.35 150.54 15.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.504 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.3 t80 -136.22 163.9 29.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.888 174.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.1 tp10 44.68 24.27 0.1 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.834 0.826 . . . . 0.0 110.682 -172.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 50' ' ' TYR . 33.7 t0 43.97 20.48 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.015 -176.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.747 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.9 OUTLIER -128.06 -46.13 1.39 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 169.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.747 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -50.97 131.06 26.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.124 -168.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.766 ' NH2' ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -116.43 108.82 44.8 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 48' ' ' VAL . 5.7 Cg_exo -65.91 147.24 84.74 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 121.965 1.777 . . . . 0.0 111.786 175.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.8 p -70.81 -36.58 73.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.835 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -55.67 -43.12 86.31 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.0 m -98.1 127.74 35.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 118.921 -0.561 . . . . 0.0 110.4 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.7 Cg_exo -62.78 161.93 27.06 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.322 1.348 . . . . 0.0 111.977 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.606 ' C ' HH21 ' A' ' 55' ' ' ARG . 47.3 t0 -60.12 3.58 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.412 178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -48.02 -27.59 2.34 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.633 -175.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.766 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 31.8 m-85 -92.07 136.55 33.08 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 122.215 -0.303 . . . . 0.0 110.663 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 77' ' ' THR . 1.4 t -125.12 123.85 40.58 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.933 178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.67 131.74 10.65 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 113.621 -1.627 . . . . 0.0 111.128 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.7 p -161.63 172.43 16.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.304 0.574 . . . . 0.0 111.224 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.443 HD12 ' HB1' ' A' ' 30' ' ' ALA . 3.6 pt -149.56 163.32 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.229 -175.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -107.85 152.76 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.698 175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.4 p -68.02 -8.32 36.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.106 0.479 . . . . 0.0 110.42 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.3 m -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.886 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.03 27.73 0.41 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.466 -178.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -99.13 -37.07 9.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.224 -174.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.755 ' C ' HD13 ' A' ' 29' ' ' ILE . 85.5 p -165.96 166.76 17.19 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.124 -0.63 . . . . 0.0 111.406 176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.01 130.04 55.47 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.084 -1.01 . . . . 0.0 109.709 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.5 m -132.9 122.45 24.37 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.12 -0.946 . . . . 0.0 113.458 -169.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.25 141.05 29.29 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 119.8 -1.813 . . . . 0.0 114.834 169.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 64' ' ' SER . 9.9 m -106.31 125.71 51.34 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 165.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.702 ' CD1' HD21 ' A' ' 76' ' ' LEU . 30.9 mm -86.86 123.51 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 O-C-N 120.195 -1.566 . . . . 0.0 110.543 171.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 t -112.95 127.71 56.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.577 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.42 43.77 10.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.801 -0.919 . . . . 0.0 110.801 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.481 ' HA ' HH22 ' A' ' 62' ' ' ARG . 2.1 tt -64.82 132.21 48.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.0 0.429 . . . . 0.0 110.453 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.458 ' C ' ' N ' ' A' ' 84' ' ' GLU . 11.9 tttp -143.65 174.72 10.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.128 178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -46.16 -21.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.542 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' C ' ' A' ' 82' ' ' LYS . 66.8 mm-40 -69.27 -42.77 75.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.132 177.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 19.8 m-20 -68.81 -5.64 22.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.433 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.6 tt0 -62.08 121.06 12.11 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.2 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.22 -179.12 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.528 177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -85.87 151.61 23.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.162 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -121.72 146.17 47.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.353 . . . . 0.0 111.068 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.8 m-85 -144.38 148.75 35.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.469 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 103' ' ' GLY . 0.7 OUTLIER -134.43 140.17 46.07 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -177.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -127.38 136.32 51.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.333 0.587 . . . . 0.0 110.019 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.546 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.3 OUTLIER -134.97 -176.39 4.23 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.546 ' CD1' ' O ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -149.02 135.05 19.06 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 123.64 0.588 . . . . 0.0 110.479 174.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.541 ' CG ' ' H ' ' A' ' 96' ' ' SER . 31.5 t0 -134.85 -145.99 0.24 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.992 176.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.541 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 4.7 t -46.62 -14.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.524 0.202 . . . . 0.0 110.694 178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.468 ' N ' ' C ' ' A' ' 95' ' ' ASP . 11.0 p -81.41 -7.12 59.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.931 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.6 m120 63.76 111.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.341 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.42 ' O ' HG23 ' A' ' 100' ' ' VAL . 37.1 m-70 42.21 31.47 0.25 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 174.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 99' ' ' HIS . 70.0 t -152.64 111.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 118.565 0.62 . . . . 0.0 111.84 -179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 93' ' ' SER . 1.0 OUTLIER -167.78 136.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 166.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 2.9 p90 -119.24 148.98 42.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.001 0.429 . . . . 0.0 111.133 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.688 ' HA3' HD13 ' A' ' 4' ' ' LEU . . . -172.2 -146.53 5.38 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.834 ' H ' HE22 ' A' ' 6' ' ' GLN . . . 65.66 -7.03 1.12 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-O 119.448 -0.64 . . . . 0.0 112.187 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . -51.96 84.94 0.01 OUTLIER Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' GLY . 20.5 m -150.09 125.67 10.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.936 0.398 . . . . 0.0 110.23 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -83.58 132.37 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.159 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.2 tp -119.74 127.04 52.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.629 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.8 125.75 50.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.264 0.554 . . . . 0.0 110.038 177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.75 ' O ' HG12 ' A' ' 110' ' ' VAL . 65.5 t -88.91 36.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.381 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.548 HD21 ' OG ' ' A' ' 11' ' ' SER . 83.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.746 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.748 HD22 ' N ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.748 ' N ' HD22 ' A' ' 1' ' ' ASN . 16.7 m-85 -150.65 124.85 9.4 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.765 ' C ' HD12 ' A' ' 4' ' ' LEU . 5.1 mtm -128.73 169.99 13.84 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.765 HD12 ' C ' ' A' ' 3' ' ' MET . 8.2 mp -132.6 108.84 9.33 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -92.12 117.53 29.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.621 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -145.79 165.66 20.17 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -51.13 151.26 12.55 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.546 2.164 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.563 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -75.83 -65.02 0.96 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.03 -179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.1 p -158.82 146.03 17.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.229 0.537 . . . . 0.0 110.373 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.28 146.21 11.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.057 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.1 p -117.07 143.64 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.827 0.346 . . . . 0.0 110.491 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -129.32 163.08 26.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.334 0.587 . . . . 0.0 110.475 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 m -94.67 142.57 24.92 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.379 -178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.27 113.99 1.78 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 121.416 1.411 . . . . 0.0 111.152 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.12 -5.02 15.85 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -94.25 177.8 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.1 p -128.96 142.79 50.81 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.76 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 19' ' ' THR . 3.4 p -137.32 155.2 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.721 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.422 ' N ' HG22 ' A' ' 18' ' ' VAL . 1.0 OUTLIER -125.63 125.36 42.99 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 176.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.53 146.51 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.367 0.603 . . . . 0.0 110.786 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -117.36 132.68 56.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.814 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.621 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -118.82 116.48 26.6 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 175.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 55.1 m -111.31 134.22 53.06 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 61.2 mtp180 -91.34 138.16 31.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.761 -1.108 . . . . 0.0 109.603 171.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.639 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.4 OUTLIER -57.81 3.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.57 176.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -96.7 -12.87 23.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.21 -173.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.22 -1.87 39.4 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.266 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.8 m -124.24 124.73 43.08 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 122.215 0.206 . . . . 0.0 110.82 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.691 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -128.86 -55.33 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 112.535 0.569 . . . . 0.0 112.535 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.691 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.34 -1.16 2.2 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 12.0 p -86.59 -32.24 20.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 111.698 -2.501 . . . . 0.0 111.075 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.445 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 1.8 m120 -122.46 159.23 28.06 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -76.15 123.39 25.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.975 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 ' H ' ' HB3' ' A' ' 52' ' ' ASP . 96.2 t -103.76 146.89 10.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.14 0.495 . . . . 0.0 110.355 -178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.418 ' CG ' ' N ' ' A' ' 36' ' ' TRP . 5.4 tt0 -133.32 158.83 41.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.519 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 12.7 m95 -129.45 124.14 33.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.929 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.519 ' CD2' ' OE1' ' A' ' 92' ' ' GLN . 0.2 OUTLIER -110.73 149.55 30.34 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.17 142.21 49.18 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.688 ' NE2' ' N ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -140.36 117.1 10.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.905 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.586 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 2.5 mpt_? -84.53 175.87 4.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.84 126.24 20.66 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 CA-C-O 121.963 0.735 . . . . 0.0 111.107 -169.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.33 -35.65 0.26 Allowed Glycine 0 CA--C 1.528 0.858 0 CA-C-N 113.654 -1.612 . . . . 0.0 114.824 166.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.414 ' C ' ' OG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -158.91 115.91 2.75 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.938 1.869 . . . . 0.0 112.688 170.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.688 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -170.75 92.7 0.46 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 119.05 0.841 . . . . 0.0 111.763 169.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.24 121.13 4.27 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 121.46 1.44 . . . . 0.0 111.687 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 64.4 m -148.7 97.95 2.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.921 0.391 . . . . 0.0 110.117 178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.486 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 28.8 m -64.25 120.18 11.67 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' A' ' 63' ' ' PHE . 24.8 t -100.16 -28.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.956 -174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -144.95 142.19 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -136.07 148.67 48.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.595 175.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' O ' ' N ' ' A' ' 53' ' ' ASN . 14.2 tp10 58.96 22.49 10.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.942 1.353 . . . . 0.0 110.243 -172.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 34' ' ' VAL . 1.0 OUTLIER 42.73 17.79 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 113.986 -1.461 . . . . 0.0 108.813 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.578 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -129.44 -47.03 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.294 0.569 . . . . 0.0 111.409 168.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.472 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -92.25 140.63 29.42 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.329 -165.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.6 144.98 32.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.99 150.89 75.83 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.314 1.343 . . . . 0.0 111.275 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.2 p -71.05 -22.35 62.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.708 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.6 96.41 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -82.94 140.79 43.31 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.9 Cg_endo -51.78 119.63 5.91 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 121.084 1.19 . . . . 0.0 110.581 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -59.74 1.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.009 -0.432 . . . . 0.0 111.037 176.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 60' ' ' PRO . 46.4 mtm180 -53.18 -22.34 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.62 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.546 ' CD1' ' O ' ' A' ' 60' ' ' PRO . 6.8 m-85 -75.27 129.09 36.86 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.978 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 5.0 t -110.17 121.59 45.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.067 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.16 126.15 8.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.528 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.7 p -164.37 166.85 20.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.832 0.349 . . . . 0.0 110.329 -176.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.2 160.9 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 70' ' ' SER . 0.9 OUTLIER -93.07 163.31 13.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.093 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.9 m -68.45 30.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -123.12 -46.33 2.08 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 m 79.0 25.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.787 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -98.33 -19.04 18.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 110.601 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HG21 ' A' ' 29' ' ' ILE . 30.9 p -158.32 169.94 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.838 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.95 114.88 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -177.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 8.0 m -99.02 110.99 23.51 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 118.73 -1.188 . . . . 0.0 109.988 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -101.15 140.45 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 171.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.471 ' O ' ' CB ' ' A' ' 64' ' ' SER . 94.9 m -112.56 124.38 52.39 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 163.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.444 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.2 mt -102.46 109.11 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 O-C-N 119.966 -1.709 . . . . 0.0 110.446 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.2 t -99.34 142.42 30.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.392 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.03 44.83 8.7 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD21 HG13 ' A' ' 110' ' ' VAL . 2.7 tt -74.75 129.91 38.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.217 0.532 . . . . 0.0 110.559 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' GLU . 15.9 tttt -138.77 172.6 12.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.83 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.433 ' H ' HG23 ' A' ' 83' ' ' THR . 29.7 p -45.88 -19.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.544 178.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.48 ' N ' ' C ' ' A' ' 82' ' ' LYS . 27.6 tt0 -73.79 -38.45 64.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.335 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -68.89 -4.38 16.24 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.03 -177.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 74.4 tt0 -60.43 129.16 40.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.425 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.76 173.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -91.02 143.58 26.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.782 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.522 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 11.5 m-85 -109.75 150.72 27.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.286 0.565 . . . . 0.0 110.223 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 49.3 m-85 -146.81 153.77 40.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.369 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 94.3 m -120.73 141.08 50.78 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' OE1' ' CD2' ' A' ' 37' ' ' TYR . 33.6 mt-30 -126.71 137.47 53.26 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.727 0.694 . . . . 0.0 110.497 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.5 ' OG ' ' NH2' ' A' ' 24' ' ' ARG . 3.0 t -128.71 143.21 50.88 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.276 0.56 . . . . 0.0 110.92 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.67 135.64 9.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.084 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 95' ' ' ASP . 1.3 m-20 -105.02 -175.89 2.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.831 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -54.01 -32.13 53.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.628 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.491 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 7.2 t -80.34 38.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.891 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 46.61 -113.33 0.45 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.491 ' ND1' ' O ' ' A' ' 97' ' ' SER . 27.4 m170 44.85 81.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.857 0.361 . . . . 0.0 110.587 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.2 m -86.13 129.46 38.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.452 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.92 158.54 43.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.918 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -136.36 144.62 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.134 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -176.25 -157.24 16.96 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 62.15 53.9 38.91 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.27 107.1 3.36 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.436 ' OG1' ' OE1' ' A' ' 6' ' ' GLN . 37.9 m -124.54 129.96 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.027 0.441 . . . . 0.0 110.71 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -88.21 115.62 25.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.276 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 35.7 tp -102.9 122.74 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 111' ' ' LEU . 93.0 m -119.68 114.99 23.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.406 0.622 . . . . 0.0 110.075 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.727 ' O ' HG12 ' A' ' 110' ' ' VAL . 57.9 t -76.83 30.93 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.822 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 109' ' ' THR . 77.3 mt . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.567 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.85 130.23 40.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.574 -177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.9 ttt -140.62 170.23 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.26 103.09 7.21 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 p -95.46 120.19 35.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.093 0.473 . . . . 0.0 110.514 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.12 167.93 12.92 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.24 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -53.33 144.91 47.41 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.644 1.563 . . . . 0.0 111.132 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.711 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.4 p80 -75.88 -51.6 12.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.82 -177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -159.27 151.16 20.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 110.809 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 11' ' ' SER . 5.4 p -161.37 155.65 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.468 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' N ' HG22 ' A' ' 10' ' ' VAL . 78.6 p -137.37 152.89 50.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -142.03 162.18 36.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.391 0.615 . . . . 0.0 110.221 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.531 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 0.8 OUTLIER -92.37 151.08 41.11 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.907 -176.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -54.87 117.77 4.38 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 121.781 1.654 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.16 9.74 31.27 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.742 -0.543 . . . . 0.0 111.742 175.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 13' ' ' SER . 72.3 mttt -98.96 -178.7 4.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.17 0.51 . . . . 0.0 110.619 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.642 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.6 p -122.54 128.07 50.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.212 176.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -123.6 139.94 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.741 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 76' ' ' LEU . 99.9 m -125.6 133.26 52.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.532 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 1.3 mt -113.06 142.02 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.198 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -117.08 131.72 56.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.556 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.664 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -119.59 124.07 45.47 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 65.1 m -120.53 142.11 49.63 Favored 'General case' 0 N--CA 1.462 0.141 0 O-C-N 120.954 -1.091 . . . . 0.0 108.24 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 26' ' ' SER . 28.2 ttm180 -99.74 144.6 28.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.294 168.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 p -60.75 3.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.837 175.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.585 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.32 -17.78 14.69 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.75 -175.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 71.3 23.68 77.79 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 t -119.86 105.27 10.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.646 0.26 . . . . 0.0 111.158 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.693 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.18 -64.23 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 -176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -3.79 4.38 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 178.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.576 ' H ' ' C ' ' A' ' 29' ' ' ILE . 6.7 m -97.85 -22.68 16.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.055 -1.884 . . . . 0.0 111.668 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -126.55 155.08 42.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -73.02 125.53 27.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.059 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.05 148.04 23.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.537 0.685 . . . . 0.0 110.779 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.428 ' OE1' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -141.45 169.97 16.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.182 -178.199 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.571 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 70.1 m95 -131.25 146.36 52.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.157 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.5 m-85 -132.9 149.04 52.29 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -127.5 135.55 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' NE2' ' O ' ' A' ' 40' ' ' ARG . 7.1 tm0? -130.26 143.48 50.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.489 0.661 . . . . 0.0 109.66 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.526 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 1.0 OUTLIER -144.55 158.24 54.21 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.061 -178.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.0 Cg_endo -52.08 130.84 36.69 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 121.817 1.678 . . . . 0.0 110.677 177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.61 -32.84 1.63 Allowed Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 41' ' ' PRO . 28.3 t -76.57 171.66 14.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 0.0 110.426 178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -121.82 156.18 59.44 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.318 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -52.87 124.05 14.53 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.313 2.009 . . . . 0.0 110.319 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 m -125.35 125.35 43.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.027 0.441 . . . . 0.0 110.666 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -65.39 119.97 11.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.383 177.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.8 t -96.92 -25.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.007 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.0 mt -144.34 135.3 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 64.7 t80 -125.77 164.36 20.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.761 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.6 tt0 45.91 22.41 0.13 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.357 -170.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 43.55 17.8 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.926 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.573 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -128.87 -46.76 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.205 0.526 . . . . 0.0 110.647 170.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.444 HE21 ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.13 154.48 17.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.27 -1.786 . . . . 0.0 107.82 -165.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.81 ' H ' HH11 ' A' ' 55' ' ' ARG . 0.0 OUTLIER -143.73 146.72 36.05 Favored Pre-proline 0 C--N 1.327 -0.374 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.257 178.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.44 145.48 88.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.389 1.392 . . . . 0.0 110.929 178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.3 m -62.07 -22.09 65.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.132 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -59.8 -44.14 97.29 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.2 142.18 24.98 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.369 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -61.15 143.18 98.63 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.479 1.453 . . . . 0.0 111.702 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.4 p30 -62.61 -2.83 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 176.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.622 ' NH1' ' CE1' ' A' ' 63' ' ' PHE . 28.8 ptt85 -47.01 -40.21 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.371 0.605 . . . . 0.0 110.576 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' CE1' ' NH1' ' A' ' 62' ' ' ARG . 97.9 m-85 -62.98 129.18 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.422 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 6.1 t -113.79 119.44 37.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.414 0.626 . . . . 0.0 110.909 -174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -108.2 112.47 3.59 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.134 -177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 75' ' ' SER . 7.3 p -149.61 167.48 26.25 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.51 0.671 . . . . 0.0 110.208 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -143.49 163.07 16.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.976 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 70' ' ' SER . 75.8 m-20 -98.77 152.75 19.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.518 175.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -68.35 31.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.687 175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 68' ' ' ASP . 30.1 m -104.12 -46.31 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.578 0.228 . . . . 0.0 110.565 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 85.43 25.08 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.473 -178.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.05 -37.34 9.02 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.066 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.641 ' C ' HD13 ' A' ' 29' ' ' ILE . 52.9 p -160.12 166.67 29.37 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.467 -0.493 . . . . 0.0 110.535 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.25 127.01 54.76 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.741 -1.224 . . . . 0.0 109.513 -178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.495 ' O ' ' O ' ' A' ' 66' ' ' SER . 0.0 OUTLIER -121.72 116.07 23.85 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 118.321 -0.847 . . . . 0.0 112.39 -172.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.772 ' O ' HG23 ' A' ' 19' ' ' THR . 0.6 OUTLIER -99.02 140.27 33.42 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 118.344 -2.722 . . . . 0.0 117.329 168.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 64' ' ' SER . 61.8 m -106.06 126.28 52.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 163.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.471 ' CD1' HD21 ' A' ' 76' ' ' LEU . 3.1 mt -97.51 112.54 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 O-C-N 119.798 -1.813 . . . . 0.0 110.918 170.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.642 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.6 OUTLIER -96.11 137.69 34.81 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 121.834 -0.541 . . . . 0.0 111.462 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 58.75 3.66 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.543 HD23 ' C ' ' A' ' 81' ' ' LEU . 0.4 OUTLIER -80.07 135.0 36.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.211 0.529 . . . . 0.0 110.478 177.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -134.36 176.44 8.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.714 174.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.5 p -47.65 -19.34 0.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' N ' ' C ' ' A' ' 82' ' ' LYS . 9.4 tp10 -70.53 -39.36 74.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.821 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.602 ' CB ' HH22 ' A' ' 62' ' ' ARG . 27.6 t0 -67.18 -7.09 20.99 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.116 -0.633 . . . . 0.0 110.399 -178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -62.41 130.62 46.02 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.89 175.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -85.03 144.77 28.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.474 175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.474 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 8.9 m-85 -108.91 154.21 22.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -150.49 145.48 26.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.727 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.571 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 59.4 m -120.28 141.01 50.38 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 5.7 mt-30 -124.45 145.39 49.54 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.445 ' OG ' ' CZ ' ' A' ' 24' ' ' ARG . 53.5 p -135.09 123.73 23.64 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 110.353 178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -159.25 131.67 6.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.589 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -99.22 -148.46 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.871 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.7 m -84.2 -26.52 28.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.615 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.43 35.85 0.51 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.334 -175.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.698 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.6 OUTLIER 51.44 -136.48 1.31 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.503 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.0 m170 48.71 82.13 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 0.0 110.4 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -101.16 138.34 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.199 0.523 . . . . 0.0 110.852 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.73 131.52 53.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.126 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.29 166.83 25.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.736 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 128.3 -139.24 10.91 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.415 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 45.12 29.67 2.36 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -176.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -54.13 158.11 5.61 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 51.9 m -126.06 130.09 50.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.845 0.355 . . . . 0.0 110.517 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -80.59 110.34 15.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.191 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.2 tp -99.39 124.81 44.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.19 124.37 46.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.092 0.472 . . . . 0.0 110.243 178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.419 ' O ' ' C ' ' A' ' 111' ' ' LEU . 61.2 t -87.63 94.43 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.452 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 110' ' ' VAL . 8.1 mt . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.234 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.495 ' ND2' ' N ' ' A' ' 2' ' ' PHE . 11.1 p-10 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.495 ' N ' ' ND2' ' A' ' 1' ' ' ASN . 72.7 m-85 -84.41 133.85 34.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.51 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.451 ' C ' HD12 ' A' ' 4' ' ' LEU . 16.8 mmm -146.96 168.45 21.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 110.308 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.451 HD12 ' C ' ' A' ' 3' ' ' MET . 7.7 mp -123.63 107.98 12.09 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 176.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.1 m -78.19 113.51 16.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.074 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.635 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 52.4 mt-30 -140.37 158.21 66.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.451 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -54.18 140.99 71.12 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.93 1.753 . . . . 0.0 110.38 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -49.25 70.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.18 129.0 2.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.065 -178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.562 HG22 ' N ' ' A' ' 11' ' ' SER . 7.4 p -139.28 161.99 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.155 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.562 ' N ' HG22 ' A' ' 10' ' ' VAL . 94.1 p -143.43 155.53 44.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.624 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -140.31 153.17 46.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.074 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.26 141.98 74.62 Favored Pre-proline 0 C--N 1.33 -0.258 0 C-N-CA 120.301 -0.559 . . . . 0.0 110.195 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -52.94 115.28 2.16 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.715 1.61 . . . . 0.0 111.246 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.37 1.03 33.13 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -98.06 161.51 13.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.942 0.401 . . . . 0.0 110.815 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.8 p -93.0 134.35 35.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.9 137.46 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.582 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -118.64 134.18 55.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.322 178.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.1 mt -99.81 137.06 28.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.426 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 m -111.62 116.68 31.2 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.578 ' HB2' HE21 ' A' ' 6' ' ' GLN . 17.5 t -118.92 113.04 20.41 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -178.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.4 m -114.79 140.78 48.64 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 26' ' ' SER . 31.8 ttp180 -92.56 136.83 32.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.445 -0.798 . . . . 0.0 108.999 171.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 p -59.05 3.74 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.611 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.645 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.79 -18.06 14.38 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.678 -174.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.85 20.05 76.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.0 m -123.07 109.62 14.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.979 0.39 . . . . 0.0 110.773 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.773 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -135.17 -62.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.4 -176.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.773 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.22 0.39 1.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.642 ' H ' ' C ' ' A' ' 29' ' ' ILE . 91.5 p -109.82 -3.13 16.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.347 -1.751 . . . . 0.0 111.566 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -135.9 158.5 44.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.124 0.487 . . . . 0.0 110.874 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.43 129.18 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.419 ' HA ' HE21 ' A' ' 35' ' ' GLN . 81.9 t -123.14 148.06 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.607 0.718 . . . . 0.0 110.728 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.527 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -138.99 153.93 48.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.07 -0.968 . . . . 0.0 110.151 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -110.3 135.13 51.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 11.4 m-85 -129.17 147.54 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.324 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.421 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -134.38 133.07 40.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.128 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -112.48 116.14 29.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.515 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.03 -173.83 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -69.72 125.62 12.38 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 CA-C-N 120.449 1.196 . . . . 0.0 110.094 -172.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.25 -36.12 0.25 Allowed Glycine 0 CA--C 1.528 0.854 0 CA-C-N 112.876 -1.965 . . . . 0.0 114.927 166.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.7 m -159.38 92.15 1.05 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.155 1.977 . . . . 0.0 114.477 171.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m -170.77 91.89 0.47 Allowed Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 118.07 -1.452 . . . . 0.0 111.727 170.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -76.75 135.39 15.9 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.84 2.36 . . . . 0.0 111.431 174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.4 p -146.93 105.4 3.8 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.757 -0.59 . . . . 0.0 111.003 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.495 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 25.8 m -63.38 120.23 11.22 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.878 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.62 -28.3 3.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.735 -176.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.4 149.95 16.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' O ' ' N ' ' A' ' 52' ' ' ASP . 6.2 t80 -134.76 164.04 28.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.793 175.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.37 23.87 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.569 1.176 . . . . 0.0 110.754 -173.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.7 p30 44.35 19.78 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.587 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.551 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -127.85 -45.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 171.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.673 ' N ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -53.54 134.89 40.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.279 -170.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -137.39 108.65 8.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -70.06 152.8 67.9 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.853 1.702 . . . . 0.0 112.013 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.6 p -70.78 -33.12 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.375 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.23 -47.7 79.97 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 59' ' ' VAL . 3.8 m -90.68 132.52 34.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.1 Cg_exo -59.3 142.07 98.62 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.462 1.441 . . . . 0.0 111.117 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.549 ' C ' ' H ' ' A' ' 63' ' ' PHE . 49.9 p-10 -61.21 1.65 0.17 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.566 HH22 ' CG ' ' A' ' 85' ' ' ASP . 8.4 ptm180 -49.69 -2.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 61' ' ' ASP . 17.3 m-85 -107.98 146.44 32.47 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.3 t -130.39 121.03 25.17 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.893 178.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -107.79 123.16 7.05 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-N 113.408 -1.724 . . . . 0.0 110.345 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.6 p -158.81 164.51 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.426 -0.455 . . . . 0.0 110.2 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.652 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -135.08 159.92 41.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.589 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' C ' ' H ' ' A' ' 70' ' ' SER . 30.7 m-20 -96.66 144.18 26.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.948 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.9 p -70.13 27.22 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.008 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 68' ' ' ASP . 21.2 m -102.23 -36.76 8.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.015 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 82.21 22.73 0.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.234 -177.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -95.8 -43.71 7.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.754 -176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.703 ' O ' HD13 ' A' ' 29' ' ' ILE . 95.0 p -162.1 174.86 12.38 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.009 -179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.9 126.78 55.07 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.331 -1.48 . . . . 0.0 110.573 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 66' ' ' SER . 19.9 m -118.23 112.31 19.95 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.569 -171.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -97.02 140.75 31.08 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 168.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.485 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.4 m -110.52 128.25 55.55 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 163.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.424 HG13 HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.0 109.95 29.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 119.812 -1.805 . . . . 0.0 110.666 173.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -98.65 141.25 31.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.555 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.82 32.99 35.0 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.423 HD21 HG13 ' A' ' 110' ' ' VAL . 2.3 tt -55.8 145.79 23.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.987 0.422 . . . . 0.0 110.318 176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' ASP . 6.6 tttp -160.66 177.87 10.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.355 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.9 t -46.01 -19.83 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 82' ' ' LYS . 77.4 mt-10 -71.85 -40.02 69.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.367 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.566 ' CG ' HH22 ' A' ' 62' ' ' ARG . 18.9 t70 -70.32 -13.12 62.02 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.173 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 32.9 tt0 -58.23 123.14 15.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.6 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.0 178.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.135 0.493 . . . . 0.0 109.942 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.07 146.38 25.48 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.726 177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.2 m-85 -121.88 146.27 47.27 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.995 0.426 . . . . 0.0 111.083 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 3.1 m-85 -141.72 149.18 40.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.17 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.635 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 p -124.85 140.87 52.53 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.527 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 23.5 mt-30 -116.83 140.06 49.88 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 110.174 173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 101' ' ' VAL . 60.9 p -135.07 119.69 18.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.016 0.436 . . . . 0.0 109.896 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' HA ' HG11 ' A' ' 100' ' ' VAL . 32.2 p90 -158.96 153.91 25.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.123 175.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -128.62 -146.54 0.32 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.655 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.92 -22.74 15.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.288 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.9 p -82.63 14.07 3.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.3 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.404 ' O ' ' C ' ' A' ' 99' ' ' HIS . 1.1 m120 44.69 -136.17 0.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.35 -176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 98' ' ' ASN . 75.6 m80 37.2 70.12 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.229 0.538 . . . . 0.0 110.825 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.674 HG22 ' H ' ' A' ' 101' ' ' VAL . 1.8 p -160.3 -171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.253 -172.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.674 ' H ' HG22 ' A' ' 100' ' ' VAL . 1.3 m -155.37 -179.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.663 0.744 . . . . 0.0 111.619 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -157.22 151.63 25.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.235 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 144.93 -129.8 3.65 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.456 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 84.92 62.57 1.67 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -76.11 110.14 2.96 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.1 m -117.16 118.89 33.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 110.394 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.4 tttm -78.44 116.75 19.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.986 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.8 tp -110.71 126.53 54.64 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.8 m -118.97 133.67 55.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.391 178.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.72 ' O ' HG12 ' A' ' 110' ' ' VAL . 79.2 t -86.03 45.44 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.228 0.537 . . . . 0.0 110.587 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.698 -1.144 . . . . 0.0 110.874 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.64 ' N ' HD22 ' A' ' 1' ' ' ASN . 54.1 m-85 -118.08 127.85 54.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.023 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.8 mmm -128.73 170.03 13.8 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.555 HD21 HH21 ' A' ' 24' ' ' ARG . 0.4 OUTLIER -130.87 102.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.1 m -91.43 138.41 31.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.69 -177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.476 ' OE1' ' O ' ' A' ' 104' ' ' GLY . 15.1 mt-30 -143.87 160.12 51.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -50.31 128.53 23.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.925 1.75 . . . . 0.0 111.023 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' CD2' ' H ' ' A' ' 9' ' ' SER . 3.7 p-80 -45.21 -59.24 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.149 0.5 . . . . 0.0 110.413 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.625 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 83.2 p -164.67 162.71 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.588 178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.506 HG22 ' N ' ' A' ' 11' ' ' SER . 3.0 p -162.42 161.27 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.029 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.506 ' N ' HG22 ' A' ' 10' ' ' VAL . 84.1 p -143.2 149.74 38.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.616 178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -141.1 153.15 45.3 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.56 147.89 82.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.566 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.76 119.7 7.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.628 1.552 . . . . 0.0 111.368 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.6 -3.25 26.23 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -98.27 -170.26 1.94 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.541 0.21 . . . . 0.0 110.967 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.5 p -127.26 150.47 49.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.732 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.56 147.82 20.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.886 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -121.69 134.23 54.96 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 94.1 mt -108.83 140.08 28.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.671 177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -108.38 142.64 38.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.507 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.13 111.63 12.13 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.3 m -119.64 140.5 50.52 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.562 -1.336 . . . . 0.0 108.099 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.66 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -107.27 145.0 33.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.238 171.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -57.86 4.3 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.546 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.66 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -105.03 -18.18 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.701 -175.281 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 78.67 -32.16 1.91 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 14.7 m -68.4 110.05 3.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.548 0.213 . . . . 0.0 111.298 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.754 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.17 -62.43 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.754 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.77 -0.9 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.627 ' H ' ' C ' ' A' ' 29' ' ' ILE . 10.7 p -98.91 -25.29 14.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.804 -179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 28' ' ' SER . 29.1 p30 -121.26 147.3 45.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -71.39 144.45 49.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.624 -177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.48 137.79 55.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.242 0.544 . . . . 0.0 110.198 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.555 ' OE1' ' NE2' ' A' ' 92' ' ' GLN . 4.1 pt20 -120.9 152.18 38.78 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 46.4 m95 -122.28 133.07 54.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.031 0.443 . . . . 0.0 110.146 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.9 m-85 -130.1 149.08 51.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.826 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.589 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -117.96 135.69 53.98 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -122.29 134.07 54.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.276 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.459 ' HE ' ' HB2' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -147.28 156.21 46.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -55.49 129.4 34.92 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.808 1.672 . . . . 0.0 111.129 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.33 -7.21 18.68 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.7 m -113.18 126.11 55.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.268 . . . . 0.0 110.333 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.62 164.72 54.24 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -54.41 131.07 43.29 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.289 1.993 . . . . 0.0 111.022 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 37.8 p -121.66 120.51 34.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.646 0.26 . . . . 0.0 110.381 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.52 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 10.4 m -62.01 117.72 6.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.831 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.73 -28.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.64 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 mt -145.22 136.63 20.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 51' ' ' GLU . 11.0 t80 -125.01 166.23 16.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.706 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' ASN . 1.4 tt0 44.81 22.45 0.06 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.145 -171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.6 p-10 42.9 18.03 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.167 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.48 -47.18 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.183 0.516 . . . . 0.0 111.129 168.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.605 HE21 ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -96.06 150.77 20.12 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 113.242 -1.799 . . . . 0.0 108.594 -167.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.34 148.32 65.71 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.14 147.6 95.21 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 121.723 1.616 . . . . 0.0 110.929 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 m -67.76 -14.91 63.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -46.28 70.2 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.1 m -93.67 141.08 23.35 Favored Pre-proline 0 C--N 1.331 -0.236 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -60.01 139.32 87.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 121.259 1.306 . . . . 0.0 111.631 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -61.17 0.95 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.601 HH12 ' CB ' ' A' ' 85' ' ' ASP . 8.8 ptm180 -47.16 -24.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.149 -175.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CE1' ' CG ' ' A' ' 62' ' ' ARG . 23.5 m-85 -88.6 142.95 27.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -128.03 124.22 36.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 119.216 -0.421 . . . . 0.0 111.084 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -109.88 124.42 7.16 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.679 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 53.3 p -154.97 166.07 34.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.212 0.529 . . . . 0.0 111.355 -178.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.6 pp -146.38 153.76 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -99.85 157.19 16.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.777 -1.101 . . . . 0.0 112.111 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 80.7 p -70.3 -8.44 50.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.087 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.0 m -60.38 -40.82 92.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.801 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' O ' ' O ' ' A' ' 27' ' ' GLY . 0.9 OUTLIER 79.0 25.76 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.284 -179.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -97.48 -42.15 7.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.598 -176.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.661 ' HA ' HG21 ' A' ' 29' ' ' ILE . 73.1 p -165.33 171.32 13.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.054 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.52 127.13 55.04 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 120.936 -1.103 . . . . 0.0 110.442 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 28.9 m -119.42 117.98 29.91 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 117.813 -1.089 . . . . 0.0 112.954 -169.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -97.54 140.59 31.74 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 118.651 -2.53 . . . . 0.0 117.217 168.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.479 ' O ' ' CB ' ' A' ' 64' ' ' SER . 75.8 m -111.49 127.72 55.79 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 162.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.507 HG23 HH21 ' A' ' 62' ' ' ARG . 3.0 mt -99.9 112.35 32.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 O-C-N 120.048 -1.657 . . . . 0.0 109.951 174.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.1 t -96.85 135.59 38.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.479 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.01 49.22 6.1 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.4 tt -71.66 137.86 48.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.064 0.459 . . . . 0.0 110.633 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.454 ' C ' ' N ' ' A' ' 84' ' ' GLU . 21.2 tttt -144.7 176.93 9.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.905 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.46 ' H ' HG23 ' A' ' 83' ' ' THR . 1.5 p -46.84 -20.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.662 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' N ' ' C ' ' A' ' 82' ' ' LYS . 26.2 tt0 -72.7 -39.05 67.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.008 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.601 ' CB ' HH12 ' A' ' 62' ' ' ARG . 6.4 t70 -67.63 -6.9 22.53 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.691 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 62.8 tt0 -63.35 124.65 21.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.534 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.28 -178.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.056 0.455 . . . . 0.0 110.552 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -87.14 136.72 32.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.675 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.589 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 27.8 m-85 -116.32 135.75 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.742 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 4.2 p90 -149.26 149.06 30.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.953 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.04 151.49 41.89 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.962 0.505 . . . . 0.0 110.924 -177.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.555 ' NE2' ' OE1' ' A' ' 35' ' ' GLN . 18.7 mt-30 -123.56 147.69 47.05 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 122.213 -0.304 . . . . 0.0 111.338 168.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' NE ' ' A' ' 24' ' ' ARG . 13.7 t -135.25 159.99 39.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.681 0.276 . . . . 0.0 111.587 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -157.73 132.62 8.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.669 176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.84 174.99 6.68 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.27 -37.44 23.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.905 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.46 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 45.9 m -79.28 39.9 0.4 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.365 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.644 ' N ' HD22 ' A' ' 98' ' ' ASN . 1.1 m120 58.57 -87.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.442 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.46 ' CD2' ' O ' ' A' ' 97' ' ' SER . 58.8 m170 40.02 78.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.04 0.448 . . . . 0.0 111.131 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 100' ' ' VAL . 1.3 m -87.15 117.48 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.159 0.504 . . . . 0.0 109.978 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.2 m -134.14 145.94 32.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.147 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -136.31 144.56 44.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 164.05 -161.89 34.74 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.069 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 96.04 34.3 5.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -59.8 95.01 0.07 OUTLIER Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 89.2 m -111.27 114.58 27.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.122 0.487 . . . . 0.0 109.798 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -80.25 108.66 14.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.422 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.8 tp -102.36 126.0 49.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.552 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.6 m -120.72 124.86 46.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.319 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.723 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.9 t -89.57 34.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.112 0.482 . . . . 0.0 110.19 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.22 -0.495 0 CA-C-O 117.695 -1.145 . . . . 0.0 110.44 179.288 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 2' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.577 ' N ' HD22 ' A' ' 1' ' ' ASN . 35.8 m-85 -83.55 161.52 21.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 4' ' ' LEU . 17.5 mtp -138.89 169.61 17.48 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 3' ' ' MET . 7.2 mp -132.77 104.78 6.78 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -78.93 126.06 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.177 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.616 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 6.8 mt-30 -145.42 164.46 26.28 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -55.83 127.21 25.16 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.135 1.89 . . . . 0.0 110.737 178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 5.8 p80 -57.74 -52.18 66.5 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 68.2 p -165.12 135.39 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.083 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -150.58 154.96 7.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.317 . . . . 0.0 110.398 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.7 p -138.45 137.58 37.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.998 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 31.3 mp0 -128.38 162.49 26.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.024 0.44 . . . . 0.0 110.323 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.0 m -78.52 146.31 69.43 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.607 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.88 125.93 19.04 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.117 1.211 . . . . 0.0 111.57 175.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.85 -4.2 28.97 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -95.34 171.69 8.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.142 0.496 . . . . 0.0 110.967 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 7.1 p -115.31 130.88 57.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.413 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -127.79 134.66 64.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.583 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -110.02 128.42 55.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.291 177.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.5 mm -98.44 145.06 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.083 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 m -117.59 116.68 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.318 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.55 ' HB2' HE21 ' A' ' 6' ' ' GLN . 42.0 t -118.84 112.28 19.49 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.1 m -116.02 137.6 51.97 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 121.078 -1.014 . . . . 0.0 108.28 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.65 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -91.68 142.77 27.25 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.607 170.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.9 t -57.88 2.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.65 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -104.68 -16.94 14.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.538 -174.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.99 -50.39 4.28 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.103 -0.799 . . . . 0.0 111.103 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 75.0 p -54.28 113.88 1.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.754 0.312 . . . . 0.0 111.166 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.79 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.4 pp -135.34 -61.97 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.181 -177.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.79 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.5 -0.53 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 5.9 m -107.01 -18.99 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 113.623 -1.626 . . . . 0.0 111.798 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.506 ' ND2' ' NH2' ' A' ' 24' ' ' ARG . 38.5 m-20 -116.87 147.82 41.83 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -176.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -78.88 132.41 36.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.489 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -120.73 146.32 25.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.11 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.423 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 8.5 pt20 -123.64 163.1 21.71 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 30.3 m95 -131.51 131.92 43.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 0.0 110.637 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 7.6 m-85 -126.32 149.39 49.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.9 139.98 53.46 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -141.83 141.26 33.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.707 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -167.29 156.19 9.17 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.252 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.48 135.39 67.38 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.633 1.555 . . . . 0.0 110.916 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.0 -2.0 75.06 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.0 m -151.26 138.8 19.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.734 0.302 . . . . 0.0 110.521 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -82.53 165.47 41.99 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.074 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -59.06 135.46 66.52 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.003 1.802 . . . . 0.0 110.805 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -132.77 137.7 46.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.774 0.321 . . . . 0.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.48 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 7.6 m -73.27 120.25 18.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.528 177.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.85 -28.0 3.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.141 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.1 mt -145.28 149.27 16.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' O ' ' N ' ' A' ' 52' ' ' ASP . 37.5 t80 -133.94 163.62 29.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.182 174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.2 tt0 45.37 23.82 0.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.686 0.755 . . . . 0.0 110.827 -173.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' TYR . 10.6 t70 44.73 19.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.594 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.534 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.83 -46.4 1.41 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.861 170.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.599 ' N ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -52.72 134.11 36.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.031 -1.44 . . . . 0.0 109.498 -167.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.731 ' NH1' ' H ' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -123.59 108.8 30.93 Favored Pre-proline 0 CA--C 1.531 0.221 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 177.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -65.66 136.81 47.47 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 121.618 1.546 . . . . 0.0 111.756 175.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.7 m -63.93 -34.48 78.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.14 -57.81 12.25 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.3 m -84.08 150.36 58.03 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.8 Cg_endo -61.55 135.45 57.05 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.067 1.178 . . . . 0.0 111.219 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.79 -0.63 0.3 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.488 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 52.0 mtm180 -48.37 -38.44 19.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.727 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -71.72 134.84 46.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.421 -0.512 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.9 t -124.12 122.71 38.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.797 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.731 ' H ' ' NH1' ' A' ' 55' ' ' ARG . . . -107.74 118.9 5.61 Favored Glycine 0 CA--C 1.525 0.697 0 CA-C-N 113.593 -1.64 . . . . 0.0 110.627 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 75' ' ' SER . 24.6 p -155.41 164.03 39.27 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.935 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.687 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -146.0 157.63 12.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 -176.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -103.03 153.17 20.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.378 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 m -68.4 1.87 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.042 175.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.2 m -65.95 -43.97 86.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.913 177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.62 27.57 0.35 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.543 -177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.38 -41.09 8.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.943 -178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.723 ' O ' HD13 ' A' ' 29' ' ' ILE . 94.4 p -166.7 175.34 7.96 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.767 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -104.78 125.51 50.91 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 120.812 -1.18 . . . . 0.0 109.881 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.412 ' O ' ' O ' ' A' ' 66' ' ' SER . 1.6 m -115.84 112.73 22.37 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 118.24 -0.886 . . . . 0.0 112.744 -175.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -98.3 140.53 32.43 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 170.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 64' ' ' SER . 89.3 m -107.72 126.7 52.93 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 163.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.472 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.7 mt -105.8 105.33 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 O-C-N 120.398 -1.439 . . . . 0.0 110.737 173.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 29.6 t -95.45 154.38 17.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.35 -0.386 . . . . 0.0 112.008 177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.04 32.37 76.78 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 176.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' CD1' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -54.21 128.01 29.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.14 0.495 . . . . 0.0 109.667 176.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' O ' ' N ' ' A' ' 84' ' ' GLU . 18.9 mttp -139.48 171.1 14.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.055 177.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.3 t -45.94 -18.73 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.648 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.567 ' N ' ' O ' ' A' ' 82' ' ' LYS . 39.9 mt-10 -69.31 -38.56 78.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.529 177.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 2.2 m-20 -73.26 -11.34 60.47 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.241 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 70.5 tt0 -52.92 120.75 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.543 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.94 173.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -86.91 144.87 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.798 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -113.18 153.07 28.89 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -149.95 147.84 28.37 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.222 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 8.6 p -132.94 142.8 49.07 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.023 0.529 . . . . 0.0 109.972 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -128.89 147.31 50.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.801 0.334 . . . . 0.0 111.108 174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.422 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 9.0 t -135.24 160.84 37.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.1 0.476 . . . . 0.0 111.226 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' CD2' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -158.42 136.61 10.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.56 179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' OD1' ' NH1' ' A' ' 24' ' ' ARG . 13.6 m-20 -97.73 177.34 5.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.985 0.421 . . . . 0.0 110.982 178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 98' ' ' ASN . 4.7 t -60.56 -38.67 85.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.06 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.8 m -76.17 32.47 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.578 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.46 ' H ' ' C ' ' A' ' 96' ' ' SER . 3.3 m120 67.34 -124.86 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.478 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 56.74 76.32 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.792 0.33 . . . . 0.0 110.643 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -89.19 122.3 40.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.122 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.15 156.21 40.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.283 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -134.08 160.67 37.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.007 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 167.82 -142.86 7.78 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.73 27.61 56.52 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -65.55 110.08 3.27 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.5 m -137.13 127.83 27.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.692 0.282 . . . . 0.0 110.286 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -88.42 99.36 12.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.018 0.437 . . . . 0.0 110.947 178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.404 HD21 ' CD1' ' A' ' 81' ' ' LEU . 19.9 tp -91.08 123.67 34.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 176.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -120.77 122.36 40.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.371 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.698 ' O ' HG12 ' A' ' 110' ' ' VAL . 80.6 t -82.11 40.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.607 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 C--O 1.221 -0.404 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.069 178.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.57 HD22 ' N ' ' A' ' 2' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.57 ' N ' HD22 ' A' ' 1' ' ' ASN . 17.9 m-85 -114.07 160.31 19.05 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.202 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.1 mtt -129.4 169.98 14.24 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 22' ' ' CYS . 0.5 OUTLIER -133.22 102.95 5.76 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.5 p -86.4 135.6 33.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.379 -177.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.537 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 30.7 mt-30 -146.19 163.14 31.91 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.715 176.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -54.51 140.38 74.91 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 121.534 1.49 . . . . 0.0 111.021 -177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.15 -69.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.257 179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 p -161.27 155.2 22.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.792 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 11' ' ' SER . 4.7 p -162.11 161.01 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.787 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.547 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 p -128.65 151.47 49.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.419 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -135.21 143.83 46.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 110.401 -177.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.57 138.05 86.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.88 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -58.48 113.24 1.46 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 121.377 1.385 . . . . 0.0 111.297 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.02 -8.23 16.39 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 176.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.1 mtpt -93.05 -177.31 4.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.276 0.56 . . . . 0.0 111.262 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.573 HG22 ' HA ' ' A' ' 79' ' ' SER . 4.1 p -111.18 140.75 45.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.131 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.6 p -137.41 138.63 44.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.547 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 76' ' ' LEU . 3.5 m -119.44 129.86 54.97 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -110.92 134.0 54.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.469 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -100.53 166.3 10.99 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.298 178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -151.33 111.85 4.19 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.972 HG23 HH21 ' A' ' 24' ' ' ARG . 19.7 m -115.89 136.22 53.25 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 120.903 -1.123 . . . . 0.0 108.065 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.972 HH21 HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER -104.02 143.1 33.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.154 171.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -58.63 5.07 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.467 176.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.37 -18.15 14.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.06 -173.317 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 68.63 29.06 72.78 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.404 ' H ' ' CD ' ' A' ' 24' ' ' ARG . 54.0 m -128.94 98.9 5.09 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.419 0.609 . . . . 0.0 111.864 -175.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.75 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -126.28 -62.27 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 122.584 0.354 . . . . 0.0 111.009 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.15 1.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 29' ' ' ILE . 35.6 t -114.11 -28.02 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 113.917 -1.492 . . . . 0.0 112.027 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -112.99 139.85 48.31 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -70.9 130.67 42.24 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.87 141.34 44.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.552 0.691 . . . . 0.0 110.667 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.427 ' NE2' ' O ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -128.26 150.46 50.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.619 178.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -106.22 121.0 43.29 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.407 ' OH ' ' OG1' ' A' ' 47' ' ' THR . 2.2 m-85 -112.38 148.63 33.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.573 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.05 133.44 41.19 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 43' ' ' SER . 2.3 tm0? -125.45 135.03 51.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.355 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.513 ' NH2' ' O ' ' A' ' 41' ' ' PRO . 1.0 OUTLIER -133.68 135.04 24.2 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 5.3 Cg_exo -55.47 137.44 77.62 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.184 1.256 . . . . 0.0 110.776 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.51 -16.26 57.97 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' NE2' ' A' ' 39' ' ' GLN . 4.5 t -144.23 161.74 38.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.608 0.242 . . . . 0.0 110.381 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.401 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -81.97 178.09 2.63 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.095 -177.228 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.8 Cg_exo -72.68 156.35 53.46 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.559 2.173 . . . . 0.0 111.513 178.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.2 p -137.59 121.27 17.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.958 0.409 . . . . 0.0 110.349 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.407 ' OG1' ' OH ' ' A' ' 37' ' ' TYR . 3.4 m -62.29 121.42 13.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.965 177.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.676 ' HA ' HG21 ' A' ' 59' ' ' VAL . 2.5 t -101.16 -28.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.318 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 mt -145.86 140.73 21.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' O ' ' N ' ' A' ' 52' ' ' ASP . 5.9 t80 -127.3 164.14 22.41 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 176.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER 44.59 22.15 0.05 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 122.009 0.909 . . . . 0.0 110.389 -170.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.9 OUTLIER 43.04 18.06 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.386 -1.279 . . . . 0.0 108.545 -179.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.564 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.23 -46.91 1.21 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.907 0.384 . . . . 0.0 111.52 172.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 54' ' ' GLN . 0.6 OUTLIER -80.06 131.37 35.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.712 -165.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.439 ' NH1' ' O ' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -108.57 111.68 61.11 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-O 118.877 -0.583 . . . . 0.0 109.465 -174.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -62.04 145.52 96.57 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.633 1.556 . . . . 0.0 112.176 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -69.41 -20.35 63.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.772 175.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.83 -31.32 67.68 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.676 HG21 ' HA ' ' A' ' 48' ' ' VAL . 16.7 m -124.2 141.82 38.33 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 110.578 -0.156 . . . . 0.0 110.578 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.8 Cg_exo -60.41 140.33 91.06 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.268 1.312 . . . . 0.0 111.412 -178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 12.3 p-10 -61.04 0.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.607 HH22 ' CB ' ' A' ' 85' ' ' ASP . 41.7 ptt85 -47.42 -24.9 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.331 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 90.8 m-85 -78.47 150.26 33.03 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.8 t -127.83 122.88 33.77 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.435 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.45 121.54 5.52 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 113.753 -1.567 . . . . 0.0 110.546 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 53.3 p -158.98 158.25 32.88 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.663 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -138.7 160.32 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.449 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 97.8 m-20 -103.63 152.9 21.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.769 177.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 m -72.61 27.89 0.06 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.14 174.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 3.5 m -97.98 -40.64 8.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.226 177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.97 27.15 0.43 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.015 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.604 ' O ' ' NH2' ' A' ' 24' ' ' ARG . 39.8 t30 -99.32 -33.67 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.561 -173.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.429 ' O ' HD13 ' A' ' 29' ' ' ILE . 24.8 p -176.9 170.8 2.26 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 124.013 0.821 . . . . 0.0 110.185 178.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.4 133.78 52.94 Favored 'General case' 0 C--N 1.331 -0.207 0 O-C-N 121.153 -0.967 . . . . 0.0 109.857 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.9 m -127.37 112.56 15.16 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 118.088 -0.958 . . . . 0.0 113.192 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.763 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.13 140.59 31.4 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 168.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 91.5 m -107.83 131.25 54.68 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.219 -0.926 . . . . 0.0 113.401 163.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 76' ' ' LEU . 5.0 mt -106.87 110.65 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 O-C-N 120.163 -1.586 . . . . 0.0 110.37 174.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.573 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.2 t -97.51 139.38 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.279 175.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.06 45.86 8.01 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.45 143.65 51.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.09 0.471 . . . . 0.0 110.525 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' ASP . 10.4 mtpt -153.14 173.18 15.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.686 179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 t -45.88 -20.07 0.08 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.579 176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 82' ' ' LYS . 48.7 mt-10 -69.38 -40.1 77.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.978 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.607 ' CB ' HH22 ' A' ' 62' ' ' ARG . 4.3 t0 -70.38 -10.44 59.06 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.211 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 56.4 tt0 -61.13 122.83 16.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.082 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.92 179.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 109.856 178.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -87.31 148.02 25.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.911 176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.438 ' OH ' ' CG ' ' A' ' 85' ' ' ASP . 17.7 m-85 -115.52 145.79 42.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.456 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 12.5 m-85 -144.19 150.35 37.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.002 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.519 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -118.93 142.45 47.76 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' O ' ' NE2' ' A' ' 35' ' ' GLN . 51.9 tt0 -126.54 121.77 33.23 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.81 -0.556 . . . . 0.0 110.937 172.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.516 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -135.15 -176.82 4.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.723 0.297 . . . . 0.0 110.619 -177.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.516 ' CD1' ' O ' ' A' ' 93' ' ' SER . 1.6 m-85 -142.85 130.9 21.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.61 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 96' ' ' SER . 37.5 t0 -126.4 -145.8 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.985 176.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.526 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -49.46 -13.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.635 -177.443 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 95' ' ' ASP . 10.3 t -83.45 5.25 24.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.569 -177.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 97' ' ' SER . 0.0 OUTLIER 46.1 102.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.082 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.451 ' O ' HG23 ' A' ' 100' ' ' VAL . 11.7 m-70 62.92 31.01 16.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.198 174.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 99' ' ' HIS . 54.5 t -150.89 111.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 O-C-N 121.681 -0.637 . . . . 0.0 112.382 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 93' ' ' SER . 1.2 t -177.55 139.93 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 166.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -159.33 151.13 20.55 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.118 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.86 169.37 21.43 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 123.08 18.11 3.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -52.29 85.93 0.01 OUTLIER Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.496 -1.041 . . . . 0.0 110.496 177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.4 m -112.24 130.36 55.96 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 122.672 -0.31 . . . . 0.0 110.242 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -90.08 110.83 21.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -177.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 34.7 tp -104.9 124.75 50.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.099 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 23.3 m -116.8 123.54 47.36 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.3 t -90.71 99.98 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.231 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.084 -0.96 . . . . 0.0 111.121 179.005 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 25' ' ' SER . 1.5 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 15.8 p90 -160.44 96.02 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.865 -178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.0 mtt -151.95 170.11 20.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 105.97 6.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 m -89.58 131.61 35.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.115 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.693 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 2.7 mt-30 -146.07 169.87 8.89 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -65.78 136.55 45.99 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.433 1.422 . . . . 0.0 111.367 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.506 ' C ' ' ND1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -48.21 -76.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.765 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 p -155.38 149.16 25.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.888 -0.597 . . . . 0.0 109.993 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -159.46 160.61 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.166 -178.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' N ' HG22 ' A' ' 10' ' ' VAL . 88.5 p -129.77 146.84 51.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.335 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' OE2' ' O ' ' A' ' 11' ' ' SER . 2.1 mp0 -130.53 162.93 28.16 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.45 140.86 22.55 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.42 117.48 4.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.418 1.412 . . . . 0.0 111.231 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.2 -11.41 14.61 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -91.01 159.97 15.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.09 0.472 . . . . 0.0 110.701 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 72.4 p -98.13 148.63 23.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.86 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.69 141.2 23.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.618 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.844 HG23 ' O ' ' A' ' 76' ' ' LEU . 55.5 m -119.92 129.72 54.48 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.7 mt -101.04 134.93 39.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.17 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -111.11 126.48 54.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.057 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.693 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.28 113.35 21.34 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 177.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 54.8 m -109.44 135.34 50.63 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.678 ' C ' ' H ' ' A' ' 26' ' ' SER . 19.3 ttp85 -97.49 141.15 30.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.223 171.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.491 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 27.3 t -57.23 3.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.991 176.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.678 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -103.06 -11.9 17.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.765 -173.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.48 5.89 25.26 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 m -125.3 111.87 15.7 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 122.366 0.267 . . . . 0.0 110.434 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.681 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.8 pp -124.31 -57.09 2.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.681 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -65.23 -2.58 3.08 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 14.5 m -89.14 -35.0 16.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 111.603 -2.544 . . . . 0.0 111.479 176.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.578 ' ND2' HH21 ' A' ' 24' ' ' ARG . 4.0 m-80 -116.83 152.94 33.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -75.16 140.93 43.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.037 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 67.9 t -126.13 148.02 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.958 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -129.38 147.15 51.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.903 178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.484 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 23.0 m95 -111.1 122.63 48.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.759 0.314 . . . . 0.0 110.296 178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.551 ' CE1' ' N ' ' A' ' 47' ' ' THR . 2.4 m-85 -123.91 144.96 49.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.587 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -147.19 143.9 28.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.279 177.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.548 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 2.9 tp-100 -107.07 142.52 36.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 176.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -135.78 146.57 57.65 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.91 177.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.24 152.52 65.75 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 121.574 1.516 . . . . 0.0 111.31 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.08 2.7 58.97 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.86 157.01 34.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.95 0.405 . . . . 0.0 110.421 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.415 ' HA ' HE22 ' A' ' 39' ' ' GLN . 0.1 OUTLIER -82.74 179.84 1.77 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.245 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.65 150.41 56.72 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.522 2.148 . . . . 0.0 112.026 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -148.9 135.3 19.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.652 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.551 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -64.93 129.29 39.19 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.45 -25.23 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.99 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.473 HD11 ' CB ' ' A' ' 63' ' ' PHE . 19.7 mt -145.01 133.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 54' ' ' GLN . 4.0 t80 -122.25 167.33 13.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.447 174.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' A' ' 53' ' ' ASN . 1.4 tp10 44.77 22.57 0.06 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.712 0.768 . . . . 0.0 111.419 -171.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER 43.16 18.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.05 -179.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.584 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -129.22 -47.01 1.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.22 0.533 . . . . 0.0 110.847 170.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.456 ' O ' ' N ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER -96.79 159.07 15.12 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.258 -167.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.432 ' NE ' ' OD2' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -140.41 149.88 59.07 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.51 157.63 22.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.584 1.523 . . . . 0.0 111.226 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.8 p -73.98 -7.19 51.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.456 177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.58 -28.18 48.49 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 59' ' ' VAL . 29.5 m -113.02 131.34 22.86 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -175.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 62' ' ' ARG . 1.9 Cg_endo -61.62 140.1 84.81 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 120.982 1.121 . . . . 0.0 111.021 -175.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.432 ' OD2' ' NE ' ' A' ' 55' ' ' ARG . 2.8 m-20 -61.25 1.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.637 HH22 ' CB ' ' A' ' 85' ' ' ASP . 22.7 ptt85 -42.1 -25.7 0.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.3 -177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.473 ' CB ' HD11 ' A' ' 49' ' ' ILE . 53.4 m-85 -75.4 144.46 42.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.87 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.0 t -118.07 122.6 43.54 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 121.491 0.663 . . . . 0.0 110.949 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -102.46 125.06 8.38 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 113.534 -1.666 . . . . 0.0 110.447 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 75' ' ' SER . 6.5 p -157.76 158.72 35.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.106 0.479 . . . . 0.0 110.849 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.94 161.15 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.777 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -95.25 163.32 13.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.379 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.6 p -67.92 -7.45 28.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.355 177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' CB ' ' A' ' 71' ' ' SER . 14.4 m -82.38 -48.26 11.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.28 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 70' ' ' SER . 3.0 p 79.03 22.12 0.63 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.661 -175.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -88.34 -18.92 27.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.566 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 54.9 p -163.24 166.5 23.13 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.249 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.79 115.5 30.3 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.1 m -104.41 110.76 23.15 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.844 ' O ' HG23 ' A' ' 19' ' ' THR . 0.2 OUTLIER -102.68 140.42 36.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.725 -1.58 . . . . 0.0 115.252 169.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 64' ' ' SER . 98.3 m -104.76 128.11 52.77 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 162.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.542 ' CD1' HD21 ' A' ' 76' ' ' LEU . 2.8 mt -103.16 113.32 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 O-C-N 120.115 -1.616 . . . . 0.0 110.043 173.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.5 t -104.62 146.69 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.791 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.83 30.46 57.72 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.99 138.42 49.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.143 0.497 . . . . 0.0 110.518 176.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 84' ' ' GLU . 28.3 mttt -150.57 177.74 9.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.024 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.453 ' H ' HG23 ' A' ' 83' ' ' THR . 1.2 p -46.78 -17.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.387 174.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' A' ' 82' ' ' LYS . 15.6 pt-20 -69.2 -40.55 77.98 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.351 177.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.637 ' CB ' HH22 ' A' ' 62' ' ' ARG . 6.4 t70 -70.99 -8.6 54.45 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.458 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.656 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 57.5 tt0 -63.7 121.4 13.86 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.348 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 159.71 -175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.326 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.22 137.35 32.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.643 176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.587 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 17.1 m-85 -119.54 134.07 55.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.669 0.271 . . . . 0.0 110.876 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 90' ' ' TYR . 1.5 p90 -150.89 138.12 19.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.33 176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.3 p -118.79 140.43 49.97 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -173.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -114.5 148.64 37.58 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.824 -0.547 . . . . 0.0 109.714 -178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 53.6 p -135.23 152.17 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.914 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -159.04 138.98 11.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.302 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' NH2' ' A' ' 24' ' ' ARG . 13.5 m-20 -99.05 178.24 4.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.88 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -20.67 64.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.651 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 43.3 p -90.81 32.33 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.431 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.0 m120 57.27 -159.1 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.432 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.2 t60 75.55 69.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.375 0.607 . . . . 0.0 110.27 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.3 m -86.93 135.8 24.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.599 -178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.93 151.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -118.07 144.04 45.95 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.401 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.82 -149.96 6.74 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -178.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 75.28 24.29 71.46 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -64.57 98.27 0.27 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 59.0 m -129.77 118.16 21.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.855 0.36 . . . . 0.0 110.325 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -79.73 120.11 23.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.256 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.479 ' CD2' ' OD2' ' A' ' 85' ' ' ASP . 25.1 tp -109.29 123.26 48.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.208 177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.2 114.89 25.06 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' HG12 ' A' ' 110' ' ' VAL . 89.0 t -85.23 40.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.152 0.501 . . . . 0.0 110.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' A' ' 110' ' ' VAL . 10.2 mt . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.665 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 21.8 p90 -139.63 86.61 2.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.954 0.407 . . . . 0.0 110.555 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.508 ' H ' ' HB2' ' A' ' 25' ' ' SER . 77.4 mtm -147.66 166.46 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.441 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.1 mp -124.81 104.25 8.52 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.0 p -88.84 118.73 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.134 -179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.488 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.66 165.42 21.26 Favored Pre-proline 0 C--N 1.33 -0.261 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 106' ' ' THR . 4.4 Cg_exo -52.6 146.7 33.19 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.184 1.923 . . . . 0.0 111.36 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.9 p80 -79.29 -55.91 4.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.498 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 p -154.84 142.79 20.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 110.635 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.4 p -159.89 146.67 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.04 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.8 p -126.55 146.39 50.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.737 0.303 . . . . 0.0 110.464 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -132.77 150.2 52.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.231 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.13 139.19 72.39 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.99 124.44 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.144 1.229 . . . . 0.0 110.94 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 116.43 -11.66 16.4 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.244 -1.143 . . . . 0.0 110.244 177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -100.33 -171.57 2.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.774 0.321 . . . . 0.0 111.038 178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.7 p -125.39 159.56 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.349 -179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.4 p -147.11 153.6 12.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.982 0.42 . . . . 0.0 110.612 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.1 m -129.2 132.02 47.21 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.47 HD12 HD22 ' A' ' 76' ' ' LEU . 10.7 mt -98.86 149.43 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.075 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 m -124.96 117.32 23.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.943 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' SG ' HD23 ' A' ' 4' ' ' LEU . 4.0 t -119.72 120.58 37.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.6 m -119.49 142.04 48.64 Favored 'General case' 0 N--CA 1.462 0.15 0 O-C-N 120.017 -1.677 . . . . 0.0 108.752 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.615 ' HG3' HH11 ' A' ' 24' ' ' ARG . 7.3 mtm-85 -87.26 139.78 30.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.847 169.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.508 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.7 OUTLIER -60.38 1.19 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.43 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -103.24 -17.86 15.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.627 -175.768 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.92 -41.9 3.05 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.417 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 77.9 p -63.82 113.22 3.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.59 0.233 . . . . 0.0 110.824 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.779 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.6 pp -135.11 -60.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.524 -176.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.779 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.8 -0.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.638 ' H ' ' C ' ' A' ' 29' ' ' ILE . 53.5 m -109.29 -2.5 17.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.636 -1.62 . . . . 0.0 111.777 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 31' ' ' SER . 3.1 m120 -133.22 149.96 51.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.977 0.418 . . . . 0.0 110.287 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -81.86 135.26 35.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.437 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.576 ' CG2' HH22 ' A' ' 24' ' ' ARG . 17.5 t -127.61 139.03 53.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.459 ' C ' ' CD1' ' A' ' 36' ' ' TRP . 7.2 pt20 -116.96 164.29 14.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.186 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.534 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 8.8 m95 -134.96 125.13 26.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.684 0.278 . . . . 0.0 110.53 -177.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 28.0 m-85 -111.23 149.36 31.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.012 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -129.06 124.67 35.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -178.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.6 134.47 47.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.167 178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -125.73 149.55 65.82 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.206 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -54.51 130.54 40.6 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.482 1.455 . . . . 0.0 110.713 -175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.01 10.0 85.24 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 m -133.38 173.86 11.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.86 0.362 . . . . 0.0 110.6 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.94 165.37 12.99 Favored Pre-proline 0 C--N 1.33 -0.279 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.31 144.27 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 121.671 1.581 . . . . 0.0 111.263 178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 m -138.16 133.56 33.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.88 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.484 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 36.4 m -60.94 120.78 10.87 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG13 ' CD2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -96.13 -25.38 4.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.718 -178.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.444 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 19.9 mt -145.08 146.13 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 176.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' H ' HE21 ' A' ' 54' ' ' GLN . 10.4 t80 -132.12 167.26 20.06 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 175.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER 44.62 22.49 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.687 0.756 . . . . 0.0 110.933 -171.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 50' ' ' TYR . 1.1 p30 43.13 17.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.03 -177.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.563 ' N ' ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -129.4 -46.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 111.121 172.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.657 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 1.7 pp0? -87.93 147.62 24.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.193 -1.367 . . . . 0.0 108.713 -165.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.736 ' N ' ' HE ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -111.23 131.93 21.99 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -57.68 146.59 84.38 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 121.563 1.509 . . . . 0.0 111.183 174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -73.38 5.24 3.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.348 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.91 -26.55 11.39 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.67 151.68 45.56 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 119.454 -0.308 . . . . 0.0 110.302 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.93 143.78 95.84 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.662 1.575 . . . . 0.0 111.653 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -63.29 -2.75 1.55 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.722 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.523 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.4 mtp-105 -42.13 -38.65 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.068 -176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CD2' HG13 ' A' ' 48' ' ' VAL . 1.7 m-85 -76.29 137.5 39.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.193 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -129.29 123.07 30.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.314 178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.06 129.71 9.96 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 113.42 -1.718 . . . . 0.0 110.3 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 75' ' ' SER . 15.8 p -158.54 158.45 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.301 0.572 . . . . 0.0 111.198 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pt -134.39 160.85 41.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.641 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.84 153.31 23.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.017 -1.901 . . . . 0.0 112.664 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.97 -4.49 13.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.909 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 71' ' ' SER . 50.2 m -65.44 -46.19 80.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.135 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.77 24.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.506 -178.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -100.06 -37.68 8.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.999 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.709 ' C ' HD13 ' A' ' 29' ' ' ILE . 82.1 p -166.07 174.55 9.25 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.8 177.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.44 123.51 49.49 Favored 'General case' 0 C--N 1.33 -0.266 0 O-C-N 120.796 -1.19 . . . . 0.0 109.84 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.51 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.1 m -112.23 116.59 30.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 117.95 -1.024 . . . . 0.0 112.722 -170.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD22 HD12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -97.96 140.36 32.42 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 118.103 -2.873 . . . . 0.0 116.627 171.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.489 ' O ' ' CB ' ' A' ' 64' ' ' SER . 7.0 m -112.37 127.54 56.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 164.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.402 ' O ' HG22 ' A' ' 78' ' ' ILE . 3.1 mt -96.66 116.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 O-C-N 120.029 -1.669 . . . . 0.0 110.459 171.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.54 132.27 42.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.449 175.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' NE ' ' A' ' 62' ' ' ARG . . . 75.74 61.08 3.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.1 tt -78.52 130.82 36.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.995 0.426 . . . . 0.0 111.063 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -154.06 176.4 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.113 -179.204 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -45.85 -19.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.315 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 82' ' ' LYS . 45.8 mt-10 -71.83 -38.0 70.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.205 177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' LYS . 9.9 t70 -74.75 -13.06 60.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.121 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 84.2 tt0 -56.97 123.22 14.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.942 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.634 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 160.74 178.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.733 0.646 . . . . 0.0 109.791 176.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 85.4 m-20 -91.84 144.49 25.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.15 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 24.6 m-85 -110.8 151.17 28.12 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.986 0.422 . . . . 0.0 110.569 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 31.8 m-85 -149.44 138.35 21.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.653 178.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.488 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -120.95 140.7 51.5 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.597 0.635 . . . . 0.0 110.28 178.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -125.6 138.28 53.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.423 0.63 . . . . 0.0 111.165 170.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.57 ' CB ' ' NH1' ' A' ' 24' ' ' ARG . 17.7 p -135.26 171.04 15.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.758 -178.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -158.51 132.29 7.69 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -81.95 -179.63 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.039 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -59.68 -38.43 81.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.255 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.1 m -81.99 39.86 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.766 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 62.84 -107.88 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 -177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.66 80.54 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.696 0.284 . . . . 0.0 110.362 -178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.51 123.27 44.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.028 0.442 . . . . 0.0 110.149 177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 6.9 m -136.55 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.538 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 102' ' ' PHE . 8.4 p90 -112.95 137.2 51.69 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -170.05 -158.7 14.36 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.034 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.454 ' O ' ' OE1' ' A' ' 6' ' ' GLN . . . 78.97 48.62 6.88 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.38 91.84 1.16 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 4.2 m -106.88 141.46 38.06 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -102.98 99.91 9.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.49 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.3 tp -90.24 125.46 35.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.532 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.95 130.16 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.001 0.429 . . . . 0.0 110.162 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 82' ' ' LYS . 65.0 t -97.47 99.32 8.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.966 0.412 . . . . 0.0 110.527 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.407 179.708 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 2' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' N ' HD22 ' A' ' 1' ' ' ASN . 2.0 m-85 -131.54 106.86 8.47 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.4 mmm -137.84 168.93 18.68 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.08 105.98 9.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.081 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -77.3 115.1 16.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.723 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 2.7 mm-40 -142.34 158.21 61.37 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.438 0.461 . . . . 0.0 110.584 177.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.95 142.47 93.57 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.662 1.575 . . . . 0.0 110.426 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.617 ' CG ' ' N ' ' A' ' 9' ' ' SER . 9.5 p80 -65.86 -53.94 33.24 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.179 177.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.617 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 9.7 p -161.87 157.26 23.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.386 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.403 HG22 ' N ' ' A' ' 11' ' ' SER . 7.6 p -164.77 154.64 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.116 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.403 ' N ' HG22 ' A' ' 10' ' ' VAL . 9.6 p -122.5 135.63 54.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.796 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -122.08 143.59 49.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.483 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.43 153.06 94.01 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.421 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -67.18 118.41 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.193 1.262 . . . . 0.0 112.103 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.55 -13.57 20.64 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.584 -1.006 . . . . 0.0 110.584 176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -88.67 161.46 16.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.081 0.467 . . . . 0.0 110.559 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.9 p -98.62 138.41 35.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.695 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -127.32 141.66 45.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.383 -179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.704 HG23 ' O ' ' A' ' 76' ' ' LEU . 35.0 m -123.59 130.92 53.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.58 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.05 134.33 44.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.386 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.452 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 11.0 m -108.77 126.44 53.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.537 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.68 111.52 17.29 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.4 m -115.13 141.03 48.56 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 120.473 -1.392 . . . . 0.0 107.351 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 26' ' ' SER . 9.5 mmm-85 -93.7 139.87 30.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.264 170.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 78.8 p -60.53 1.08 0.14 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.371 175.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.619 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.49 -18.37 14.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.58 -173.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.73 -25.18 11.97 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 m -80.35 117.01 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.741 0.305 . . . . 0.0 111.312 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.759 HD13 ' C ' ' A' ' 73' ' ' SER . 1.3 pp -135.34 -64.32 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -67.27 -1.08 4.04 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' ILE . 4.3 t -97.56 -22.13 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.04 -1.891 . . . . 0.0 111.917 177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' CB ' HH12 ' A' ' 24' ' ' ARG . 12.8 m120 -118.51 148.51 42.54 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -175.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.47 137.72 42.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.989 -176.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.44 141.1 47.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.538 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.9 pt20 -119.7 153.26 35.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.963 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -117.76 128.79 55.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.083 0.468 . . . . 0.0 110.34 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.423 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 26.2 m-85 -132.6 149.88 52.24 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.68 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.43 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -121.09 128.79 52.92 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -108.46 129.74 55.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.274 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.6 142.7 19.57 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.607 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.82 147.36 95.49 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.117 1.878 . . . . 0.0 110.96 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.82 8.88 82.82 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.1 t -156.71 140.21 15.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.107 0.48 . . . . 0.0 110.506 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 156.36 81.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.465 -178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.14 142.7 65.9 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.281 1.987 . . . . 0.0 110.55 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -121.79 138.76 54.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.116 0.484 . . . . 0.0 110.451 178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.423 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 5.7 m -77.4 120.18 22.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.704 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.525 HG11 ' CD2' ' A' ' 63' ' ' PHE . 3.7 t -101.02 -28.24 3.28 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.832 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.2 mt -145.18 152.25 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 80.6 t80 -133.5 163.77 28.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.403 174.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.1 tt0 45.22 23.79 0.12 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.202 1.001 . . . . 0.0 110.44 -172.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 2.4 p30 44.59 19.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.668 -1.606 . . . . 0.0 109.964 -177.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.6 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -127.89 -41.38 1.64 Allowed 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 171.37 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.647 HE21 ' CA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.55 131.85 51.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 113.56 -1.654 . . . . 0.0 109.254 -167.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.772 HH21 ' H ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -117.31 108.89 42.96 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -70.99 145.29 49.66 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.707 1.605 . . . . 0.0 111.418 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 m -73.59 -24.46 60.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.56 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.56 -29.54 72.9 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -107.09 148.16 36.5 Favored Pre-proline 0 C--N 1.332 -0.19 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.442 ' C ' ' H ' ' A' ' 62' ' ' ARG . 5.6 Cg_exo -59.22 128.48 27.73 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.621 1.547 . . . . 0.0 110.655 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.99 -0.85 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.668 0.271 . . . . 0.0 111.708 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' A' ' 85' ' ' ASP . 33.1 mtp180 -43.94 -23.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.217 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' CD2' HG11 ' A' ' 48' ' ' VAL . 14.9 m-85 -79.49 140.79 37.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -127.32 122.84 34.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.919 0.39 . . . . 0.0 110.509 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.772 ' H ' HH21 ' A' ' 55' ' ' ARG . . . -100.1 124.81 8.36 Favored Glycine 0 CA--C 1.525 0.672 0 CA-C-N 113.558 -1.655 . . . . 0.0 110.124 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 75' ' ' SER . 10.1 p -159.67 165.65 32.2 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.211 -178.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.681 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -151.49 167.4 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.538 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 70' ' ' SER . 67.2 m-20 -104.1 153.03 21.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.815 174.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.1 m -69.89 13.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.103 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 68' ' ' ASP . 5.0 m -87.86 -41.5 13.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.453 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 m 79.15 27.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.077 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -98.46 -33.98 10.81 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.154 -173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.759 ' C ' HD13 ' A' ' 29' ' ' ILE . 90.9 p -165.36 168.62 16.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.753 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.05 130.83 55.48 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.832 -1.168 . . . . 0.0 109.641 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.481 ' O ' ' O ' ' A' ' 66' ' ' SER . 16.2 m -128.34 112.81 14.84 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -171.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.776 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.72 140.52 32.8 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 118.564 -2.585 . . . . 0.0 116.711 168.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.499 ' O ' ' CB ' ' A' ' 64' ' ' SER . 85.4 m -99.85 127.55 46.0 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 162.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.563 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.9 mt -107.9 106.69 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 O-C-N 120.107 -1.62 . . . . 0.0 109.701 172.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.4 p -102.29 154.95 18.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.968 0.413 . . . . 0.0 110.644 179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' C ' ' HE ' ' A' ' 62' ' ' ARG . . . 79.93 25.62 57.55 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -58.16 138.32 56.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.12 0.486 . . . . 0.0 110.706 176.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 85' ' ' ASP . 2.9 tttm -149.82 176.9 10.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.528 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 t -46.38 -21.33 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.45 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 82' ' ' LYS . 2.6 mt-10 -72.01 -38.51 69.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.549 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 62' ' ' ARG . 0.3 OUTLIER -70.63 -12.97 61.89 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -178.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 79.8 tt0 -52.76 122.72 9.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.364 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 164.42 -178.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.505 0.503 . . . . 0.0 109.874 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -90.95 132.39 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.72 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' OH ' ' OD1' ' A' ' 85' ' ' ASP . 16.2 m-85 -113.15 133.5 55.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -150.96 144.89 25.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.704 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.723 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.5 OUTLIER -118.53 143.25 46.88 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -177.061 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -117.06 149.11 40.84 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 121.031 0.443 . . . . 0.0 111.142 171.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.423 ' C ' ' CD2' ' A' ' 94' ' ' TYR . 23.2 t -135.19 163.96 28.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 0.0 111.6 -177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.538 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -158.75 135.05 9.2 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.207 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' OD1' ' NH2' ' A' ' 24' ' ' ARG . 96.5 m-20 -85.05 172.83 10.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.437 176.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 m -60.66 -35.24 75.75 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.126 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.6 p -80.11 34.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.447 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 67.05 -135.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.378 . . . . 0.0 111.156 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.7 m170 60.54 81.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.268 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.6 m -87.17 135.42 25.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.314 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.6 p -142.28 153.66 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -113.73 147.63 37.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.839 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -162.49 -160.88 11.48 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 106' ' ' THR . . . 80.73 18.94 69.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.55 85.11 0.01 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 104' ' ' GLY . 90.5 m -133.84 124.19 26.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.845 0.355 . . . . 0.0 110.237 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -89.93 127.31 35.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.0 tp -111.65 126.11 54.68 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.46 0.475 . . . . 0.0 110.365 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.7 m -120.99 128.82 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.001 0.429 . . . . 0.0 110.607 177.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' O ' ' OXT' ' A' ' 111' ' ' LEU . 64.0 t -93.7 104.22 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.998 0.428 . . . . 0.0 110.242 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.412 ' OXT' ' O ' ' A' ' 110' ' ' VAL . 9.5 mt . . . . . 0 C--O 1.221 -0.419 0 CA-C-O 117.849 -1.072 . . . . 0.0 110.75 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.785 HD22 ' N ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.785 ' N ' HD22 ' A' ' 1' ' ' ASN . 95.0 m-85 -144.6 83.34 1.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.648 0.261 . . . . 0.0 110.305 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 tpp -156.6 169.99 23.41 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.52 103.04 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -78.82 127.44 32.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.581 -176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.703 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 16.3 mt-30 -143.47 159.76 53.68 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -53.72 125.46 18.7 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.498 1.465 . . . . 0.0 110.64 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -60.56 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 p -156.74 153.22 28.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.62 154.89 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.693 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 52.0 p -130.4 145.77 51.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -135.37 162.51 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -91.5 148.68 37.98 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.577 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -60.55 118.34 5.2 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.438 1.425 . . . . 0.0 111.296 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.37 3.54 29.16 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 176.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -95.01 -173.41 2.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.016 0.436 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.1 p -122.65 142.5 50.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.145 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -132.73 145.07 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.751 HG23 ' O ' ' A' ' 76' ' ' LEU . 87.9 m -127.48 122.59 33.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.023 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.0 mt -103.36 135.99 38.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.913 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.1 m -106.19 135.61 47.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.335 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.703 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 4.1 m -118.72 115.63 24.89 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 175.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.0 m -118.92 140.0 50.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.631 ' C ' ' H ' ' A' ' 26' ' ' SER . 45.5 mtp180 -93.21 139.74 30.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.137 169.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.8 m -58.75 1.68 0.06 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.393 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.631 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -103.67 -18.07 14.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.789 -175.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 77.92 21.76 70.49 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 p -125.47 113.91 18.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.517 0.198 . . . . 0.0 110.731 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.1 pp -135.14 -63.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.902 -176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.682 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.88 -3.22 2.3 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' ILE . 38.6 m -92.98 -21.86 19.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.372 -2.194 . . . . 0.0 111.226 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -132.61 156.64 46.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.041 0.448 . . . . 0.0 110.065 -178.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 23.3 m-85 -82.04 145.11 30.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.42 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.91 146.76 31.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.219 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.756 HE22 ' N ' ' A' ' 37' ' ' TYR . 1.9 pp0? -117.1 163.06 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 27.5 m95 -132.98 126.46 32.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.994 0.426 . . . . 0.0 110.936 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.756 ' N ' HE22 ' A' ' 35' ' ' GLN . 4.6 m-85 -124.86 149.4 47.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.913 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 1.5 mm100 -124.64 131.02 53.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.26 137.9 52.72 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.83 149.82 21.72 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.49 140.22 93.07 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 121.564 1.509 . . . . 0.0 111.051 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.83 10.05 86.25 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -147.04 163.84 34.94 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.49 160.79 28.08 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.01 129.49 33.51 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.198 1.932 . . . . 0.0 110.777 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.7 m -125.31 116.56 22.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.915 0.388 . . . . 0.0 110.559 179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.444 ' N ' ' CE1' ' A' ' 37' ' ' TYR . 0.3 OUTLIER -62.13 122.29 15.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -178.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.1 t -100.78 -28.02 3.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.548 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.5 mt -145.02 148.91 17.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -138.3 143.49 40.0 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' A' ' 53' ' ' ASN . 8.5 tt0 57.68 23.57 9.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.454 1.121 . . . . 0.0 110.17 -173.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.4 t0 44.14 18.94 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.025 177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -128.6 -46.57 1.3 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.231 165.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.521 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -54.54 141.89 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.027 -1.897 . . . . 0.0 109.123 -168.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.52 ' N ' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -125.62 108.86 25.96 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 119.169 -0.444 . . . . 0.0 109.849 178.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.498 ' N ' HE22 ' A' ' 54' ' ' GLN . 2.8 Cg_exo -60.18 144.31 99.49 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.725 1.617 . . . . 0.0 111.575 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -70.64 -26.85 63.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.525 175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.14 -33.21 86.64 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.03 144.34 28.91 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 62' ' ' ARG . 3.3 Cg_exo -60.37 139.95 89.26 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.459 1.439 . . . . 0.0 110.771 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -60.97 0.95 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.658 HH22 ' CB ' ' A' ' 85' ' ' ASP . 35.7 ptt85 -50.55 -29.09 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.986 -175.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.572 ' CZ ' ' CZ ' ' A' ' 62' ' ' ARG . 63.0 m-85 -78.61 131.8 36.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.482 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 t -112.19 123.66 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.293 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.36 122.24 5.31 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 113.755 -1.566 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 75' ' ' SER . 5.9 p -154.97 156.49 36.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.181 0.515 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.58 HD13 ' HB1' ' A' ' 30' ' ' ALA . 2.4 pp -132.96 159.06 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.675 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -103.13 148.63 25.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.438 -1.255 . . . . 0.0 112.413 177.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.2 m -67.96 -6.43 22.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.386 175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.0 m -64.33 -42.64 96.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.916 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' GLY . 11.0 p 79.0 31.48 0.3 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.649 -175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -97.3 -43.64 7.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.403 -177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.605 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.1 p -167.11 168.35 13.69 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.325 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.71 122.79 47.45 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.8 m -114.52 112.89 23.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 117.664 -1.16 . . . . 0.0 112.684 -170.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.86 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -97.24 140.64 31.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 118.66 -2.525 . . . . 0.0 117.207 168.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.5 m -110.69 127.1 55.17 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 165.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.695 ' CD1' HD21 ' A' ' 76' ' ' LEU . 26.4 mm -93.84 113.09 27.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 O-C-N 120.057 -1.652 . . . . 0.0 110.887 171.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.76 129.22 45.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.523 0.201 . . . . 0.0 110.728 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.39 58.39 3.13 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.59 HD21 HG13 ' A' ' 110' ' ' VAL . 3.8 tt -75.16 138.61 42.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.952 0.406 . . . . 0.0 110.502 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 84' ' ' GLU . 16.5 mttt -144.74 175.66 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.802 177.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.447 HG23 ' H ' ' A' ' 83' ' ' THR . 1.1 p -45.99 -18.74 0.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.311 176.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' N ' ' O ' ' A' ' 82' ' ' LYS . 68.1 mm-40 -69.85 -38.36 76.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.461 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.658 ' CB ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -67.43 -6.91 21.39 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.529 -178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 21.9 tt0 -67.21 121.21 15.17 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.812 -0.355 . . . . 0.0 110.394 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.85 178.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.185 0.516 . . . . 0.0 110.176 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -87.4 134.15 33.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.596 176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.476 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 10.9 m-85 -113.56 132.79 55.58 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 2.9 p90 -151.25 151.87 32.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.55 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.422 ' O ' ' O ' ' A' ' 103' ' ' GLY . 28.3 p -132.62 143.4 49.65 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.159 -173.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.641 ' H ' ' HG3' ' A' ' 35' ' ' GLN . 7.3 mt-30 -115.3 147.29 40.6 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 121.12 -0.988 . . . . 0.0 110.573 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.413 ' O ' ' O ' ' A' ' 101' ' ' VAL . 78.7 p -135.21 118.93 17.13 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.939 0.399 . . . . 0.0 110.844 178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.412 ' O ' ' CD1' ' A' ' 94' ' ' TYR . 37.7 p90 -159.28 131.08 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.102 176.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.469 ' H ' HG21 ' A' ' 100' ' ' VAL . 0.8 OUTLIER -112.64 -159.98 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.986 -179.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 -12.7 46.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.038 -179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.2 m -90.02 0.31 57.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -176.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 53.44 -165.46 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.712 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.32 29.96 5.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 178.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -113.92 -171.52 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.722 -178.6 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 93' ' ' SER . 27.4 m -148.42 -178.63 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.019 0.437 . . . . 0.0 111.354 -178.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -151.27 163.43 38.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.043 178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 91' ' ' CYS . . . 141.09 -123.43 2.31 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.39 42.21 9.46 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.13 118.61 11.58 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 98.4 m -135.91 118.87 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.873 0.368 . . . . 0.0 110.478 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -88.06 115.89 25.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.615 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.2 tp -108.56 124.34 50.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.086 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 111' ' ' LEU . 55.4 m -117.42 113.7 22.45 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.767 ' O ' HG12 ' A' ' 110' ' ' VAL . 90.0 t -78.57 38.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.123 0.487 . . . . 0.0 110.36 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.512 ' H ' HG22 ' A' ' 109' ' ' THR . 6.3 mt . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 117.862 -1.066 . . . . 0.0 111.152 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.558 HD22 ' C ' ' A' ' 1' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -130.67 146.23 52.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 110.579 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.541 ' H ' ' HB2' ' A' ' 25' ' ' SER . 5.0 ptt? -157.03 169.64 24.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.031 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.698 HD12 ' NH1' ' A' ' 24' ' ' ARG . 0.6 OUTLIER -114.66 102.83 10.4 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.26 127.77 35.8 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.094 -0.643 . . . . 0.0 109.349 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.6 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.0 161.6 47.72 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.147 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 2.2 Cg_endo -47.73 136.43 21.79 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.477 2.118 . . . . 0.0 111.676 178.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -70.36 -45.35 66.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.845 -178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 p -157.56 157.15 33.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.375 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.06 125.99 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.647 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 63.5 p -108.0 130.37 55.06 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -119.45 164.92 15.04 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.7 m -96.6 143.44 26.13 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-O 119.663 -0.208 . . . . 0.0 110.448 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.09 115.07 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.44 1.427 . . . . 0.0 111.039 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.75 -10.77 21.17 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -91.85 -171.64 2.93 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.5 p -126.41 153.71 44.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.895 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.9 p -149.33 147.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.099 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 1.2 m -122.25 134.4 54.69 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.2 mm -98.88 128.64 50.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.7 m -102.38 120.53 40.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.6 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -118.7 111.84 19.02 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -178.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 87.7 m -119.07 142.17 48.11 Favored 'General case' 0 C--O 1.231 0.116 0 O-C-N 120.932 -1.105 . . . . 0.0 108.609 -177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' NH1' HD12 ' A' ' 4' ' ' LEU . 1.5 mmp_? -89.45 140.18 29.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.782 169.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.541 ' HB2' ' H ' ' A' ' 3' ' ' MET . 0.1 OUTLIER -59.05 -2.38 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.124 175.207 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.79 -18.18 14.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.072 -175.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 -36.26 3.72 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.2 m -66.78 110.73 3.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.641 0.258 . . . . 0.0 111.226 -176.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.761 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -135.13 -60.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.561 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.761 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -61.92 1.18 0.3 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.693 ' H ' ' C ' ' A' ' 29' ' ' ILE . 85.1 p -109.02 -26.61 10.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.744 -177.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.524 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -103.34 144.17 31.72 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -175.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -73.8 119.11 17.57 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG22 ' OG ' ' A' ' 93' ' ' SER . 93.3 t -121.47 143.25 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.782 0.801 . . . . 0.0 110.8 -175.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.539 ' NE2' ' OH ' ' A' ' 94' ' ' TYR . 3.6 pm0 -139.09 169.6 17.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.895 179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.6 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 64.5 m95 -125.74 128.26 47.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.207 0.527 . . . . 0.0 110.474 -177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -113.99 149.43 35.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.754 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.63 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.39 129.86 50.73 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.264 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 40' ' ' ARG . 5.7 tm0? -124.1 142.41 51.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.529 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -167.75 147.04 4.23 Favored Pre-proline 0 C--N 1.328 -0.347 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.159 177.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.43 148.89 69.28 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 121.222 1.281 . . . . 0.0 110.765 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.17 -17.26 48.38 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 176.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.46 ' OG ' ' N ' ' A' ' 44' ' ' SER . 39.8 t -153.44 -168.95 3.15 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.46 ' N ' ' OG ' ' A' ' 43' ' ' SER . 0.2 OUTLIER -111.16 161.27 25.84 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.1 143.52 73.75 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 121.807 1.671 . . . . 0.0 110.943 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -140.84 132.45 27.13 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.957 0.408 . . . . 0.0 110.873 178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.5 m -62.08 123.54 18.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.917 177.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 1.7 t -96.24 -27.96 3.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.306 -0.558 . . . . 0.0 109.524 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.7 mt -145.4 152.02 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 52' ' ' ASP . 31.2 t80 -132.87 163.26 29.5 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 174.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 53' ' ' ASN . 5.2 tt0 45.94 24.18 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.953 -173.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.3 OUTLIER 44.16 19.89 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.962 -177.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.564 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -128.04 -46.1 1.39 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.934 169.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.564 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.94 135.62 48.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 113.991 -1.459 . . . . 0.0 108.728 -168.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -130.48 108.66 16.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 119.239 -0.41 . . . . 0.0 110.261 177.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -67.17 143.23 64.05 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 121.873 1.715 . . . . 0.0 111.58 177.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.0 m -74.14 -18.54 60.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.011 175.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.66 -51.18 54.17 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -85.24 149.97 53.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -59.29 135.76 67.67 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 120.655 0.903 . . . . 0.0 110.171 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' PHE . 47.9 p30 -59.99 0.97 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.147 178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.782 HH12 ' N ' ' A' ' 85' ' ' ASP . 30.8 mtm105 -54.39 4.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.891 -177.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASP . 4.2 m-85 -118.47 143.38 46.75 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.21 -0.306 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 77' ' ' THR . 4.5 t -135.28 123.57 23.16 Favored 'General case' 0 C--O 1.224 -0.252 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.073 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.49 119.53 6.29 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.582 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 75' ' ' SER . 12.7 p -153.98 160.46 42.07 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.064 -178.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -142.34 163.89 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.119 -176.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 70' ' ' SER . 62.4 m-20 -108.72 146.35 33.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 113.216 -1.811 . . . . 0.0 112.507 177.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.9 p -67.98 2.73 1.89 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.372 . . . . 0.0 110.796 174.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' SER . 28.5 m -71.27 -42.38 68.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 80.83 27.89 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.566 -178.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -97.19 -43.6 7.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.671 ' C ' HD13 ' A' ' 29' ' ' ILE . 93.7 p -164.63 168.44 18.12 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.279 -0.569 . . . . 0.0 111.403 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.48 125.17 52.18 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 121.114 -0.991 . . . . 0.0 109.604 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' SER . 5.5 m -123.38 115.57 21.85 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.013 -0.994 . . . . 0.0 113.074 -169.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.651 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -95.02 140.58 29.78 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.806 -1.809 . . . . 0.0 115.758 169.765 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 64' ' ' SER . 1.0 OUTLIER -103.56 128.34 50.82 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.167 0.508 . . . . 0.0 112.185 166.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.54 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.1 mt -108.36 108.24 24.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 120.758 -1.213 . . . . 0.0 110.116 172.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.7 t -102.96 173.04 6.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.839 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 58.09 18.8 35.75 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 tt -47.16 143.38 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 85' ' ' ASP . 3.9 tttm -163.49 176.9 9.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.059 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 83' ' ' THR . 0.1 OUTLIER -45.96 -20.89 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.586 175.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 82' ' ' LYS . 97.2 mt-10 -71.85 -38.71 70.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.559 177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.782 ' N ' HH12 ' A' ' 62' ' ' ARG . 0.5 OUTLIER -73.09 -9.29 58.56 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.251 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.654 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 72.2 tt0 -58.41 122.26 12.86 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.851 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 161.7 -175.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.176 0.513 . . . . 0.0 110.668 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -91.28 136.13 33.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.949 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.63 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 22.3 m-85 -119.93 132.83 55.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.023 0.439 . . . . 0.0 110.809 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 6.1 p90 -151.21 154.98 37.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.391 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.6 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 4.6 m -117.9 141.59 48.27 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -172.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.41 ' O ' ' OE1' ' A' ' 35' ' ' GLN . 55.7 tt0 -117.44 121.52 41.28 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.857 -0.527 . . . . 0.0 109.669 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.561 ' OG ' HG22 ' A' ' 34' ' ' VAL . 0.6 OUTLIER -135.09 -177.19 4.53 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.333 -0.854 . . . . 0.0 110.365 -178.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' OH ' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -147.69 130.86 16.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.396 0.617 . . . . 0.0 110.629 175.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 97' ' ' SER . 34.2 t0 -131.67 -145.58 0.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.134 178.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.5 ' H ' ' CG ' ' A' ' 95' ' ' ASP . 0.2 OUTLIER -45.36 -12.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.019 176.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.53 ' H ' ' C ' ' A' ' 95' ' ' ASP . 32.2 m -81.01 -6.36 58.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.768 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 97' ' ' SER . 0.1 OUTLIER 61.76 109.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.005 177.277 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 37.97 40.28 0.29 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.668 173.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.668 ' O ' HG13 ' A' ' 100' ' ' VAL . 6.7 p -164.77 112.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.533 ' CG1' HH12 ' A' ' 24' ' ' ARG . 0.9 OUTLIER -176.87 140.62 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 170.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 11.8 p90 -165.29 161.12 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.159 176.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 157.55 -147.37 15.36 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.302 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.411 ' O ' ' CD ' ' A' ' 6' ' ' GLN . . . 62.15 52.49 49.45 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -75.42 102.96 1.54 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 42.1 m -106.84 126.34 52.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -88.22 98.36 11.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.172 -177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 44.0 tp -82.28 122.86 28.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.155 177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 5.3 m -120.73 117.33 27.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.992 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' A' ' 111' ' ' LEU . 95.2 t -81.85 93.53 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.148 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' C ' ' O ' ' A' ' 110' ' ' VAL . 12.2 mt . . . . . 0 C--O 1.22 -0.478 0 CA-C-O 117.599 -1.191 . . . . 0.0 111.898 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.583 HD22 ' C ' ' A' ' 1' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.6 ' CG ' ' NE2' ' A' ' 99' ' ' HIS . 1.1 m-85 -146.97 141.0 26.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.318 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.585 ' O ' ' N ' ' A' ' 25' ' ' SER . 50.0 mtt -151.24 170.52 19.27 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.493 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.06 118.75 15.0 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.587 178.503 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -71.86 134.43 46.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.235 -0.916 . . . . 0.0 109.629 -172.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.421 ' NE2' ' HB2' ' A' ' 91' ' ' CYS . 2.8 mm-40 -146.08 157.65 49.65 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.277 179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -56.08 168.67 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.218 1.946 . . . . 0.0 111.463 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.528 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -82.89 -66.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.163 179.667 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.418 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 9.6 m -165.04 162.85 20.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -165.5 150.1 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.599 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 97.6 p -130.2 128.32 41.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.137 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.98 162.57 18.31 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.487 ' H ' ' HD2' ' A' ' 16' ' ' LYS . 3.8 m -96.88 147.02 32.3 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.411 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -56.75 120.0 7.61 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.481 1.454 . . . . 0.0 111.106 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.84 4.96 27.71 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.487 ' HD2' ' H ' ' A' ' 13' ' ' SER . 61.8 mttm -101.66 -172.94 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.062 0.458 . . . . 0.0 111.209 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.4 p -126.58 145.11 50.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.29 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.3 p -140.02 141.74 33.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.707 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 m -123.11 130.27 52.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -103.73 135.49 41.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' O ' ' OE1' ' A' ' 6' ' ' GLN . 2.7 m -106.37 128.59 54.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.986 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 42.1 t -119.06 121.64 40.3 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.548 ' O ' ' N ' ' A' ' 5' ' ' THR . 91.9 m -125.96 131.1 52.33 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 -178.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 26' ' ' SER . 13.7 ttp180 -81.47 134.21 35.5 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.531 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 3' ' ' MET . 91.6 p -55.48 1.43 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.488 174.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.71 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.03 -18.05 14.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.19 -172.045 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.05 21.05 68.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.769 178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.54 111.24 14.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.2 0.5 . . . . 0.0 110.985 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.2 pp -135.34 -63.89 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.67 -177.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.726 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -64.04 0.21 0.97 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 34.6 m -109.27 -29.6 8.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 113.331 -1.759 . . . . 0.0 111.158 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.672 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.7 OUTLIER -116.81 155.05 29.64 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -177.082 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -73.15 125.52 27.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.926 -174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 t -121.03 148.15 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.917 -178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' OE1' ' CE1' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -142.0 160.41 40.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.339 -172.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -119.68 126.59 51.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.317 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.2 m-85 -108.01 149.11 28.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.866 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.478 ' OE1' ' CD1' ' A' ' 89' ' ' TYR . 0.6 OUTLIER -138.1 132.2 31.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.787 -178.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.611 ' NE2' ' N ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -133.53 146.61 51.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.753 177.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.611 ' N ' ' NE2' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -152.28 174.84 3.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -70.27 141.33 42.89 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.934 1.756 . . . . 0.0 111.61 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.36 0.75 82.14 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 p -154.02 176.32 12.35 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.2 163.09 24.75 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.486 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -55.26 138.77 80.28 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.558 2.172 . . . . 0.0 111.48 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -149.08 143.17 25.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.442 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.51 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 0.7 OUTLIER -71.88 126.27 29.32 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.946 178.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 63' ' ' PHE . 2.5 t -95.11 -26.66 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.4 mt -145.26 140.76 22.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 54' ' ' GLN . 50.2 t80 -127.66 152.96 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.357 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 53' ' ' ASN . 11.9 tt0 54.69 23.45 4.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.127 -170.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.8 t0 43.74 18.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.817 178.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.571 ' H ' ' C ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -128.44 -46.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.567 0.698 . . . . 0.0 109.5 167.409 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.504 ' NE2' ' C ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -62.69 114.63 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.893 -1.958 . . . . 0.0 108.758 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' HE ' ' CB ' ' A' ' 61' ' ' ASP . 25.4 ttp-105 -118.67 108.75 40.77 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -68.21 148.03 73.82 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.97 1.78 . . . . 0.0 111.57 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.3 p -74.12 -19.37 60.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.96 -46.89 92.61 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -87.5 148.72 44.93 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.496 ' C ' ' H ' ' A' ' 62' ' ' ARG . 4.8 Cg_exo -51.65 121.85 9.3 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.799 1.666 . . . . 0.0 111.675 -177.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' PHE . 38.6 p-10 -60.91 1.28 0.16 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.418 177.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.578 HH22 ' CG ' ' A' ' 85' ' ' ASP . 12.5 mtp-105 -64.53 16.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.446 -175.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASP . 14.4 m-85 -116.9 144.02 45.02 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -177.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.494 ' CB ' ' O ' ' A' ' 77' ' ' THR . 3.4 t -131.66 123.28 27.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.37 126.41 8.72 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.46 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 75' ' ' SER . 11.1 p -158.62 164.28 36.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.083 0.468 . . . . 0.0 111.257 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.6 pp -143.9 161.58 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.969 -178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -99.07 178.96 4.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.658 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 p -91.25 9.14 32.54 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.023 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' CB ' ' A' ' 71' ' ' SER . 18.5 m -83.12 -44.41 15.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.027 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 82.71 28.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.463 -176.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -100.07 -38.63 8.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.805 -176.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.642 ' C ' HD13 ' A' ' 29' ' ' ILE . 60.4 p -161.3 167.05 26.61 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.735 -177.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.88 124.74 50.55 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 121.013 -1.054 . . . . 0.0 109.576 -179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 66' ' ' SER . 6.3 m -115.21 112.64 22.79 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 118.29 -0.862 . . . . 0.0 112.702 -171.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.61 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -96.72 140.59 31.08 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 119.345 -2.097 . . . . 0.0 116.515 170.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.494 ' O ' ' CB ' ' A' ' 64' ' ' SER . 78.3 m -108.0 130.21 55.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.905 0.859 . . . . 0.0 113.153 163.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.548 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -108.13 113.55 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 O-C-N 120.381 -1.45 . . . . 0.0 109.915 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 t -99.24 168.0 10.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.085 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 59.2 38.38 93.1 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.494 HD21 HG13 ' A' ' 110' ' ' VAL . 3.5 tt -65.37 134.53 53.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.032 0.444 . . . . 0.0 110.97 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.567 ' C ' HG11 ' A' ' 110' ' ' VAL . 9.2 tttt -151.94 176.26 11.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.275 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.416 ' H ' HG22 ' A' ' 83' ' ' THR . 0.0 OUTLIER -45.91 -19.68 0.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.791 174.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' N ' ' C ' ' A' ' 82' ' ' LYS . 65.0 tt0 -74.55 -38.61 62.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.179 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.578 ' CG ' HH22 ' A' ' 62' ' ' ARG . 3.8 t70 -72.64 -11.41 60.63 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.9 -177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 76.7 tt0 -57.42 125.75 24.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.869 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.619 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.39 176.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -90.88 142.46 27.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.897 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.478 ' CD1' ' OE1' ' A' ' 38' ' ' GLN . 13.4 m-85 -113.99 147.62 38.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.569 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -146.48 154.13 41.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.631 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.421 ' HB2' ' NE2' ' A' ' 6' ' ' GLN . 42.2 t -127.66 140.66 51.95 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.639 ' NE2' ' N ' ' A' ' 93' ' ' SER . 8.8 tp60 -128.26 131.99 48.74 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.639 ' N ' ' NE2' ' A' ' 92' ' ' GLN . 35.4 p -134.99 145.19 47.87 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.054 -0.404 . . . . 0.0 111.172 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -154.79 150.65 27.76 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.149 179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -109.94 -165.66 1.03 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.937 177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 98' ' ' ASN . 6.0 m -72.37 -40.54 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.399 -0.818 . . . . 0.0 110.373 177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -76.28 38.64 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.432 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.437 ' H ' ' C ' ' A' ' 96' ' ' SER . 84.9 m-20 56.2 -114.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.567 -177.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.6 ' NE2' ' CG ' ' A' ' 2' ' ' PHE . 7.3 t-160 43.97 75.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.619 0.247 . . . . 0.0 110.477 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 94' ' ' TYR . 11.1 m -102.99 129.9 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.829 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.51 155.4 9.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.438 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -146.25 152.65 39.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.698 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.49 ' H ' HD11 ' A' ' 4' ' ' LEU . . . 178.25 -166.84 37.12 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.238 177.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.22 48.57 4.01 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.26 96.38 0.06 OUTLIER Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 53.1 m -105.27 116.33 31.76 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.45 123.94 30.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.027 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 62.1 tp -110.86 122.91 49.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.797 178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -116.23 120.28 38.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.803 178.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.735 ' O ' HG12 ' A' ' 110' ' ' VAL . 60.4 t -91.65 34.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.377 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.329 -0.844 . . . . 0.0 110.408 179.282 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 2' ' ' PHE . 3.7 t30 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.684 ' H ' ' ND2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER -142.35 106.88 4.82 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.5 mmm -148.12 169.29 20.31 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.78 103.05 7.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.68 121.75 25.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.597 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -143.78 -177.68 0.69 Allowed Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.8 Cg_exo -74.38 151.83 43.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.188 1.925 . . . . 0.0 111.658 178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.62 ' CG ' ' N ' ' A' ' 9' ' ' SER . 19.0 p-80 -82.44 -57.01 3.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.625 0.25 . . . . 0.0 111.182 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.62 ' N ' ' CG ' ' A' ' 8' ' ' HIS . 30.6 p -152.6 149.04 28.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 0.0 110.582 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -165.38 153.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.288 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.1 p -132.15 141.85 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.423 179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -131.81 158.1 42.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 m -76.74 148.9 80.09 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.79 -178.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -63.46 120.23 7.58 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.572 1.515 . . . . 0.0 112.044 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.14 -6.3 17.32 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.704 -0.959 . . . . 0.0 110.704 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -96.45 164.94 12.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.162 0.506 . . . . 0.0 111.147 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.5 p -95.52 132.3 40.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.065 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -122.51 135.16 63.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.079 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.417 HG23 ' O ' ' A' ' 76' ' ' LEU . 1.2 m -120.13 134.88 55.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.465 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.06 134.29 49.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.125 176.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -110.23 125.93 53.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.355 179.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.597 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 30.7 m -118.75 125.27 49.27 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.6 m -116.88 131.73 56.88 Favored 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.653 ' C ' ' H ' ' A' ' 26' ' ' SER . 41.7 ttt180 -83.86 136.54 34.08 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.301 171.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.5 m -58.6 2.68 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.554 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.653 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -104.9 -18.04 14.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.921 -174.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.17 -32.29 4.14 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.1 t -72.47 110.24 6.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.7 0.286 . . . . 0.0 110.935 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.778 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.5 pp -134.59 -60.53 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.588 -178.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.778 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -62.89 0.3 0.56 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.637 ' H ' ' C ' ' A' ' 29' ' ' ILE . 30.4 p -110.13 -26.98 9.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 113.449 -1.705 . . . . 0.0 111.358 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' ND2' HH11 ' A' ' 24' ' ' ARG . 98.3 m-20 -104.26 151.3 23.56 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -175.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -81.55 114.76 20.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -172.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -97.97 148.0 6.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 -177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.442 HE21 HG23 ' A' ' 47' ' ' THR . 18.7 tt0 -135.84 156.61 48.52 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.26 135.36 54.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.906 0.384 . . . . 0.0 110.427 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.544 ' O ' ' N ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -139.06 137.07 35.9 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.63 ' CD ' HG21 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -132.0 148.08 52.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.185 0.517 . . . . 0.0 110.098 176.073 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.73 140.01 47.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.219 178.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.448 ' N ' ' CD ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -114.98 148.27 40.16 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.8 Cg_exo -57.81 135.21 67.67 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.817 1.678 . . . . 0.0 111.261 -179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.83 -12.98 4.49 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 41' ' ' PRO . 1.8 t -120.67 150.8 40.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.038 0.447 . . . . 0.0 110.579 -178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.405 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -78.3 179.8 1.59 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.826 -176.388 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.3 Cg_exo -72.43 156.24 54.6 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.557 2.171 . . . . 0.0 112.039 176.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.402 ' C ' ' CE1' ' A' ' 37' ' ' TYR . 81.2 p -140.4 126.56 19.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.629 176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.491 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 64.6 m -61.14 121.14 11.75 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.726 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.63 HG21 ' CD ' ' A' ' 38' ' ' GLN . 40.4 t -101.36 -28.56 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.928 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.3 mt -145.63 146.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 172.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CG ' ' N ' ' A' ' 51' ' ' GLU . 70.8 t80 -132.99 159.16 40.82 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 174.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 53' ' ' ASN . 4.2 tt0 50.98 24.03 1.69 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 122.2 1.0 . . . . 0.0 110.361 -175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 38.5 t0 44.35 19.57 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.658 -1.156 . . . . 0.0 109.361 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -127.87 -46.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 170.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.519 ' NE2' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -55.29 140.46 39.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.909 -168.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 ttp180 -142.34 108.68 5.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 119.051 -0.5 . . . . 0.0 110.295 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -68.37 143.94 59.95 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 121.407 1.405 . . . . 0.0 111.992 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -69.64 -35.79 75.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.685 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.96 -50.58 26.85 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 178.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.0 m -91.54 139.51 25.12 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 62' ' ' ARG . 6.3 Cg_exo -57.83 137.18 79.77 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.137 1.225 . . . . 0.0 110.54 -176.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' C ' ' N ' ' A' ' 63' ' ' PHE . 4.0 p-10 -62.75 -0.89 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.61 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.552 HH22 ' CG ' ' A' ' 85' ' ' ASP . 17.9 mtp-105 -38.33 -24.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.495 -175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.545 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 7.2 m-85 -89.77 141.01 29.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.5 t -126.38 124.36 40.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.951 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -103.39 117.52 5.76 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.509 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 75' ' ' SER . 8.1 p -153.93 167.05 31.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.125 0.462 . . . . 0.0 110.722 -177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.691 ' C ' HD12 ' A' ' 67' ' ' ILE . 2.5 pp -149.14 160.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -101.15 153.75 19.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.605 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 94.0 p -68.09 -7.46 29.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.248 175.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' CB ' ' A' ' 71' ' ' SER . 5.7 m -61.96 -42.8 99.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.8 OUTLIER 80.84 27.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.481 -179.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -100.07 -38.25 8.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.786 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.698 ' C ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -166.28 171.41 12.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.042 177.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.04 135.41 48.65 Favored 'General case' 0 C--N 1.331 -0.234 0 O-C-N 120.784 -1.198 . . . . 0.0 109.467 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 66' ' ' SER . 4.9 m -130.42 115.69 17.21 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 117.794 -1.098 . . . . 0.0 112.825 -172.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -96.99 140.73 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 118.927 -2.358 . . . . 0.0 116.284 169.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 64' ' ' SER . 52.4 m -102.48 126.13 49.42 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.473 -0.767 . . . . 0.0 112.969 162.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.523 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.5 mt -105.25 103.46 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 O-C-N 120.79 -1.194 . . . . 0.0 109.788 172.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.4 m -98.98 154.31 18.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.841 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.21 17.25 78.43 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.91 131.91 22.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.981 0.42 . . . . 0.0 110.318 178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.49 ' C ' ' N ' ' A' ' 84' ' ' GLU . 26.6 mttt -148.99 176.09 10.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.818 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -46.03 -18.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.627 174.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' N ' ' C ' ' A' ' 82' ' ' LYS . 94.0 mt-10 -75.67 -37.0 59.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.326 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.552 ' CG ' HH22 ' A' ' 62' ' ' ARG . 6.9 t70 -74.3 -10.7 59.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.816 0.341 . . . . 0.0 110.189 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 38.8 tt0 -57.59 123.94 17.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.614 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.666 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 162.14 -175.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.922 177.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -89.11 150.01 22.92 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.59 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.563 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 19.1 m-85 -122.26 151.76 40.75 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 122.543 0.337 . . . . 0.0 110.526 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 37' ' ' TYR . 56.0 m-85 -150.45 137.37 19.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.427 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 16.2 p -118.9 140.66 49.61 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 117.951 0.341 . . . . 0.0 111.368 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -118.08 134.71 54.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -135.12 146.99 49.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.612 -178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -156.91 133.96 10.36 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -87.3 -175.87 5.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.193 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 98' ' ' ASN . 13.8 m -65.26 -41.98 93.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.959 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.3 m -77.72 37.89 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.492 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 98' ' ' ASN . 0.9 OUTLIER 70.21 -127.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.544 -178.725 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 64.59 78.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.914 0.388 . . . . 0.0 110.599 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 100' ' ' VAL . 2.6 m -89.15 119.32 36.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.37 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.9 m -141.49 141.22 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.233 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -154.1 161.39 41.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.359 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.37 -131.43 6.23 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 48.75 24.13 3.94 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -56.09 164.71 4.79 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 28.8 m -131.81 130.57 41.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.87 112.89 15.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.507 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.9 tp -105.83 124.45 49.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.116 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.2 m -117.62 124.76 49.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.119 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.8 t -91.07 99.21 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.204 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.887 178.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 12.9 t30 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -119.04 124.38 46.8 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.32 168.17 21.75 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.403 HD23 ' SG ' ' A' ' 22' ' ' CYS . 5.3 mp -133.78 103.87 6.05 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.6 p -90.41 135.35 33.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.825 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.662 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 30.5 mt-30 -136.55 163.42 49.94 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.829 177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -54.49 135.46 66.26 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.899 1.733 . . . . 0.0 110.817 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -41.49 -74.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 0.0 110.982 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.5 m -161.28 157.46 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.87 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.572 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -163.62 162.88 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.447 -178.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 10' ' ' VAL . 15.1 t -137.07 156.88 47.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.064 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -149.68 151.78 34.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.436 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -71.73 142.32 85.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.528 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.88 113.9 1.68 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.459 1.439 . . . . 0.0 111.176 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.82 1.34 22.74 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -94.9 -174.16 3.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.917 0.389 . . . . 0.0 111.004 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -113.44 127.81 56.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.138 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.37 144.06 27.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.5 m -130.58 131.45 45.0 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.97 140.17 28.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.303 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 m -113.88 120.08 39.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.363 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB2' HE21 ' A' ' 6' ' ' GLN . 31.9 t -120.75 123.6 43.08 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.6 m -119.69 142.09 48.8 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.019 -1.05 . . . . 0.0 108.278 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.605 ' C ' ' H ' ' A' ' 26' ' ' SER . 75.3 mtp85 -92.94 141.1 28.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.685 170.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 p -59.74 2.9 0.06 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.246 175.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.605 ' H ' ' C ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -105.09 -18.15 14.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.132 -175.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 71' ' ' SER . . . 74.3 8.93 80.68 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 31' ' ' SER . 6.7 t -110.85 105.46 14.29 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.786 -0.244 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -129.61 -63.05 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -176.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -63.53 -0.46 0.93 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.639 ' H ' ' C ' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -98.91 -27.05 14.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 113.524 -1.671 . . . . 0.0 110.719 -178.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' ND2' ' CG ' ' A' ' 95' ' ' ASP . 78.4 m-20 -131.71 152.22 51.05 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -71.07 149.09 46.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.676 -178.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.465 ' H ' ' HB2' ' A' ' 52' ' ' ASP . 17.1 t -125.5 148.21 30.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.504 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -120.24 155.41 33.26 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -120.97 131.04 54.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.054 0.454 . . . . 0.0 110.425 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.511 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 0.2 OUTLIER -127.91 146.19 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.391 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.84 136.66 48.87 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.796 ' NE2' ' H ' ' A' ' 44' ' ' SER . 7.2 tp-100 -120.49 121.75 39.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.348 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.503 ' NE ' ' OG ' ' A' ' 44' ' ' SER . 16.2 mtt180 -79.83 -168.67 0.19 Allowed Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 40' ' ' ARG . 5.6 Cg_exo -68.89 125.75 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 CA-C-N 121.419 1.542 . . . . 0.0 110.779 -169.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.12 -36.14 0.25 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 113.225 -1.807 . . . . 0.0 114.529 164.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.7 p -159.38 103.21 1.59 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 119.336 1.568 . . . . 0.0 112.762 171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.796 ' H ' ' NE2' ' A' ' 39' ' ' GLN . 26.0 t -170.7 92.35 0.47 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 119.462 1.028 . . . . 0.0 112.162 171.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.09 127.92 7.95 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.224 1.949 . . . . 0.0 111.456 175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.9 m -139.92 97.94 3.36 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 121.914 -0.491 . . . . 0.0 110.202 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.511 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 33.9 m -64.83 118.89 9.66 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.4 t -104.94 -28.41 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.199 -176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.44 151.47 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 173.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 54' ' ' GLN . 5.7 t80 -134.13 161.01 36.07 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 174.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' O ' ' N ' ' A' ' 53' ' ' ASN . 4.0 tt0 48.6 23.86 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.351 0.596 . . . . 0.0 111.217 -175.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' HB2' ' H ' ' A' ' 34' ' ' VAL . 35.0 t0 44.48 19.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.119 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.767 HD22 ' NE2' ' A' ' 54' ' ' GLN . 0.7 OUTLIER -127.93 -46.19 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.153 0.502 . . . . 0.0 109.825 170.483 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.767 ' NE2' HD22 ' A' ' 53' ' ' ASN . 0.0 OUTLIER -54.52 132.33 44.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.951 -168.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.8 ttp180 -134.64 108.63 10.97 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -70.08 149.09 64.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.964 1.776 . . . . 0.0 111.62 177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -71.55 -36.75 71.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.698 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.8 -50.76 42.48 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 59' ' ' VAL . 3.7 m -86.6 138.09 33.8 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 62' ' ' ARG . 2.5 Cg_endo -59.89 131.37 39.2 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 CA-C-N 119.88 0.993 . . . . 0.0 110.665 -177.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.563 ' C ' ' H ' ' A' ' 63' ' ' PHE . 25.6 p-10 -60.95 1.14 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 85' ' ' ASP . 13.6 mtm105 -46.65 -5.1 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.165 -175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 6.0 m-85 -107.19 137.45 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.888 0.375 . . . . 0.0 110.075 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 77' ' ' THR . 5.4 t -119.06 124.36 46.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.075 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -106.72 122.46 6.98 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 113.421 -1.718 . . . . 0.0 110.636 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 75' ' ' SER . 37.8 p -159.15 163.35 36.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.051 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.503 ' O ' HD12 ' A' ' 67' ' ' ILE . 1.2 pp -134.91 158.82 41.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.858 -177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 70' ' ' SER . 73.5 m-20 -98.62 148.96 23.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.864 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.22 30.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.892 178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.467 ' H ' ' C ' ' A' ' 68' ' ' ASP . 6.7 m -107.19 -40.46 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.765 -0.198 . . . . 0.0 110.537 -177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 70' ' ' SER . 0.7 OUTLIER 83.79 25.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.391 -179.637 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.46 -42.17 7.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.678 -177.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.611 ' O ' HD13 ' A' ' 29' ' ' ILE . 77.1 p -164.69 170.73 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.976 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.63 133.94 51.35 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 120.61 -1.306 . . . . 0.0 110.177 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 66' ' ' SER . 12.5 m -125.47 113.56 17.65 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.055 -0.974 . . . . 0.0 113.092 -171.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -98.44 140.6 32.46 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 118.591 -2.568 . . . . 0.0 116.994 170.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 64' ' ' SER . 19.5 m -105.1 125.53 51.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 163.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.644 ' CD1' HD21 ' A' ' 76' ' ' LEU . 38.4 mm -89.79 103.62 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 O-C-N 120.565 -1.334 . . . . 0.0 110.724 172.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.8 m -99.32 141.56 31.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.371 . . . . 0.0 111.486 175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 79.94 15.42 79.1 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tt -43.03 135.66 3.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.296 0.57 . . . . 0.0 110.461 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' C ' ' N ' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -144.04 176.06 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.302 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 83' ' ' THR . 0.7 OUTLIER -49.73 -19.06 0.56 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.432 175.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' OE1' ' NH2' ' A' ' 62' ' ' ARG . 3.2 tt0 -70.97 -42.02 70.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.352 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 4.6 m-20 -66.86 -7.07 19.12 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 119.936 -0.705 . . . . 0.0 110.22 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.649 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 33.0 tt0 -58.99 121.03 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.977 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 158.5 -175.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -93.0 147.36 22.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.21 177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.481 ' C ' ' CD1' ' A' ' 90' ' ' TYR . 17.6 m-85 -116.73 145.33 43.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.159 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.481 ' CD1' ' C ' ' A' ' 89' ' ' TYR . 14.0 m-85 -145.93 152.62 39.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.859 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.662 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -125.08 140.89 52.49 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -118.98 139.81 51.05 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.487 ' C ' ' CD1' ' A' ' 94' ' ' TYR . 2.4 m -135.09 158.29 44.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.974 0.416 . . . . 0.0 110.834 -177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 93' ' ' SER . 0.1 OUTLIER -157.25 138.21 13.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.435 -179.499 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.472 ' CG ' ' ND2' ' A' ' 32' ' ' ASN . 0.7 OUTLIER -106.18 -170.99 1.81 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.67 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' ASN . 2.9 m -62.17 -42.03 98.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.237 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.6 40.11 0.23 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.278 0.561 . . . . 0.0 110.146 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 96' ' ' SER . 1.1 m-80 54.64 -101.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.008 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 43.06 70.84 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.708 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -87.25 121.51 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.116 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.66 157.64 41.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.425 . . . . 0.0 110.619 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 1.9 p90 -134.23 142.7 47.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.074 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -178.83 -150.13 8.66 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.941 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 89' ' ' TYR . . . 86.1 35.91 10.58 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -58.36 110.08 2.3 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -142.13 137.79 31.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.769 0.319 . . . . 0.0 110.371 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -106.31 112.72 25.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.565 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.3 tp -103.11 125.93 50.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.085 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.88 125.19 48.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.8 t -96.21 103.21 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 110.494 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 117.897 -1.049 . . . . 0.0 111.209 179.069 . . . . . . . . 0 0 . 1 stop_ save_